Validation pour Ingenuity412

vers la météo de la validation par utilisateur

Ingenuity412

precedent - 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 - suivant

Phrase 71 - PMID ?

SB203580 in cell culture decreases production of SP NODE protein in Hela cells treated with agonist anti SP Apo 1 [NODE] protein antibody and with cycloheximide and with zVAD FMK and overproducing SP NODE protein .

Non annotée
Je ne sais pas
Je n'ai pas trouvé d'analyse satisfaisante

Commentaires :

Analyse 0

                              +----------------------------------------------------------------------------------------------COMP:V-N(with)----------------------------------------------------------------------------------------------+     
                              +--------------------------------------------------------------------------COMP:V-N(with)--------------------------------------------------------------------------+                                       |     
                              +---------------------------------------------------------------COMP:V-N(with)--------------------------------------------------------------+                      |                                       |     
                              +---------------------------------------COMP:V-N(with)--------------------------------------+                                               |                      |                                       |     
                              +---------------------COMP:V-N(in)--------------------+                                     |                                               |                      |                                       |     
                              |          +--------COMP:N-N(of)-------+              |             +----------------------OBJ:V-N----------------------+                   |                      |            +-------MOD_ATT:N-ADJ------+     
     +--MOD_ATT:N-N--+        |          |           +-MOD_ATT:N-ADJ-+              |             |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                      |            |          +-MOD_ATT:N-ADJ-+     
     |         +MOD_A+SUBJ:V-N+--OBJ:V-N-+           |       +MOD_ATT+         +MOD_+SUBJ:V+      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          |       +MOD_ATT+     
     |         |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,SB203580)
MOD_ATT:N-N (culture,cell)
SUBJ:V-N (decrease,culture)
OBJ:V-N (decrease,production)
COMP:V-N(in) (decrease,cell)
COMP:V-N(with) (decrease,Apo)
COMP:V-N(with) (decrease,cycloheximide)
COMP:V-N(with) (decrease,FMK)
COMP:V-N(with) (decrease,protein)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,antibody)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 1

                                                                                           +-------------------------------------------------------------COMP:V_PASS-N(with)-------------------------------------------------------------+     
                                                                                           +-----------------------------------------COMP:V_PASS-N(with)-----------------------------------------+                                       |     
                                                                                           +------------------------------COMP:V_PASS-N(with)-----------------------------+                      |                                       |     
                                                                                           |      +----------------------OBJ:V-N----------------------+                   |                      |                                       |     
                                         +--------COMP:N-N(of)-------+                     +------COMP:V_PASS-N(with)-----+                           |                   |                      |            +-------MOD_ATT:N-ADJ------+     
     +--MOD_ATT:N-N--+                   |           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                      |            |          +-MOD_ATT:N-ADJ-+     
     |         +MOD_A+SUBJ:V-N+--OBJ:V-N-+           |       +MOD_ATT+         +MOD_+SUBJ:V+      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          |       +MOD_ATT+     
     |         |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,SB203580)
MOD_ATT:N-N (culture,cell)
SUBJ:V-N (decrease,culture)
OBJ:V-N (decrease,production)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,Apo)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
COMP:V_PASS-N(with) (treat,protein)
OBJ:V-N (with,antibody)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 2

                                                                                           +-------------------------------------------------------------COMP:V_PASS-N(with)-------------------------------------------------------------+     
                                                                                           +-----------------------------------------COMP:V_PASS-N(with)-----------------------------------------+                                       |     
                                                                                           +------------------------------COMP:V_PASS-N(with)-----------------------------+                      |                                       |     
                                         +------------------SUBJ:V_PASS-N------------------+      +----------------------OBJ:V-N----------------------+                   |                      |                                       |     
                                         +--------COMP:N-N(of)-------+                     +------COMP:V_PASS-N(with)-----+                           |                   |                      |            +-------MOD_ATT:N-ADJ------+     
     +--MOD_ATT:N-N--+                   |           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                      |            |          +-MOD_ATT:N-ADJ-+     
     |         +MOD_A+SUBJ:V-N+--OBJ:V-N-+           |       +MOD_ATT+         +MOD_+      |      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          |       +MOD_ATT+     
     |         |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,SB203580)
MOD_ATT:N-N (culture,cell)
SUBJ:V-N (decrease,culture)
OBJ:V-N (decrease,production)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,production)
COMP:V_PASS-N(with) (treat,Apo)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
COMP:V_PASS-N(with) (treat,protein)
OBJ:V-N (with,antibody)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 3

                              +----------------------------------------------------------------------------------------------COMP:V-N(with)----------------------------------------------------------------------------------------------+     
                              +--------------------------------------------------------------------------COMP:V-N(with)--------------------------------------------------------------------------+                                       |     
                              +---------------------------------------------------------------COMP:V-N(with)--------------------------------------------------------------+                      |                                       |     
                              +---------------------------------------COMP:V-N(with)--------------------------------------+                                               |                      |                                       |     
                              |          +---------------COMP:N-N(in)---------------+                                     |                                               |                      |                                       |     
                              |          +--------COMP:N-N(of)-------+              |             +----------------------OBJ:V-N----------------------+                   |                      |            +-------MOD_ATT:N-ADJ------+     
     +--MOD_ATT:N-N--+        |          |           +-MOD_ATT:N-ADJ-+              |             |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                      |            |          +-MOD_ATT:N-ADJ-+     
     |         +MOD_A+SUBJ:V-N+--OBJ:V-N-+           |       +MOD_ATT+         +MOD_+SUBJ:V+      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          |       +MOD_ATT+     
     |         |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,SB203580)
MOD_ATT:N-N (culture,cell)
SUBJ:V-N (decrease,culture)
OBJ:V-N (decrease,production)
COMP:V-N(with) (decrease,Apo)
COMP:V-N(with) (decrease,cycloheximide)
COMP:V-N(with) (decrease,FMK)
COMP:V-N(with) (decrease,protein)
COMP:N-N(of) (production,protein)
COMP:N-N(in) (production,cell)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,antibody)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 4

                              +---------------------------------------------------------------------------------------------SUBJ:V-N---------------------------------------------------------------------------------------------+             
                              |                                                            +--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+       |             
                              +---------------------------OBJ:V-N--------------------------+--------------------------------COMP:V-N(with)--------------------------------+                                              |       |             
                              |          +---------------------SUBJ:V-N--------------------+      +----------------------OBJ:V-N----------------------+                   |                                              |       |             
     +-------MOD_ATT:N-N------+          +--------COMP:N-N(of)-------+                     +--------COMP:V-N(with)--------+                           |                   |                  +-------MOD_ATT:N-ADJ-------+       |             
     |         +--MOD_ATT:N-N-+          |           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                  |   +------MOD_ATT:N-N------+       |             
     |         |     +MOD_ATT:+          |           |       +MOD_ATT+         +MOD_+      |      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  |   |            +MOD_ATT:N-+       +OBJ:V-N+     
     |         |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (decrease,SB203580)
MOD_ATT:N-N (decrease,cell)
MOD_ATT:N-N (decrease,culture)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,decrease)
SUBJ:V-N (treat,production)
COMP:V-N(with) (treat,Apo)
COMP:V-N(with) (treat,cycloheximide)
COMP:V-N(with) (treat,__SP__)
OBJ:V-N (with,antibody)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,zVAD)
MOD_ATT:N-N (__SP__,FMK)
MOD_ATT:N-N (__SP__,overproduce)
SUBJ:V-N (__NODE__,decrease)
OBJ:V-N (__NODE__,protein)

Analyse 5

                                                                                           +----------------------------------------------------------------COMP:V-N(with)---------------------------------------------------------------+     
                                                                                           +--------------------------------------------COMP:V-N(with)-------------------------------------------+                                       |     
                                                                                           +--------------------------------COMP:V-N(with)--------------------------------+                      |                                       |     
                                                                                           |      +----------------------OBJ:V-N----------------------+                   |                      |                                       |     
                                         +--------COMP:N-N(of)-------+                     +--------COMP:V-N(with)--------+                           |                   |                      |            +-------MOD_ATT:N-ADJ------+     
     +--MOD_ATT:N-N--+                   |           +-MOD_ATT:N-ADJ-+-------OBJ:V-N-------+      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                      |            |          +-MOD_ATT:N-ADJ-+     
     |         +MOD_A+SUBJ:V-N+--OBJ:V-N-+           |       +MOD_ATT+COMP:N-N(+    +SUBJ:V+      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          |       +MOD_ATT+     
     |         |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,SB203580)
MOD_ATT:N-N (culture,cell)
SUBJ:V-N (decrease,culture)
OBJ:V-N (decrease,production)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,Hela)
OBJ:V-N (treat,protein)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,Apo)
COMP:V-N(with) (treat,cycloheximide)
COMP:V-N(with) (treat,FMK)
COMP:V-N(with) (treat,protein)
OBJ:V-N (with,antibody)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 6

                              +----------------------------------------------------------------------------------------------COMP:V-N(with)----------------------------------------------------------------------------------------------+     
                              +--------------------------------------------------------------------------COMP:V-N(with)--------------------------------------------------------------------------+                                       |     
                              +---------------------------------------------------------------COMP:V-N(with)--------------------------------------------------------------+                      |                                       |     
                              +---------------------------------------COMP:V-N(with)--------------------------------------+                                               |                      |                                       |     
                              |          +--------COMP:N-N(of)-------+                            +----------------------OBJ:V-N----------------------+                   |                      |            +-------MOD_ATT:N-ADJ------+     
     +--MOD_ATT:N-N--+        |          |           +-MOD_ATT:N-ADJ-+-------OBJ:V-N-------+      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                      |            |          +-MOD_ATT:N-ADJ-+     
     |         +MOD_A+SUBJ:V-N+--OBJ:V-N-+           |       +MOD_ATT+COMP:N-N(+    +SUBJ:V+      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          |       +MOD_ATT+     
     |         |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,SB203580)
MOD_ATT:N-N (culture,cell)
SUBJ:V-N (decrease,culture)
OBJ:V-N (decrease,production)
COMP:V-N(with) (decrease,Apo)
COMP:V-N(with) (decrease,cycloheximide)
COMP:V-N(with) (decrease,FMK)
COMP:V-N(with) (decrease,protein)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,Hela)
OBJ:V-N (treat,protein)
SUBJ:V-N (treat,cell)
OBJ:V-N (with,antibody)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 7

                                                                                           +----------------------------------------------------------------COMP:V-N(with)---------------------------------------------------------------+     
                                                                                           +--------------------------------------------COMP:V-N(with)-------------------------------------------+                                       |     
                                                                                           +--------------------------------COMP:V-N(with)--------------------------------+                      |                                       |     
                                         +---------------------OBJ:V-N---------------------+      +----------------------OBJ:V-N----------------------+                   |                      |                                       |     
                                         |                           +-------SUBJ:V-N------+--------COMP:V-N(with)--------+                           |                   |                      |            +-------MOD_ATT:N-ADJ------+     
     +--MOD_ATT:N-N--+                   |                           +-COMP:N-N(in)-+      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                      |            |          +-MOD_ATT:N-ADJ-+     
     |         +MOD_A+SUBJ:V-N+--OBJ:V-N-+COMP:N-N(of+       +MOD_ATT+         +MOD_+      |      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          |       +MOD_ATT+     
     |         |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,SB203580)
MOD_ATT:N-N (culture,cell)
SUBJ:V-N (decrease,culture)
OBJ:V-N (decrease,production)
COMP:N-N(of) (production,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,production)
SUBJ:V-N (treat,protein)
COMP:V-N(with) (treat,Apo)
COMP:V-N(with) (treat,cycloheximide)
COMP:V-N(with) (treat,FMK)
COMP:V-N(with) (treat,protein)
OBJ:V-N (with,antibody)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 8

                                                                                           +----------------------------------------------------------------COMP:V-N(with)---------------------------------------------------------------+     
                                                                                           +--------------------------------------------COMP:V-N(with)-------------------------------------------+                                       |     
                                         +---------------------OBJ:V-N---------------------+--------------------------------COMP:V-N(with)--------------------------------+                      |                                       |     
                                         +-------------COMP:N-N(in)------------+           |      +----------------------OBJ:V-N----------------------+                   |                      |                                       |     
                                         +--------COMP:N-N(of)-------+         |           +--------COMP:V-N(with)--------+                           |                   |                      |            +-------MOD_ATT:N-ADJ------+     
     +--MOD_ATT:N-N--+                   |           +-MOD_ATT:N-ADJ-+         |           |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                      |            |          +-MOD_ATT:N-ADJ-+     
     |         +MOD_A+SUBJ:V-N+--OBJ:V-N-+           |       +MOD_ATT+         |    +SUBJ:V+      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          |       +MOD_ATT+     
     |         |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,SB203580)
MOD_ATT:N-N (culture,cell)
SUBJ:V-N (decrease,culture)
OBJ:V-N (decrease,production)
COMP:N-N(of) (production,protein)
COMP:N-N(in) (production,Hela)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (treat,production)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,Apo)
COMP:V-N(with) (treat,cycloheximide)
COMP:V-N(with) (treat,FMK)
COMP:V-N(with) (treat,protein)
OBJ:V-N (with,antibody)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 9

                              +----------------------------------------------------------------------------------------------COMP:V-N(with)----------------------------------------------------------------------------------------------+     
                              +--------------------------------------------------------------------------COMP:V-N(with)--------------------------------------------------------------------------+                                       |     
                              +---------------------------------------------------------------COMP:V-N(with)--------------------------------------------------------------+                      |                                       |     
                              +---------------------------------------COMP:V-N(with)--------------------------------------+                                               |                      |                                       |     
                              |          +---------------------OBJ:V-N---------------------+                              |                                               |                      |                                       |     
                              |          |                           +-------SUBJ:V-N------+      +----------------------OBJ:V-N----------------------+                   |                      |            +-------MOD_ATT:N-ADJ------+     
     +--MOD_ATT:N-N--+        |          +----COMP:N-N(of)---+       +-COMP:N-N(in)-+      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                      |            |          +-MOD_ATT:N-ADJ-+     
     |         +MOD_A+SUBJ:V-N+--OBJ:V-N-+           +MOD_ATT+       |         +MOD_+      |      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          |       +MOD_ATT+     
     |         |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,SB203580)
MOD_ATT:N-N (culture,cell)
SUBJ:V-N (decrease,culture)
OBJ:V-N (decrease,production)
COMP:V-N(with) (decrease,Apo)
COMP:V-N(with) (decrease,cycloheximide)
COMP:V-N(with) (decrease,FMK)
COMP:V-N(with) (decrease,protein)
COMP:N-N(of) (production,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,production)
SUBJ:V-N (treat,protein)
OBJ:V-N (with,antibody)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 10

                              +---------------------------------------------------------------------------------------------SUBJ:V-N---------------------------------------------------------------------------------------------+             
                              |                                                            +--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+       |             
                              |                                                            +--------------------------------------------COMP:V-N(with)-------------------------------------------+                       |       |             
                              +---------------------------OBJ:V-N--------------------------+--------------------------------COMP:V-N(with)--------------------------------+                      |                       |       |             
                              |          +---------------------SUBJ:V-N--------------------+      +----------------------OBJ:V-N----------------------+                   |                      |                       |       |             
     +-------MOD_ATT:N-N------+          +--------COMP:N-N(of)-------+                     +--------COMP:V-N(with)--------+                           |                   |                      |                       |       |             
     |         +--MOD_ATT:N-N-+          |           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                      |                       |       |             
     |         |     +MOD_ATT:+          |           |       +MOD_ATT+         +MOD_+      |      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            +MOD_ATT:N-+       +OBJ:V-N+     
     |         |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (decrease,SB203580)
MOD_ATT:N-N (decrease,cell)
MOD_ATT:N-N (decrease,culture)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,decrease)
SUBJ:V-N (treat,production)
COMP:V-N(with) (treat,Apo)
COMP:V-N(with) (treat,cycloheximide)
COMP:V-N(with) (treat,FMK)
COMP:V-N(with) (treat,__SP__)
OBJ:V-N (with,antibody)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__SP__,overproduce)
SUBJ:V-N (__NODE__,decrease)
OBJ:V-N (__NODE__,protein)

Analyse 11

                              +--------------------------------------------------------------------------------------COMP:V-N(with)--------------------------------------------------------------------------------------+                     
                              +---------------------------------------------------------------COMP:V-N(with)--------------------------------------------------------------+                                              |                     
                              +---------------------------------------COMP:V-N(with)--------------------------------------+                                               |                                              |                     
                              |          +------------------SUBJ:V_PASS-N------------------+                              |                                               |             +---------------------OBJ:V-N--------------------+     
                              |          +--------COMP:N-N(of)-------+                     |      +----------------------OBJ:V-N----------------------+                   |             |    +-------MOD_ATT:N-ADJ-------+               |     
     +--MOD_ATT:N-N--+        |          |           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |             |    |   +------MOD_ATT:N-N------+               |     
     |         +MOD_A+SUBJ:V-N+--OBJ:V-N-+           |       +MOD_ATT+         +MOD_+      |      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |             |    |   |            +MOD_ATT:N-+       +MOD_ATT+     
     |         |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |             |    |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,SB203580)
MOD_ATT:N-N (culture,cell)
SUBJ:V-N (decrease,culture)
OBJ:V-N (decrease,production)
COMP:V-N(with) (decrease,Apo)
COMP:V-N(with) (decrease,cycloheximide)
COMP:V-N(with) (decrease,__SP__)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,production)
OBJ:V-N (with,antibody)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (__SP__,zVAD)
MOD_ATT:N-N (__SP__,FMK)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 12

                                                                                           +---------------------------------------------------------COMP:V_PASS-N(with)---------------------------------------------------------+             
                                                                                           +-----------------------------------------COMP:V_PASS-N(with)-----------------------------------------+                               |             
                                                                                           +------------------------------COMP:V_PASS-N(with)-----------------------------+                      |                               |             
                                                                                           |      +----------------------OBJ:V-N----------------------+                   |                      |                               |             
                                         +--------COMP:N-N(of)-------+----SUBJ:V_PASS-N----+------COMP:V_PASS-N(with)-----+                           |                   |             +---------------------OBJ:V-N--------------------+     
     +--MOD_ATT:N-N--+                   |           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |             |        |            +---MOD_ATT:N-ADJ--+       |     
     |         +MOD_A+SUBJ:V-N+--OBJ:V-N-+           |       +MOD_ATT+         +MOD_+      |      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |             |    +MOD+            |          +MOD_ATT+       |     
     |         |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |             |    |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,SB203580)
MOD_ATT:N-N (culture,cell)
SUBJ:V-N (decrease,culture)
OBJ:V-N (decrease,production)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,protein)
COMP:V_PASS-N(with) (treat,Apo)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
COMP:V_PASS-N(with) (treat,__NODE__)
OBJ:V-N (with,antibody)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__NODE__,overproduce)
MOD_ATT:N-ADJ (__NODE__,__SP__)

Analyse 13

                                                                                           +---------------------------------------------------------COMP:V_PASS-N(with)---------------------------------------------------------+             
                                                                                           +-----------------------------------------COMP:V_PASS-N(with)-----------------------------------------+                               |             
                                                                                           +------------------------------COMP:V_PASS-N(with)-----------------------------+                      |                               |             
                                         +---------------COMP:N-N(in)---------------+      |      +----------------------OBJ:V-N----------------------+                   |                      |                               |             
                                         +--------COMP:N-N(of)-------+              |      +------COMP:V_PASS-N(with)-----+                           |                   |             +---------------------OBJ:V-N--------------------+     
     +--MOD_ATT:N-N--+                   |           +-MOD_ATT:N-ADJ-+              |      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |             |        |            +---MOD_ATT:N-ADJ--+       |     
     |         +MOD_A+SUBJ:V-N+--OBJ:V-N-+           |       +MOD_ATT+         +MOD_+SUBJ:V+      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |             |    +MOD+            |          +MOD_ATT+       |     
     |         |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |             |    |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,SB203580)
MOD_ATT:N-N (culture,cell)
SUBJ:V-N (decrease,culture)
OBJ:V-N (decrease,production)
COMP:N-N(of) (production,protein)
COMP:N-N(in) (production,cell)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,Apo)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
COMP:V_PASS-N(with) (treat,__NODE__)
OBJ:V-N (with,antibody)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__NODE__,overproduce)
MOD_ATT:N-ADJ (__NODE__,__SP__)

Analyse 14

                                                                                           +---------------------------------------------------------COMP:V_PASS-N(with)---------------------------------------------------------+             
                                                                                           +-----------------------------------------COMP:V_PASS-N(with)-----------------------------------------+                               |             
                                                                                           +------------------------------COMP:V_PASS-N(with)-----------------------------+                      |                               |             
                                         +------------------SUBJ:V_PASS-N------------------+      +----------------------OBJ:V-N----------------------+                   |                      |                               |             
                                         +--------COMP:N-N(of)-------+                     +------COMP:V_PASS-N(with)-----+                           |                   |             +---------------------OBJ:V-N--------------------+     
     +--MOD_ATT:N-N--+                   |           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |             |        |            +---MOD_ATT:N-ADJ--+       |     
     |         +MOD_A+SUBJ:V-N+--OBJ:V-N-+           |       +MOD_ATT+         +MOD_+      |      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |             |    +MOD+            |          +MOD_ATT+       |     
     |         |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |             |    |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,SB203580)
MOD_ATT:N-N (culture,cell)
SUBJ:V-N (decrease,culture)
OBJ:V-N (decrease,production)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,production)
COMP:V_PASS-N(with) (treat,Apo)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
COMP:V_PASS-N(with) (treat,__NODE__)
OBJ:V-N (with,antibody)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__NODE__,overproduce)
MOD_ATT:N-ADJ (__NODE__,__SP__)

Analyse 15

                                                                                           +-----------------------------------------------------COMP:V_PASS-N(with)-----------------------------------------------------+                     
                                                                                           +-----------------------------------------COMP:V_PASS-N(with)-----------------------------------------+                       |                     
                                                                                           +------------------------------COMP:V_PASS-N(with)-----------------------------+                      |                       |                     
                                         +---------------COMP:N-N(in)---------------+      |      +----------------------OBJ:V-N----------------------+                   |                      |                       |                     
                                         +--------COMP:N-N(of)-------+              |      +------COMP:V_PASS-N(with)-----+                           |                   |                      |                       |                     
     +--MOD_ATT:N-N--+                   |           +-MOD_ATT:N-ADJ-+              |      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |             +---------------------OBJ:V-N--------------------+     
     |         +MOD_A+SUBJ:V-N+--OBJ:V-N-+           |       +MOD_ATT+         +MOD_+SUBJ:V+      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |             |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+     
     |         |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |             |    |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,SB203580)
MOD_ATT:N-N (culture,cell)
SUBJ:V-N (decrease,culture)
OBJ:V-N (decrease,production)
COMP:N-N(of) (production,protein)
COMP:N-N(in) (production,cell)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,Apo)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
COMP:V_PASS-N(with) (treat,__SP__)
OBJ:V-N (with,antibody)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 16

                              +--------------------------------------------------------------------------------------COMP:V-N(with)--------------------------------------------------------------------------------------+                     
                              +---------------------------------------------------------------COMP:V-N(with)--------------------------------------------------------------+                                              |                     
                              +---------------------------------------COMP:V-N(with)--------------------------------------+                                               |             +---------------------OBJ:V-N--------------------+     
                              |          +--------COMP:N-N(of)-------+----SUBJ:V_PASS-N----+      +----------------------OBJ:V-N----------------------+                   |             |    +-------MOD_ATT:N-ADJ-------+               |     
     +--MOD_ATT:N-N--+        |          |           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |             |    |   +------MOD_ATT:N-N------+               |     
     |         +MOD_A+SUBJ:V-N+--OBJ:V-N-+           |       +MOD_ATT+         +MOD_+      |      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |             |    |   |            +MOD_ATT:N-+       +MOD_ATT+     
     |         |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |             |    |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,SB203580)
MOD_ATT:N-N (culture,cell)
SUBJ:V-N (decrease,culture)
OBJ:V-N (decrease,production)
COMP:V-N(with) (decrease,Apo)
COMP:V-N(with) (decrease,cycloheximide)
COMP:V-N(with) (decrease,__SP__)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,protein)
OBJ:V-N (with,antibody)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (__SP__,zVAD)
MOD_ATT:N-N (__SP__,FMK)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 17

                              +------------------------------------------------------------------------------------------COMP:V-N(with)------------------------------------------------------------------------------------------+             
                              +--------------------------------------------------------------------------COMP:V-N(with)--------------------------------------------------------------------------+                               |             
                              +---------------------------------------------------------------COMP:V-N(with)--------------------------------------------------------------+                      |                               |             
                              +---------------------------------------COMP:V-N(with)--------------------------------------+                                               |                      |                               |             
                              |          +------------------SUBJ:V_PASS-N------------------+                              |                                               |                      |                               |             
                              |          +--------COMP:N-N(of)-------+                     |      +----------------------OBJ:V-N----------------------+                   |             +---------------------OBJ:V-N--------------------+     
     +--MOD_ATT:N-N--+        |          |           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |             |        |            +---MOD_ATT:N-ADJ--+       |     
     |         +MOD_A+SUBJ:V-N+--OBJ:V-N-+           |       +MOD_ATT+         +MOD_+      |      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |             |    +MOD+            |          +MOD_ATT+       |     
     |         |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |             |    |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,SB203580)
MOD_ATT:N-N (culture,cell)
SUBJ:V-N (decrease,culture)
OBJ:V-N (decrease,production)
COMP:V-N(with) (decrease,Apo)
COMP:V-N(with) (decrease,cycloheximide)
COMP:V-N(with) (decrease,FMK)
COMP:V-N(with) (decrease,__NODE__)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,production)
OBJ:V-N (with,antibody)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__NODE__,overproduce)
MOD_ATT:N-ADJ (__NODE__,__SP__)

Analyse 18

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                          +------------------------------------------------------------------SUBJ:V-N------------------------------------------------------------------+             
                                         |                                          |      +-----------------------------------------------------COMP:V_PASS-N(with)-----------------------------------------------------+       |             
                                         |                                          |      +-----------------------------------------COMP:V_PASS-N(with)-----------------------------------------+                       |       |             
                                         |                                          |      +------------------------------COMP:V_PASS-N(with)-----------------------------+                      |                       |       |             
                                         +-------------COMP:N-N(in)------------+    |      |      +----------------------OBJ:V-N----------------------+                   |                      |                       |       |             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+         |    |      +------COMP:V_PASS-N(with)-----+                           |                   |                      |                       |       |             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+         |    |      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                      |                       |       |             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         |    +SUBJ:V+      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            +MOD_ATT:N-+       +OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
COMP:N-N(in) (production,Hela)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,Apo)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
COMP:V_PASS-N(with) (treat,__SP__)
OBJ:V-N (with,antibody)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,production)
SUBJ:V-N (__NODE__,cell)
OBJ:V-N (__NODE__,protein)

Analyse 19

                                                                                           +-----------------------------------------------------COMP:V_PASS-N(with)-----------------------------------------------------+                     
                                                                                           +------------------------------COMP:V_PASS-N(with)-----------------------------+                                              |                     
                                                                                           |                                                                     +--------------------------------OBJ:V-N--------------------------------+     
                              +---------------------COMP:V-N(in)--------------------+      |      +----------------------OBJ:V-N----------------------+          |        |             +---------------------OBJ:V-N--------------------+     
                              |          +--------COMP:N-N(of)-------+              |      +------COMP:V_PASS-N(with)-----+                           |          |        |             |    +-------MOD_ATT:N-ADJ-------+               |     
     +--MOD_ATT:N-N--+        |          |           +-MOD_ATT:N-ADJ-+              |      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+          |        |             |    |   +------MOD_ATT:N-N------+               |     
     |         +MOD_A+SUBJ:V-N+--OBJ:V-N-+           |       +MOD_ATT+         +MOD_+SUBJ:V+      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+          |        |             |    |   |            +MOD_ATT:N-+       +MOD_ATT+     
     |         |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |          |        |             |    |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,SB203580)
MOD_ATT:N-N (culture,cell)
SUBJ:V-N (decrease,culture)
OBJ:V-N (decrease,production)
COMP:V-N(in) (decrease,cell)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,Apo)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,__SP__)
OBJ:V-N (with,antibody)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (with,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (__SP__,zVAD)
MOD_ATT:N-N (__SP__,FMK)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 20

                                                                                           +--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+                     
                                                                                           +--------------------------------------------COMP:V-N(with)-------------------------------------------+                       |                     
                                                                                           +--------------------------------COMP:V-N(with)--------------------------------+                      |                       |                     
                                                             +-----------OBJ:V-N-----------+      +----------------------OBJ:V-N----------------------+                   |                      |                       |                     
                                                             |       +-------SUBJ:V-N------+--------COMP:V-N(with)--------+                           |                   |                      |                       |                     
     +--MOD_ATT:N-N--+                   +----COMP:N-N(of)---+       +-COMP:N-N(in)-+      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |             +---------------------OBJ:V-N--------------------+     
     |         +MOD_A+SUBJ:V-N+--OBJ:V-N-+           +MOD_ATT+       |         +MOD_+      |      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |             |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+     
     |         |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |             |    |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,SB203580)
MOD_ATT:N-N (culture,cell)
SUBJ:V-N (decrease,culture)
OBJ:V-N (decrease,production)
COMP:N-N(of) (production,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__NODE__)
SUBJ:V-N (treat,protein)
COMP:V-N(with) (treat,Apo)
COMP:V-N(with) (treat,cycloheximide)
COMP:V-N(with) (treat,FMK)
COMP:V-N(with) (treat,__SP__)
OBJ:V-N (with,antibody)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 21

                              +--------------------------------------------------------------------------------------COMP:V-N(with)--------------------------------------------------------------------------------------+                     
                              +---------------------------------------------------------------COMP:V-N(with)--------------------------------------------------------------+                                              |                     
                              +---------------------------------------COMP:V-N(with)--------------------------------------+                                               |                                              |                     
                              |                      +---------------OBJ:V-N---------------+                              |                                               |             +---------------------OBJ:V-N--------------------+     
                              |                      |               +-------SUBJ:V-N------+      +----------------------OBJ:V-N----------------------+                   |             |    +-------MOD_ATT:N-ADJ-------+               |     
     +--MOD_ATT:N-N--+        |                      |               +-COMP:N-N(in)-+      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |             |    |   +------MOD_ATT:N-N------+               |     
     |         +MOD_A+SUBJ:V-N+--OBJ:V-N-+COMP:N-N(of+       +MOD_ATT+         +MOD_+      |      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |             |    |   |            +MOD_ATT:N-+       +MOD_ATT+     
     |         |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |             |    |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,SB203580)
MOD_ATT:N-N (culture,cell)
SUBJ:V-N (decrease,culture)
OBJ:V-N (decrease,production)
COMP:V-N(with) (decrease,Apo)
COMP:V-N(with) (decrease,cycloheximide)
COMP:V-N(with) (decrease,__SP__)
COMP:N-N(of) (production,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__SP__)
SUBJ:V-N (treat,protein)
OBJ:V-N (with,antibody)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (__SP__,zVAD)
MOD_ATT:N-N (__SP__,FMK)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 22

                              +------------------------COMP:V-N(in)------------------------+--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+                     
                              |          +---------------------SUBJ:V-N--------------------+--------------------------------COMP:V-N(with)--------------------------------+                                              |                     
                              |          +---------------COMP:N-N(in)---------------+      |      +----------------------OBJ:V-N----------------------+                   |             +---------------------OBJ:V-N--------------------+     
                              |          +--------COMP:N-N(of)-------+              |      +--------COMP:V-N(with)--------+                           |                   |             |    +-------MOD_ATT:N-ADJ-------+               |     
               +--MOD_ATT:N-N-+          |           +-MOD_ATT:N-ADJ-+              |      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |             |    |   +------MOD_ATT:N-N------+               |     
               |     +MOD_ATT:+          |           |       +MOD_ATT+         +MOD_+      |      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |             |    |   |            +MOD_ATT:N-+       +MOD_ATT+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |             |    |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (decrease,cell)
MOD_ATT:N-N (decrease,culture)
COMP:N-N(of) (production,protein)
COMP:N-N(in) (production,cell)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (cell,Hela)
COMP:V-N(in) (treat,decrease)
SUBJ:V-N (treat,production)
COMP:V-N(with) (treat,Apo)
COMP:V-N(with) (treat,cycloheximide)
COMP:V-N(with) (treat,__SP__)
OBJ:V-N (with,antibody)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (__SP__,zVAD)
MOD_ATT:N-N (__SP__,FMK)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 23

                                                                                           +----------------------------------------------------------------COMP:V-N(with)---------------------------------------------------------------+     
                                                                                           +--------------------------------------------COMP:V-N(with)-------------------------------------------+                                       |     
                                                                                           +--------------------------------COMP:V-N(with)--------------------------------+                      |                                       |     
                                         +-------------------COMP:V-N(in)------------------+      +----------------------OBJ:V-N----------------------+                   |                      |                                       |     
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+                     +--------COMP:V-N(with)--------+                           |                   |                      |            +-------MOD_ATT:N-ADJ------+     
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+         +COMP:V-N(in+      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                      |            |          +-MOD_ATT:N-ADJ-+     
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         |    +SUBJ:V+      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          |       +MOD_ATT+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:V-N(in) (treat,production)
COMP:V-N(in) (treat,Hela)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,Apo)
COMP:V-N(with) (treat,cycloheximide)
COMP:V-N(with) (treat,FMK)
COMP:V-N(with) (treat,protein)
OBJ:V-N (with,antibody)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 24

                                                                                           +--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+                     
                                                                                           +--------------------------------------------COMP:V-N(with)-------------------------------------------+                       |                     
                                                                                           +--------------------------------COMP:V-N(with)--------------------------------+                      |                       |                     
                                         +---------------------OBJ:V-N---------------------+      +----------------------OBJ:V-N----------------------+                   |                      |                       |                     
                                         |                           +-------SUBJ:V-N------+--------COMP:V-N(with)--------+                           |                   |                      |                       |                     
     +--MOD_ATT:N-N--+                   |                           +-COMP:N-N(in)-+      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |             +---------------------OBJ:V-N--------------------+     
     |         +MOD_A+SUBJ:V-N+--OBJ:V-N-+COMP:N-N(of+       +MOD_ATT+         +MOD_+      |      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |             |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+     
     |         |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |             |    |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,SB203580)
MOD_ATT:N-N (culture,cell)
SUBJ:V-N (decrease,culture)
OBJ:V-N (decrease,production)
COMP:N-N(of) (production,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,production)
SUBJ:V-N (treat,protein)
COMP:V-N(with) (treat,Apo)
COMP:V-N(with) (treat,cycloheximide)
COMP:V-N(with) (treat,FMK)
COMP:V-N(with) (treat,__SP__)
OBJ:V-N (with,antibody)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 25

                              +--------------------------------------------------------------------------------------COMP:V-N(with)--------------------------------------------------------------------------------------+                     
                              +--------------------------------------------------------------------------COMP:V-N(with)--------------------------------------------------------------------------+                       |                     
                              +---------------------------------------------------------------COMP:V-N(with)--------------------------------------------------------------+                      |                       |                     
                              +---------------------------------------COMP:V-N(with)--------------------------------------+                                               |                      |                       |                     
                              +---------------------COMP:V-N(in)--------------------+                                     |                                               |                      |                       |                     
                              |          +--------COMP:N-N(of)-------+              |             +----------------------OBJ:V-N----------------------+                   |                      |                       |                     
     +--MOD_ATT:N-N--+        |          |           +-MOD_ATT:N-ADJ-+              |             |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |             +---------------------OBJ:V-N--------------------+     
     |         +MOD_A+SUBJ:V-N+--OBJ:V-N-+           |       +MOD_ATT+         +MOD_+SUBJ:V+      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |             |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+     
     |         |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |             |    |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,SB203580)
MOD_ATT:N-N (culture,cell)
SUBJ:V-N (decrease,culture)
OBJ:V-N (decrease,production)
COMP:V-N(in) (decrease,cell)
COMP:V-N(with) (decrease,Apo)
COMP:V-N(with) (decrease,cycloheximide)
COMP:V-N(with) (decrease,FMK)
COMP:V-N(with) (decrease,__SP__)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,antibody)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 26

                                                                                           +--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+                     
                                                                                           +--------------------------------------------COMP:V-N(with)-------------------------------------------+                       |                     
                                         +---------------------OBJ:V-N---------------------+--------------------------------COMP:V-N(with)--------------------------------+                      |                       |                     
                                         +-------------COMP:N-N(in)------------+           |      +----------------------OBJ:V-N----------------------+                   |                      |                       |                     
                                         +--------COMP:N-N(of)-------+         |           +--------COMP:V-N(with)--------+                           |                   |                      |                       |                     
     +--MOD_ATT:N-N--+                   |           +-MOD_ATT:N-ADJ-+         |           |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |             +---------------------OBJ:V-N--------------------+     
     |         +MOD_A+SUBJ:V-N+--OBJ:V-N-+           |       +MOD_ATT+         |    +SUBJ:V+      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |             |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+     
     |         |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |             |    |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,SB203580)
MOD_ATT:N-N (culture,cell)
SUBJ:V-N (decrease,culture)
OBJ:V-N (decrease,production)
COMP:N-N(of) (production,protein)
COMP:N-N(in) (production,Hela)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (treat,production)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,Apo)
COMP:V-N(with) (treat,cycloheximide)
COMP:V-N(with) (treat,FMK)
COMP:V-N(with) (treat,__SP__)
OBJ:V-N (with,antibody)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 27

                                                                                           +--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+                     
                                                                                           +--------------------------------COMP:V-N(with)--------------------------------+                                              |                     
                                         +---------------------OBJ:V-N---------------------+      +----------------------OBJ:V-N----------------------+                   |             +---------------------OBJ:V-N--------------------+     
                                         +--------COMP:N-N(of)-------+                     +--------COMP:V-N(with)--------+                           |                   |             |    +-------MOD_ATT:N-ADJ-------+               |     
     +--MOD_ATT:N-N--+                   |           +-MOD_ATT:N-ADJ-+                     |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |             |    |   +------MOD_ATT:N-N------+               |     
     |         +MOD_A+SUBJ:V-N+--OBJ:V-N-+           |       +MOD_ATT+COMP:N-N(+    +SUBJ:V+      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |             |    |   |            +MOD_ATT:N-+       +MOD_ATT+     
     |         |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |             |    |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,SB203580)
MOD_ATT:N-N (culture,cell)
SUBJ:V-N (decrease,culture)
OBJ:V-N (decrease,production)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,Hela)
OBJ:V-N (treat,production)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,Apo)
COMP:V-N(with) (treat,cycloheximide)
COMP:V-N(with) (treat,__SP__)
OBJ:V-N (with,antibody)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (__SP__,zVAD)
MOD_ATT:N-N (__SP__,FMK)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 28

                                                                                           +----------------------------------------------------------------COMP:V-N(with)---------------------------------------------------------------+     
                                                                                           +--------------------------------------------COMP:V-N(with)-------------------------------------------+                                       |     
                                                                                           +--------------------------------COMP:V-N(with)--------------------------------+                      |                                       |     
                                         +-------------------COMP:V-N(in)------------------+      +----------------------OBJ:V-N----------------------+                   |                      |                                       |     
               +-------MOD_ATT:N-N-------+                           +-------SUBJ:V-N------+--------COMP:V-N(with)--------+                           |                   |                      |            +-------MOD_ATT:N-ADJ------+     
               |     +----MOD_ATT:N-N----+                           +-COMP:N-N(in)-+      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                      |            |          +-MOD_ATT:N-ADJ-+     
               |     |        +MOD_ATT:N-+COMP:N-N(of+       +MOD_ATT+         +MOD_+      |      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          |       +MOD_ATT+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
COMP:V-N(in) (treat,production)
SUBJ:V-N (treat,protein)
COMP:V-N(with) (treat,Apo)
COMP:V-N(with) (treat,cycloheximide)
COMP:V-N(with) (treat,FMK)
COMP:V-N(with) (treat,protein)
OBJ:V-N (with,antibody)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 29

                                                                                           +----------------------------------------------------------------COMP:V-N(with)---------------------------------------------------------------+     
                                                                                           +--------------------------------------------COMP:V-N(with)-------------------------------------------+                                       |     
                                                                                           +--------------------------------COMP:V-N(with)--------------------------------+                      |                                       |     
                                         +-------------------COMP:V-N(in)------------------+      +----------------------OBJ:V-N----------------------+                   |                      |                                       |     
               +-------MOD_ATT:N-N-------+                           +-------SUBJ:V-N------+--------COMP:V-N(with)--------+                           |                   |                      |            +-------MOD_ATT:N-ADJ------+     
               |     +----MOD_ATT:N-N----+----COMP:N-N(of)---+       +-COMP:N-N(in)-+      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                      |            |          +-MOD_ATT:N-ADJ-+     
               |     |        +MOD_ATT:N-+           +MOD_ATT+       |         +MOD_+      |      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          |       +MOD_ATT+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
COMP:V-N(in) (treat,production)
SUBJ:V-N (treat,protein)
COMP:V-N(with) (treat,Apo)
COMP:V-N(with) (treat,cycloheximide)
COMP:V-N(with) (treat,FMK)
COMP:V-N(with) (treat,protein)
OBJ:V-N (with,antibody)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 30

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                     +-------------------------------------------------------------------COMP:V-N(in)------------------------------------------------------------------+             
                                         |                                     |    +------------------------------------------------------------------SUBJ:V-N------------------------------------------------------------------+             
                                         |                                     |    |      +-----------------------------------------------------COMP:V_PASS-N(with)-----------------------------------------------------+       |             
                                         |                                     |    |      +------------------------------COMP:V_PASS-N(with)-----------------------------+                                              |       |             
                                         |                                     |    |      |      +----------------------OBJ:V-N----------------------+                   |                                              |       |             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+         |    |      +------COMP:V_PASS-N(with)-----+                           |                   |                  +-------MOD_ATT:N-ADJ-------+       |             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+         |    |      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                  |   +------MOD_ATT:N-N------+       |             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         |    +SUBJ:V+      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  |   |            +MOD_ATT:N-+       +OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,Apo)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,__SP__)
OBJ:V-N (with,antibody)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,zVAD)
MOD_ATT:N-N (__SP__,FMK)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(in) (__NODE__,Hela)
SUBJ:V-N (__NODE__,cell)
OBJ:V-N (__NODE__,protein)

Analyse 31

                     +------------------------------------------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------------------------------------------+             
                     |        +---------------------------------------------------------------------------------------------SUBJ:V-N---------------------------------------------------------------------------------------------+             
                     |        |                                                            +--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+       |             
                     |        |                                                            +--------------------------------------------COMP:V-N(with)-------------------------------------------+                       |       |             
                     |        +---------------------------OBJ:V-N--------------------------+--------------------------------COMP:V-N(with)--------------------------------+                      |                       |       |             
                     |        |          +---------------------SUBJ:V-N--------------------+      +----------------------OBJ:V-N----------------------+                   |                      |                       |       |             
                     |        |          +--------COMP:N-N(of)-------+                     +--------COMP:V-N(with)--------+                           |                   |                      |                       |       |             
                     |        |          |           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                      |                       |       |             
               +MOD_A+        |          |           |       +MOD_ATT+         +MOD_+      |      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            +MOD_ATT:N-+       +OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,decrease)
SUBJ:V-N (treat,production)
COMP:V-N(with) (treat,Apo)
COMP:V-N(with) (treat,cycloheximide)
COMP:V-N(with) (treat,FMK)
COMP:V-N(with) (treat,__SP__)
OBJ:V-N (with,antibody)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(in) (__NODE__,culture)
SUBJ:V-N (__NODE__,decrease)
OBJ:V-N (__NODE__,protein)

Analyse 32

                                                                                           +-----------------------------------------------------COMP:V_PASS-N(with)-----------------------------------------------------+                     
                                                                                           +-----------------------------------------COMP:V_PASS-N(with)-----------------------------------------+                       |                     
                                                                                           +------------------------------COMP:V_PASS-N(with)-----------------------------+                      |                       |                     
                                                                                           |      +----------------------OBJ:V-N----------------------+                   |                      |                       |                     
                                         +--------COMP:N-N(of)-------+                     +------COMP:V_PASS-N(with)-----+                           |          +--------------------------------OBJ:V-N--------------------------------+     
     +--MOD_ATT:N-N--+                   |           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+          |        |             +---------------------OBJ:V-N--------------------+     
     |         +MOD_A+SUBJ:V-N+--OBJ:V-N-+           |       +MOD_ATT+         +MOD_+SUBJ:V+      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+          |        |             |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+     
     |         |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |          |        |             |    |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,SB203580)
MOD_ATT:N-N (culture,cell)
SUBJ:V-N (decrease,culture)
OBJ:V-N (decrease,production)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,Apo)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
COMP:V_PASS-N(with) (treat,__SP__)
OBJ:V-N (with,antibody)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (with,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 33

                                                                                           +-----------------------------------------------------COMP:V_PASS-N(with)-----------------------------------------------------+                     
                                                                                           +-----------------------------------------COMP:V_PASS-N(with)-----------------------------------------+                       |                     
                                                                                           +------------------------------COMP:V_PASS-N(with)-----------------------------+                      |                       |                     
                                                                                           |      +----------------------OBJ:V-N----------------------+                   |                      |                       |                     
                                         +--------COMP:N-N(of)-------+----SUBJ:V_PASS-N----+------COMP:V_PASS-N(with)-----+                           |          +--------------------------------OBJ:V-N--------------------------------+     
     +--MOD_ATT:N-N--+                   |           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+          |        |             +---------------------OBJ:V-N--------------------+     
     |         +MOD_A+SUBJ:V-N+--OBJ:V-N-+           |       +MOD_ATT+         +MOD_+      |      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+          |        |             |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+     
     |         |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |          |        |             |    |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,SB203580)
MOD_ATT:N-N (culture,cell)
SUBJ:V-N (decrease,culture)
OBJ:V-N (decrease,production)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,protein)
COMP:V_PASS-N(with) (treat,Apo)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
COMP:V_PASS-N(with) (treat,__SP__)
OBJ:V-N (with,antibody)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (with,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 34

                              +--------------------------------------------------------------------------------------COMP:V-N(with)--------------------------------------------------------------------------------------+                     
                              +---------------------------------------------------------------COMP:V-N(with)--------------------------------------------------------------+                                              |                     
                              +---------------------------------------COMP:V-N(with)--------------------------------------+                                               |                                              |                     
                              |          +------------------SUBJ:V_PASS-N------------------+                              |                                      +--------------------------------OBJ:V-N--------------------------------+     
                              |          +---------------COMP:N-N(in)---------------+      |                              |                                      |        |             +---------------------OBJ:V-N--------------------+     
                              |          +--------COMP:N-N(of)-------+              |      |      +----------------------OBJ:V-N----------------------+          |        |             |    +-------MOD_ATT:N-ADJ-------+               |     
     +--MOD_ATT:N-N--+        |          |           +-MOD_ATT:N-ADJ-+              |      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+          |        |             |    |   +------MOD_ATT:N-N------+               |     
     |         +MOD_A+SUBJ:V-N+--OBJ:V-N-+           |       +MOD_ATT+         +MOD_+      |      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+          |        |             |    |   |            +MOD_ATT:N-+       +MOD_ATT+     
     |         |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |          |        |             |    |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,SB203580)
MOD_ATT:N-N (culture,cell)
SUBJ:V-N (decrease,culture)
OBJ:V-N (decrease,production)
COMP:V-N(with) (decrease,Apo)
COMP:V-N(with) (decrease,cycloheximide)
COMP:V-N(with) (decrease,__SP__)
COMP:N-N(of) (production,protein)
COMP:N-N(in) (production,cell)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,production)
OBJ:V-N (with,antibody)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (with,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (__SP__,zVAD)
MOD_ATT:N-N (__SP__,FMK)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 35

                                                                                           +-----------------------------------------------------COMP:V_PASS-N(with)-----------------------------------------------------+                     
                                                                                           +-----------------------------------------COMP:V_PASS-N(with)-----------------------------------------+                       |                     
                                                                                           +------------------------------COMP:V_PASS-N(with)-----------------------------+                      |                       |                     
                                                                                           |      +----------------------OBJ:V-N----------------------+                   |                      |                       |                     
                                         +--------COMP:N-N(of)-------+                     +------COMP:V_PASS-N(with)-----+                           |                   |                      |                       |                     
     +--MOD_ATT:N-N--+                   |           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |             +---------------------OBJ:V-N--------------------+     
     |         +MOD_A+SUBJ:V-N+--OBJ:V-N-+           |       +MOD_ATT+         +MOD_+SUBJ:V+      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |             |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+     
     |         |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |             |    |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,SB203580)
MOD_ATT:N-N (culture,cell)
SUBJ:V-N (decrease,culture)
OBJ:V-N (decrease,production)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,Apo)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
COMP:V_PASS-N(with) (treat,__SP__)
OBJ:V-N (with,antibody)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 36

                                                                                           +-----------------------------------------------------COMP:V_PASS-N(with)-----------------------------------------------------+                     
                                                                                           +-----------------------------------------COMP:V_PASS-N(with)-----------------------------------------+                       |                     
                                                                                           +------------------------------COMP:V_PASS-N(with)-----------------------------+                      |                       |                     
                                         +------------------SUBJ:V_PASS-N------------------+      +----------------------OBJ:V-N----------------------+                   |                      |                       |                     
                                         +--------COMP:N-N(of)-------+                     +------COMP:V_PASS-N(with)-----+                           |                   |             +---------------------OBJ:V-N--------------------+     
     +--MOD_ATT:N-N--+                   |           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |             |    +-------MOD_ATT:N-ADJ-------+               |     
     |         +MOD_A+SUBJ:V-N+--OBJ:V-N-+           |       +MOD_ATT+         +MOD_+      |      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |             |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+     
     |         |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |             |    |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,SB203580)
MOD_ATT:N-N (culture,cell)
SUBJ:V-N (decrease,culture)
OBJ:V-N (decrease,production)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,production)
COMP:V_PASS-N(with) (treat,Apo)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
COMP:V_PASS-N(with) (treat,__SP__)
OBJ:V-N (with,antibody)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__SP__,zVAD)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 37

                              +--------------------------------------------------------------------------------------COMP:V-N(with)--------------------------------------------------------------------------------------+                     
                              +--------------------------------------------------------------------------COMP:V-N(with)--------------------------------------------------------------------------+                       |                     
                              +---------------------------------------------------------------COMP:V-N(with)--------------------------------------------------------------+                      |                       |                     
                              +---------------------------------------COMP:V-N(with)--------------------------------------+                                               |                      |                       |                     
                              |          +--------COMP:N-N(of)-------+                            +----------------------OBJ:V-N----------------------+                   |             +---------------------OBJ:V-N--------------------+     
     +--MOD_ATT:N-N--+        |          |           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+             |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |             |    +-------MOD_ATT:N-ADJ-------+               |     
     |         +MOD_A+SUBJ:V-N+--OBJ:V-N-+           |       +MOD_ATT+         +MOD_+SUBJ:V+      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |             |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+     
     |         |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |             |    |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,SB203580)
MOD_ATT:N-N (culture,cell)
SUBJ:V-N (decrease,culture)
OBJ:V-N (decrease,production)
COMP:V-N(with) (decrease,Apo)
COMP:V-N(with) (decrease,cycloheximide)
COMP:V-N(with) (decrease,FMK)
COMP:V-N(with) (decrease,__SP__)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,antibody)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__SP__,zVAD)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 38

                              +----------------------------------------------------------------------------------------------COMP:V-N(with)----------------------------------------------------------------------------------------------+     
                              +--------------------------------------------------------------------------COMP:V-N(with)--------------------------------------------------------------------------+                                       |     
                              +---------------------------------------------------------------COMP:V-N(with)--------------------------------------------------------------+                      |                                       |     
                              +---------------------------------------COMP:V-N(with)--------------------------------------+                                               |                      |                                       |     
                              |          +--------COMP:N-N(of)-------+----SUBJ:V_PASS-N----+      +----------------------OBJ:V-N----------------------+                   |                      |            +--------MOD_ATT:N-N-------+     
     +--MOD_ATT:N-N--+        |          |           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                      |            |          +-MOD_ATT:N-ADJ-+     
     |         +MOD_A+SUBJ:V-N+--OBJ:V-N-+           |       +MOD_ATT+         +MOD_+      |      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          |       +MOD_ATT+     
     |         |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,SB203580)
MOD_ATT:N-N (culture,cell)
SUBJ:V-N (decrease,culture)
OBJ:V-N (decrease,production)
COMP:V-N(with) (decrease,Apo)
COMP:V-N(with) (decrease,cycloheximide)
COMP:V-N(with) (decrease,FMK)
COMP:V-N(with) (decrease,protein)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,protein)
OBJ:V-N (with,antibody)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 39

                                                                                           +-----------------------------------------------------COMP:V_PASS-N(with)-----------------------------------------------------+                     
                                                                                           +-----------------------------------------COMP:V_PASS-N(with)-----------------------------------------+                       |                     
                                                                                           +------------------------------COMP:V_PASS-N(with)-----------------------------+                      |                       |                     
                                                                                           |      +----------------------OBJ:V-N----------------------+                   |                      |                       |                     
                                         +--------COMP:N-N(of)-------+----SUBJ:V_PASS-N----+------COMP:V_PASS-N(with)-----+                           |                   |                      |                       |                     
     +--MOD_ATT:N-N--+                   |           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |             +---------------------OBJ:V-N--------------------+     
     |         +MOD_A+SUBJ:V-N+--OBJ:V-N-+           |       +MOD_ATT+         +MOD_+      |      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |             |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+     
     |         |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |             |    |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,SB203580)
MOD_ATT:N-N (culture,cell)
SUBJ:V-N (decrease,culture)
OBJ:V-N (decrease,production)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,protein)
COMP:V_PASS-N(with) (treat,Apo)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
COMP:V_PASS-N(with) (treat,__SP__)
OBJ:V-N (with,antibody)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 40

                                                                                           +-----------------------------------------------------COMP:V_PASS-N(with)-----------------------------------------------------+                     
                                                                                           +-----------------------------------------COMP:V_PASS-N(with)-----------------------------------------+                       |                     
                                                                                           +------------------------------COMP:V_PASS-N(with)-----------------------------+                      |                       |                     
                                         +------------------SUBJ:V_PASS-N------------------+      +----------------------OBJ:V-N----------------------+                   |                      |                       |                     
                                         +--------COMP:N-N(of)-------+                     +------COMP:V_PASS-N(with)-----+                           |                   |                      |                       |                     
     +--MOD_ATT:N-N--+                   |           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |             +---------------------OBJ:V-N--------------------+     
     |         +MOD_A+SUBJ:V-N+--OBJ:V-N-+           |       +MOD_ATT+         +MOD_+      |      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |             |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+     
     |         |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |             |    |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,SB203580)
MOD_ATT:N-N (culture,cell)
SUBJ:V-N (decrease,culture)
OBJ:V-N (decrease,production)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,production)
COMP:V_PASS-N(with) (treat,Apo)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
COMP:V_PASS-N(with) (treat,__SP__)
OBJ:V-N (with,antibody)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 41

                                                                                           +--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+                     
                                                                                           +--------------------------------------------COMP:V-N(with)-------------------------------------------+                       |                     
                                                                                           +--------------------------------COMP:V-N(with)--------------------------------+                      |                       |                     
     +------------MOD_ATT:N-N------------+---------------------SUBJ:V-N--------------------+      +----------------------OBJ:V-N----------------------+                   |                      |                       |                     
     |         +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+                     +--------COMP:V-N(with)--------+                           |                   |                      |                       |                     
     |         |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |             +---------------------OBJ:V-N--------------------+     
     |         |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+      |      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |             |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+     
     |         |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |             |    |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,SB203580)
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V-N (treat,production)
COMP:V-N(with) (treat,Apo)
COMP:V-N(with) (treat,cycloheximide)
COMP:V-N(with) (treat,FMK)
COMP:V-N(with) (treat,__SP__)
OBJ:V-N (with,antibody)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 42

                                                                                           +--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+                     
                                                                                           +--------------------------------COMP:V-N(with)--------------------------------+                                              |                     
     +------------MOD_ATT:N-N------------+---------------------SUBJ:V-N--------------------+      +----------------------OBJ:V-N----------------------+                   |             +---------------------OBJ:V-N--------------------+     
     |         +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+                     +--------COMP:V-N(with)--------+                           |                   |             |    +-------MOD_ATT:N-ADJ-------+               |     
     |         |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |             |    |   +------MOD_ATT:N-N------+               |     
     |         |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+      |      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |             |    |   |            +MOD_ATT:N-+       +MOD_ATT+     
     |         |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |             |    |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,SB203580)
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V-N (treat,production)
COMP:V-N(with) (treat,Apo)
COMP:V-N(with) (treat,cycloheximide)
COMP:V-N(with) (treat,__SP__)
OBJ:V-N (with,antibody)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (__SP__,zVAD)
MOD_ATT:N-N (__SP__,FMK)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 43

                              +--------------------------------------------------------------------------------------COMP:V-N(with)--------------------------------------------------------------------------------------+                     
                              +--------------------------------------------------------------------------COMP:V-N(with)--------------------------------------------------------------------------+                       |                     
                              +---------------------------------------------------------------COMP:V-N(with)--------------------------------------------------------------+                      |                       |                     
                              +---------------------------------------COMP:V-N(with)--------------------------------------+                                               |                      |                       |                     
                              |          +--------COMP:N-N(of)-------+                            +----------------------OBJ:V-N----------------------+                   |             +---------------------OBJ:V-N--------------------+     
     +--MOD_ATT:N-N--+        |          |           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+             |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |             |    +-------MOD_ATT:N-ADJ-------+               |     
     |         +MOD_A+SUBJ:V-N+--OBJ:V-N-+           |       +MOD_ATT+         +MOD_+SUBJ:V+      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |             |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+     
     |         |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |             |    |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,SB203580)
MOD_ATT:N-N (culture,cell)
SUBJ:V-N (decrease,culture)
OBJ:V-N (decrease,production)
COMP:V-N(with) (decrease,Apo)
COMP:V-N(with) (decrease,cycloheximide)
COMP:V-N(with) (decrease,FMK)
COMP:V-N(with) (decrease,__SP__)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,antibody)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__SP__,zVAD)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 44

                                                                                           +------------------------------------------------------------COMP:V-N(with)-----------------------------------------------------------+             
                                                                                           +--------------------------------------------COMP:V-N(with)-------------------------------------------+                               |             
                                                                                           +--------------------------------COMP:V-N(with)--------------------------------+                      |                               |             
     +------------MOD_ATT:N-N------------+---------------------SUBJ:V-N--------------------+      +----------------------OBJ:V-N----------------------+                   |                      |                               |             
     |         +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+                     +--------COMP:V-N(with)--------+                           |                   |             +---------------------OBJ:V-N--------------------+     
     |         |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |             |        |            +---MOD_ATT:N-ADJ--+       |     
     |         |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+      |      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |             |    +MOD+            |          +MOD_ATT+       |     
     |         |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |             |    |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,SB203580)
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V-N (treat,production)
COMP:V-N(with) (treat,Apo)
COMP:V-N(with) (treat,cycloheximide)
COMP:V-N(with) (treat,FMK)
COMP:V-N(with) (treat,__NODE__)
OBJ:V-N (with,antibody)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__NODE__,overproduce)
MOD_ATT:N-ADJ (__NODE__,__SP__)

Analyse 45

                                                                                           +-------------------------------------------------------------COMP:V_PASS-N(with)-------------------------------------------------------------+     
                                                                                           +-----------------------------------------COMP:V_PASS-N(with)-----------------------------------------+                                       |     
                                                                                           +------------------------------COMP:V_PASS-N(with)-----------------------------+                      |                                       |     
                                         +------------------SUBJ:V_PASS-N------------------+      +----------------------OBJ:V-N----------------------+                   |                      |                                       |     
                                         +--------COMP:N-N(of)-------+                     +------COMP:V_PASS-N(with)-----+                           |                   |                      |            +--------MOD_ATT:N-N-------+     
     +--MOD_ATT:N-N--+                   |           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                      |            |          +-MOD_ATT:N-ADJ-+     
     |         +MOD_A+SUBJ:V-N+--OBJ:V-N-+           |       +MOD_ATT+         +MOD_+      |      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          |       +MOD_ATT+     
     |         |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,SB203580)
MOD_ATT:N-N (culture,cell)
SUBJ:V-N (decrease,culture)
OBJ:V-N (decrease,production)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,production)
COMP:V_PASS-N(with) (treat,Apo)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
COMP:V_PASS-N(with) (treat,protein)
OBJ:V-N (with,antibody)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 46

                              +-----------------------------------------------------------------------------------------SUBJ:V-N-----------------------------------------------------------------------------------------+                     
                              |                                                            +--------------------------------------------------COMP:V-N(with)--------------------------------------------------+          |                     
                              |                                                            +--------------------------------------------COMP:V-N(with)-------------------------------------------+            |          |                     
                              +---------------------------OBJ:V-N--------------------------+--------------------------------COMP:V-N(with)--------------------------------+                      |            |          |                     
                              |          +---------------------SUBJ:V-N--------------------+      +----------------------OBJ:V-N----------------------+                   |                      |            |          |                     
     +-------MOD_ATT:N-N------+          +--------COMP:N-N(of)-------+                     +--------COMP:V-N(with)--------+                           |                   |                      |            |          |                     
     |         +--MOD_ATT:N-N-+          |           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+          +----OBJ:V-N----+     
     |         |     +MOD_ATT:+          |           |       +MOD_ATT+         +MOD_+      |      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          |       +MOD_ATT+     
     |         |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (decrease,SB203580)
MOD_ATT:N-N (decrease,cell)
MOD_ATT:N-N (decrease,culture)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,decrease)
SUBJ:V-N (treat,production)
COMP:V-N(with) (treat,Apo)
COMP:V-N(with) (treat,cycloheximide)
COMP:V-N(with) (treat,FMK)
COMP:V-N(with) (treat,overproduce)
OBJ:V-N (with,antibody)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
SUBJ:V-N (__SP__,decrease)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 47

                                                                                           +--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+                     
                                                                                           +--------------------------------COMP:V-N(with)--------------------------------+                                              |                     
                                                                                           |                                                                     +--------------------------------OBJ:V-N--------------------------------+     
                                                                                           |      +----------------------OBJ:V-N----------------------+          |        |             +---------------------OBJ:V-N--------------------+     
                                         +--------COMP:N-N(of)-------+                     +--------COMP:V-N(with)--------+                           |          |        |             |    +-------MOD_ATT:N-ADJ-------+               |     
     +--MOD_ATT:N-N--+                   |           +-MOD_ATT:N-ADJ-+-------OBJ:V-N-------+      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+          |        |             |    |   +------MOD_ATT:N-N------+               |     
     |         +MOD_A+SUBJ:V-N+--OBJ:V-N-+           |       +MOD_ATT+COMP:N-N(+    +SUBJ:V+      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+          |        |             |    |   |            +MOD_ATT:N-+       +MOD_ATT+     
     |         |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |          |        |             |    |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,SB203580)
MOD_ATT:N-N (culture,cell)
SUBJ:V-N (decrease,culture)
OBJ:V-N (decrease,production)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,Hela)
OBJ:V-N (treat,protein)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,Apo)
COMP:V-N(with) (treat,cycloheximide)
COMP:V-N(with) (treat,__SP__)
OBJ:V-N (with,antibody)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (with,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (__SP__,zVAD)
MOD_ATT:N-N (__SP__,FMK)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 48

                                                                                           +--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+                     
                                                                                           +--------------------------------COMP:V-N(with)--------------------------------+                                              |                     
                                                                                           |                                                                     +--------------------------------OBJ:V-N--------------------------------+     
                                                             +-----------OBJ:V-N-----------+      +----------------------OBJ:V-N----------------------+          |        |             +---------------------OBJ:V-N--------------------+     
                                                             |       +-------SUBJ:V-N------+--------COMP:V-N(with)--------+                           |          |        |             |    +-------MOD_ATT:N-ADJ-------+               |     
     +--MOD_ATT:N-N--+                   +----COMP:N-N(of)---+       +-COMP:N-N(in)-+      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+          |        |             |    |   +------MOD_ATT:N-N------+               |     
     |         +MOD_A+SUBJ:V-N+--OBJ:V-N-+           +MOD_ATT+       |         +MOD_+      |      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+          |        |             |    |   |            +MOD_ATT:N-+       +MOD_ATT+     
     |         |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |          |        |             |    |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,SB203580)
MOD_ATT:N-N (culture,cell)
SUBJ:V-N (decrease,culture)
OBJ:V-N (decrease,production)
COMP:N-N(of) (production,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__NODE__)
SUBJ:V-N (treat,protein)
COMP:V-N(with) (treat,Apo)
COMP:V-N(with) (treat,cycloheximide)
COMP:V-N(with) (treat,__SP__)
OBJ:V-N (with,antibody)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (with,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (__SP__,zVAD)
MOD_ATT:N-N (__SP__,FMK)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 49

                                                                                           +--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+                     
                                                                                           +--------------------------------------------COMP:V-N(with)-------------------------------------------+                       |                     
                                                                                           +--------------------------------COMP:V-N(with)--------------------------------+                      |                       |                     
                                         +---------------------OBJ:V-N---------------------+      +----------------------OBJ:V-N----------------------+                   |                      |                       |                     
                                         |                           +-------SUBJ:V-N------+--------COMP:V-N(with)--------+                           |          +--------------------------------OBJ:V-N--------------------------------+     
     +--MOD_ATT:N-N--+                   +----COMP:N-N(of)---+       +-COMP:N-N(in)-+      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+          |        |             +---------------------OBJ:V-N--------------------+     
     |         +MOD_A+SUBJ:V-N+--OBJ:V-N-+           +MOD_ATT+       |         +MOD_+      |      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+          |        |             |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+     
     |         |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |          |        |             |    |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,SB203580)
MOD_ATT:N-N (culture,cell)
SUBJ:V-N (decrease,culture)
OBJ:V-N (decrease,production)
COMP:N-N(of) (production,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,production)
SUBJ:V-N (treat,protein)
COMP:V-N(with) (treat,Apo)
COMP:V-N(with) (treat,cycloheximide)
COMP:V-N(with) (treat,FMK)
COMP:V-N(with) (treat,__SP__)
OBJ:V-N (with,antibody)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (with,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 50

                                                                                           +--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+                     
                                                                                           +--------------------------------COMP:V-N(with)--------------------------------+                                              |                     
                              +------------------------COMP:V-N(in)------------------------+                                                                     +--------------------------------OBJ:V-N--------------------------------+     
                              |          +---------------------SUBJ:V-N--------------------+      +----------------------OBJ:V-N----------------------+          |        |             +---------------------OBJ:V-N--------------------+     
                              |          +--------COMP:N-N(of)-------+                     +--------COMP:V-N(with)--------+                           |          |        |             |    +-------MOD_ATT:N-ADJ-------+               |     
               +--MOD_ATT:N-N-+          |           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+          |        |             |    |   +------MOD_ATT:N-N------+               |     
               |     +MOD_ATT:+          |           |       +MOD_ATT+         +MOD_+      |      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+          |        |             |    |   |            +MOD_ATT:N-+       +MOD_ATT+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |          |        |             |    |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (decrease,cell)
MOD_ATT:N-N (decrease,culture)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
COMP:V-N(in) (treat,decrease)
SUBJ:V-N (treat,production)
COMP:V-N(with) (treat,Apo)
COMP:V-N(with) (treat,cycloheximide)
COMP:V-N(with) (treat,__SP__)
OBJ:V-N (with,antibody)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (with,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (__SP__,zVAD)
MOD_ATT:N-N (__SP__,FMK)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 51

                                                                                           +------------------------------------------------------------COMP:V-N(with)-----------------------------------------------------------+             
                                                                                           +--------------------------------------------COMP:V-N(with)-------------------------------------------+                               |             
                                                                                           +--------------------------------COMP:V-N(with)--------------------------------+                      |                               |             
                                         +---------------------OBJ:V-N---------------------+      +----------------------OBJ:V-N----------------------+          +--------------------------------OBJ:V-N--------------------------------+     
                                         |                           +-------SUBJ:V-N------+--------COMP:V-N(with)--------+                           |          |        |             +---------------------OBJ:V-N--------------------+     
     +--MOD_ATT:N-N--+                   |                           +-COMP:N-N(in)-+      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+          |        |             |        |            +---MOD_ATT:N-ADJ--+       |     
     |         +MOD_A+SUBJ:V-N+--OBJ:V-N-+COMP:N-N(of+       +MOD_ATT+         +MOD_+      |      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+          |        |             |    +MOD+            |          +MOD_ATT+       |     
     |         |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |          |        |             |    |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,SB203580)
MOD_ATT:N-N (culture,cell)
SUBJ:V-N (decrease,culture)
OBJ:V-N (decrease,production)
COMP:N-N(of) (production,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,production)
SUBJ:V-N (treat,protein)
COMP:V-N(with) (treat,Apo)
COMP:V-N(with) (treat,cycloheximide)
COMP:V-N(with) (treat,FMK)
COMP:V-N(with) (treat,__NODE__)
OBJ:V-N (with,antibody)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (with,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__NODE__,overproduce)
MOD_ATT:N-ADJ (__NODE__,__SP__)

Analyse 52

                              +--------------------------------------------------------------------------------------COMP:V-N(with)--------------------------------------------------------------------------------------+                     
                              +--------------------------------------------------------------------------COMP:V-N(with)--------------------------------------------------------------------------+                       |                     
                              +---------------------------------------------------------------COMP:V-N(with)--------------------------------------------------------------+                      |                       |                     
                              +---------------------------------------COMP:V-N(with)--------------------------------------+                                               |                      |                       |                     
                              |                      +---------------OBJ:V-N---------------+                              |                                               |                      |                       |                     
                              |                      |               +-------SUBJ:V-N------+      +----------------------OBJ:V-N----------------------+                   |                      |                       |                     
     +--MOD_ATT:N-N--+        |                      |               +-COMP:N-N(in)-+      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |             +---------------------OBJ:V-N--------------------+     
     |         +MOD_A+SUBJ:V-N+--OBJ:V-N-+COMP:N-N(of+       +MOD_ATT+         +MOD_+      |      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |             |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+     
     |         |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |             |    |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,SB203580)
MOD_ATT:N-N (culture,cell)
SUBJ:V-N (decrease,culture)
OBJ:V-N (decrease,production)
COMP:V-N(with) (decrease,Apo)
COMP:V-N(with) (decrease,cycloheximide)
COMP:V-N(with) (decrease,FMK)
COMP:V-N(with) (decrease,__SP__)
COMP:N-N(of) (production,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__SP__)
SUBJ:V-N (treat,protein)
OBJ:V-N (with,antibody)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 53

                              +------------------------------------------------------------------------------------------COMP:V-N(with)------------------------------------------------------------------------------------------+             
                              +--------------------------------------------------------------------------COMP:V-N(with)--------------------------------------------------------------------------+                               |             
                              +---------------------------------------------------------------COMP:V-N(with)--------------------------------------------------------------+                      |                               |             
                              +---------------------------------------COMP:V-N(with)--------------------------------------+                                               |                      |                               |             
                              |          +---------------------OBJ:V-N---------------------+                              |                                      +--------------------------------OBJ:V-N--------------------------------+     
                              |          +--------COMP:N-N(of)-------+                     |      +----------------------OBJ:V-N----------------------+          |        |             +---------------------OBJ:V-N--------------------+     
     +--MOD_ATT:N-N--+        |          |           +-MOD_ATT:N-ADJ-+                     |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+          |        |             |        |            +---MOD_ATT:N-ADJ--+       |     
     |         +MOD_A+SUBJ:V-N+--OBJ:V-N-+           |       +MOD_ATT+COMP:N-N(+    +SUBJ:V+      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+          |        |             |    +MOD+            |          +MOD_ATT+       |     
     |         |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |          |        |             |    |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,SB203580)
MOD_ATT:N-N (culture,cell)
SUBJ:V-N (decrease,culture)
OBJ:V-N (decrease,production)
COMP:V-N(with) (decrease,Apo)
COMP:V-N(with) (decrease,cycloheximide)
COMP:V-N(with) (decrease,FMK)
COMP:V-N(with) (decrease,__NODE__)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,Hela)
OBJ:V-N (treat,production)
SUBJ:V-N (treat,cell)
OBJ:V-N (with,antibody)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (with,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__NODE__,overproduce)
MOD_ATT:N-ADJ (__NODE__,__SP__)

Analyse 54

                                                                                           +--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+                     
                                         +-------------------COMP:V-N(in)------------------+--------------------------------COMP:V-N(with)--------------------------------+                                              |                     
                                         +-------------COMP:N-N(in)------------+           |      +----------------------OBJ:V-N----------------------+                   |             +---------------------OBJ:V-N--------------------+     
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+         |           +--------COMP:V-N(with)--------+                           |                   |             |    +-------MOD_ATT:N-ADJ-------+               |     
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+         |           |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |             |    |   +------MOD_ATT:N-N------+               |     
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         |    +SUBJ:V+      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |             |    |   |            +MOD_ATT:N-+       +MOD_ATT+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |             |    |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
COMP:N-N(in) (production,Hela)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:V-N(in) (treat,production)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,Apo)
COMP:V-N(with) (treat,cycloheximide)
COMP:V-N(with) (treat,__SP__)
OBJ:V-N (with,antibody)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (__SP__,zVAD)
MOD_ATT:N-N (__SP__,FMK)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 55

                                                                                           +--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+                     
                                                                                           +--------------------------------------------COMP:V-N(with)-------------------------------------------+                       |                     
                                                                                           +--------------------------------COMP:V-N(with)--------------------------------+                      |                       |                     
                                                                                           |      +----------------------OBJ:V-N----------------------+                   |                      |                       |                     
                                         +--------COMP:N-N(of)-------+                     +--------COMP:V-N(with)--------+                           |                   |             +---------------------OBJ:V-N--------------------+     
     +--MOD_ATT:N-N--+                   |           +-MOD_ATT:N-ADJ-+-------OBJ:V-N-------+      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |             |    +-------MOD_ATT:N-ADJ-------+               |     
     |         +MOD_A+SUBJ:V-N+--OBJ:V-N-+           |       +MOD_ATT+COMP:N-N(+    +SUBJ:V+      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |             |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+     
     |         |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |             |    |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,SB203580)
MOD_ATT:N-N (culture,cell)
SUBJ:V-N (decrease,culture)
OBJ:V-N (decrease,production)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,Hela)
OBJ:V-N (treat,protein)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,Apo)
COMP:V-N(with) (treat,cycloheximide)
COMP:V-N(with) (treat,FMK)
COMP:V-N(with) (treat,__SP__)
OBJ:V-N (with,antibody)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__SP__,zVAD)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 56

                                                                                           +------------------------------------------------------------COMP:V-N(with)-----------------------------------------------------------+             
                     +-----------------------------COMP:V-N(in)----------------------------+--------------------------------------------COMP:V-N(with)-------------------------------------------+                               |             
                     |                   +---------------------SUBJ:V-N--------------------+--------------------------------COMP:V-N(with)--------------------------------+                      |                               |             
                     |                   +---------------COMP:N-N(in)---------------+      |      +----------------------OBJ:V-N----------------------+                   |                      |                               |             
                     |                   +--------COMP:N-N(of)-------+              |      +--------COMP:V-N(with)--------+                           |                   |             +---------------------OBJ:V-N--------------------+     
                     |                   |           +-MOD_ATT:N-ADJ-+              |      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |             |        |            +---MOD_ATT:N-ADJ--+       |     
               +MOD_A+        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+      |      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |             |    +MOD+            |          +MOD_ATT+       |     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |             |    |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
COMP:N-N(in) (production,cell)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (cell,Hela)
COMP:V-N(in) (treat,culture)
SUBJ:V-N (treat,production)
COMP:V-N(with) (treat,Apo)
COMP:V-N(with) (treat,cycloheximide)
COMP:V-N(with) (treat,FMK)
COMP:V-N(with) (treat,__NODE__)
OBJ:V-N (with,antibody)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__NODE__,overproduce)
MOD_ATT:N-ADJ (__NODE__,__SP__)

Analyse 57

                              +--------------------------------------------------------------------------------------COMP:V-N(with)--------------------------------------------------------------------------------------+                     
                              +--------------------------------------------------------------------------COMP:V-N(with)--------------------------------------------------------------------------+                       |                     
                              +---------------------------------------------------------------COMP:V-N(with)--------------------------------------------------------------+                      |                       |                     
                              +---------------------------------------COMP:V-N(with)--------------------------------------+                                               |                      |                       |                     
                              |          +---------------------OBJ:V-N---------------------+                              |                                               |                      |                       |                     
                              |          |                           +-------SUBJ:V-N------+      +----------------------OBJ:V-N----------------------+                   |             +---------------------OBJ:V-N--------------------+     
     +--MOD_ATT:N-N--+        |          |                           +-COMP:N-N(in)-+      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |             |    +-------MOD_ATT:N-ADJ-------+               |     
     |         +MOD_A+SUBJ:V-N+--OBJ:V-N-+COMP:N-N(of+       +MOD_ATT+         +MOD_+      |      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |             |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+     
     |         |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |             |    |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,SB203580)
MOD_ATT:N-N (culture,cell)
SUBJ:V-N (decrease,culture)
OBJ:V-N (decrease,production)
COMP:V-N(with) (decrease,Apo)
COMP:V-N(with) (decrease,cycloheximide)
COMP:V-N(with) (decrease,FMK)
COMP:V-N(with) (decrease,__SP__)
COMP:N-N(of) (production,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,production)
SUBJ:V-N (treat,protein)
OBJ:V-N (with,antibody)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__SP__,zVAD)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 58

                                                                                           +----------------------------------------------------------------COMP:V-N(with)---------------------------------------------------------------+     
                                                                                           +--------------------------------------------COMP:V-N(with)-------------------------------------------+                                       |     
                                                                                           +--------------------------------COMP:V-N(with)--------------------------------+                      |                                       |     
                                         +---------------------OBJ:V-N---------------------+      +----------------------OBJ:V-N----------------------+                   |                      |                                       |     
                                         +--------COMP:N-N(of)-------+                     +--------COMP:V-N(with)--------+                           |                   |                      |            +--------MOD_ATT:N-N-------+     
     +--MOD_ATT:N-N--+                   |           +-MOD_ATT:N-ADJ-+                     |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                      |            |          +-MOD_ATT:N-ADJ-+     
     |         +MOD_A+SUBJ:V-N+--OBJ:V-N-+           |       +MOD_ATT+COMP:N-N(+    +SUBJ:V+      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          |       +MOD_ATT+     
     |         |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,SB203580)
MOD_ATT:N-N (culture,cell)
SUBJ:V-N (decrease,culture)
OBJ:V-N (decrease,production)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,Hela)
OBJ:V-N (treat,production)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,Apo)
COMP:V-N(with) (treat,cycloheximide)
COMP:V-N(with) (treat,FMK)
COMP:V-N(with) (treat,protein)
OBJ:V-N (with,antibody)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 59

                                                                                           +----------------------------------------------------------------COMP:V-N(with)---------------------------------------------------------------+     
                                                                                           +--------------------------------------------COMP:V-N(with)-------------------------------------------+                                       |     
                                         +-------------------COMP:V-N(in)------------------+--------------------------------COMP:V-N(with)--------------------------------+                      |                                       |     
                                         |                   +---------COMP:V-N(of)--------+      +----------------------OBJ:V-N----------------------+                   |                      |                                       |     
               +-------MOD_ATT:N-N-------+                   |       +-------SUBJ:V-N------+--------COMP:V-N(with)--------+                           |                   |                      |            +-------MOD_ATT:N-ADJ------+     
               |     +----MOD_ATT:N-N----+                   |       +-COMP:N-N(in)-+      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                      |            |          +-MOD_ATT:N-ADJ-+     
               |     |        +MOD_ATT:N-+           +MOD_ATT+       |         +MOD_+      |      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          |       +MOD_ATT+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
COMP:V-N(in) (treat,production)
COMP:V-N(of) (treat,__NODE__)
SUBJ:V-N (treat,protein)
COMP:V-N(with) (treat,Apo)
COMP:V-N(with) (treat,cycloheximide)
COMP:V-N(with) (treat,FMK)
COMP:V-N(with) (treat,protein)
OBJ:V-N (with,antibody)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 60

                                                                                           +--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+                     
                                                                                           +--------------------------------------------COMP:V-N(with)-------------------------------------------+                       |                     
                                                                                           +--------------------------------COMP:V-N(with)--------------------------------+                      |                       |                     
                                                                                           |      +----------------------OBJ:V-N----------------------+                   |                      |                       |                     
                                         +--------COMP:N-N(of)-------+                     +--------COMP:V-N(with)--------+                           |                   |                      |                       |                     
     +--MOD_ATT:N-N--+                   |           +-MOD_ATT:N-ADJ-+-------OBJ:V-N-------+      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |             +---------------------OBJ:V-N--------------------+     
     |         +MOD_A+SUBJ:V-N+--OBJ:V-N-+           |       +MOD_ATT+COMP:N-N(+    +SUBJ:V+      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |             |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+     
     |         |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |             |    |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,SB203580)
MOD_ATT:N-N (culture,cell)
SUBJ:V-N (decrease,culture)
OBJ:V-N (decrease,production)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,Hela)
OBJ:V-N (treat,protein)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,Apo)
COMP:V-N(with) (treat,cycloheximide)
COMP:V-N(with) (treat,FMK)
COMP:V-N(with) (treat,__SP__)
OBJ:V-N (with,antibody)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 61

                                                                                           +------------------------------------------------COMP:V_PASS-N(with)-----------------------------------------------+                                
                                                                                           +-----------------------------------------COMP:V_PASS-N(with)-----------------------------------------+            |                                
                                                                                           +------------------------------COMP:V_PASS-N(with)-----------------------------+                      |            |                                
                              +---------------------COMP:V-N(in)--------------------+      |      +----------------------OBJ:V-N----------------------+                   |                      |            |                                
                              |          +--------COMP:N-N(of)-------+              |      +------COMP:V_PASS-N(with)-----+                           |                   |             +---------------------OBJ:V-N--------------------+     
     +--MOD_ATT:N-N--+        |          |           +-MOD_ATT:N-ADJ-+              |      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |             |    +--MOD_ATT:N-ADJ-+          +-MOD_ATT:N-ADJ-+     
     |         +MOD_A+SUBJ:V-N+--OBJ:V-N-+           |       +MOD_ATT+         +MOD_+SUBJ:V+      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |             |    +MOD+            |          |       +MOD_ATT+     
     |         |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |             |    |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,SB203580)
MOD_ATT:N-N (culture,cell)
SUBJ:V-N (decrease,culture)
OBJ:V-N (decrease,production)
COMP:V-N(in) (decrease,cell)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,Apo)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
COMP:V_PASS-N(with) (treat,overproduce)
OBJ:V-N (with,antibody)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 62

                                                                                           +--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+                     
                                                                                           +--------------------------------------------COMP:V-N(with)-------------------------------------------+                       |                     
                              +------------------------COMP:V-N(in)------------------------+--------------------------------COMP:V-N(with)--------------------------------+                      |                       |                     
                              |          +---------------------SUBJ:V-N--------------------+      +----------------------OBJ:V-N----------------------+                   |                      |                       |                     
                              |          +--------COMP:N-N(of)-------+                     +--------COMP:V-N(with)--------+                           |                   |                      |                       |                     
               +--MOD_ATT:N-N-+          |           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |             +---------------------OBJ:V-N--------------------+     
               |     +MOD_ATT:+          |           |       +MOD_ATT+         +MOD_+      |      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |             |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |             |    |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (decrease,cell)
MOD_ATT:N-N (decrease,culture)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
COMP:V-N(in) (treat,decrease)
SUBJ:V-N (treat,production)
COMP:V-N(with) (treat,Apo)
COMP:V-N(with) (treat,cycloheximide)
COMP:V-N(with) (treat,FMK)
COMP:V-N(with) (treat,__SP__)
OBJ:V-N (with,antibody)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 63

                                                                                           +--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+                     
                                                                                           +--------------------------------COMP:V-N(with)--------------------------------+                                              |                     
                                         +-------------------COMP:V-N(in)------------------+      +----------------------OBJ:V-N----------------------+                   |             +---------------------OBJ:V-N--------------------+     
               +-------MOD_ATT:N-N-------+                           +-------SUBJ:V-N------+--------COMP:V-N(with)--------+                           |                   |             |    +-------MOD_ATT:N-ADJ-------+               |     
               |     +----MOD_ATT:N-N----+                           +-COMP:N-N(in)-+      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |             |    |   +------MOD_ATT:N-N------+               |     
               |     |        +MOD_ATT:N-+COMP:N-N(of+       +MOD_ATT+         +MOD_+      |      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |             |    |   |            +MOD_ATT:N-+       +MOD_ATT+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |             |    |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
COMP:V-N(in) (treat,production)
SUBJ:V-N (treat,protein)
COMP:V-N(with) (treat,Apo)
COMP:V-N(with) (treat,cycloheximide)
COMP:V-N(with) (treat,__SP__)
OBJ:V-N (with,antibody)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (__SP__,zVAD)
MOD_ATT:N-N (__SP__,FMK)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 64

                                                                                           +---------------------------------------------------------COMP:V_PASS-N(with)---------------------------------------------------------+             
                                                                                           +-----------------------------------------COMP:V_PASS-N(with)-----------------------------------------+                               |             
                                                                                           +------------------------------COMP:V_PASS-N(with)-----------------------------+                      |                               |             
                              +---------------------COMP:V-N(in)--------------------+      |      +----------------------OBJ:V-N----------------------+                   |                      |                               |             
                              |          +--------COMP:N-N(of)-------+              |      +------COMP:V_PASS-N(with)-----+                           |                   |             +---------------------OBJ:V-N--------------------+     
     +--MOD_ATT:N-N--+        |          |           +-MOD_ATT:N-ADJ-+              |      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |             |        |            +----MOD_ATT:N-N---+       |     
     |         +MOD_A+SUBJ:V-N+--OBJ:V-N-+           |       +MOD_ATT+         +MOD_+SUBJ:V+      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |             |    +MOD+            |          +MOD_ATT+       |     
     |         |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |             |    |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,SB203580)
MOD_ATT:N-N (culture,cell)
SUBJ:V-N (decrease,culture)
OBJ:V-N (decrease,production)
COMP:V-N(in) (decrease,cell)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,Apo)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
COMP:V_PASS-N(with) (treat,__NODE__)
OBJ:V-N (with,antibody)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (__NODE__,overproduce)
MOD_ATT:N-ADJ (__NODE__,__SP__)

Analyse 65

                              +--------------------------------------------------------------------------------------COMP:V-N(with)--------------------------------------------------------------------------------------+                     
                              +--------------------------------------------------------------------------COMP:V-N(with)--------------------------------------------------------------------------+                       |                     
                              +---------------------------------------------------------------COMP:V-N(with)--------------------------------------------------------------+                      |                       |                     
                              +---------------------------------------COMP:V-N(with)--------------------------------------+                                               |                      |                       |                     
                              |          +---------------------OBJ:V-N---------------------+                              |                                               |                      |                       |                     
                              |          +--------COMP:N-N(of)-------+                     |      +----------------------OBJ:V-N----------------------+                   |             +---------------------OBJ:V-N--------------------+     
     +--MOD_ATT:N-N--+        |          |           +-MOD_ATT:N-ADJ-+                     |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |             |    +-------MOD_ATT:N-ADJ-------+               |     
     |         +MOD_A+SUBJ:V-N+--OBJ:V-N-+           |       +MOD_ATT+COMP:N-N(+    +SUBJ:V+      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |             |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+     
     |         |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |             |    |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,SB203580)
MOD_ATT:N-N (culture,cell)
SUBJ:V-N (decrease,culture)
OBJ:V-N (decrease,production)
COMP:V-N(with) (decrease,Apo)
COMP:V-N(with) (decrease,cycloheximide)
COMP:V-N(with) (decrease,FMK)
COMP:V-N(with) (decrease,__SP__)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,Hela)
OBJ:V-N (treat,production)
SUBJ:V-N (treat,cell)
OBJ:V-N (with,antibody)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__SP__,zVAD)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 66

                                                                                           +----------------------------------------------------------------COMP:V-N(with)---------------------------------------------------------------+     
                                                                                           +--------------------------------------------COMP:V-N(with)-------------------------------------------+                                       |     
                                                                                           +--------------------------------COMP:V-N(with)--------------------------------+                      |                                       |     
                                                     +---------------OBJ:V-N---------------+      +----------------------OBJ:V-N----------------------+                   |                      |                                       |     
                                                     |               +-------SUBJ:V-N------+--------COMP:V-N(with)--------+                           |                   |                      |            +--------MOD_ATT:N-N-------+     
     +--MOD_ATT:N-N--+                               |               +-COMP:N-N(in)-+      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                      |            |          +-MOD_ATT:N-ADJ-+     
     |         +MOD_A+SUBJ:V-N+--OBJ:V-N-+COMP:N-N(of+       +MOD_ATT+         +MOD_+      |      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          |       +MOD_ATT+     
     |         |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,SB203580)
MOD_ATT:N-N (culture,cell)
SUBJ:V-N (decrease,culture)
OBJ:V-N (decrease,production)
COMP:N-N(of) (production,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__SP__)
SUBJ:V-N (treat,protein)
COMP:V-N(with) (treat,Apo)
COMP:V-N(with) (treat,cycloheximide)
COMP:V-N(with) (treat,FMK)
COMP:V-N(with) (treat,protein)
OBJ:V-N (with,antibody)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 67

                              +----------------------------------------------------------------------------------------------COMP:V-N(with)----------------------------------------------------------------------------------------------+     
                              +--------------------------------------------------------------------------COMP:V-N(with)--------------------------------------------------------------------------+                                       |     
                              +---------------------------------------------------------------COMP:V-N(with)--------------------------------------------------------------+                      |                                       |     
                              +---------------------------------------COMP:V-N(with)--------------------------------------+                                               |                      |                                       |     
                              |          +--------COMP:N-N(of)-------+                            +----------------------OBJ:V-N----------------------+                   |                      |            +--------MOD_ATT:N-N-------+     
     +--MOD_ATT:N-N--+        |          |           +-MOD_ATT:N-ADJ-+-------OBJ:V-N-------+      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                      |            |          +-MOD_ATT:N-ADJ-+     
     |         +MOD_A+SUBJ:V-N+--OBJ:V-N-+           |       +MOD_ATT+COMP:N-N(+    +SUBJ:V+      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          |       +MOD_ATT+     
     |         |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,SB203580)
MOD_ATT:N-N (culture,cell)
SUBJ:V-N (decrease,culture)
OBJ:V-N (decrease,production)
COMP:V-N(with) (decrease,Apo)
COMP:V-N(with) (decrease,cycloheximide)
COMP:V-N(with) (decrease,FMK)
COMP:V-N(with) (decrease,protein)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,Hela)
OBJ:V-N (treat,protein)
SUBJ:V-N (treat,cell)
OBJ:V-N (with,antibody)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 68

                              +----------------------------------------------------------------------------------------------COMP:V-N(with)----------------------------------------------------------------------------------------------+     
                              +--------------------------------------------------------------------------COMP:V-N(with)--------------------------------------------------------------------------+                                       |     
                              +---------------------------------------------------------------COMP:V-N(with)--------------------------------------------------------------+                      |                                       |     
                              +---------------------------------------COMP:V-N(with)--------------------------------------+                                               |                      |                                       |     
                              |                              +-----------OBJ:V-N-----------+                              |                                               |                      |                                       |     
                              |                              |       +-------SUBJ:V-N------+      +----------------------OBJ:V-N----------------------+                   |                      |            +--------MOD_ATT:N-N-------+     
     +--MOD_ATT:N-N--+        |          +----COMP:N-N(of)---+       +-COMP:N-N(in)-+      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                      |            |          +-MOD_ATT:N-ADJ-+     
     |         +MOD_A+SUBJ:V-N+--OBJ:V-N-+           +MOD_ATT+       |         +MOD_+      |      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          |       +MOD_ATT+     
     |         |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,SB203580)
MOD_ATT:N-N (culture,cell)
SUBJ:V-N (decrease,culture)
OBJ:V-N (decrease,production)
COMP:V-N(with) (decrease,Apo)
COMP:V-N(with) (decrease,cycloheximide)
COMP:V-N(with) (decrease,FMK)
COMP:V-N(with) (decrease,protein)
COMP:N-N(of) (production,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__NODE__)
SUBJ:V-N (treat,protein)
OBJ:V-N (with,antibody)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 69

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                          +------------------------------------------------------------------SUBJ:V-N------------------------------------------------------------------+             
                                         |                                          |      +-----------------------------------------------------COMP:V_PASS-N(with)-----------------------------------------------------+       |             
                                         |                                          |      +-----------------------------------------COMP:V_PASS-N(with)-----------------------------------------+                       |       |             
                                         |                                          |      +------------------------------COMP:V_PASS-N(with)-----------------------------+                      |                       |       |             
                                         +-------------COMP:N-N(in)------------+    |      |      +----------------------OBJ:V-N----------------------+                   |                      |                       |       |             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+         |    |      +------COMP:V_PASS-N(with)-----+                           |                   |                      |                       |       |             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+         |    |      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                      |                       |       |             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         |    +SUBJ:V+      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            +MOD_ATT:N-+       +OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
COMP:N-N(in) (production,Hela)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,Apo)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
COMP:V_PASS-N(with) (treat,__SP__)
OBJ:V-N (with,antibody)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(in) (__NODE__,production)
SUBJ:V-N (__NODE__,cell)
OBJ:V-N (__NODE__,protein)

Analyse 70

                              +-------------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------------+             
                              +---------------------------OBJ:V-N--------------------------+                                                          +---------------------------------SUBJ:V-N---------------------------------+             
                              |          +---------------------SUBJ:V-N--------------------+------COMP:V-N(with)-----+                                |                   +--------------------COMP:V-N(with)--------------------+             
                              |          +--------COMP:N-N(of)-------+                     |      +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               +--MOD_ATT:N-N-+          |           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     +MOD_ATT:+          |           |       +MOD_ATT+         +MOD_+      |      |     |      +MOD_A+    |         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (decrease,cell)
MOD_ATT:N-N (decrease,culture)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,decrease)
SUBJ:V-N (treat,production)
COMP:V-N(with) (treat,__SP__)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,decrease)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 71

                              +-------------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------------+             
                              +---------------------------OBJ:V-N--------------------------+                                                          +---------------------------------SUBJ:V-N---------------------------------+             
                              |          +---------------------SUBJ:V-N--------------------+------COMP:V-N(with)-----+                                |                   +--------------------COMP:V-N(with)--------------------+             
                              |          +--------COMP:N-N(of)-------+                     |      +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               +--MOD_ATT:N-N-+          |           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     +MOD_ATT:+          |           |       +MOD_ATT+         +MOD_+      |      |     |      +MOD_A+    |         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (decrease,cell)
MOD_ATT:N-N (decrease,culture)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,decrease)
SUBJ:V-N (treat,production)
COMP:V-N(with) (treat,__SP__)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,decrease)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 72

                              +-------------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------------+             
                              +---------------------------OBJ:V-N--------------------------+                                                          +---------------------------------SUBJ:V-N---------------------------------+             
                              |          +---------------------SUBJ:V-N--------------------+------COMP:V-N(with)-----+                                |                   +--------------------COMP:V-N(with)--------------------+             
                              |          +--------COMP:N-N(of)-------+                     |      +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               +--MOD_ATT:N-N-+          |           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     +MOD_ATT:+          |           |       +MOD_ATT+         +MOD_+      |      |     |      +MOD_A+    |         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (decrease,cell)
MOD_ATT:N-N (decrease,culture)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,decrease)
SUBJ:V-N (treat,production)
COMP:V-N(with) (treat,__SP__)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,decrease)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 73

                              +---------------------------------------------------------------------------------------------SUBJ:V-N---------------------------------------------------------------------------------------------+             
                              |                                                            +--------------------------------------------------COMP:V-N(with)--------------------------------------------------+                  |             
                              +---------------------------OBJ:V-N--------------------------+--------------------------------------------COMP:V-N(with)-------------------------------------------+            |                  |             
                              |          +---------------------SUBJ:V-N--------------------+--------------------------------COMP:V-N(with)--------------------------------+                      |            |                  |             
                              |          +---------------COMP:N-N(in)---------------+      |      +----------------------OBJ:V-N----------------------+                   |                      |            |                  |             
     +-------MOD_ATT:N-N------+          +--------COMP:N-N(of)-------+              |      +--------COMP:V-N(with)--------+                           |                   |                      |            |                  |             
     |         +--MOD_ATT:N-N-+          |           +-MOD_ATT:N-ADJ-+              |      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+                  |             
     |         |     +MOD_ATT:+          |           |       +MOD_ATT+         +MOD_+      |      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |                  +OBJ:V-N+     
     |         |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |                  |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (decrease,SB203580)
MOD_ATT:N-N (decrease,cell)
MOD_ATT:N-N (decrease,culture)
COMP:N-N(of) (production,protein)
COMP:N-N(in) (production,cell)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,decrease)
SUBJ:V-N (treat,production)
COMP:V-N(with) (treat,Apo)
COMP:V-N(with) (treat,cycloheximide)
COMP:V-N(with) (treat,FMK)
COMP:V-N(with) (treat,overproduce)
OBJ:V-N (with,antibody)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
SUBJ:V-N (__NODE__,decrease)
OBJ:V-N (__NODE__,protein)

Analyse 74

                                                                                           +-----------------------------------------------------COMP:V_PASS-N(with)-----------------------------------------------------+                     
                                                                                           +-----------------------------------------COMP:V_PASS-N(with)-----------------------------------------+                       |                     
                                                                                           +------------------------------COMP:V_PASS-N(with)-----------------------------+                      |                       |                     
                                         +---------------COMP:N-N(in)---------------+      |      +----------------------OBJ:V-N----------------------+                   |                      |                       |                     
                                         +--------COMP:N-N(of)-------+              |      +------COMP:V_PASS-N(with)-----+                           |          +--------------------------------OBJ:V-N--------------------------------+     
     +--MOD_ATT:N-N--+                   |           +-MOD_ATT:N-ADJ-+              |      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+          |        |             +---------------------OBJ:V-N--------------------+     
     |         +MOD_A+SUBJ:V-N+--OBJ:V-N-+           |       +MOD_ATT+         +MOD_+SUBJ:V+      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+          |        |             |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+     
     |         |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |          |        |             |    |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,SB203580)
MOD_ATT:N-N (culture,cell)
SUBJ:V-N (decrease,culture)
OBJ:V-N (decrease,production)
COMP:N-N(of) (production,protein)
COMP:N-N(in) (production,cell)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,Apo)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
COMP:V_PASS-N(with) (treat,__SP__)
OBJ:V-N (with,antibody)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (with,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 75

                              +--------------------------------------------------------------------------------------COMP:V-N(with)--------------------------------------------------------------------------------------+                     
                              +--------------------------------------------------------------------------COMP:V-N(with)--------------------------------------------------------------------------+                       |                     
                              +---------------------------------------------------------------COMP:V-N(with)--------------------------------------------------------------+                      |                       |                     
                              +---------------------------------------COMP:V-N(with)--------------------------------------+                                               |                      |                       |                     
                              |          +--------COMP:N-N(of)-------+----SUBJ:V_PASS-N----+      +----------------------OBJ:V-N----------------------+          +--------------------------------OBJ:V-N--------------------------------+     
     +--MOD_ATT:N-N--+        |          |           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+          |        |             +---------------------OBJ:V-N--------------------+     
     |         +MOD_A+SUBJ:V-N+--OBJ:V-N-+           |       +MOD_ATT+         +MOD_+      |      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+          |        |             |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+     
     |         |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |          |        |             |    |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,SB203580)
MOD_ATT:N-N (culture,cell)
SUBJ:V-N (decrease,culture)
OBJ:V-N (decrease,production)
COMP:V-N(with) (decrease,Apo)
COMP:V-N(with) (decrease,cycloheximide)
COMP:V-N(with) (decrease,FMK)
COMP:V-N(with) (decrease,__SP__)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,protein)
OBJ:V-N (with,antibody)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (with,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 76

                              +--------------------------------------------------------------------------------------COMP:V-N(with)--------------------------------------------------------------------------------------+                     
                              +--------------------------------------------------------------------------COMP:V-N(with)--------------------------------------------------------------------------+                       |                     
                              +---------------------------------------------------------------COMP:V-N(with)--------------------------------------------------------------+                      |                       |                     
                              +---------------------------------------COMP:V-N(with)--------------------------------------+                                               |                      |                       |                     
                              |          +------------------SUBJ:V_PASS-N------------------+                              |                                               |                      |                       |                     
                              |          +--------COMP:N-N(of)-------+                     |      +----------------------OBJ:V-N----------------------+          +--------------------------------OBJ:V-N--------------------------------+     
     +--MOD_ATT:N-N--+        |          |           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+          |        |             +---------------------OBJ:V-N--------------------+     
     |         +MOD_A+SUBJ:V-N+--OBJ:V-N-+           |       +MOD_ATT+         +MOD_+      |      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+          |        |             |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+     
     |         |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |          |        |             |    |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,SB203580)
MOD_ATT:N-N (culture,cell)
SUBJ:V-N (decrease,culture)
OBJ:V-N (decrease,production)
COMP:V-N(with) (decrease,Apo)
COMP:V-N(with) (decrease,cycloheximide)
COMP:V-N(with) (decrease,FMK)
COMP:V-N(with) (decrease,__SP__)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,production)
OBJ:V-N (with,antibody)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (with,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 77

                                                                                           +--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+                     
                                                                                           +--------------------------------COMP:V-N(with)--------------------------------+                                              |                     
                                                                                           |                                                                     +--------------------------------OBJ:V-N--------------------------------+     
     +------------MOD_ATT:N-N------------+---------------------SUBJ:V-N--------------------+      +----------------------OBJ:V-N----------------------+          |        |             +---------------------OBJ:V-N--------------------+     
     |         +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+                     +--------COMP:V-N(with)--------+                           |          |        |             |    +-------MOD_ATT:N-ADJ-------+               |     
     |         |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+          |        |             |    |   +------MOD_ATT:N-N------+               |     
     |         |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+      |      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+          |        |             |    |   |            +MOD_ATT:N-+       +MOD_ATT+     
     |         |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |          |        |             |    |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,SB203580)
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V-N (treat,production)
COMP:V-N(with) (treat,Apo)
COMP:V-N(with) (treat,cycloheximide)
COMP:V-N(with) (treat,__SP__)
OBJ:V-N (with,antibody)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (with,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (__SP__,zVAD)
MOD_ATT:N-N (__SP__,FMK)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 78

                              +--------------------------------------------------------------------------------------COMP:V-N(with)--------------------------------------------------------------------------------------+                     
                              +--------------------------------------------------------------------------COMP:V-N(with)--------------------------------------------------------------------------+                       |                     
                              +---------------------------------------------------------------COMP:V-N(with)--------------------------------------------------------------+                      |                       |                     
                              +---------------------------------------COMP:V-N(with)--------------------------------------+                                               |                      |                       |                     
                              |          +------------------SUBJ:V_PASS-N------------------+                              |                                               |                      |                       |                     
                              |          +---------------COMP:N-N(in)---------------+      |                              |                                      +--------------------------------OBJ:V-N--------------------------------+     
                              |          +--------COMP:N-N(of)-------+              |      |      +----------------------OBJ:V-N----------------------+          |        |             +---------------------OBJ:V-N--------------------+     
     +--MOD_ATT:N-N--+        |          |           +-MOD_ATT:N-ADJ-+              |      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+          |        |             |    +-------MOD_ATT:N-ADJ-------+               |     
     |         +MOD_A+SUBJ:V-N+--OBJ:V-N-+           |       +MOD_ATT+         +MOD_+      |      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+          |        |             |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+     
     |         |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |          |        |             |    |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,SB203580)
MOD_ATT:N-N (culture,cell)
SUBJ:V-N (decrease,culture)
OBJ:V-N (decrease,production)
COMP:V-N(with) (decrease,Apo)
COMP:V-N(with) (decrease,cycloheximide)
COMP:V-N(with) (decrease,FMK)
COMP:V-N(with) (decrease,__SP__)
COMP:N-N(of) (production,protein)
COMP:N-N(in) (production,cell)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,production)
OBJ:V-N (with,antibody)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (with,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__SP__,zVAD)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 79

                                                                                           +------------------------------------------------COMP:V_PASS-N(with)-----------------------------------------------+                                
                                                                                           +-----------------------------------------COMP:V_PASS-N(with)-----------------------------------------+            |                                
                                                                                           +------------------------------COMP:V_PASS-N(with)-----------------------------+                      |            |                                
                                                                                           |      +----------------------OBJ:V-N----------------------+                   |                      |            |                                
                                         +--------COMP:N-N(of)-------+----SUBJ:V_PASS-N----+------COMP:V_PASS-N(with)-----+                           |                   |             +---------------------OBJ:V-N--------------------+     
     +--MOD_ATT:N-N--+                   |           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |             |    +--MOD_ATT:N-ADJ-+          +-MOD_ATT:N-ADJ-+     
     |         +MOD_A+SUBJ:V-N+--OBJ:V-N-+           |       +MOD_ATT+         +MOD_+      |      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |             |    +MOD+            |          |       +MOD_ATT+     
     |         |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |             |    |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,SB203580)
MOD_ATT:N-N (culture,cell)
SUBJ:V-N (decrease,culture)
OBJ:V-N (decrease,production)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,protein)
COMP:V_PASS-N(with) (treat,Apo)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
COMP:V_PASS-N(with) (treat,overproduce)
OBJ:V-N (with,antibody)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 80

                              +---------------------------------------------------------------------------------COMP:V-N(with)--------------------------------------------------------------------------------+                                
                              +--------------------------------------------------------------------------COMP:V-N(with)--------------------------------------------------------------------------+            |                                
                              +---------------------------------------------------------------COMP:V-N(with)--------------------------------------------------------------+                      |            |                                
                              +---------------------------------------COMP:V-N(with)--------------------------------------+                                               |                      |            |                                
                              |          +--------COMP:N-N(of)-------+                            +----------------------OBJ:V-N----------------------+                   |             +---------------------OBJ:V-N--------------------+     
     +--MOD_ATT:N-N--+        |          |           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+             |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |             |    +--MOD_ATT:N-ADJ-+          +-MOD_ATT:N-ADJ-+     
     |         +MOD_A+SUBJ:V-N+--OBJ:V-N-+           |       +MOD_ATT+         +MOD_+SUBJ:V+      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |             |    +MOD+            |          |       +MOD_ATT+     
     |         |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |             |    |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,SB203580)
MOD_ATT:N-N (culture,cell)
SUBJ:V-N (decrease,culture)
OBJ:V-N (decrease,production)
COMP:V-N(with) (decrease,Apo)
COMP:V-N(with) (decrease,cycloheximide)
COMP:V-N(with) (decrease,FMK)
COMP:V-N(with) (decrease,overproduce)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,antibody)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 81

                                                                                           +------------------------------------------------COMP:V_PASS-N(with)-----------------------------------------------+                                
                                                                                           +-----------------------------------------COMP:V_PASS-N(with)-----------------------------------------+            |                                
                                                                                           +------------------------------COMP:V_PASS-N(with)-----------------------------+                      |            |                                
                                         +---------------COMP:N-N(in)---------------+      |      +----------------------OBJ:V-N----------------------+                   |                      |            |                                
                                         +--------COMP:N-N(of)-------+              |      +------COMP:V_PASS-N(with)-----+                           |                   |             +---------------------OBJ:V-N--------------------+     
     +--MOD_ATT:N-N--+                   |           +-MOD_ATT:N-ADJ-+              |      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |             |        |            |          +-MOD_ATT:N-ADJ-+     
     |         +MOD_A+SUBJ:V-N+--OBJ:V-N-+           |       +MOD_ATT+         +MOD_+SUBJ:V+      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |             |    +MOD+            |          |       +MOD_ATT+     
     |         |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |             |    |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,SB203580)
MOD_ATT:N-N (culture,cell)
SUBJ:V-N (decrease,culture)
OBJ:V-N (decrease,production)
COMP:N-N(of) (production,protein)
COMP:N-N(in) (production,cell)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,Apo)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
COMP:V_PASS-N(with) (treat,overproduce)
OBJ:V-N (with,antibody)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 82

                                                                                           +------------------------------------------------COMP:V_PASS-N(with)-----------------------------------------------+                                
                                                                                           +-----------------------------------------COMP:V_PASS-N(with)-----------------------------------------+            |                                
                                                                                           +------------------------------COMP:V_PASS-N(with)-----------------------------+                      |            |                                
                                         +------------------SUBJ:V_PASS-N------------------+      +----------------------OBJ:V-N----------------------+                   |                      |            |                                
                                         +--------COMP:N-N(of)-------+                     +------COMP:V_PASS-N(with)-----+                           |                   |             +---------------------OBJ:V-N--------------------+     
     +--MOD_ATT:N-N--+                   |           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |             |        |            |          +-MOD_ATT:N-ADJ-+     
     |         +MOD_A+SUBJ:V-N+--OBJ:V-N-+           |       +MOD_ATT+         +MOD_+      |      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |             |    +MOD+            |          |       +MOD_ATT+     
     |         |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |             |    |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,SB203580)
MOD_ATT:N-N (culture,cell)
SUBJ:V-N (decrease,culture)
OBJ:V-N (decrease,production)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,production)
COMP:V_PASS-N(with) (treat,Apo)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
COMP:V_PASS-N(with) (treat,overproduce)
OBJ:V-N (with,antibody)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 83

                                                                                           +------------------------------------------------COMP:V_PASS-N(with)-----------------------------------------------+                                
                                                                                           +-----------------------------------------COMP:V_PASS-N(with)-----------------------------------------+            |                                
                                                                                           +------------------------------COMP:V_PASS-N(with)-----------------------------+                      |            |                                
                                                                                           |      +----------------------OBJ:V-N----------------------+                   |                      |            |                                
                                         +--------COMP:N-N(of)-------+----SUBJ:V_PASS-N----+------COMP:V_PASS-N(with)-----+                           |                   |             +---------------------OBJ:V-N--------------------+     
     +--MOD_ATT:N-N--+                   |           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |             |    +--MOD_ATT:N-ADJ-+          +-MOD_ATT:N-ADJ-+     
     |         +MOD_A+SUBJ:V-N+--OBJ:V-N-+           |       +MOD_ATT+         +MOD_+      |      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |             |    +MOD+            |          |       +MOD_ATT+     
     |         |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |             |    |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,SB203580)
MOD_ATT:N-N (culture,cell)
SUBJ:V-N (decrease,culture)
OBJ:V-N (decrease,production)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,protein)
COMP:V_PASS-N(with) (treat,Apo)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
COMP:V_PASS-N(with) (treat,overproduce)
OBJ:V-N (with,antibody)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 84

                              +---------------------------------------------------------------------------------COMP:V-N(with)--------------------------------------------------------------------------------+                                
                              +--------------------------------------------------------------------------COMP:V-N(with)--------------------------------------------------------------------------+            |                                
                              +---------------------------------------------------------------COMP:V-N(with)--------------------------------------------------------------+                      |            |                                
                              +---------------------------------------COMP:V-N(with)--------------------------------------+                                               |                      |            |                                
                              |          +--------COMP:N-N(of)-------+----SUBJ:V_PASS-N----+      +----------------------OBJ:V-N----------------------+                   |             +---------------------OBJ:V-N--------------------+     
     +--MOD_ATT:N-N--+        |          |           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |             |    +--MOD_ATT:N-ADJ-+          +-MOD_ATT:N-ADJ-+     
     |         +MOD_A+SUBJ:V-N+--OBJ:V-N-+           |       +MOD_ATT+         +MOD_+      |      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |             |    +MOD+            |          |       +MOD_ATT+     
     |         |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |             |    |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,SB203580)
MOD_ATT:N-N (culture,cell)
SUBJ:V-N (decrease,culture)
OBJ:V-N (decrease,production)
COMP:V-N(with) (decrease,Apo)
COMP:V-N(with) (decrease,cycloheximide)
COMP:V-N(with) (decrease,FMK)
COMP:V-N(with) (decrease,overproduce)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,protein)
OBJ:V-N (with,antibody)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 85

                                                                                           +------------------------------------------------COMP:V_PASS-N(with)-----------------------------------------------+                                
                                                                                           +-----------------------------------------COMP:V_PASS-N(with)-----------------------------------------+            |                                
                                                                                           +------------------------------COMP:V_PASS-N(with)-----------------------------+                      |            |                                
                                                                                           |      +----------------------OBJ:V-N----------------------+                   |                      |            |                                
                                         +--------COMP:N-N(of)-------+                     +------COMP:V_PASS-N(with)-----+                           |                   |             +---------------------OBJ:V-N--------------------+     
     +--MOD_ATT:N-N--+                   |           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |             |        |            |          +-MOD_ATT:N-ADJ-+     
     |         +MOD_A+SUBJ:V-N+--OBJ:V-N-+           |       +MOD_ATT+         +MOD_+SUBJ:V+      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |             |    +MOD+            |          |       +MOD_ATT+     
     |         |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |             |    |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,SB203580)
MOD_ATT:N-N (culture,cell)
SUBJ:V-N (decrease,culture)
OBJ:V-N (decrease,production)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,Apo)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
COMP:V_PASS-N(with) (treat,overproduce)
OBJ:V-N (with,antibody)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 86

                                                                                           +---------------------------------------------------------COMP:V_PASS-N(with)---------------------------------------------------------+             
                                                                                           +-----------------------------------------COMP:V_PASS-N(with)-----------------------------------------+                               |             
                                                                                           +------------------------------COMP:V_PASS-N(with)-----------------------------+                      |                               |             
                                         +---------------COMP:N-N(in)---------------+      |      +----------------------OBJ:V-N----------------------+                   |                      |                               |             
                                         +--------COMP:N-N(of)-------+              |      +------COMP:V_PASS-N(with)-----+                           |                   |             +---------------------OBJ:V-N--------------------+     
     +--MOD_ATT:N-N--+                   |           +-MOD_ATT:N-ADJ-+              |      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |             |        |            +----MOD_ATT:N-N---+       |     
     |         +MOD_A+SUBJ:V-N+--OBJ:V-N-+           |       +MOD_ATT+         +MOD_+SUBJ:V+      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |             |    +MOD+            |          +MOD_ATT+       |     
     |         |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |             |    |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,SB203580)
MOD_ATT:N-N (culture,cell)
SUBJ:V-N (decrease,culture)
OBJ:V-N (decrease,production)
COMP:N-N(of) (production,protein)
COMP:N-N(in) (production,cell)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,Apo)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
COMP:V_PASS-N(with) (treat,__NODE__)
OBJ:V-N (with,antibody)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (__NODE__,overproduce)
MOD_ATT:N-ADJ (__NODE__,__SP__)

Analyse 87

                                                                                           +------------------------------------------------COMP:V_PASS-N(with)-----------------------------------------------+                                
                                                                                           +-----------------------------------------COMP:V_PASS-N(with)-----------------------------------------+            |                                
                                                                                           +------------------------------COMP:V_PASS-N(with)-----------------------------+                      |            |                                
                                         +------------------SUBJ:V_PASS-N------------------+      +----------------------OBJ:V-N----------------------+                   |                      |            |                                
                                         +--------COMP:N-N(of)-------+                     +------COMP:V_PASS-N(with)-----+                           |                   |             +---------------------OBJ:V-N--------------------+     
     +--MOD_ATT:N-N--+                   |           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |             |        |            |          +-MOD_ATT:N-ADJ-+     
     |         +MOD_A+SUBJ:V-N+--OBJ:V-N-+           |       +MOD_ATT+         +MOD_+      |      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |             |    +MOD+            |          |       +MOD_ATT+     
     |         |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |             |    |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,SB203580)
MOD_ATT:N-N (culture,cell)
SUBJ:V-N (decrease,culture)
OBJ:V-N (decrease,production)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,production)
COMP:V_PASS-N(with) (treat,Apo)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
COMP:V_PASS-N(with) (treat,overproduce)
OBJ:V-N (with,antibody)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 88

                     +--------------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------------+                     
                     |        +-----------------------------------------------------------------------------------------SUBJ:V-N-----------------------------------------------------------------------------------------+                     
                     |        |                                                            +--------------------------------------------------COMP:V-N(with)--------------------------------------------------+          |                     
                     |        |                                                            +--------------------------------------------COMP:V-N(with)-------------------------------------------+            |          |                     
                     |        +---------------------------OBJ:V-N--------------------------+--------------------------------COMP:V-N(with)--------------------------------+                      |            |          |                     
                     |        |          +---------------------SUBJ:V-N--------------------+      +----------------------OBJ:V-N----------------------+                   |                      |            |          |                     
                     |        |          +--------COMP:N-N(of)-------+                     +--------COMP:V-N(with)--------+                           |                   |                      |            |          |                     
                     |        |          |           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                      |            |          +----OBJ:V-N----+     
               +MOD_A+        |          |           |       +MOD_ATT+         +MOD_+      |      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          |       +MOD_ATT+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,decrease)
SUBJ:V-N (treat,production)
COMP:V-N(with) (treat,Apo)
COMP:V-N(with) (treat,cycloheximide)
COMP:V-N(with) (treat,FMK)
COMP:V-N(with) (treat,overproduce)
OBJ:V-N (with,antibody)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__SP__,culture)
SUBJ:V-N (__SP__,decrease)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 89

                     +--------------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------------+                     
                     |        +-----------------------------------------------------------------------------------------SUBJ:V-N-----------------------------------------------------------------------------------------+                     
                     |        |                                                            +--------------------------------------------------COMP:V-N(with)--------------------------------------------------+          |                     
                     |        +---------------------------OBJ:V-N--------------------------+--------------------------------------------COMP:V-N(with)-------------------------------------------+            |          |                     
                     |        |          +---------------------SUBJ:V-N--------------------+--------------------------------COMP:V-N(with)--------------------------------+                      |            |          |                     
                     |        |          +---------------COMP:N-N(in)---------------+      |      +----------------------OBJ:V-N----------------------+                   |                      |            |          |                     
                     |        |          +--------COMP:N-N(of)-------+              |      +--------COMP:V-N(with)--------+                           |                   |                      |            |          |                     
                     |        |          |           +-MOD_ATT:N-ADJ-+              |      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                      |            |          +----OBJ:V-N----+     
               +MOD_A+        |          |           |       +MOD_ATT+         +MOD_+      |      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          |       +MOD_ATT+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
COMP:N-N(of) (production,protein)
COMP:N-N(in) (production,cell)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,decrease)
SUBJ:V-N (treat,production)
COMP:V-N(with) (treat,Apo)
COMP:V-N(with) (treat,cycloheximide)
COMP:V-N(with) (treat,FMK)
COMP:V-N(with) (treat,overproduce)
OBJ:V-N (with,antibody)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__SP__,culture)
SUBJ:V-N (__SP__,decrease)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 90

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                                                                            +---------------------------------SUBJ:V-N---------------------------------+             
                                         +---------------COMP:N-N(in)---------------+      +---COMP:V_PASS-N(with)---+                                |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+              |      |      +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+              |      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+SUBJ:V+      |     |      +MOD_A+    |         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
COMP:N-N(in) (production,cell)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,__SP__)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 91

                              +-------------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------------+             
                              +---------------------------OBJ:V-N--------------------------+                                                          +---------------------------------SUBJ:V-N---------------------------------+             
                              |          +---------------------SUBJ:V-N--------------------+                                                          |                   +--------------------COMP:V-N(with)--------------------+             
                              |          +--------COMP:N-N(of)-------+                     +--------COMP:V-N(with)--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               +--MOD_ATT:N-N-+          |           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+      |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     +MOD_ATT:+          |           |       +MOD_ATT+         +MOD_+      |            |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |            |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (decrease,cell)
MOD_ATT:N-N (decrease,culture)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,decrease)
SUBJ:V-N (treat,production)
COMP:V-N(with) (treat,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,decrease)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 92

                              +-------------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------------+             
                              +---------------------------OBJ:V-N--------------------------+                                                          +---------------------------------SUBJ:V-N---------------------------------+             
                              |          +---------------------SUBJ:V-N--------------------+                                                          |                   +--------------------COMP:V-N(with)--------------------+             
                              |          +--------COMP:N-N(of)-------+                     |      +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               +--MOD_ATT:N-N-+          |           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+      |      |     +---OBJ:V-N--+    |         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     +MOD_ATT:+          |           |       +MOD_ATT+         +MOD_+      +COMP:V-N(wit+      +SUBJ:+    |         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (decrease,cell)
MOD_ATT:N-N (decrease,culture)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,decrease)
SUBJ:V-N (treat,production)
COMP:V-N(with) (treat,agonist)
OBJ:V-N (with,Apo)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,decrease)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 93

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         +------------------SUBJ:V_PASS-N------------------+                                                          +---------------------------------SUBJ:V-N---------------------------------+             
                                         +---------------COMP:N-N(in)---------------+      +---COMP:V_PASS-N(with)---+                                |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+              |      |      +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+              |      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+      |      |     |      +MOD_A+    |         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
COMP:N-N(in) (production,cell)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,production)
COMP:V_PASS-N(with) (treat,__SP__)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 94

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                          +----------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------+             
                                         |                                          |                                                                 +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                                          |      +---COMP:V_PASS-N(with)---+                                |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+              |      |      +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+              |      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+SUBJ:V+      |     |      +MOD_A+    |         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,__SP__)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(in) (__NODE__,cell)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 95

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                          +----------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------+             
                                         |                                          |                                                                 +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                                          |      +---COMP:V_PASS-N(with)---+                                |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+              |      |      +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+              |      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+SUBJ:V+      |     |      +MOD_A+    |         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,__SP__)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(in) (__NODE__,cell)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 96

                              +-------------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------------+             
                              +---------------------------OBJ:V-N--------------------------+                                                                                                                                     |             
                              |          +---------------------SUBJ:V-N--------------------+                                                          +---------------------------------SUBJ:V-N---------------------------------+             
                              |          +---------------COMP:N-N(in)---------------+      |                                                          |                   +--------------------COMP:V-N(with)--------------------+             
                              |          +--------COMP:N-N(of)-------+              |      |      +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               +--MOD_ATT:N-N-+          |           +-MOD_ATT:N-ADJ-+              |      |      |     +---OBJ:V-N--+    |         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     +MOD_ATT:+          |           |       +MOD_ATT+         +MOD_+      +COMP:V-N(wit+      +SUBJ:+    |         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (decrease,cell)
MOD_ATT:N-N (decrease,culture)
COMP:N-N(of) (production,protein)
COMP:N-N(in) (production,cell)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,decrease)
SUBJ:V-N (treat,production)
COMP:V-N(with) (treat,agonist)
OBJ:V-N (with,Apo)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,decrease)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 97

                              +-------------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------------+             
                              |                                                                                      +-----------------------------------------------COMP:V-N(with)----------------------------------------------+             
                              +---------------------------OBJ:V-N--------------------------+                         |                                +---------------------------------SUBJ:V-N---------------------------------+             
                              |          +---------------------SUBJ:V-N--------------------+                         |                                |                   +--------------------COMP:V-N(with)--------------------+             
                              |          +--------COMP:N-N(of)-------+                     |      +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               +--MOD_ATT:N-N-+          |           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     +MOD_ATT:+          |           |       +MOD_ATT+         +MOD_+      |      |     |      +MOD_A+    |         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (decrease,cell)
MOD_ATT:N-N (decrease,culture)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,decrease)
SUBJ:V-N (treat,production)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,decrease)
COMP:V-N(with) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 98

                              +-------------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------------+             
                              +---------------------------OBJ:V-N--------------------------+                         +-----------------------------------------------COMP:V-N(with)----------------------------------------------+             
                              |          +---------------------SUBJ:V-N--------------------+                         |                                +---------------------------------SUBJ:V-N---------------------------------+             
                              |          +---------------COMP:N-N(in)---------------+      |                         |                                |                   +--------------------COMP:V-N(with)--------------------+             
                              |          +--------COMP:N-N(of)-------+              |      |      +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               +--MOD_ATT:N-N-+          |           +-MOD_ATT:N-ADJ-+              |      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     +MOD_ATT:+          |           |       +MOD_ATT+         +MOD_+      |      |     |      +MOD_A+    |         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (decrease,cell)
MOD_ATT:N-N (decrease,culture)
COMP:N-N(of) (production,protein)
COMP:N-N(in) (production,cell)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,decrease)
SUBJ:V-N (treat,production)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,decrease)
COMP:V-N(with) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 99

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                                                                            +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                                                 +---COMP:V_PASS-N(with)---+                                |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+----SUBJ:V_PASS-N----+      +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+      |      |     |      +MOD_A+    |         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,protein)
COMP:V_PASS-N(with) (treat,__SP__)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 100

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                                                                            +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                                                 +---COMP:V_PASS-N(with)---+                                |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+----SUBJ:V_PASS-N----+      +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+      |      |     |      +MOD_A+    |         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,protein)
COMP:V_PASS-N(with) (treat,__SP__)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 101

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                                                                            +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                                                 +---COMP:V_PASS-N(with)---+                                |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+----SUBJ:V_PASS-N----+      +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+      |      |     |      +MOD_A+    |         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,protein)
COMP:V_PASS-N(with) (treat,__SP__)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 102

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                                                                            +---------------------------------SUBJ:V-N---------------------------------+             
                                         +---------------COMP:N-N(in)---------------+      +---COMP:V_PASS-N(with)---+                                |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+              |      |      +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+              |      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+SUBJ:V+      |     |      +MOD_A+    |         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
COMP:N-N(in) (production,cell)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,__SP__)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 103

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                                                                            +---------------------------------SUBJ:V-N---------------------------------+             
                                         +------------------SUBJ:V_PASS-N------------------+---COMP:V_PASS-N(with)---+                                |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+                     |      +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+      |      |     |      +MOD_A+    |         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,production)
COMP:V_PASS-N(with) (treat,__SP__)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 104

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                                                                            +---------------------------------SUBJ:V-N---------------------------------+             
                                         +------------------SUBJ:V_PASS-N------------------+---COMP:V_PASS-N(with)---+                                |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+                     |      +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+      |      |     |      +MOD_A+    |         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,production)
COMP:V_PASS-N(with) (treat,__SP__)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 105

                              +-------------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------------+             
                              +---------------------------OBJ:V-N--------------------------+                                                          +---------------------------------SUBJ:V-N---------------------------------+             
                              |          +---------------------SUBJ:V-N--------------------+                                                          |                   +--------------------COMP:V-N(with)--------------------+             
                              |          +--------COMP:N-N(of)-------+                     |      +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               +--MOD_ATT:N-N-+          |           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+      |      |     +---OBJ:V-N--+    |         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     +MOD_ATT:+          |           |       +MOD_ATT+         +MOD_+      +COMP:V-N(wit+      +SUBJ:+    |         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (decrease,cell)
MOD_ATT:N-N (decrease,culture)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,decrease)
SUBJ:V-N (treat,production)
COMP:V-N(with) (treat,agonist)
OBJ:V-N (with,Apo)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,decrease)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 106

                              +-------------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------------+             
                              +---------------------------OBJ:V-N--------------------------+                                                          +---------------------------------SUBJ:V-N---------------------------------+             
                              |          +---------------------SUBJ:V-N--------------------+                                                          |                   +--------------------COMP:V-N(with)--------------------+             
                              |          +--------COMP:N-N(of)-------+                     +--------COMP:V-N(with)--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               +--MOD_ATT:N-N-+          |           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+      |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     +MOD_ATT:+          |           |       +MOD_ATT+         +MOD_+      |            |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |            |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (decrease,cell)
MOD_ATT:N-N (decrease,culture)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,decrease)
SUBJ:V-N (treat,production)
COMP:V-N(with) (treat,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,decrease)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 107

                              +-------------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------------+             
                              +---------------------------OBJ:V-N--------------------------+                                                          +---------------------------------SUBJ:V-N---------------------------------+             
                              |          +---------------------SUBJ:V-N--------------------+                                                          |                   +--------------------COMP:V-N(with)--------------------+             
                              |          +--------COMP:N-N(of)-------+                     |      +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               +--MOD_ATT:N-N-+          |           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+      |      |     +---OBJ:V-N--+    |         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     +MOD_ATT:+          |           |       +MOD_ATT+         +MOD_+      +COMP:V-N(wit+      +SUBJ:+    |         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (decrease,cell)
MOD_ATT:N-N (decrease,culture)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,decrease)
SUBJ:V-N (treat,production)
COMP:V-N(with) (treat,agonist)
OBJ:V-N (with,Apo)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,decrease)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 108

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                          +----------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------+             
                                         |                                          |                                                                 +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                                          |      +---COMP:V_PASS-N(with)---+                                |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+              |      |      +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+              |      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+SUBJ:V+      |     |      +MOD_A+    |         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,__SP__)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(in) (__NODE__,cell)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 109

                              +-------------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------------+             
                              +---------------------------OBJ:V-N--------------------------+                                                                                                                                     |             
                              |          +---------------------SUBJ:V-N--------------------+                                                          +---------------------------------SUBJ:V-N---------------------------------+             
                              |          +---------------COMP:N-N(in)---------------+      |                                                          |                   +--------------------COMP:V-N(with)--------------------+             
                              |          +--------COMP:N-N(of)-------+              |      +--------COMP:V-N(with)--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               +--MOD_ATT:N-N-+          |           +-MOD_ATT:N-ADJ-+              |      |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     +MOD_ATT:+          |           |       +MOD_ATT+         +MOD_+      |            |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |            |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (decrease,cell)
MOD_ATT:N-N (decrease,culture)
COMP:N-N(of) (production,protein)
COMP:N-N(in) (production,cell)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,decrease)
SUBJ:V-N (treat,production)
COMP:V-N(with) (treat,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,decrease)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 110

                              +-------------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------------+             
                              +---------------------------OBJ:V-N--------------------------+                                                                                                                                     |             
                              |          +---------------------SUBJ:V-N--------------------+                                                          +---------------------------------SUBJ:V-N---------------------------------+             
                              |          +---------------COMP:N-N(in)---------------+      |                                                          |                   +--------------------COMP:V-N(with)--------------------+             
                              |          +--------COMP:N-N(of)-------+              |      +--------COMP:V-N(with)--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               +--MOD_ATT:N-N-+          |           +-MOD_ATT:N-ADJ-+              |      |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     +MOD_ATT:+          |           |       +MOD_ATT+         +MOD_+      |            |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |            |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (decrease,cell)
MOD_ATT:N-N (decrease,culture)
COMP:N-N(of) (production,protein)
COMP:N-N(in) (production,cell)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,decrease)
SUBJ:V-N (treat,production)
COMP:V-N(with) (treat,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,decrease)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 111

                              +-------------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------------+             
                              +---------------------------OBJ:V-N--------------------------+                                                                                                                                     |             
                              |          +---------------------SUBJ:V-N--------------------+                                                          +---------------------------------SUBJ:V-N---------------------------------+             
                              |          +---------------COMP:N-N(in)---------------+      |                                                          |                   +--------------------COMP:V-N(with)--------------------+             
                              |          +--------COMP:N-N(of)-------+              |      +--------COMP:V-N(with)--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               +--MOD_ATT:N-N-+          |           +-MOD_ATT:N-ADJ-+              |      |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     +MOD_ATT:+          |           |       +MOD_ATT+         +MOD_+      |            |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |            |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (decrease,cell)
MOD_ATT:N-N (decrease,culture)
COMP:N-N(of) (production,protein)
COMP:N-N(in) (production,cell)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,decrease)
SUBJ:V-N (treat,production)
COMP:V-N(with) (treat,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,decrease)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 112

                              +-------------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------------+             
                              +---------------------------OBJ:V-N--------------------------+                                                                                                                                     |             
                              |          +---------------------SUBJ:V-N--------------------+                                                          +---------------------------------SUBJ:V-N---------------------------------+             
                              |          +---------------COMP:N-N(in)---------------+      |                                                          |                   +--------------------COMP:V-N(with)--------------------+             
                              |          +--------COMP:N-N(of)-------+              |      +--------COMP:V-N(with)--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               +--MOD_ATT:N-N-+          |           +-MOD_ATT:N-ADJ-+              |      |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     +MOD_ATT:+          |           |       +MOD_ATT+         +MOD_+      |            |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |            |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (decrease,cell)
MOD_ATT:N-N (decrease,culture)
COMP:N-N(of) (production,protein)
COMP:N-N(in) (production,cell)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,decrease)
SUBJ:V-N (treat,production)
COMP:V-N(with) (treat,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,decrease)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 113

                              +-------------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------------+             
                              +---------------------------OBJ:V-N--------------------------+                         +-----------------------------------------------COMP:V-N(with)----------------------------------------------+             
                              |          +---------------------SUBJ:V-N--------------------+                         |                                +---------------------------------SUBJ:V-N---------------------------------+             
                              |          +---------------COMP:N-N(in)---------------+      |                         |                                |                   +--------------------COMP:V-N(with)--------------------+             
                              |          +--------COMP:N-N(of)-------+              |      |      +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               +--MOD_ATT:N-N-+          |           +-MOD_ATT:N-ADJ-+              |      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     +MOD_ATT:+          |           |       +MOD_ATT+         +MOD_+      |      |     |      +MOD_A+    |         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (decrease,cell)
MOD_ATT:N-N (decrease,culture)
COMP:N-N(of) (production,protein)
COMP:N-N(in) (production,cell)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,decrease)
SUBJ:V-N (treat,production)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,decrease)
COMP:V-N(with) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 114

                                         +----------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------+                     
                                         |                                          +--------------------------------------------------------------SUBJ:V-N--------------------------------------------------------------+                     
                                         |                                          |      +------------------------------------------------COMP:V_PASS-N(with)-----------------------------------------------+          |                     
                                         |                                          |      +-----------------------------------------COMP:V_PASS-N(with)-----------------------------------------+            |          |                     
                                         |                                          |      +------------------------------COMP:V_PASS-N(with)-----------------------------+                      |            |          |                     
                                         |                                          |      |      +----------------------OBJ:V-N----------------------+                   |                      |            |          |                     
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+              |      +------COMP:V_PASS-N(with)-----+                           |                   |                      |            |          |                     
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+              |      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+          +----OBJ:V-N----+     
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+COMP:N-N(+    +SUBJ:V+      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          |       +MOD_ATT+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,Apo)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
COMP:V_PASS-N(with) (treat,overproduce)
OBJ:V-N (with,antibody)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__SP__,production)
SUBJ:V-N (__SP__,cell)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 115

                              +---------------------------------------------------------------------------------COMP:V-N(with)--------------------------------------------------------------------------------+                                
                              +--------------------------------------------------------------------------COMP:V-N(with)--------------------------------------------------------------------------+            |                                
                              +---------------------------------------------------------------COMP:V-N(with)--------------------------------------------------------------+                      |            |                                
                              +---------------------------------------COMP:V-N(with)--------------------------------------+                                               |                      |            |                                
                              +---------------------COMP:V-N(in)--------------------+                                     |                                      +--------------------------------OBJ:V-N--------------------------------+     
                              |          +--------COMP:N-N(of)-------+              |             +----------------------OBJ:V-N----------------------+          |        |             +---------------------OBJ:V-N--------------------+     
     +--MOD_ATT:N-N--+        |          |           +-MOD_ATT:N-ADJ-+              |             |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+          |        |             |    +--MOD_ATT:N-ADJ-+          +-MOD_ATT:N-ADJ-+     
     |         +MOD_A+SUBJ:V-N+--OBJ:V-N-+           |       +MOD_ATT+         +MOD_+SUBJ:V+      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+          |        |             |    +MOD+            |          |       +MOD_ATT+     
     |         |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |          |        |             |    |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,SB203580)
MOD_ATT:N-N (culture,cell)
SUBJ:V-N (decrease,culture)
OBJ:V-N (decrease,production)
COMP:V-N(in) (decrease,cell)
COMP:V-N(with) (decrease,Apo)
COMP:V-N(with) (decrease,cycloheximide)
COMP:V-N(with) (decrease,FMK)
COMP:V-N(with) (decrease,overproduce)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,antibody)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (with,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 116

                              +---------------------------------------------------------------------------------------------SUBJ:V-N---------------------------------------------------------------------------------------------+             
                              |                                                            +--------------------------------------------------COMP:V-N(with)--------------------------------------------------+                  |             
                              +---------------------------OBJ:V-N--------------------------+--------------------------------------------COMP:V-N(with)-------------------------------------------+            |                  |             
                              |          +---------------------SUBJ:V-N--------------------+--------------------------------COMP:V-N(with)--------------------------------+                      |            |                  |             
                              |          +---------------COMP:N-N(in)---------------+      |      +----------------------OBJ:V-N----------------------+                   |                      |            |                  |             
     +-------MOD_ATT:N-N------+          +--------COMP:N-N(of)-------+              |      +--------COMP:V-N(with)--------+                           |                   |                      |            |                  |             
     |         +--MOD_ATT:N-N-+          |           +-MOD_ATT:N-ADJ-+              |      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |             +-------------OBJ:V-N------------+       |             
     |         |     +MOD_ATT:+          |           |       +MOD_ATT+         +MOD_+      |      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |             |    +MOD+            |          |       +OBJ:V-N+     
     |         |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |             |    |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (decrease,SB203580)
MOD_ATT:N-N (decrease,cell)
MOD_ATT:N-N (decrease,culture)
COMP:N-N(of) (production,protein)
COMP:N-N(in) (production,cell)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,decrease)
SUBJ:V-N (treat,production)
COMP:V-N(with) (treat,Apo)
COMP:V-N(with) (treat,cycloheximide)
COMP:V-N(with) (treat,FMK)
COMP:V-N(with) (treat,overproduce)
OBJ:V-N (with,antibody)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (with,__SP__)
MOD_ATT:N-ADJ (FMK,zVAD)
SUBJ:V-N (__NODE__,decrease)
OBJ:V-N (__NODE__,protein)

Analyse 117

                                                                                           +------------------------------------------------COMP:V_PASS-N(with)-----------------------------------------------+                                
                                                                                           +-----------------------------------------COMP:V_PASS-N(with)-----------------------------------------+            |                                
                                                                                           +------------------------------COMP:V_PASS-N(with)-----------------------------+                      |            |                                
                              +---------------------COMP:V-N(in)--------------------+      |      +----------------------OBJ:V-N----------------------+          +--------------------------------OBJ:V-N--------------------------------+     
                              |          +--------COMP:N-N(of)-------+              |      +------COMP:V_PASS-N(with)-----+                           |          |        |             +---------------------OBJ:V-N--------------------+     
     +--MOD_ATT:N-N--+        |          |           +-MOD_ATT:N-ADJ-+              |      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+          |        |             |        |            |          +-MOD_ATT:N-ADJ-+     
     |         +MOD_A+SUBJ:V-N+--OBJ:V-N-+           |       +MOD_ATT+         +MOD_+SUBJ:V+      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+          |        |             |    +MOD+            |          |       +MOD_ATT+     
     |         |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |          |        |             |    |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,SB203580)
MOD_ATT:N-N (culture,cell)
SUBJ:V-N (decrease,culture)
OBJ:V-N (decrease,production)
COMP:V-N(in) (decrease,cell)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,Apo)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
COMP:V_PASS-N(with) (treat,overproduce)
OBJ:V-N (with,antibody)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (with,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 118

                                                                                           +--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+                     
                                                                                           +--------------------------------COMP:V-N(with)--------------------------------+                                              |                     
                     +-----------------------------COMP:V-N(in)----------------------------+                                                                     +--------------------------------OBJ:V-N--------------------------------+     
                     |                   +---------------------SUBJ:V-N--------------------+      +----------------------OBJ:V-N----------------------+          |        |             +---------------------OBJ:V-N--------------------+     
                     |                   +--------COMP:N-N(of)-------+                     +--------COMP:V-N(with)--------+                           |          |        |             |    +-------MOD_ATT:N-ADJ-------+               |     
                     |                   |           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+          |        |             |    |   +------MOD_ATT:N-N------+               |     
               +MOD_A+        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+      |      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+          |        |             |    |   |            +MOD_ATT:N-+       +MOD_ATT+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |          |        |             |    |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
COMP:V-N(in) (treat,culture)
SUBJ:V-N (treat,production)
COMP:V-N(with) (treat,Apo)
COMP:V-N(with) (treat,cycloheximide)
COMP:V-N(with) (treat,__SP__)
OBJ:V-N (with,antibody)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (with,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (__SP__,zVAD)
MOD_ATT:N-N (__SP__,FMK)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 119

                                                                                           +--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+                     
                                                                                           +--------------------------------------------COMP:V-N(with)-------------------------------------------+                       |                     
                                                                                           +--------------------------------COMP:V-N(with)--------------------------------+                      |                       |                     
                                         +---------------------OBJ:V-N---------------------+      +----------------------OBJ:V-N----------------------+          +--------------------------------OBJ:V-N--------------------------------+     
                                         +--------COMP:N-N(of)-------+                     +--------COMP:V-N(with)--------+                           |          |        |             +---------------------OBJ:V-N--------------------+     
     +--MOD_ATT:N-N--+                   |           +-MOD_ATT:N-ADJ-+                     |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+          |        |             |    +-------MOD_ATT:N-ADJ-------+               |     
     |         +MOD_A+SUBJ:V-N+--OBJ:V-N-+           |       +MOD_ATT+COMP:N-N(+    +SUBJ:V+      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+          |        |             |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+     
     |         |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |          |        |             |    |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,SB203580)
MOD_ATT:N-N (culture,cell)
SUBJ:V-N (decrease,culture)
OBJ:V-N (decrease,production)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,Hela)
OBJ:V-N (treat,production)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,Apo)
COMP:V-N(with) (treat,cycloheximide)
COMP:V-N(with) (treat,FMK)
COMP:V-N(with) (treat,__SP__)
OBJ:V-N (with,antibody)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (with,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__SP__,zVAD)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 120

                              +--------------------------------------------------------------------------------------COMP:V-N(with)--------------------------------------------------------------------------------------+                     
                              +--------------------------------------------------------------------------COMP:V-N(with)--------------------------------------------------------------------------+                       |                     
                              +---------------------------------------------------------------COMP:V-N(with)--------------------------------------------------------------+                      |                       |                     
                              +---------------------------------------COMP:V-N(with)--------------------------------------+                                               |                      |                       |                     
                              |                              +-----------OBJ:V-N-----------+                              |                                      +--------------------------------OBJ:V-N--------------------------------+     
                              |                              |       +-------SUBJ:V-N------+      +----------------------OBJ:V-N----------------------+          |        |             +---------------------OBJ:V-N--------------------+     
     +--MOD_ATT:N-N--+        |          +----COMP:N-N(of)---+       +-COMP:N-N(in)-+      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+          |        |             |    +-------MOD_ATT:N-ADJ-------+               |     
     |         +MOD_A+SUBJ:V-N+--OBJ:V-N-+           +MOD_ATT+       |         +MOD_+      |      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+          |        |             |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+     
     |         |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |          |        |             |    |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,SB203580)
MOD_ATT:N-N (culture,cell)
SUBJ:V-N (decrease,culture)
OBJ:V-N (decrease,production)
COMP:V-N(with) (decrease,Apo)
COMP:V-N(with) (decrease,cycloheximide)
COMP:V-N(with) (decrease,FMK)
COMP:V-N(with) (decrease,__SP__)
COMP:N-N(of) (production,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__NODE__)
SUBJ:V-N (treat,protein)
OBJ:V-N (with,antibody)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (with,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__SP__,zVAD)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 121

                                                                                           +--------------------------------------------------COMP:V-N(with)--------------------------------------------------+                                
                                                                                           +--------------------------------------------COMP:V-N(with)-------------------------------------------+            |                                
                                                                                           +--------------------------------COMP:V-N(with)--------------------------------+                      |            |                                
                                         +---------------------OBJ:V-N---------------------+      +----------------------OBJ:V-N----------------------+                   |                      |            |                                
                                         |                           +-------SUBJ:V-N------+--------COMP:V-N(with)--------+                           |                   |             +---------------------OBJ:V-N--------------------+     
     +--MOD_ATT:N-N--+                   |                           +-COMP:N-N(in)-+      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |             |    +--MOD_ATT:N-ADJ-+          +-MOD_ATT:N-ADJ-+     
     |         +MOD_A+SUBJ:V-N+--OBJ:V-N-+COMP:N-N(of+       +MOD_ATT+         +MOD_+      |      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |             |    +MOD+            |          |       +MOD_ATT+     
     |         |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |             |    |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,SB203580)
MOD_ATT:N-N (culture,cell)
SUBJ:V-N (decrease,culture)
OBJ:V-N (decrease,production)
COMP:N-N(of) (production,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,production)
SUBJ:V-N (treat,protein)
COMP:V-N(with) (treat,Apo)
COMP:V-N(with) (treat,cycloheximide)
COMP:V-N(with) (treat,FMK)
COMP:V-N(with) (treat,overproduce)
OBJ:V-N (with,antibody)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 122

                                                                                           +------------------------------------------------------------COMP:V-N(with)-----------------------------------------------------------+             
                                                                                           +--------------------------------------------COMP:V-N(with)-------------------------------------------+                               |             
                     +-----------------------------COMP:V-N(in)----------------------------+--------------------------------COMP:V-N(with)--------------------------------+                      |                               |             
                     |                   +---------------------SUBJ:V-N--------------------+      +----------------------OBJ:V-N----------------------+          +--------------------------------OBJ:V-N--------------------------------+     
                     |                   +--------COMP:N-N(of)-------+                     +--------COMP:V-N(with)--------+                           |          |        |             +---------------------OBJ:V-N--------------------+     
                     |                   |           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+          |        |             |        |            +---MOD_ATT:N-ADJ--+       |     
               +MOD_A+        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+      |      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+          |        |             |    +MOD+            |          +MOD_ATT+       |     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |          |        |             |    |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
COMP:V-N(in) (treat,culture)
SUBJ:V-N (treat,production)
COMP:V-N(with) (treat,Apo)
COMP:V-N(with) (treat,cycloheximide)
COMP:V-N(with) (treat,FMK)
COMP:V-N(with) (treat,__NODE__)
OBJ:V-N (with,antibody)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (with,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__NODE__,overproduce)
MOD_ATT:N-ADJ (__NODE__,__SP__)

Analyse 123

                                                                                           +--------------------------------------------------COMP:V-N(with)--------------------------------------------------+                                
                                                                                           +--------------------------------------------COMP:V-N(with)-------------------------------------------+            |                                
                              +------------------------COMP:V-N(in)------------------------+--------------------------------COMP:V-N(with)--------------------------------+                      |            |                                
                              |          +---------------------SUBJ:V-N--------------------+      +----------------------OBJ:V-N----------------------+                   |                      |            |                                
                              |          +--------COMP:N-N(of)-------+                     +--------COMP:V-N(with)--------+                           |                   |             +---------------------OBJ:V-N--------------------+     
               +--MOD_ATT:N-N-+          |           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |             |    +--MOD_ATT:N-ADJ-+          +-MOD_ATT:N-ADJ-+     
               |     +MOD_ATT:+          |           |       +MOD_ATT+         +MOD_+      |      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |             |    +MOD+            |          |       +MOD_ATT+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |             |    |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (decrease,cell)
MOD_ATT:N-N (decrease,culture)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
COMP:V-N(in) (treat,decrease)
SUBJ:V-N (treat,production)
COMP:V-N(with) (treat,Apo)
COMP:V-N(with) (treat,cycloheximide)
COMP:V-N(with) (treat,FMK)
COMP:V-N(with) (treat,overproduce)
OBJ:V-N (with,antibody)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 124

                                                                                           +--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+                     
                     +-----------------------------COMP:V-N(in)----------------------------+--------------------------------------------COMP:V-N(with)-------------------------------------------+                       |                     
                     |                   +---------------------SUBJ:V-N--------------------+--------------------------------COMP:V-N(with)--------------------------------+                      |                       |                     
                     |                   +---------------COMP:N-N(in)---------------+      |      +----------------------OBJ:V-N----------------------+                   |                      |                       |                     
                     |                   +--------COMP:N-N(of)-------+              |      +--------COMP:V-N(with)--------+                           |                   |                      |                       |                     
                     |                   |           +-MOD_ATT:N-ADJ-+              |      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |             +---------------------OBJ:V-N--------------------+     
               +MOD_A+        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+      |      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |             |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |             |    |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
COMP:N-N(in) (production,cell)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (cell,Hela)
COMP:V-N(in) (treat,culture)
SUBJ:V-N (treat,production)
COMP:V-N(with) (treat,Apo)
COMP:V-N(with) (treat,cycloheximide)
COMP:V-N(with) (treat,FMK)
COMP:V-N(with) (treat,__SP__)
OBJ:V-N (with,antibody)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 125

                                                                                           +--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+                     
                                                                                           +--------------------------------------------COMP:V-N(with)-------------------------------------------+                       |                     
                                         +-------------------COMP:V-N(in)------------------+--------------------------------COMP:V-N(with)--------------------------------+                      |                       |                     
                                         |                   +---------COMP:V-N(of)--------+      +----------------------OBJ:V-N----------------------+                   |                      |                       |                     
               +-------MOD_ATT:N-N-------+                   |       +-------SUBJ:V-N------+--------COMP:V-N(with)--------+                           |                   |                      |                       |                     
               |     +----MOD_ATT:N-N----+                   |       +-COMP:N-N(in)-+      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |             +---------------------OBJ:V-N--------------------+     
               |     |        +MOD_ATT:N-+           +MOD_ATT+       |         +MOD_+      |      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |             |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |             |    |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
COMP:V-N(in) (treat,production)
COMP:V-N(of) (treat,__NODE__)
SUBJ:V-N (treat,protein)
COMP:V-N(with) (treat,Apo)
COMP:V-N(with) (treat,cycloheximide)
COMP:V-N(with) (treat,FMK)
COMP:V-N(with) (treat,__SP__)
OBJ:V-N (with,antibody)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 126

                                                                                           +--------------------------------------------------COMP:V-N(with)--------------------------------------------------+                                
                                                                                           +--------------------------------------------COMP:V-N(with)-------------------------------------------+            |                                
                                                                                           +--------------------------------COMP:V-N(with)--------------------------------+                      |            |                                
                                                     +---------------OBJ:V-N---------------+      +----------------------OBJ:V-N----------------------+                   |                      |            |                                
                                                     |               +-------SUBJ:V-N------+--------COMP:V-N(with)--------+                           |                   |             +---------------------OBJ:V-N--------------------+     
     +--MOD_ATT:N-N--+                               |               +-COMP:N-N(in)-+      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |             |        |            |          +-MOD_ATT:N-ADJ-+     
     |         +MOD_A+SUBJ:V-N+--OBJ:V-N-+COMP:N-N(of+       +MOD_ATT+         +MOD_+      |      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |             |    +MOD+            |          |       +MOD_ATT+     
     |         |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |             |    |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,SB203580)
MOD_ATT:N-N (culture,cell)
SUBJ:V-N (decrease,culture)
OBJ:V-N (decrease,production)
COMP:N-N(of) (production,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__SP__)
SUBJ:V-N (treat,protein)
COMP:V-N(with) (treat,Apo)
COMP:V-N(with) (treat,cycloheximide)
COMP:V-N(with) (treat,FMK)
COMP:V-N(with) (treat,overproduce)
OBJ:V-N (with,antibody)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 127

                                                                                           +------------------------------------------------------------COMP:V-N(with)-----------------------------------------------------------+             
                                                                                           +--------------------------------------------COMP:V-N(with)-------------------------------------------+                               |             
                                                                                           +--------------------------------COMP:V-N(with)--------------------------------+                      |                               |             
                                                             +-----------OBJ:V-N-----------+      +----------------------OBJ:V-N----------------------+                   |                      |                               |             
                                                             |       +-------SUBJ:V-N------+--------COMP:V-N(with)--------+                           |                   |             +---------------------OBJ:V-N--------------------+     
     +--MOD_ATT:N-N--+                   +----COMP:N-N(of)---+       +-COMP:N-N(in)-+      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |             |        |            +----MOD_ATT:N-N---+       |     
     |         +MOD_A+SUBJ:V-N+--OBJ:V-N-+           +MOD_ATT+       |         +MOD_+      |      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |             |    +MOD+            |          +MOD_ATT+       |     
     |         |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |             |    |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,SB203580)
MOD_ATT:N-N (culture,cell)
SUBJ:V-N (decrease,culture)
OBJ:V-N (decrease,production)
COMP:N-N(of) (production,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__NODE__)
SUBJ:V-N (treat,protein)
COMP:V-N(with) (treat,Apo)
COMP:V-N(with) (treat,cycloheximide)
COMP:V-N(with) (treat,FMK)
COMP:V-N(with) (treat,__NODE__)
OBJ:V-N (with,antibody)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (__NODE__,overproduce)
MOD_ATT:N-ADJ (__NODE__,__SP__)

Analyse 128

                              +------------------------------------------------------------------------------------------COMP:V-N(with)------------------------------------------------------------------------------------------+             
                              +--------------------------------------------------------------------------COMP:V-N(with)--------------------------------------------------------------------------+                               |             
                              +---------------------------------------------------------------COMP:V-N(with)--------------------------------------------------------------+                      |                               |             
                              +---------------------------------------COMP:V-N(with)--------------------------------------+                                               |                      |                               |             
                              |          +--------COMP:N-N(of)-------+                            +----------------------OBJ:V-N----------------------+                   |             +---------------------OBJ:V-N--------------------+     
     +--MOD_ATT:N-N--+        |          |           +-MOD_ATT:N-ADJ-+-------OBJ:V-N-------+      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |             |        |            +----MOD_ATT:N-N---+       |     
     |         +MOD_A+SUBJ:V-N+--OBJ:V-N-+           |       +MOD_ATT+COMP:N-N(+    +SUBJ:V+      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |             |    +MOD+            |          +MOD_ATT+       |     
     |         |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |             |    |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,SB203580)
MOD_ATT:N-N (culture,cell)
SUBJ:V-N (decrease,culture)
OBJ:V-N (decrease,production)
COMP:V-N(with) (decrease,Apo)
COMP:V-N(with) (decrease,cycloheximide)
COMP:V-N(with) (decrease,FMK)
COMP:V-N(with) (decrease,__NODE__)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,Hela)
OBJ:V-N (treat,protein)
SUBJ:V-N (treat,cell)
OBJ:V-N (with,antibody)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (__NODE__,overproduce)
MOD_ATT:N-ADJ (__NODE__,__SP__)

Analyse 129

                                                                                           +------------------------------------------------------------COMP:V-N(with)-----------------------------------------------------------+             
                              +------------------------COMP:V-N(in)------------------------+--------------------------------------------COMP:V-N(with)-------------------------------------------+                               |             
                              |          +---------------------SUBJ:V-N--------------------+--------------------------------COMP:V-N(with)--------------------------------+                      |                               |             
                              |          +---------------COMP:N-N(in)---------------+      |      +----------------------OBJ:V-N----------------------+                   |                      |                               |             
                              |          +--------COMP:N-N(of)-------+              |      +--------COMP:V-N(with)--------+                           |                   |             +---------------------OBJ:V-N--------------------+     
               +--MOD_ATT:N-N-+          |           +-MOD_ATT:N-ADJ-+              |      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |             |        |            +----MOD_ATT:N-N---+       |     
               |     +MOD_ATT:+          |           |       +MOD_ATT+         +MOD_+      |      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |             |    +MOD+            |          +MOD_ATT+       |     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |             |    |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (decrease,cell)
MOD_ATT:N-N (decrease,culture)
COMP:N-N(of) (production,protein)
COMP:N-N(in) (production,cell)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (cell,Hela)
COMP:V-N(in) (treat,decrease)
SUBJ:V-N (treat,production)
COMP:V-N(with) (treat,Apo)
COMP:V-N(with) (treat,cycloheximide)
COMP:V-N(with) (treat,FMK)
COMP:V-N(with) (treat,__NODE__)
OBJ:V-N (with,antibody)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (__NODE__,overproduce)
MOD_ATT:N-ADJ (__NODE__,__SP__)

Analyse 130

                              +---------------------------------------------------------------------------------COMP:V-N(with)--------------------------------------------------------------------------------+                                
                              +--------------------------------------------------------------------------COMP:V-N(with)--------------------------------------------------------------------------+            |                                
                              +---------------------------------------------------------------COMP:V-N(with)--------------------------------------------------------------+                      |            |                                
                              +---------------------------------------COMP:V-N(with)--------------------------------------+                                               |                      |            |                                
                              |          +---------------------OBJ:V-N---------------------+                              |                                               |                      |            |                                
                              |          |                           +-------SUBJ:V-N------+      +----------------------OBJ:V-N----------------------+                   |             +---------------------OBJ:V-N--------------------+     
     +--MOD_ATT:N-N--+        |          +----COMP:N-N(of)---+       +-COMP:N-N(in)-+      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |             |        |            |          +-MOD_ATT:N-ADJ-+     
     |         +MOD_A+SUBJ:V-N+--OBJ:V-N-+           +MOD_ATT+       |         +MOD_+      |      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |             |    +MOD+            |          |       +MOD_ATT+     
     |         |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |             |    |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,SB203580)
MOD_ATT:N-N (culture,cell)
SUBJ:V-N (decrease,culture)
OBJ:V-N (decrease,production)
COMP:V-N(with) (decrease,Apo)
COMP:V-N(with) (decrease,cycloheximide)
COMP:V-N(with) (decrease,FMK)
COMP:V-N(with) (decrease,overproduce)
COMP:N-N(of) (production,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,production)
SUBJ:V-N (treat,protein)
OBJ:V-N (with,antibody)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 131

                              +------------------------------------------------------------------------------------------COMP:V-N(with)------------------------------------------------------------------------------------------+             
                              +--------------------------------------------------------------------------COMP:V-N(with)--------------------------------------------------------------------------+                               |             
                              +---------------------------------------------------------------COMP:V-N(with)--------------------------------------------------------------+                      |                               |             
                              +---------------------------------------COMP:V-N(with)--------------------------------------+                                               |                      |                               |             
                              |          +---------------------OBJ:V-N---------------------+                              |                                               |                      |                               |             
                              |          +--------COMP:N-N(of)-------+                     |      +----------------------OBJ:V-N----------------------+                   |             +---------------------OBJ:V-N--------------------+     
     +--MOD_ATT:N-N--+        |          |           +-MOD_ATT:N-ADJ-+                     |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |             |        |            +----MOD_ATT:N-N---+       |     
     |         +MOD_A+SUBJ:V-N+--OBJ:V-N-+           |       +MOD_ATT+COMP:N-N(+    +SUBJ:V+      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |             |    +MOD+            |          +MOD_ATT+       |     
     |         |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |             |    |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,SB203580)
MOD_ATT:N-N (culture,cell)
SUBJ:V-N (decrease,culture)
OBJ:V-N (decrease,production)
COMP:V-N(with) (decrease,Apo)
COMP:V-N(with) (decrease,cycloheximide)
COMP:V-N(with) (decrease,FMK)
COMP:V-N(with) (decrease,__NODE__)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,Hela)
OBJ:V-N (treat,production)
SUBJ:V-N (treat,cell)
OBJ:V-N (with,antibody)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (__NODE__,overproduce)
MOD_ATT:N-ADJ (__NODE__,__SP__)

Analyse 132

                                                                                           +--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+                     
                                                                                           +--------------------------------------------COMP:V-N(with)-------------------------------------------+                       |                     
                                         +-------------------COMP:V-N(in)------------------+--------------------------------COMP:V-N(with)--------------------------------+                      |                       |                     
                                         +-------------COMP:N-N(in)------------+           |      +----------------------OBJ:V-N----------------------+                   |                      |                       |                     
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+         |           +--------COMP:V-N(with)--------+                           |                   |             +---------------------OBJ:V-N--------------------+     
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+         |           |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |             |    +-------MOD_ATT:N-ADJ-------+               |     
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         |    +SUBJ:V+      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |             |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |             |    |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
COMP:N-N(in) (production,Hela)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:V-N(in) (treat,production)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,Apo)
COMP:V-N(with) (treat,cycloheximide)
COMP:V-N(with) (treat,FMK)
COMP:V-N(with) (treat,__SP__)
OBJ:V-N (with,antibody)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__SP__,zVAD)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 133

                                                                                           +--------------------------------------------------COMP:V-N(with)--------------------------------------------------+                                
                                                                                           +--------------------------------------------COMP:V-N(with)-------------------------------------------+            |                                
                                                                                           +--------------------------------COMP:V-N(with)--------------------------------+                      |            |                                
                                                     +---------------OBJ:V-N---------------+      +----------------------OBJ:V-N----------------------+                   |                      |            |                                
                                                     |               +-------SUBJ:V-N------+--------COMP:V-N(with)--------+                           |                   |             +---------------------OBJ:V-N--------------------+     
     +--MOD_ATT:N-N--+                               |               +-COMP:N-N(in)-+      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |             |    +--MOD_ATT:N-ADJ-+          +-MOD_ATT:N-ADJ-+     
     |         +MOD_A+SUBJ:V-N+--OBJ:V-N-+COMP:N-N(of+       +MOD_ATT+         +MOD_+      |      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |             |    +MOD+            |          |       +MOD_ATT+     
     |         |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |             |    |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,SB203580)
MOD_ATT:N-N (culture,cell)
SUBJ:V-N (decrease,culture)
OBJ:V-N (decrease,production)
COMP:N-N(of) (production,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__SP__)
SUBJ:V-N (treat,protein)
COMP:V-N(with) (treat,Apo)
COMP:V-N(with) (treat,cycloheximide)
COMP:V-N(with) (treat,FMK)
COMP:V-N(with) (treat,overproduce)
OBJ:V-N (with,antibody)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 134

                                                                                           +--------------------------------------------------COMP:V-N(with)--------------------------------------------------+                                
                                                                                           +--------------------------------------------COMP:V-N(with)-------------------------------------------+            |                                
                                                                                           +--------------------------------COMP:V-N(with)--------------------------------+                      |            |                                
                                         +---------------------OBJ:V-N---------------------+      +----------------------OBJ:V-N----------------------+                   |                      |            |                                
                                         |                           +-------SUBJ:V-N------+--------COMP:V-N(with)--------+                           |                   |             +---------------------OBJ:V-N--------------------+     
     +--MOD_ATT:N-N--+                   +----COMP:N-N(of)---+       +-COMP:N-N(in)-+      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |             |    +--MOD_ATT:N-ADJ-+          +-MOD_ATT:N-ADJ-+     
     |         +MOD_A+SUBJ:V-N+--OBJ:V-N-+           +MOD_ATT+       |         +MOD_+      |      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |             |    +MOD+            |          |       +MOD_ATT+     
     |         |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |             |    |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,SB203580)
MOD_ATT:N-N (culture,cell)
SUBJ:V-N (decrease,culture)
OBJ:V-N (decrease,production)
COMP:N-N(of) (production,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,production)
SUBJ:V-N (treat,protein)
COMP:V-N(with) (treat,Apo)
COMP:V-N(with) (treat,cycloheximide)
COMP:V-N(with) (treat,FMK)
COMP:V-N(with) (treat,overproduce)
OBJ:V-N (with,antibody)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 135

                                                                                           +--------------------------------------------------COMP:V-N(with)--------------------------------------------------+                                
                                                                                           +--------------------------------------------COMP:V-N(with)-------------------------------------------+            |                                
                                                                                           +--------------------------------COMP:V-N(with)--------------------------------+                      |            |                                
                                         +---------------------OBJ:V-N---------------------+      +----------------------OBJ:V-N----------------------+                   |                      |            |                                
                                         |                           +-------SUBJ:V-N------+--------COMP:V-N(with)--------+                           |                   |             +---------------------OBJ:V-N--------------------+     
     +--MOD_ATT:N-N--+                   +----COMP:N-N(of)---+       +-COMP:N-N(in)-+      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |             |    +--MOD_ATT:N-ADJ-+          +-MOD_ATT:N-ADJ-+     
     |         +MOD_A+SUBJ:V-N+--OBJ:V-N-+           +MOD_ATT+       |         +MOD_+      |      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |             |    +MOD+            |          |       +MOD_ATT+     
     |         |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |             |    |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,SB203580)
MOD_ATT:N-N (culture,cell)
SUBJ:V-N (decrease,culture)
OBJ:V-N (decrease,production)
COMP:N-N(of) (production,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,production)
SUBJ:V-N (treat,protein)
COMP:V-N(with) (treat,Apo)
COMP:V-N(with) (treat,cycloheximide)
COMP:V-N(with) (treat,FMK)
COMP:V-N(with) (treat,overproduce)
OBJ:V-N (with,antibody)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 136

                                                                                           +--------------------------------------------------COMP:V-N(with)--------------------------------------------------+                                
                                                                                           +--------------------------------------------COMP:V-N(with)-------------------------------------------+            |                                
                                                                                           +--------------------------------COMP:V-N(with)--------------------------------+                      |            |                                
                                                                                           |      +----------------------OBJ:V-N----------------------+                   |                      |            |                                
                                         +--------COMP:N-N(of)-------+                     +--------COMP:V-N(with)--------+                           |                   |             +---------------------OBJ:V-N--------------------+     
     +--MOD_ATT:N-N--+                   |           +-MOD_ATT:N-ADJ-+-------OBJ:V-N-------+      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |             |        |            |          +-MOD_ATT:N-ADJ-+     
     |         +MOD_A+SUBJ:V-N+--OBJ:V-N-+           |       +MOD_ATT+COMP:N-N(+    +SUBJ:V+      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |             |    +MOD+            |          |       +MOD_ATT+     
     |         |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |             |    |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,SB203580)
MOD_ATT:N-N (culture,cell)
SUBJ:V-N (decrease,culture)
OBJ:V-N (decrease,production)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,Hela)
OBJ:V-N (treat,protein)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,Apo)
COMP:V-N(with) (treat,cycloheximide)
COMP:V-N(with) (treat,FMK)
COMP:V-N(with) (treat,overproduce)
OBJ:V-N (with,antibody)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 137

                                                                                           +--------------------------------------------------COMP:V-N(with)--------------------------------------------------+                                
                                                                                           +--------------------------------------------COMP:V-N(with)-------------------------------------------+            |                                
                                                                                           +--------------------------------COMP:V-N(with)--------------------------------+                      |            |                                
                                                             +-----------OBJ:V-N-----------+      +----------------------OBJ:V-N----------------------+                   |                      |            |                                
                                                             |       +-------SUBJ:V-N------+--------COMP:V-N(with)--------+                           |                   |             +---------------------OBJ:V-N--------------------+     
     +--MOD_ATT:N-N--+                   +----COMP:N-N(of)---+       +-COMP:N-N(in)-+      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |             |        |            |          +-MOD_ATT:N-ADJ-+     
     |         +MOD_A+SUBJ:V-N+--OBJ:V-N-+           +MOD_ATT+       |         +MOD_+      |      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |             |    +MOD+            |          |       +MOD_ATT+     
     |         |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |             |    |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,SB203580)
MOD_ATT:N-N (culture,cell)
SUBJ:V-N (decrease,culture)
OBJ:V-N (decrease,production)
COMP:N-N(of) (production,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__NODE__)
SUBJ:V-N (treat,protein)
COMP:V-N(with) (treat,Apo)
COMP:V-N(with) (treat,cycloheximide)
COMP:V-N(with) (treat,FMK)
COMP:V-N(with) (treat,overproduce)
OBJ:V-N (with,antibody)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 138

                                                                                           +------------------------------------------------------------COMP:V-N(with)-----------------------------------------------------------+             
                                                                                           +--------------------------------------------COMP:V-N(with)-------------------------------------------+                               |             
                                                                                           +--------------------------------COMP:V-N(with)--------------------------------+                      |                               |             
                                         +---------------------OBJ:V-N---------------------+      +----------------------OBJ:V-N----------------------+                   |                      |                               |             
                                         |                           +-------SUBJ:V-N------+--------COMP:V-N(with)--------+                           |                   |             +---------------------OBJ:V-N--------------------+     
     +--MOD_ATT:N-N--+                   +----COMP:N-N(of)---+       +-COMP:N-N(in)-+      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |             |        |            +----MOD_ATT:N-N---+       |     
     |         +MOD_A+SUBJ:V-N+--OBJ:V-N-+           +MOD_ATT+       |         +MOD_+      |      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |             |    +MOD+            |          +MOD_ATT+       |     
     |         |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |             |    |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,SB203580)
MOD_ATT:N-N (culture,cell)
SUBJ:V-N (decrease,culture)
OBJ:V-N (decrease,production)
COMP:N-N(of) (production,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,production)
SUBJ:V-N (treat,protein)
COMP:V-N(with) (treat,Apo)
COMP:V-N(with) (treat,cycloheximide)
COMP:V-N(with) (treat,FMK)
COMP:V-N(with) (treat,__NODE__)
OBJ:V-N (with,antibody)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (__NODE__,overproduce)
MOD_ATT:N-ADJ (__NODE__,__SP__)

Analyse 139

                                                                                           +--------------------------------------------------COMP:V-N(with)--------------------------------------------------+                                
                                                                                           +--------------------------------------------COMP:V-N(with)-------------------------------------------+            |                                
                              +------------------------COMP:V-N(in)------------------------+--------------------------------COMP:V-N(with)--------------------------------+                      |            |                                
                              |          +---------------------SUBJ:V-N--------------------+      +----------------------OBJ:V-N----------------------+                   |                      |            |                                
                              |          +--------COMP:N-N(of)-------+                     +--------COMP:V-N(with)--------+                           |                   |             +---------------------OBJ:V-N--------------------+     
               +--MOD_ATT:N-N-+          |           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |             |        |            |          +-MOD_ATT:N-ADJ-+     
               |     +MOD_ATT:+          |           |       +MOD_ATT+         +MOD_+      |      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |             |    +MOD+            |          |       +MOD_ATT+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |             |    |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (decrease,cell)
MOD_ATT:N-N (decrease,culture)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
COMP:V-N(in) (treat,decrease)
SUBJ:V-N (treat,production)
COMP:V-N(with) (treat,Apo)
COMP:V-N(with) (treat,cycloheximide)
COMP:V-N(with) (treat,FMK)
COMP:V-N(with) (treat,overproduce)
OBJ:V-N (with,antibody)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 140

                              +---------------------------------------------------------------------------------COMP:V-N(with)--------------------------------------------------------------------------------+                                
                              +--------------------------------------------------------------------------COMP:V-N(with)--------------------------------------------------------------------------+            |                                
                              +---------------------------------------------------------------COMP:V-N(with)--------------------------------------------------------------+                      |            |                                
                              +---------------------------------------COMP:V-N(with)--------------------------------------+                                               |                      |            |                                
                              |                      +---------------OBJ:V-N---------------+                              |                                               |                      |            |                                
                              |                      |               +-------SUBJ:V-N------+      +----------------------OBJ:V-N----------------------+                   |             +---------------------OBJ:V-N--------------------+     
     +--MOD_ATT:N-N--+        |                      |               +-COMP:N-N(in)-+      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |             |        |            |          +-MOD_ATT:N-ADJ-+     
     |         +MOD_A+SUBJ:V-N+--OBJ:V-N-+COMP:N-N(of+       +MOD_ATT+         +MOD_+      |      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |             |    +MOD+            |          |       +MOD_ATT+     
     |         |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |             |    |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,SB203580)
MOD_ATT:N-N (culture,cell)
SUBJ:V-N (decrease,culture)
OBJ:V-N (decrease,production)
COMP:V-N(with) (decrease,Apo)
COMP:V-N(with) (decrease,cycloheximide)
COMP:V-N(with) (decrease,FMK)
COMP:V-N(with) (decrease,overproduce)
COMP:N-N(of) (production,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__SP__)
SUBJ:V-N (treat,protein)
OBJ:V-N (with,antibody)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 141

                              +------------------------------------------------------------------------------------------COMP:V-N(with)------------------------------------------------------------------------------------------+             
                              +--------------------------------------------------------------------------COMP:V-N(with)--------------------------------------------------------------------------+                               |             
                              +---------------------------------------------------------------COMP:V-N(with)--------------------------------------------------------------+                      |                               |             
                              +---------------------------------------COMP:V-N(with)--------------------------------------+                                               |                      |                               |             
                              |                              +-----------OBJ:V-N-----------+                              |                                               |                      |                               |             
                              |                              |       +-------SUBJ:V-N------+      +----------------------OBJ:V-N----------------------+                   |             +---------------------OBJ:V-N--------------------+     
     +--MOD_ATT:N-N--+        |          +----COMP:N-N(of)---+       +-COMP:N-N(in)-+      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |             |        |            +----MOD_ATT:N-N---+       |     
     |         +MOD_A+SUBJ:V-N+--OBJ:V-N-+           +MOD_ATT+       |         +MOD_+      |      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |             |    +MOD+            |          +MOD_ATT+       |     
     |         |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |             |    |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,SB203580)
MOD_ATT:N-N (culture,cell)
SUBJ:V-N (decrease,culture)
OBJ:V-N (decrease,production)
COMP:V-N(with) (decrease,Apo)
COMP:V-N(with) (decrease,cycloheximide)
COMP:V-N(with) (decrease,FMK)
COMP:V-N(with) (decrease,__NODE__)
COMP:N-N(of) (production,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__NODE__)
SUBJ:V-N (treat,protein)
OBJ:V-N (with,antibody)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (__NODE__,overproduce)
MOD_ATT:N-ADJ (__NODE__,__SP__)

Analyse 142

                                                                                           +--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+                     
                                                                                           +--------------------------------------------COMP:V-N(with)-------------------------------------------+                       |                     
                                                                                           +--------------------------------COMP:V-N(with)--------------------------------+                      |                       |                     
                                         +-------------------COMP:V-N(in)------------------+      +----------------------OBJ:V-N----------------------+                   |                      |                       |                     
               +-------MOD_ATT:N-N-------+                           +-------SUBJ:V-N------+--------COMP:V-N(with)--------+                           |                   |             +---------------------OBJ:V-N--------------------+     
               |     +----MOD_ATT:N-N----+                           +-COMP:N-N(in)-+      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |             |    +-------MOD_ATT:N-ADJ-------+               |     
               |     |        +MOD_ATT:N-+COMP:N-N(of+       +MOD_ATT+         +MOD_+      |      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |             |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |             |    |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
COMP:V-N(in) (treat,production)
SUBJ:V-N (treat,protein)
COMP:V-N(with) (treat,Apo)
COMP:V-N(with) (treat,cycloheximide)
COMP:V-N(with) (treat,FMK)
COMP:V-N(with) (treat,__SP__)
OBJ:V-N (with,antibody)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__SP__,zVAD)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 143

                              +---------------------------------------------------------------------------------COMP:V-N(with)--------------------------------------------------------------------------------+                                
                              +--------------------------------------------------------------------------COMP:V-N(with)--------------------------------------------------------------------------+            |                                
                              +---------------------------------------------------------------COMP:V-N(with)--------------------------------------------------------------+                      |            |                                
                              +---------------------------------------COMP:V-N(with)--------------------------------------+                                               |                      |            |                                
                              |          +---------------------OBJ:V-N---------------------+                              |                                               |                      |            |                                
                              |          |                           +-------SUBJ:V-N------+      +----------------------OBJ:V-N----------------------+                   |             +---------------------OBJ:V-N--------------------+     
     +--MOD_ATT:N-N--+        |          |                           +-COMP:N-N(in)-+      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |             |        |            |          +-MOD_ATT:N-ADJ-+     
     |         +MOD_A+SUBJ:V-N+--OBJ:V-N-+COMP:N-N(of+       +MOD_ATT+         +MOD_+      |      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |             |    +MOD+            |          |       +MOD_ATT+     
     |         |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |             |    |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,SB203580)
MOD_ATT:N-N (culture,cell)
SUBJ:V-N (decrease,culture)
OBJ:V-N (decrease,production)
COMP:V-N(with) (decrease,Apo)
COMP:V-N(with) (decrease,cycloheximide)
COMP:V-N(with) (decrease,FMK)
COMP:V-N(with) (decrease,overproduce)
COMP:N-N(of) (production,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,production)
SUBJ:V-N (treat,protein)
OBJ:V-N (with,antibody)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 144

                                                                                           +--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+                     
                                                                                           +--------------------------------------------COMP:V-N(with)-------------------------------------------+                       |                     
                                                                                           +--------------------------------COMP:V-N(with)--------------------------------+                      |                       |                     
                                         +-------------------COMP:V-N(in)------------------+      +----------------------OBJ:V-N----------------------+                   |                      |                       |                     
               +-------MOD_ATT:N-N-------+                           +-------SUBJ:V-N------+--------COMP:V-N(with)--------+                           |                   |             +---------------------OBJ:V-N--------------------+     
               |     +----MOD_ATT:N-N----+----COMP:N-N(of)---+       +-COMP:N-N(in)-+      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |             |    +-------MOD_ATT:N-ADJ-------+               |     
               |     |        +MOD_ATT:N-+           +MOD_ATT+       |         +MOD_+      |      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |             |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |             |    |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
COMP:V-N(in) (treat,production)
SUBJ:V-N (treat,protein)
COMP:V-N(with) (treat,Apo)
COMP:V-N(with) (treat,cycloheximide)
COMP:V-N(with) (treat,FMK)
COMP:V-N(with) (treat,__SP__)
OBJ:V-N (with,antibody)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__SP__,zVAD)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 145

                              +------------------------------------------------------------------------------------------COMP:V-N(with)------------------------------------------------------------------------------------------+             
                              +--------------------------------------------------------------------------COMP:V-N(with)--------------------------------------------------------------------------+                               |             
                              +---------------------------------------------------------------COMP:V-N(with)--------------------------------------------------------------+                      |                               |             
                              +---------------------------------------COMP:V-N(with)--------------------------------------+                                               |                      |                               |             
                              |          +---------------------OBJ:V-N---------------------+                              |                                               |                      |                               |             
                              |          |                           +-------SUBJ:V-N------+      +----------------------OBJ:V-N----------------------+                   |             +---------------------OBJ:V-N--------------------+     
     +--MOD_ATT:N-N--+        |          |                           +-COMP:N-N(in)-+      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |             |        |            +----MOD_ATT:N-N---+       |     
     |         +MOD_A+SUBJ:V-N+--OBJ:V-N-+COMP:N-N(of+       +MOD_ATT+         +MOD_+      |      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |             |    +MOD+            |          +MOD_ATT+       |     
     |         |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |             |    |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,SB203580)
MOD_ATT:N-N (culture,cell)
SUBJ:V-N (decrease,culture)
OBJ:V-N (decrease,production)
COMP:V-N(with) (decrease,Apo)
COMP:V-N(with) (decrease,cycloheximide)
COMP:V-N(with) (decrease,FMK)
COMP:V-N(with) (decrease,__NODE__)
COMP:N-N(of) (production,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,production)
SUBJ:V-N (treat,protein)
OBJ:V-N (with,antibody)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (__NODE__,overproduce)
MOD_ATT:N-ADJ (__NODE__,__SP__)

Analyse 146

                                                                                           +------------------------------------------------------------COMP:V-N(with)-----------------------------------------------------------+             
                                                                                           +--------------------------------------------COMP:V-N(with)-------------------------------------------+                               |             
                                         +-------------------COMP:V-N(in)------------------+--------------------------------COMP:V-N(with)--------------------------------+                      |                               |             
                                         |                   +---------COMP:V-N(of)--------+      +----------------------OBJ:V-N----------------------+                   |                      |                               |             
               +-------MOD_ATT:N-N-------+                   |       +-------SUBJ:V-N------+--------COMP:V-N(with)--------+                           |                   |             +---------------------OBJ:V-N--------------------+     
               |     +----MOD_ATT:N-N----+                   |       +-COMP:N-N(in)-+      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |             |        |            +---MOD_ATT:N-ADJ--+       |     
               |     |        +MOD_ATT:N-+           +MOD_ATT+       |         +MOD_+      |      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |             |    +MOD+            |          +MOD_ATT+       |     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |             |    |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
COMP:V-N(in) (treat,production)
COMP:V-N(of) (treat,__NODE__)
SUBJ:V-N (treat,protein)
COMP:V-N(with) (treat,Apo)
COMP:V-N(with) (treat,cycloheximide)
COMP:V-N(with) (treat,FMK)
COMP:V-N(with) (treat,__NODE__)
OBJ:V-N (with,antibody)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__NODE__,overproduce)
MOD_ATT:N-ADJ (__NODE__,__SP__)

Analyse 147

                                                                                           +--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+                     
                                                                                           +--------------------------------------------COMP:V-N(with)-------------------------------------------+                       |                     
                                                                                           +--------------------------------COMP:V-N(with)--------------------------------+                      |                       |                     
                                         +-------------------COMP:V-N(in)------------------+      +----------------------OBJ:V-N----------------------+                   |                      |                       |                     
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+                     +--------COMP:V-N(with)--------+                           |                   |             +---------------------OBJ:V-N--------------------+     
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+                     |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |             |    +-------MOD_ATT:N-ADJ-------+               |     
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+COMP:N-N(+    +SUBJ:V+      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |             |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |             |    |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,Hela)
COMP:V-N(in) (treat,production)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,Apo)
COMP:V-N(with) (treat,cycloheximide)
COMP:V-N(with) (treat,FMK)
COMP:V-N(with) (treat,__SP__)
OBJ:V-N (with,antibody)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__SP__,zVAD)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 148

                              +---------------------------------------------------------------------------------COMP:V-N(with)--------------------------------------------------------------------------------+                                
                              +--------------------------------------------------------------------------COMP:V-N(with)--------------------------------------------------------------------------+            |                                
                              +---------------------------------------------------------------COMP:V-N(with)--------------------------------------------------------------+                      |            |                                
                              +---------------------------------------COMP:V-N(with)--------------------------------------+                                               |                      |            |                                
                              |          +---------------------OBJ:V-N---------------------+                              |                                               |                      |            |                                
                              |          +-------------COMP:N-N(in)------------+           |                              |                                               |                      |            |                                
                              |          +--------COMP:N-N(of)-------+         |           |      +----------------------OBJ:V-N----------------------+                   |             +---------------------OBJ:V-N--------------------+     
     +--MOD_ATT:N-N--+        |          |           +-MOD_ATT:N-ADJ-+         |           |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |             |        |            |          +-MOD_ATT:N-ADJ-+     
     |         +MOD_A+SUBJ:V-N+--OBJ:V-N-+           |       +MOD_ATT+         |    +SUBJ:V+      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |             |    +MOD+            |          |       +MOD_ATT+     
     |         |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |             |    |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,SB203580)
MOD_ATT:N-N (culture,cell)
SUBJ:V-N (decrease,culture)
OBJ:V-N (decrease,production)
COMP:V-N(with) (decrease,Apo)
COMP:V-N(with) (decrease,cycloheximide)
COMP:V-N(with) (decrease,FMK)
COMP:V-N(with) (decrease,overproduce)
COMP:N-N(of) (production,protein)
COMP:N-N(in) (production,Hela)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (treat,production)
SUBJ:V-N (treat,cell)
OBJ:V-N (with,antibody)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 149

                              +---------------------------------------------------------------------------------------------SUBJ:V-N---------------------------------------------------------------------------------------------+             
                              |                                                            +--------------------------------------------------COMP:V-N(with)--------------------------------------------------+                  |             
                              |                                                            +--------------------------------------------COMP:V-N(with)-------------------------------------------+            |                  |             
                              +---------------------------OBJ:V-N--------------------------+--------------------------------COMP:V-N(with)--------------------------------+                      |            |                  |             
                              |          +---------------------SUBJ:V-N--------------------+      +----------------------OBJ:V-N----------------------+                   |                      |            |                  |             
     +-------MOD_ATT:N-N------+          +--------COMP:N-N(of)-------+                     +--------COMP:V-N(with)--------+                           |                   |             +-------------OBJ:V-N------------+       |             
     |         +--MOD_ATT:N-N-+          |           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |             |    +--MOD_ATT:N-ADJ-+          |       |             
     |         |     +MOD_ATT:+          |           |       +MOD_ATT+         +MOD_+      |      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |             |    +MOD+            |          |       +OBJ:V-N+     
     |         |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |             |    |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (decrease,SB203580)
MOD_ATT:N-N (decrease,cell)
MOD_ATT:N-N (decrease,culture)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,decrease)
SUBJ:V-N (treat,production)
COMP:V-N(with) (treat,Apo)
COMP:V-N(with) (treat,cycloheximide)
COMP:V-N(with) (treat,FMK)
COMP:V-N(with) (treat,overproduce)
OBJ:V-N (with,antibody)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (with,__SP__)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
SUBJ:V-N (__NODE__,decrease)
OBJ:V-N (__NODE__,protein)

Analyse 150

                     +------------------------------------------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------------------------------------------+             
                     |        +---------------------------------------------------------------------------------------------SUBJ:V-N---------------------------------------------------------------------------------------------+             
                     |        |                                                            +--------------------------------------------------COMP:V-N(with)--------------------------------------------------+                  |             
                     |        |                                                            +--------------------------------------------COMP:V-N(with)-------------------------------------------+            |                  |             
                     |        +---------------------------OBJ:V-N--------------------------+--------------------------------COMP:V-N(with)--------------------------------+                      |            |                  |             
                     |        |          +---------------------SUBJ:V-N--------------------+      +----------------------OBJ:V-N----------------------+                   |                      |            |                  |             
                     |        |          +--------COMP:N-N(of)-------+                     +--------COMP:V-N(with)--------+                           |                   |                      |            |                  |             
                     |        |          |           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                      |            |                  |             
               +MOD_A+        |          |           |       +MOD_ATT+         +MOD_+      |      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |                  +OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |                  |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,decrease)
SUBJ:V-N (treat,production)
COMP:V-N(with) (treat,Apo)
COMP:V-N(with) (treat,cycloheximide)
COMP:V-N(with) (treat,FMK)
COMP:V-N(with) (treat,overproduce)
OBJ:V-N (with,antibody)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,culture)
SUBJ:V-N (__NODE__,decrease)
OBJ:V-N (__NODE__,protein)

Analyse 151

                              +---------------------------------------------------------------------------------------------SUBJ:V-N---------------------------------------------------------------------------------------------+             
                              |                                                            +--------------------------------------------------COMP:V-N(with)--------------------------------------------------+                  |             
                              +---------------------------OBJ:V-N--------------------------+--------------------------------------------COMP:V-N(with)-------------------------------------------+            |                  |             
                              |          +---------------------SUBJ:V-N--------------------+--------------------------------COMP:V-N(with)--------------------------------+                      |            |                  |             
                              |          +---------------COMP:N-N(in)---------------+      |      +----------------------OBJ:V-N----------------------+                   |                      |            |                  |             
     +-------MOD_ATT:N-N------+          +--------COMP:N-N(of)-------+              |      +--------COMP:V-N(with)--------+                           |                   |                      |            |                  |             
     |         +--MOD_ATT:N-N-+          |           +-MOD_ATT:N-ADJ-+              |      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |             +-------------OBJ:V-N------------+       |             
     |         |     +MOD_ATT:+          |           |       +MOD_ATT+         +MOD_+      |      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |             |    +MOD+            |          |       +OBJ:V-N+     
     |         |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |             |    |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (decrease,SB203580)
MOD_ATT:N-N (decrease,cell)
MOD_ATT:N-N (decrease,culture)
COMP:N-N(of) (production,protein)
COMP:N-N(in) (production,cell)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,decrease)
SUBJ:V-N (treat,production)
COMP:V-N(with) (treat,Apo)
COMP:V-N(with) (treat,cycloheximide)
COMP:V-N(with) (treat,FMK)
COMP:V-N(with) (treat,overproduce)
OBJ:V-N (with,antibody)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (with,__SP__)
MOD_ATT:N-ADJ (FMK,zVAD)
SUBJ:V-N (__NODE__,decrease)
OBJ:V-N (__NODE__,protein)

Analyse 152

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                                                                            +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                                                                                                            |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+                            +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+             |     +---OBJ:V-N--+    |         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+SUBJ:V+COMP:V_PASS-+      +SUBJ:+    |         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,agonist)
OBJ:V-N (with,Apo)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 153

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                                                                            +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                                                                                                            |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+                            +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+             |     +---OBJ:V-N--+    |         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+SUBJ:V+COMP:V_PASS-+      +SUBJ:+    |         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,agonist)
OBJ:V-N (with,Apo)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 154

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                                                                            +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                                                                                                            |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+                     +------COMP:V_PASS-N(with)-----+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+      |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+SUBJ:V+            |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |            |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 155

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                                                                            +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                                                                                                            |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+----SUBJ:V_PASS-N----+------COMP:V_PASS-N(with)-----+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+      |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+      |            |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |            |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,protein)
COMP:V_PASS-N(with) (treat,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 156

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                                                                            +---------------------------------SUBJ:V-N---------------------------------+             
                                         +---------------COMP:N-N(in)---------------+                                                                 |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+              |      +------COMP:V_PASS-N(with)-----+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+              |      |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+SUBJ:V+            |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |            |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
COMP:N-N(in) (production,cell)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 157

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                                                                            +---------------------------------SUBJ:V-N---------------------------------+             
                                         +---------------COMP:N-N(in)---------------+                                                                 |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+              |      +------COMP:V_PASS-N(with)-----+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+              |      |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+SUBJ:V+            |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |            |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
COMP:N-N(in) (production,cell)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 158

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                                                                            +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                                                 +------COMP:V-N(with)-----+                                |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+                     |      +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+-------OBJ:V-N-------+      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+COMP:N-N(+    +SUBJ:V+      |     |      +MOD_A+    |         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,Hela)
OBJ:V-N (treat,protein)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,__SP__)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 159

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                                                                            +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                                                 +------COMP:V-N(with)-----+                                |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+                     |      +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+-------OBJ:V-N-------+      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+COMP:N-N(+    +SUBJ:V+      |     |      +MOD_A+    |         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,Hela)
OBJ:V-N (treat,protein)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,__SP__)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 160

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                                                                            +---------------------------------SUBJ:V-N---------------------------------+             
                                         +------------------SUBJ:V_PASS-N------------------+                                                          |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+                     +------COMP:V_PASS-N(with)-----+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+      |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+      |            |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |            |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,production)
COMP:V_PASS-N(with) (treat,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 161

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                                                                            +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                   +-----------OBJ:V-N-----------+------COMP:V-N(with)-----+                                |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+                   |       +-------SUBJ:V-N------+      +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+----COMP:N-N(of)---+       +-COMP:N-N(in)-+      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           +MOD_ATT+       |         +MOD_+      |      |     |      +MOD_A+    |         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__NODE__)
SUBJ:V-N (treat,protein)
COMP:V-N(with) (treat,__SP__)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 162

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                                                                            +---------------------------------SUBJ:V-N---------------------------------+             
                                         |           +---------------OBJ:V-N---------------+------COMP:V-N(with)-----+                                |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+           |               +-------SUBJ:V-N------+      +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           |               +-COMP:N-N(in)-+      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+COMP:N-N(of+       +MOD_ATT+         +MOD_+      |      |     |      +MOD_A+    |         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__SP__)
SUBJ:V-N (treat,protein)
COMP:V-N(with) (treat,__SP__)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 163

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                          +----------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------+             
                                         |                                          |                                                                 +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                                          |                                                                 |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+              |             +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+              |             |     +---OBJ:V-N--+    |         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+SUBJ:V+COMP:V_PASS-+      +SUBJ:+    |         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,agonist)
OBJ:V-N (with,Apo)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(in) (__NODE__,cell)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 164

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         +------------------SUBJ:V_PASS-N------------------+                                                          +---------------------------------SUBJ:V-N---------------------------------+             
                                         +---------------COMP:N-N(in)---------------+      |                                                          |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+              |      +------COMP:V_PASS-N(with)-----+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+              |      |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+      |            |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |            |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
COMP:N-N(in) (production,cell)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,production)
COMP:V_PASS-N(with) (treat,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 165

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                          +----------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------+             
                                         |                                          |                                                                 +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                                          |                                                                 |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+              |      +------COMP:V_PASS-N(with)-----+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+              |      |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+SUBJ:V+            |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |            |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(in) (__NODE__,cell)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 166

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                                           +-----------------------------------------------COMP:V-N(with)----------------------------------------------+             
                                         |                                                                           |                                +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                                                                           |                                |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+----SUBJ:V_PASS-N----+      +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+      |      |     |      +MOD_A+    |         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,protein)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(with) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 167

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                                                                            +---------------------------------SUBJ:V-N---------------------------------+             
                                         +---------------------OBJ:V-N---------------------+------COMP:V-N(with)-----+                                |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+                           +-------SUBJ:V-N------+      +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+----COMP:N-N(of)---+       +-COMP:N-N(in)-+      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           +MOD_ATT+       |         +MOD_+      |      |     |      +MOD_A+    |         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,production)
SUBJ:V-N (treat,protein)
COMP:V-N(with) (treat,__SP__)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 168

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                                           +-----------------------------------------------COMP:V-N(with)----------------------------------------------+             
                                         |                                                                           |                                +---------------------------------SUBJ:V-N---------------------------------+             
                                         +---------------COMP:N-N(in)---------------+                                |                                |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+              |             +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+              |             |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+SUBJ:V+      |     |      +MOD_A+    |         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
COMP:N-N(in) (production,cell)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(with) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 169

                     +------------------------------------------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------------------------------------------+             
                     +-------------------------------OBJ:V-N-------------------------------+                                                          +---------------------------------SUBJ:V-N---------------------------------+             
                     |                   +---------------------SUBJ:V-N--------------------+------COMP:V-N(with)-----+                                |                   +--------------------COMP:V-N(with)--------------------+             
                     |                   +--------COMP:N-N(of)-------+                     |      +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
                     |                   |           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               +MOD_A+        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+      |      |     |      +MOD_A+    |         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,culture)
SUBJ:V-N (treat,production)
COMP:V-N(with) (treat,__SP__)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,culture)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 170

                              +-------------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------------+             
                              +---------------------------OBJ:V-N--------------------------+                                                                                                                                     |             
                              |          +---------------------SUBJ:V-N--------------------+                                                          +---------------------------------SUBJ:V-N---------------------------------+             
                              |          +---------------COMP:N-N(in)---------------+      |                                                          |                   +--------------------COMP:V-N(with)--------------------+             
                              |          +--------COMP:N-N(of)-------+              |      |      +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               +--MOD_ATT:N-N-+          |           +-MOD_ATT:N-ADJ-+              |      +---COMP:V-N(with)--+          |         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     +MOD_ATT:+          |           |       +MOD_ATT+         +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (decrease,cell)
MOD_ATT:N-N (decrease,culture)
COMP:N-N(of) (production,protein)
COMP:N-N(in) (production,cell)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,decrease)
SUBJ:V-N (treat,production)
COMP:V-N(with) (treat,anti)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,decrease)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 171

                     +------------------------------------------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------------------------------------------+             
                     +-------------------------------OBJ:V-N-------------------------------+                                                                                                                                     |             
                     |                   +---------------------SUBJ:V-N--------------------+                                                          +---------------------------------SUBJ:V-N---------------------------------+             
                     |                   +---------------COMP:N-N(in)---------------+      +------COMP:V-N(with)-----+                                |                   +--------------------COMP:V-N(with)--------------------+             
                     |                   +--------COMP:N-N(of)-------+              |      |      +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
                     |                   |           +-MOD_ATT:N-ADJ-+              |      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               +MOD_A+        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+      |      |     |      +MOD_A+    |         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
COMP:N-N(in) (production,cell)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,culture)
SUBJ:V-N (treat,production)
COMP:V-N(with) (treat,__SP__)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,culture)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 172

                              +-------------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------------+             
                              |                                                                                           +--------------------------------------------COMP:V-N(with)--------------------------------------------+             
                              +---------------------------OBJ:V-N--------------------------+                              |                           +---------------------------------SUBJ:V-N---------------------------------+             
                              |          +---------------------SUBJ:V-N--------------------+                              |                           |                   +--------------------COMP:V-N(with)--------------------+             
                              |          +--------COMP:N-N(of)-------+                     |                              |                           |                   |                      +---------COMP:V-N(with)--------+             
               +--MOD_ATT:N-N-+          |           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+      |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     +MOD_ATT:+          |           |       +MOD_ATT+         +MOD_+      |            |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |            |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (decrease,cell)
MOD_ATT:N-N (decrease,culture)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,decrease)
SUBJ:V-N (treat,production)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,decrease)
COMP:V-N(with) (__NODE__,Apo)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 173

                              +-------------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------------+             
                              |                                                                         +-----------------------------------------------------COMP:V-N(with)-----------------------------------------------------+             
                              +---------------------------OBJ:V-N--------------------------+            |                                             +---------------------------------SUBJ:V-N---------------------------------+             
                              |          +---------------------SUBJ:V-N--------------------+            |                                             |                   +--------------------COMP:V-N(with)--------------------+             
                              |          +--------COMP:N-N(of)-------+                     |      +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               +--MOD_ATT:N-N-+          |           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+      |      |     +---OBJ:V-N--+    |         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     +MOD_ATT:+          |           |       +MOD_ATT+         +MOD_+      |      |     |      +SUBJ:+    |         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (decrease,cell)
MOD_ATT:N-N (decrease,culture)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,decrease)
SUBJ:V-N (treat,production)
OBJ:V-N (with,Apo)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,decrease)
COMP:V-N(with) (__NODE__,agonist)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 174

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                                           +-----------------------------------------------COMP:V-N(with)----------------------------------------------+             
                                         +------------------SUBJ:V_PASS-N------------------+                         |                                +---------------------------------SUBJ:V-N---------------------------------+             
                                         +---------------COMP:N-N(in)---------------+      |                         |                                |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+              |      |      +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+              |      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+      |      |     |      +MOD_A+    |         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
COMP:N-N(in) (production,cell)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,production)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(with) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 175

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                                           +-----------------------------------------------COMP:V-N(with)----------------------------------------------+             
                                         +------------------SUBJ:V_PASS-N------------------+                         |                                +---------------------------------SUBJ:V-N---------------------------------+             
                                         +---------------COMP:N-N(in)---------------+      |                         |                                |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+              |      |      +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+              |      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+      |      |     |      +MOD_A+    |         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
COMP:N-N(in) (production,cell)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,production)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(with) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 176

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                                                                            +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                                                                                                            |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+                            +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+             |     +---OBJ:V-N--+    |         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+SUBJ:V+COMP:V_PASS-+      +SUBJ:+    |         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,agonist)
OBJ:V-N (with,Apo)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 177

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                                                                            +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                                                                                                            |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+----SUBJ:V_PASS-N----+------COMP:V_PASS-N(with)-----+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+      |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+      |            |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |            |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,protein)
COMP:V_PASS-N(with) (treat,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 178

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                                                                            +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                                                                                                            |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+----SUBJ:V_PASS-N----+------COMP:V_PASS-N(with)-----+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+      |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+      |            |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |            |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,protein)
COMP:V_PASS-N(with) (treat,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 179

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                                                                            +---------------------------------SUBJ:V-N---------------------------------+             
                                         +---------------COMP:N-N(in)---------------+                                                                 |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+              |             +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+              |             |     +---OBJ:V-N--+    |         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+SUBJ:V+COMP:V_PASS-+      +SUBJ:+    |         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
COMP:N-N(in) (production,cell)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,agonist)
OBJ:V-N (with,Apo)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 180

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                                                                            +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                   +-----------OBJ:V-N-----------+------COMP:V-N(with)-----+                                |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+                   |       +-------SUBJ:V-N------+      +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+----COMP:N-N(of)---+       +-COMP:N-N(in)-+      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           +MOD_ATT+       |         +MOD_+      |      |     |      +MOD_A+    |         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__NODE__)
SUBJ:V-N (treat,protein)
COMP:V-N(with) (treat,__SP__)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 181

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                                                                            +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                   +-----------OBJ:V-N-----------+------COMP:V-N(with)-----+                                |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+                   |       +-------SUBJ:V-N------+      +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+----COMP:N-N(of)---+       +-COMP:N-N(in)-+      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           +MOD_ATT+       |         +MOD_+      |      |     |      +MOD_A+    |         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__NODE__)
SUBJ:V-N (treat,protein)
COMP:V-N(with) (treat,__SP__)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 182

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                                                                            +---------------------------------SUBJ:V-N---------------------------------+             
                                         +------------------SUBJ:V_PASS-N------------------+                                                          |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+                     |      +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+      |      |     +---OBJ:V-N--+    |         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+      +COMP:V_PASS-+      +SUBJ:+    |         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,production)
COMP:V_PASS-N(with) (treat,agonist)
OBJ:V-N (with,Apo)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 183

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         +------------------SUBJ:V_PASS-N------------------+                                                          +---------------------------------SUBJ:V-N---------------------------------+             
                                         +---------------COMP:N-N(in)---------------+      |                                                          |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+              |      |      +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+              |      |      |     +---OBJ:V-N--+    |         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+      +COMP:V_PASS-+      +SUBJ:+    |         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
COMP:N-N(in) (production,cell)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,production)
COMP:V_PASS-N(with) (treat,agonist)
OBJ:V-N (with,Apo)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 184

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                          +----------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------+             
                                         |                                          |                                                                 +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                                          |                                                                 |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+              |      +------COMP:V_PASS-N(with)-----+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+              |      |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+SUBJ:V+            |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |            |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(in) (__NODE__,cell)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 185

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                          +----------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------+             
                                         |                                          |                                                                 +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                                          |                                                                 |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+              |      +------COMP:V_PASS-N(with)-----+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+              |      |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+SUBJ:V+            |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |            |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(in) (__NODE__,cell)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 186

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                                                                            +---------------------------------SUBJ:V-N---------------------------------+             
                                         +---------------------OBJ:V-N---------------------+------COMP:V-N(with)-----+                                |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+                           +-------SUBJ:V-N------+      +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+                           +-COMP:N-N(in)-+      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+COMP:N-N(of+       +MOD_ATT+         +MOD_+      |      |     |      +MOD_A+    |         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,production)
SUBJ:V-N (treat,protein)
COMP:V-N(with) (treat,__SP__)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 187

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                                           +-----------------------------------------------COMP:V-N(with)----------------------------------------------+             
                                         |                                                                           |                                +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                                                                           |                                |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+----SUBJ:V_PASS-N----+      +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+      |      |     |      +MOD_A+    |         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,protein)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(with) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 188

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                                                                            +---------------------------------SUBJ:V-N---------------------------------+             
                                         +---------------------OBJ:V-N---------------------+------COMP:V-N(with)-----+                                |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+                           +-------SUBJ:V-N------+      +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+----COMP:N-N(of)---+       +-COMP:N-N(in)-+      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           +MOD_ATT+       |         +MOD_+      |      |     |      +MOD_A+    |         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,production)
SUBJ:V-N (treat,protein)
COMP:V-N(with) (treat,__SP__)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 189

                     +------------------------------------------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------------------------------------------+             
                     +-------------------------------OBJ:V-N-------------------------------+                                                          +---------------------------------SUBJ:V-N---------------------------------+             
                     |                   +---------------------SUBJ:V-N--------------------+------COMP:V-N(with)-----+                                |                   +--------------------COMP:V-N(with)--------------------+             
                     |                   +--------COMP:N-N(of)-------+                     |      +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
                     |                   |           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               +MOD_A+        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+      |      |     |      +MOD_A+    |         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,culture)
SUBJ:V-N (treat,production)
COMP:V-N(with) (treat,__SP__)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,culture)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 190

                     +------------------------------------------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------------------------------------------+             
                     +-------------------------------OBJ:V-N-------------------------------+                                                          +---------------------------------SUBJ:V-N---------------------------------+             
                     |                   +---------------------SUBJ:V-N--------------------+------COMP:V-N(with)-----+                                |                   +--------------------COMP:V-N(with)--------------------+             
                     |                   +--------COMP:N-N(of)-------+                     |      +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
                     |                   |           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               +MOD_A+        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+      |      |     |      +MOD_A+    |         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,culture)
SUBJ:V-N (treat,production)
COMP:V-N(with) (treat,__SP__)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,culture)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 191

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                                           +-----------------------------------------------COMP:V-N(with)----------------------------------------------+             
                                         |                                                                           |                                +---------------------------------SUBJ:V-N---------------------------------+             
                                         +------------------SUBJ:V_PASS-N------------------+                         |                                |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+                     |      +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+      |      |     |      +MOD_A+    |         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,production)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(with) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 192

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         +---------------------OBJ:V-N---------------------+                                                          +---------------------------------SUBJ:V-N---------------------------------+             
                                         +-------------COMP:N-N(in)------------+           +------COMP:V-N(with)-----+                                |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+         |           |      +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+         |           |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         |    +SUBJ:V+      |     |      +MOD_A+    |         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
COMP:N-N(in) (production,Hela)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (treat,production)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,__SP__)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 193

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         +---------------------OBJ:V-N---------------------+                                                          +---------------------------------SUBJ:V-N---------------------------------+             
                                         +-------------COMP:N-N(in)------------+           +------COMP:V-N(with)-----+                                |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+         |           |      +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+         |           |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         |    +SUBJ:V+      |     |      +MOD_A+    |         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
COMP:N-N(in) (production,Hela)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (treat,production)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,__SP__)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 194

                              +-------------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------------+             
                              |                                                                         +-----------------------------------------------------COMP:V-N(with)-----------------------------------------------------+             
                              +---------------------------OBJ:V-N--------------------------+            |                                             +---------------------------------SUBJ:V-N---------------------------------+             
                              |          +---------------------SUBJ:V-N--------------------+            |                                             |                   +--------------------COMP:V-N(with)--------------------+             
                              |          +--------COMP:N-N(of)-------+                     |      +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               +--MOD_ATT:N-N-+          |           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+      |      |     +---OBJ:V-N--+    |         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     +MOD_ATT:+          |           |       +MOD_ATT+         +MOD_+      |      |     |      +SUBJ:+    |         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (decrease,cell)
MOD_ATT:N-N (decrease,culture)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,decrease)
SUBJ:V-N (treat,production)
OBJ:V-N (with,Apo)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,decrease)
COMP:V-N(with) (__NODE__,agonist)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 195

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                          +----------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------+             
                                         |                                          |                                +-----------------------------------------------COMP:V-N(with)----------------------------------------------+             
                                         |                                          |                                |                                +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                                          |                                |                                |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+              |             +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+              |             |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+SUBJ:V+      |     |      +MOD_A+    |         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(in) (__NODE__,cell)
COMP:V-N(with) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 196

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                                           +-----------------------------------------------COMP:V-N(with)----------------------------------------------+             
                                         +------------------SUBJ:V_PASS-N------------------+                         |                                +---------------------------------SUBJ:V-N---------------------------------+             
                                         +---------------COMP:N-N(in)---------------+      |                         |                                |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+              |      |      +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+              |      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+      |      |     |      +MOD_A+    |         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
COMP:N-N(in) (production,cell)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,production)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(with) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 197

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                          +----------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------+             
                                         |                                          |                                +-----------------------------------------------COMP:V-N(with)----------------------------------------------+             
                                         |                                          |                                |                                +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                                          |                                |                                |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+              |             +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+              |             |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+SUBJ:V+      |     |      +MOD_A+    |         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(in) (__NODE__,cell)
COMP:V-N(with) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 198

                              +-------------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------------+             
                              +---------------------------OBJ:V-N--------------------------+                              +--------------------------------------------COMP:V-N(with)--------------------------------------------+             
                              |          +---------------------SUBJ:V-N--------------------+                              |                           +---------------------------------SUBJ:V-N---------------------------------+             
                              |          +---------------COMP:N-N(in)---------------+      |                              |                           |                   +--------------------COMP:V-N(with)--------------------+             
                              |          +--------COMP:N-N(of)-------+              |      |                              |                           |                   |                      +---------COMP:V-N(with)--------+             
               +--MOD_ATT:N-N-+          |           +-MOD_ATT:N-ADJ-+              |      |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     +MOD_ATT:+          |           |       +MOD_ATT+         +MOD_+      |            |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |            |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (decrease,cell)
MOD_ATT:N-N (decrease,culture)
COMP:N-N(of) (production,protein)
COMP:N-N(in) (production,cell)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,decrease)
SUBJ:V-N (treat,production)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,decrease)
COMP:V-N(with) (__NODE__,Apo)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 199

                              +-------------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------------+             
                              +---------------------------OBJ:V-N--------------------------+            +-----------------------------------------------------COMP:V-N(with)-----------------------------------------------------+             
                              |          +---------------------SUBJ:V-N--------------------+            |                                             +---------------------------------SUBJ:V-N---------------------------------+             
                              |          +---------------COMP:N-N(in)---------------+      |            |                                             |                   +--------------------COMP:V-N(with)--------------------+             
                              |          +--------COMP:N-N(of)-------+              |      |      +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               +--MOD_ATT:N-N-+          |           +-MOD_ATT:N-ADJ-+              |      |      |     +---OBJ:V-N--+    |         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     +MOD_ATT:+          |           |       +MOD_ATT+         +MOD_+      |      |     |      +SUBJ:+    |         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (decrease,cell)
MOD_ATT:N-N (decrease,culture)
COMP:N-N(of) (production,protein)
COMP:N-N(in) (production,cell)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,decrease)
SUBJ:V-N (treat,production)
OBJ:V-N (with,Apo)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,decrease)
COMP:V-N(with) (__NODE__,agonist)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 200

                              +-------------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------------+             
                              +---------------------------OBJ:V-N--------------------------+            +-----------------------------------------------------COMP:V-N(with)-----------------------------------------------------+             
                              |          +---------------------SUBJ:V-N--------------------+            |                                             +---------------------------------SUBJ:V-N---------------------------------+             
                              |          +---------------COMP:N-N(in)---------------+      |            |                                             |                   +--------------------COMP:V-N(with)--------------------+             
                              |          +--------COMP:N-N(of)-------+              |      |      +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               +--MOD_ATT:N-N-+          |           +-MOD_ATT:N-ADJ-+              |      |      |     +---OBJ:V-N--+    |         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     +MOD_ATT:+          |           |       +MOD_ATT+         +MOD_+      |      |     |      +SUBJ:+    |         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (decrease,cell)
MOD_ATT:N-N (decrease,culture)
COMP:N-N(of) (production,protein)
COMP:N-N(in) (production,cell)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,decrease)
SUBJ:V-N (treat,production)
OBJ:V-N (with,Apo)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,decrease)
COMP:V-N(with) (__NODE__,agonist)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 201

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                          +------------------------------------------------------------------SUBJ:V-N------------------------------------------------------------------+             
                                         |                                          |      +------------------------------------------------COMP:V_PASS-N(with)-----------------------------------------------+                  |             
                                         |                                          |      +-----------------------------------------COMP:V_PASS-N(with)-----------------------------------------+            |                  |             
                                         |                                          |      +------------------------------COMP:V_PASS-N(with)-----------------------------+                      |            |                  |             
                                         +-------------COMP:N-N(in)------------+    |      |      +----------------------OBJ:V-N----------------------+                   |                      |            |                  |             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+         |    |      +------COMP:V_PASS-N(with)-----+                           |                   |                      |            |                  |             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+         |    |      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+                  |             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         |    +SUBJ:V+      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |                  +OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |                  |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
COMP:N-N(in) (production,Hela)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,Apo)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
COMP:V_PASS-N(with) (treat,overproduce)
OBJ:V-N (with,antibody)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
SUBJ:V-N (__NODE__,cell)
OBJ:V-N (__NODE__,protein)

Analyse 202

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                          +------------------------------------------------------------------SUBJ:V-N------------------------------------------------------------------+             
                                         |                                          |      +------------------------------------------------COMP:V_PASS-N(with)-----------------------------------------------+                  |             
                                         |                                          |      +-----------------------------------------COMP:V_PASS-N(with)-----------------------------------------+            |                  |             
                                         |                                          |      +------------------------------COMP:V_PASS-N(with)-----------------------------+                      |            |                  |             
                                         +-------------COMP:N-N(in)------------+    |      |      +----------------------OBJ:V-N----------------------+                   |                      |            |                  |             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+         |    |      +------COMP:V_PASS-N(with)-----+                           |                   |                      |            |                  |             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+         |    |      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                      |            |                  |             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         |    +SUBJ:V+      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |                  +OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |                  |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
COMP:N-N(in) (production,Hela)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,Apo)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
COMP:V_PASS-N(with) (treat,overproduce)
OBJ:V-N (with,antibody)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
SUBJ:V-N (__NODE__,cell)
OBJ:V-N (__NODE__,protein)

Analyse 203

                              +---------------------------------------------------------------------------------COMP:V-N(with)--------------------------------------------------------------------------------+                                
                              +--------------------------------------------------------------------------COMP:V-N(with)--------------------------------------------------------------------------+            |                                
                              +---------------------------------------------------------------COMP:V-N(with)--------------------------------------------------------------+                      |            |                                
                              +---------------------------------------COMP:V-N(with)--------------------------------------+                                      +--------------------------------OBJ:V-N--------------------------------+     
                              |          +--------COMP:N-N(of)-------+                            +----------------------OBJ:V-N----------------------+          |        |             +---------------------OBJ:V-N--------------------+     
     +--MOD_ATT:N-N--+        |          |           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+             |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+          |        |             |        |            |          +-MOD_ATT:N-ADJ-+     
     |         +MOD_A+SUBJ:V-N+--OBJ:V-N-+           |       +MOD_ATT+         +MOD_+SUBJ:V+      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+          |        |             |    +MOD+            |          |       +MOD_ATT+     
     |         |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |          |        |             |    |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,SB203580)
MOD_ATT:N-N (culture,cell)
SUBJ:V-N (decrease,culture)
OBJ:V-N (decrease,production)
COMP:V-N(with) (decrease,Apo)
COMP:V-N(with) (decrease,cycloheximide)
COMP:V-N(with) (decrease,FMK)
COMP:V-N(with) (decrease,overproduce)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,antibody)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (with,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 204

                                                                                           +------------------------------------------------COMP:V_PASS-N(with)-----------------------------------------------+                                
                                                                                           +-----------------------------------------COMP:V_PASS-N(with)-----------------------------------------+            |                                
                                         +------------------SUBJ:V_PASS-N------------------+------------------------------COMP:V_PASS-N(with)-----------------------------+                      |            |                                
                                         +---------------COMP:N-N(in)---------------+      |      +----------------------OBJ:V-N----------------------+          +--------------------------------OBJ:V-N--------------------------------+     
                                         +--------COMP:N-N(of)-------+              |      +------COMP:V_PASS-N(with)-----+                           |          |        |             +---------------------OBJ:V-N--------------------+     
     +--MOD_ATT:N-N--+                   |           +-MOD_ATT:N-ADJ-+              |      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+          |        |             |        |            |          +-MOD_ATT:N-ADJ-+     
     |         +MOD_A+SUBJ:V-N+--OBJ:V-N-+           |       +MOD_ATT+         +MOD_+      |      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+          |        |             |    +MOD+            |          |       +MOD_ATT+     
     |         |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |          |        |             |    |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,SB203580)
MOD_ATT:N-N (culture,cell)
SUBJ:V-N (decrease,culture)
OBJ:V-N (decrease,production)
COMP:N-N(of) (production,protein)
COMP:N-N(in) (production,cell)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,production)
COMP:V_PASS-N(with) (treat,Apo)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
COMP:V_PASS-N(with) (treat,overproduce)
OBJ:V-N (with,antibody)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (with,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 205

                              +---------------------------------------------------------------------------------COMP:V-N(with)--------------------------------------------------------------------------------+                                
                              +--------------------------------------------------------------------------COMP:V-N(with)--------------------------------------------------------------------------+            |                                
                              +---------------------------------------------------------------COMP:V-N(with)--------------------------------------------------------------+                      |            |                                
                              +---------------------------------------COMP:V-N(with)--------------------------------------+                                               |                      |            |                                
                              |          +------------------SUBJ:V_PASS-N------------------+                              |                                      +--------------------------------OBJ:V-N--------------------------------+     
                              |          +--------COMP:N-N(of)-------+                     |      +----------------------OBJ:V-N----------------------+          |        |             +---------------------OBJ:V-N--------------------+     
     +--MOD_ATT:N-N--+        |          |           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+          |        |             |        |            |          +-MOD_ATT:N-ADJ-+     
     |         +MOD_A+SUBJ:V-N+--OBJ:V-N-+           |       +MOD_ATT+         +MOD_+      |      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+          |        |             |    +MOD+            |          |       +MOD_ATT+     
     |         |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |          |        |             |    |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,SB203580)
MOD_ATT:N-N (culture,cell)
SUBJ:V-N (decrease,culture)
OBJ:V-N (decrease,production)
COMP:V-N(with) (decrease,Apo)
COMP:V-N(with) (decrease,cycloheximide)
COMP:V-N(with) (decrease,FMK)
COMP:V-N(with) (decrease,overproduce)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,production)
OBJ:V-N (with,antibody)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (with,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 206

                                                                                           +--------------------------------------------------COMP:V-N(with)--------------------------------------------------+                                
                                                                                           +--------------------------------------------COMP:V-N(with)-------------------------------------------+            |                                
                                                                                           +--------------------------------COMP:V-N(with)--------------------------------+                      |            |                                
     +------------MOD_ATT:N-N------------+---------------------SUBJ:V-N--------------------+      +----------------------OBJ:V-N----------------------+                   |                      |            |                                
     |         +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+                     +--------COMP:V-N(with)--------+                           |                   |             +---------------------OBJ:V-N--------------------+     
     |         |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |             |    +--MOD_ATT:N-ADJ-+          +-MOD_ATT:N-ADJ-+     
     |         |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+      |      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |             |    +MOD+            |          |       +MOD_ATT+     
     |         |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |             |    |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,SB203580)
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V-N (treat,production)
COMP:V-N(with) (treat,Apo)
COMP:V-N(with) (treat,cycloheximide)
COMP:V-N(with) (treat,FMK)
COMP:V-N(with) (treat,overproduce)
OBJ:V-N (with,antibody)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 207

                                                                                           +--------------------------------------------------COMP:V-N(with)--------------------------------------------------+                                
                                                                                           +--------------------------------------------COMP:V-N(with)-------------------------------------------+            |                                
                                         +---------------------SUBJ:V-N--------------------+--------------------------------COMP:V-N(with)--------------------------------+                      |            |                                
     +------------MOD_ATT:N-N------------+---------------COMP:N-N(in)---------------+      |      +----------------------OBJ:V-N----------------------+                   |                      |            |                                
     |         +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+              |      +--------COMP:V-N(with)--------+                           |                   |             +---------------------OBJ:V-N--------------------+     
     |         |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+              |      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |             |    +--MOD_ATT:N-ADJ-+          +-MOD_ATT:N-ADJ-+     
     |         |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+      |      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |             |    +MOD+            |          |       +MOD_ATT+     
     |         |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |             |    |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,SB203580)
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
COMP:N-N(in) (production,cell)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V-N (treat,production)
COMP:V-N(with) (treat,Apo)
COMP:V-N(with) (treat,cycloheximide)
COMP:V-N(with) (treat,FMK)
COMP:V-N(with) (treat,overproduce)
OBJ:V-N (with,antibody)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 208

                                                                                           +------------------------------------------------------------COMP:V-N(with)-----------------------------------------------------------+             
                                                                                           +--------------------------------------------COMP:V-N(with)-------------------------------------------+                               |             
                                         +---------------------SUBJ:V-N--------------------+--------------------------------COMP:V-N(with)--------------------------------+                      |                               |             
     +------------MOD_ATT:N-N------------+---------------COMP:N-N(in)---------------+      |      +----------------------OBJ:V-N----------------------+                   |                      |                               |             
     |         +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+              |      +--------COMP:V-N(with)--------+                           |                   |             +---------------------OBJ:V-N--------------------+     
     |         |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+              |      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |             |        |            +----MOD_ATT:N-N---+       |     
     |         |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+      |      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |             |    +MOD+            |          +MOD_ATT+       |     
     |         |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |             |    |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,SB203580)
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
COMP:N-N(in) (production,cell)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V-N (treat,production)
COMP:V-N(with) (treat,Apo)
COMP:V-N(with) (treat,cycloheximide)
COMP:V-N(with) (treat,FMK)
COMP:V-N(with) (treat,__NODE__)
OBJ:V-N (with,antibody)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (__NODE__,overproduce)
MOD_ATT:N-ADJ (__NODE__,__SP__)

Analyse 209

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                          +------------------------------------------------------------------SUBJ:V-N------------------------------------------------------------------+             
                                         |                                          |      +------------------------------------------------COMP:V_PASS-N(with)-----------------------------------------------+                  |             
                                         |                                          |      +-----------------------------------------COMP:V_PASS-N(with)-----------------------------------------+            |                  |             
                                         |                                          |      +------------------------------COMP:V_PASS-N(with)-----------------------------+                      |            |                  |             
                                         |                                          |      |      +----------------------OBJ:V-N----------------------+                   |                      |            |                  |             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+              |      +------COMP:V_PASS-N(with)-----+                           |                   |                      |            |                  |             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+              |      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+                  |             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+COMP:N-N(+    +SUBJ:V+      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |                  +OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |                  |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,Apo)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
COMP:V_PASS-N(with) (treat,overproduce)
OBJ:V-N (with,antibody)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
SUBJ:V-N (__NODE__,cell)
OBJ:V-N (__NODE__,protein)

Analyse 210

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                                                                            +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                                                                                                            |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+              +------------COMP:N-N(with)-----------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+                   +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+SUBJ:V+            |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |            |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
COMP:N-N(with) (cell,Apo)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 211

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                                                                            +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                                                                                                            |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+              +------------COMP:N-N(with)-----------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+                   +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+SUBJ:V+            |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |            |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
COMP:N-N(with) (cell,Apo)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 212

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                                                                            +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                   +-----------OBJ:V-N-----------+                                                          |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+                   |       +-------SUBJ:V-N------+--------COMP:V-N(with)--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+----COMP:N-N(of)---+       +-COMP:N-N(in)-+      |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           +MOD_ATT+       |         +MOD_+      |            |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |            |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__NODE__)
SUBJ:V-N (treat,protein)
COMP:V-N(with) (treat,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 213

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                                                                            +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                   +-----------OBJ:V-N-----------+                                                          |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+                   |       +-------SUBJ:V-N------+--------COMP:V-N(with)--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+----COMP:N-N(of)---+       +-COMP:N-N(in)-+      |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           +MOD_ATT+       |         +MOD_+      |            |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |            |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__NODE__)
SUBJ:V-N (treat,protein)
COMP:V-N(with) (treat,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 214

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                                                                            +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                   +-----------OBJ:V-N-----------+                                                          |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+                   |       +-------SUBJ:V-N------+--------COMP:V-N(with)--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+----COMP:N-N(of)---+       +-COMP:N-N(in)-+      |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           +MOD_ATT+       |         +MOD_+      |            |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |            |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__NODE__)
SUBJ:V-N (treat,protein)
COMP:V-N(with) (treat,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 215

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                                                                            +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                   +-----------OBJ:V-N-----------+                                                          |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+                   |       +-------SUBJ:V-N------+--------COMP:V-N(with)--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+----COMP:N-N(of)---+       +-COMP:N-N(in)-+      |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           +MOD_ATT+       |         +MOD_+      |            |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |            |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__NODE__)
SUBJ:V-N (treat,protein)
COMP:V-N(with) (treat,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 216

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                                                                            +---------------------------------SUBJ:V-N---------------------------------+             
                                         |           +---------------OBJ:V-N---------------+                                                          |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+           |               +-------SUBJ:V-N------+      +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           |               +-COMP:N-N(in)-+      |      |     +---OBJ:V-N--+    |         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+COMP:N-N(of+       +MOD_ATT+         +MOD_+      +COMP:V-N(wit+      +SUBJ:+    |         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__SP__)
SUBJ:V-N (treat,protein)
COMP:V-N(with) (treat,agonist)
OBJ:V-N (with,Apo)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 217

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                                                                            +---------------------------------SUBJ:V-N---------------------------------+             
                                         |           +---------------OBJ:V-N---------------+                                                          |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+           |               +-------SUBJ:V-N------+      +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           |               +-COMP:N-N(in)-+      |      |     +---OBJ:V-N--+    |         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+COMP:N-N(of+       +MOD_ATT+         +MOD_+      +COMP:V-N(wit+      +SUBJ:+    |         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__SP__)
SUBJ:V-N (treat,protein)
COMP:V-N(with) (treat,agonist)
OBJ:V-N (with,Apo)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 218

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                                                                            +---------------------------------SUBJ:V-N---------------------------------+             
                                         |           +---------------OBJ:V-N---------------+                                                          |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+           |               +-------SUBJ:V-N------+--------COMP:V-N(with)--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           |               +-COMP:N-N(in)-+      |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+COMP:N-N(of+       +MOD_ATT+         +MOD_+      |            |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |            |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__SP__)
SUBJ:V-N (treat,protein)
COMP:V-N(with) (treat,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 219

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                                                                            +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                           +-------------------COMP:N-N(with)-------------------+                           |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+----SUBJ:V_PASS-N----+                              |                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+      |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+      |            |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |            |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
COMP:N-N(with) (protein,Apo)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,protein)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 220

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                              +-----------------------------------------------------COMP:V-N(with)-----------------------------------------------------+             
                                         |                                                              |                                             +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                                                              |                                             |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+                            +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+             |     +---OBJ:V-N--+    |         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+SUBJ:V+      |     |      +SUBJ:+    |         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,Apo)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(with) (__NODE__,agonist)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 221

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                                                                            +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                           +-------------------COMP:N-N(with)-------------------+                           |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+----SUBJ:V_PASS-N----+                              |                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+      |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+      |            |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |            |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
COMP:N-N(with) (protein,Apo)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,protein)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 222

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                                                                            +---------------------------------SUBJ:V-N---------------------------------+             
                                         +------------------SUBJ:V_PASS-N------------------+                                                          |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+                     |      +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+      +COMP:V_PASS-N(with)+          |         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,production)
COMP:V_PASS-N(with) (treat,anti)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 223

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                                                +--------------------------------------------COMP:V-N(with)--------------------------------------------+             
                                         |                                                                                |                           +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                                                                                |                           |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+                                                    |                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+                   +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+SUBJ:V+            |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |            |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(with) (__NODE__,Apo)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 224

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                                                                            +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                           +-------------------COMP:N-N(with)-------------------+                           |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+----SUBJ:V_PASS-N----+                              |                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+      |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+      |            |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |            |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
COMP:N-N(with) (protein,Apo)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,protein)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 225

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                                                +--------------------------------------------COMP:V-N(with)--------------------------------------------+             
                                         |                                                                                |                           +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                                                                                |                           |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+                                                    |                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+                   +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+SUBJ:V+            |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |            |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(with) (__NODE__,Apo)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 226

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                                                                            +---------------------------------SUBJ:V-N---------------------------------+             
                                         +---------------------OBJ:V-N---------------------+                                                          |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+                           +-------SUBJ:V-N------+--------COMP:V-N(with)--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+                           +-COMP:N-N(in)-+      |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+COMP:N-N(of+       +MOD_ATT+         +MOD_+      |            |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |            |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,production)
SUBJ:V-N (treat,protein)
COMP:V-N(with) (treat,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 227

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                                                                            +---------------------------------SUBJ:V-N---------------------------------+             
                                         +---------------------------------COMP:N-N(with)---------------------------------+                           |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+----SUBJ:V_PASS-N----+                              |                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+      |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+      |            |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |            |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
COMP:N-N(with) (production,Apo)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,protein)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 228

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                              +-----------------------------------------------------COMP:V-N(with)-----------------------------------------------------+             
                                         |                                                              |                                             +---------------------------------SUBJ:V-N---------------------------------+             
                                         +---------------COMP:N-N(in)---------------+                   |                                             |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+              |             +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+              |             |     +---OBJ:V-N--+    |         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+SUBJ:V+      |     |      +SUBJ:+    |         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
COMP:N-N(in) (production,cell)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,Apo)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(with) (__NODE__,agonist)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 229

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                                                                            +---------------------------------SUBJ:V-N---------------------------------+             
                                         +---------------------OBJ:V-N---------------------+                                                          |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+                           +-------SUBJ:V-N------+--------COMP:V-N(with)--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+----COMP:N-N(of)---+       +-COMP:N-N(in)-+      |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           +MOD_ATT+       |         +MOD_+      |            |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |            |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,production)
SUBJ:V-N (treat,protein)
COMP:V-N(with) (treat,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 230

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                          +----------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------+             
                                         |                                          |                                                                 +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                                          |                                                                 |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+              |             +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+              |      +COMP:V_PASS-N(with)+          |         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+SUBJ:V+      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,anti)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(in) (__NODE__,cell)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 231

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                          +----------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------+             
                                         |                                          |                                                                 +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                                          |                                                                 |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+              |             +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+              |      +COMP:V_PASS-N(with)+          |         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+SUBJ:V+      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,anti)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(in) (__NODE__,cell)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 232

                              +-------------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------------+             
                              +---------------------------OBJ:V-N--------------------------+                                                          +---------------------------------SUBJ:V-N---------------------------------+             
                              |          +---------------------SUBJ:V-N--------------------+                                                          |                   +--------------------COMP:V-N(with)--------------------+             
                              |          +--------COMP:N-N(of)-------+                     |                                                          |                   |                      +---------COMP:V-N(with)--------+             
               +--MOD_ATT:N-N-+          |           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     +MOD_ATT:+          |           |       +MOD_ATT+         +MOD_+      +COMP:V-N(wit+      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (decrease,cell)
MOD_ATT:N-N (decrease,culture)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,decrease)
SUBJ:V-N (treat,production)
COMP:V-N(with) (treat,agonist)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,decrease)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 233

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                                                                            +---------------------------------SUBJ:V-N---------------------------------+             
                                         +---------------------OBJ:V-N---------------------+                                                          |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+                           +-------SUBJ:V-N------+      +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+----COMP:N-N(of)---+       +-COMP:N-N(in)-+      |      |     +---OBJ:V-N--+    |         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           +MOD_ATT+       |         +MOD_+      +COMP:V-N(wit+      +SUBJ:+    |         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,production)
SUBJ:V-N (treat,protein)
COMP:V-N(with) (treat,agonist)
OBJ:V-N (with,Apo)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 234

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                              +-----------------------------------------------------COMP:V-N(with)-----------------------------------------------------+             
                                         |                                                              |                                             +---------------------------------SUBJ:V-N---------------------------------+             
                                         +---------------COMP:N-N(in)---------------+                   |                                             |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+              |             +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+              |             |     +---OBJ:V-N--+    |         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+SUBJ:V+      |     |      +SUBJ:+    |         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
COMP:N-N(in) (production,cell)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,Apo)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(with) (__NODE__,agonist)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 235

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                              +-----------------------------------------------------COMP:V-N(with)-----------------------------------------------------+             
                                         |                                                              |                                             +---------------------------------SUBJ:V-N---------------------------------+             
                                         +---------------COMP:N-N(in)---------------+                   |                                             |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+              |             +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+              |             |     +---OBJ:V-N--+    |         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+SUBJ:V+      |     |      +SUBJ:+    |         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
COMP:N-N(in) (production,cell)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,Apo)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(with) (__NODE__,agonist)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 236

                     +------------------------------------------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------------------------------------------+             
                     +-------------------------------OBJ:V-N-------------------------------+                                                          +---------------------------------SUBJ:V-N---------------------------------+             
                     |                   +---------------------SUBJ:V-N--------------------+                                                          |                   +--------------------COMP:V-N(with)--------------------+             
                     |                   +--------COMP:N-N(of)-------+                     +--------COMP:V-N(with)--------+                           |                   |                      +---------COMP:V-N(with)--------+             
                     |                   |           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+      |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               +MOD_A+        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+      |            |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |            |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,culture)
SUBJ:V-N (treat,production)
COMP:V-N(with) (treat,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,culture)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 237

                     +------------------------------------------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------------------------------------------+             
                     +-------------------------------OBJ:V-N-------------------------------+                                                          +---------------------------------SUBJ:V-N---------------------------------+             
                     |                   +---------------------SUBJ:V-N--------------------+                                                          |                   +--------------------COMP:V-N(with)--------------------+             
                     |                   +--------COMP:N-N(of)-------+                     |      +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
                     |                   |           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+      |      |     +---OBJ:V-N--+    |         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               +MOD_A+        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+      +COMP:V-N(wit+      +SUBJ:+    |         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,culture)
SUBJ:V-N (treat,production)
COMP:V-N(with) (treat,agonist)
OBJ:V-N (with,Apo)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,culture)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 238

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         +---------------------------------COMP:N-N(with)---------------------------------+                           +---------------------------------SUBJ:V-N---------------------------------+             
                                         +---------------COMP:N-N(in)---------------+                                     |                           |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+              |                                     |                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+              |                   +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+SUBJ:V+            |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |            |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
COMP:N-N(in) (production,cell)
COMP:N-N(with) (production,Apo)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 239

                     +------------------------------------------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------------------------------------------+             
                     +-------------------------------OBJ:V-N-------------------------------+                                                          +---------------------------------SUBJ:V-N---------------------------------+             
                     |                   +---------------------SUBJ:V-N--------------------+                                                          |                   +--------------------COMP:V-N(with)--------------------+             
                     |                   +--------COMP:N-N(of)-------+                     |      +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
                     |                   |           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+      |      |     +---OBJ:V-N--+    |         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               +MOD_A+        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+      +COMP:V-N(wit+      +SUBJ:+    |         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,culture)
SUBJ:V-N (treat,production)
COMP:V-N(with) (treat,agonist)
OBJ:V-N (with,Apo)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,culture)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 240

                              +-------------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------------+             
                              +---------------------------OBJ:V-N--------------------------+                                                          +---------------------------------SUBJ:V-N---------------------------------+             
                              |          +---------------------SUBJ:V-N--------------------+                                                          |                   +--------------------COMP:V-N(with)--------------------+             
                              |          +--------COMP:N-N(of)-------+                     |      +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               +--MOD_ATT:N-N-+          |           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+      +---COMP:V-N(with)--+          |         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     +MOD_ATT:+          |           |       +MOD_ATT+         +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (decrease,cell)
MOD_ATT:N-N (decrease,culture)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,decrease)
SUBJ:V-N (treat,production)
COMP:V-N(with) (treat,anti)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,decrease)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 241

                     +------------------------------------------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------------------------------------------+             
                     +-------------------------------OBJ:V-N-------------------------------+                                                          +---------------------------------SUBJ:V-N---------------------------------+             
                     |                   +---------------------SUBJ:V-N--------------------+                                                          |                   +--------------------COMP:V-N(with)--------------------+             
                     |                   +--------COMP:N-N(of)-------+                     +--------COMP:V-N(with)--------+                           |                   |                      +---------COMP:V-N(with)--------+             
                     |                   |           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+      |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               +MOD_A+        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+      |            |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |            |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,culture)
SUBJ:V-N (treat,production)
COMP:V-N(with) (treat,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,culture)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 242

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         +---------------------------------COMP:N-N(with)---------------------------------+                           +---------------------------------SUBJ:V-N---------------------------------+             
                                         +---------------COMP:N-N(in)---------------+                                     |                           |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+              |                                     |                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+              |                   +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+SUBJ:V+            |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |            |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
COMP:N-N(in) (production,cell)
COMP:N-N(with) (production,Apo)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 243

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                              +-----------------------------------------------------COMP:V-N(with)-----------------------------------------------------+             
                                         |                                                              |                                             +---------------------------------SUBJ:V-N---------------------------------+             
                                         +------------------SUBJ:V_PASS-N------------------+            |                                             |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+                     |      +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+      |      |     +---OBJ:V-N--+    |         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+      |      |     |      +SUBJ:+    |         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,production)
OBJ:V-N (with,Apo)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(with) (__NODE__,agonist)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 244

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                                           +-----------------------------------------------COMP:V-N(with)----------------------------------------------+             
                                         |                                                                           |                                +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                   +-----------OBJ:V-N-----------+                         |                                |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+                   |       +-------SUBJ:V-N------+      +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+----COMP:N-N(of)---+       +-COMP:N-N(in)-+      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           +MOD_ATT+       |         +MOD_+      |      |     |      +MOD_A+    |         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__NODE__)
SUBJ:V-N (treat,protein)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(with) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 245

                              +-------------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------------+             
                              +---------------------------OBJ:V-N--------------------------+                                                                                                                                     |             
                              |          +---------------------SUBJ:V-N--------------------+                                                          +---------------------------------SUBJ:V-N---------------------------------+             
                              |          +---------------COMP:N-N(in)---------------+      |                                                          |                   +--------------------COMP:V-N(with)--------------------+             
                              |          +--------COMP:N-N(of)-------+              |      |                                                          |                   |                      +---------COMP:V-N(with)--------+             
               +--MOD_ATT:N-N-+          |           +-MOD_ATT:N-ADJ-+              |      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     +MOD_ATT:+          |           |       +MOD_ATT+         +MOD_+      +COMP:V-N(wit+      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (decrease,cell)
MOD_ATT:N-N (decrease,culture)
COMP:N-N(of) (production,protein)
COMP:N-N(in) (production,cell)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,decrease)
SUBJ:V-N (treat,production)
COMP:V-N(with) (treat,agonist)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,decrease)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 246

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                                           +-----------------------------------------------COMP:V-N(with)----------------------------------------------+             
                                         |                                                                           |                                +---------------------------------SUBJ:V-N---------------------------------+             
                                         |           +---------------OBJ:V-N---------------+                         |                                |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+           |               +-------SUBJ:V-N------+      +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           |               +-COMP:N-N(in)-+      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+COMP:N-N(of+       +MOD_ATT+         +MOD_+      |      |     |      +MOD_A+    |         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__SP__)
SUBJ:V-N (treat,protein)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(with) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 247

                              +-------------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------------+             
                              +---------------------------OBJ:V-N--------------------------+                                                                                                                                     |             
                              |          +---------------------SUBJ:V-N--------------------+                                                          +---------------------------------SUBJ:V-N---------------------------------+             
                              |          +---------------COMP:N-N(in)---------------+      |                                                          |                   +--------------------COMP:V-N(with)--------------------+             
                              |          +--------COMP:N-N(of)-------+              |      |                                                          |                   |                      +---------COMP:V-N(with)--------+             
               +--MOD_ATT:N-N-+          |           +-MOD_ATT:N-ADJ-+              |      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     +MOD_ATT:+          |           |       +MOD_ATT+         +MOD_+      +COMP:V-N(wit+      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (decrease,cell)
MOD_ATT:N-N (decrease,culture)
COMP:N-N(of) (production,protein)
COMP:N-N(in) (production,cell)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,decrease)
SUBJ:V-N (treat,production)
COMP:V-N(with) (treat,agonist)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,decrease)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 248

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         +---------------------OBJ:V-N---------------------+                                                          +---------------------------------SUBJ:V-N---------------------------------+             
                                         +-------------COMP:N-N(in)------------+           |                                                          |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+         |           |      +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+         |           |      |     +---OBJ:V-N--+    |         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         |    +SUBJ:V+COMP:V-N(wit+      +SUBJ:+    |         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
COMP:N-N(in) (production,Hela)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (treat,production)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,agonist)
OBJ:V-N (with,Apo)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 249

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         +---------------------OBJ:V-N---------------------+                                                          +---------------------------------SUBJ:V-N---------------------------------+             
                                         +-------------COMP:N-N(in)------------+           |                                                          |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+         |           |      +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+         |           |      |     +---OBJ:V-N--+    |         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         |    +SUBJ:V+COMP:V-N(wit+      +SUBJ:+    |         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
COMP:N-N(in) (production,Hela)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (treat,production)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,agonist)
OBJ:V-N (with,Apo)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 250

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                           +------------------------------------------------------------------------COMP:V-N(of)-----------------------------------------------------------------------+             
                                         |                           |                                                                                +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                           |                     +---COMP:V_PASS-N(with)---+                                |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+                           |                     |      +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+SUBJ:V+      |     |      +MOD_A+    |         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,__SP__)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(of) (__NODE__,protein)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 251

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                           +------------------------------------------------------------------------COMP:V-N(of)-----------------------------------------------------------------------+             
                                         |                           |                                                                                +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                           |                     +---COMP:V_PASS-N(with)---+                                |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+                           |                     |      +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+SUBJ:V+      |     |      +MOD_A+    |         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,__SP__)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(of) (__NODE__,protein)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 252

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                              +-----------------------------------------------------COMP:V-N(with)-----------------------------------------------------+             
                                         +------------------SUBJ:V_PASS-N------------------+            |                                             +---------------------------------SUBJ:V-N---------------------------------+             
                                         +---------------COMP:N-N(in)---------------+      |            |                                             |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+              |      |      +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+              |      |      |     +---OBJ:V-N--+    |         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+      |      |     |      +SUBJ:+    |         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
COMP:N-N(in) (production,cell)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,production)
OBJ:V-N (with,Apo)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(with) (__NODE__,agonist)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 253

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         +---------------------------------COMP:N-N(with)---------------------------------+                                                                                                      |             
                                         +------------------SUBJ:V_PASS-N------------------+                              |                           +---------------------------------SUBJ:V-N---------------------------------+             
                                         +---------------COMP:N-N(in)---------------+      |                              |                           |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+              |      |                              |                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+              |      |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+      |            |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |            |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
COMP:N-N(in) (production,cell)
COMP:N-N(with) (production,Apo)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,production)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 254

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         +---------------------------------COMP:N-N(with)---------------------------------+                                                                                                      |             
                                         +------------------SUBJ:V_PASS-N------------------+                              |                           +---------------------------------SUBJ:V-N---------------------------------+             
                                         +---------------COMP:N-N(in)---------------+      |                              |                           |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+              |      |                              |                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+              |      |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+      |            |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |            |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
COMP:N-N(in) (production,cell)
COMP:N-N(with) (production,Apo)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,production)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 255

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                                           +-----------------------------------------------COMP:V-N(with)----------------------------------------------+             
                                         |                                                                           |                                +---------------------------------SUBJ:V-N---------------------------------+             
                                         +---------------------OBJ:V-N---------------------+                         |                                |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+                           +-------SUBJ:V-N------+      +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+                           +-COMP:N-N(in)-+      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+COMP:N-N(of+       +MOD_ATT+         +MOD_+      |      |     |      +MOD_A+    |         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,production)
SUBJ:V-N (treat,protein)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(with) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 256

                     +------------------------------------------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------------------------------------------+             
                     |                                                                                               +-----------------------------------------------COMP:V-N(with)----------------------------------------------+             
                     +-------------------------------OBJ:V-N-------------------------------+                         |                                +---------------------------------SUBJ:V-N---------------------------------+             
                     |                   +---------------------SUBJ:V-N--------------------+                         |                                |                   +--------------------COMP:V-N(with)--------------------+             
                     |                   +--------COMP:N-N(of)-------+                     |      +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
                     |                   |           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               +MOD_A+        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+      |      |     |      +MOD_A+    |         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,culture)
SUBJ:V-N (treat,production)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(with) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 257

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                                           +-----------------------------------------------COMP:V-N(with)----------------------------------------------+             
                                         |                                                                           |                                +---------------------------------SUBJ:V-N---------------------------------+             
                                         +---------------------OBJ:V-N---------------------+                         |                                |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+                     |      +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+                     |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+COMP:N-N(+    +SUBJ:V+      |     |      +MOD_A+    |         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,Hela)
OBJ:V-N (treat,production)
SUBJ:V-N (treat,cell)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(with) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 258

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                                           +-----------------------------------------------COMP:V-N(with)----------------------------------------------+             
                                         |                                                                           |                                +---------------------------------SUBJ:V-N---------------------------------+             
                                         +---------------------OBJ:V-N---------------------+                         |                                |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+                     |      +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+                     |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+COMP:N-N(+    +SUBJ:V+      |     |      +MOD_A+    |         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,Hela)
OBJ:V-N (treat,production)
SUBJ:V-N (treat,cell)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(with) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 259

                     +------------------------------------------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------------------------------------------+             
                     +-------------------------------OBJ:V-N-------------------------------+                         +-----------------------------------------------COMP:V-N(with)----------------------------------------------+             
                     |                   +---------------------SUBJ:V-N--------------------+                         |                                +---------------------------------SUBJ:V-N---------------------------------+             
                     |                   +---------------COMP:N-N(in)---------------+      |                         |                                |                   +--------------------COMP:V-N(with)--------------------+             
                     |                   +--------COMP:N-N(of)-------+              |      |      +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
                     |                   |           +-MOD_ATT:N-ADJ-+              |      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               +MOD_A+        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+      |      |     |      +MOD_A+    |         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
COMP:N-N(in) (production,cell)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,culture)
SUBJ:V-N (treat,production)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(with) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 260

                     +------------------------------------------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------------------------------------------+             
                     +-------------------------------OBJ:V-N-------------------------------+                         +-----------------------------------------------COMP:V-N(with)----------------------------------------------+             
                     |                   +---------------------SUBJ:V-N--------------------+                         |                                +---------------------------------SUBJ:V-N---------------------------------+             
                     |                   +---------------COMP:N-N(in)---------------+      |                         |                                |                   +--------------------COMP:V-N(with)--------------------+             
                     |                   +--------COMP:N-N(of)-------+              |      |      +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
                     |                   |           +-MOD_ATT:N-ADJ-+              |      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               +MOD_A+        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+      |      |     |      +MOD_A+    |         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
COMP:N-N(in) (production,cell)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,culture)
SUBJ:V-N (treat,production)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(with) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 261

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                           +------------------------------------------------------------------------COMP:V-N(of)-----------------------------------------------------------------------+             
                                         |                           |              +----------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------+             
                                         |                           |              |                                                                 +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                           |              |      +---COMP:V_PASS-N(with)---+                                |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+                           |              |      |      +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+              |      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+SUBJ:V+      |     |      +MOD_A+    |         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,__SP__)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(of) (__NODE__,protein)
COMP:V-N(in) (__NODE__,cell)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 262

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                                                                            +---------------------------------SUBJ:V-N---------------------------------+             
                                         +---------------COMP:N-N(in)---------------+                                                                 |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+              |             +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+              |      +COMP:V_PASS-N(with)+          |         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+SUBJ:V+      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
COMP:N-N(in) (production,cell)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,anti)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 263

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                                                                            +---------------------------------SUBJ:V-N---------------------------------+             
                                         +---------------COMP:N-N(in)---------------+                                                                 |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+              |             +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+              |      +COMP:V_PASS-N(with)+          |         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+SUBJ:V+      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
COMP:N-N(in) (production,cell)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,anti)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 264

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                                                                            +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                                                                                                            |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+                            +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+-------OBJ:V-N-------+      |     +---OBJ:V-N--+    |         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+COMP:N-N(+    +SUBJ:V+COMP:V-N(wit+      +SUBJ:+    |         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,Hela)
OBJ:V-N (treat,protein)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,agonist)
OBJ:V-N (with,Apo)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 265

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                                                                            +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                   +-----------OBJ:V-N-----------+                                                          |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+                   |       +-------SUBJ:V-N------+      +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+----COMP:N-N(of)---+       +-COMP:N-N(in)-+      |      |     +---OBJ:V-N--+    |         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           +MOD_ATT+       |         +MOD_+      +COMP:V-N(wit+      +SUBJ:+    |         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__NODE__)
SUBJ:V-N (treat,protein)
COMP:V-N(with) (treat,agonist)
OBJ:V-N (with,Apo)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 266

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                                                                            +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                   +-----------OBJ:V-N-----------+                                                          |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+                   |       +-------SUBJ:V-N------+--------COMP:V-N(with)--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+----COMP:N-N(of)---+       +-COMP:N-N(in)-+      |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           +MOD_ATT+       |         +MOD_+      |            |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |            |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__NODE__)
SUBJ:V-N (treat,protein)
COMP:V-N(with) (treat,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 267

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                                                                            +---------------------------------SUBJ:V-N---------------------------------+             
                                         +------------------SUBJ:V_PASS-N------------------+                                                          |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+                     |      +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+      +COMP:V_PASS-N(with)+          |         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,production)
COMP:V_PASS-N(with) (treat,anti)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 268

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                                                                            +---------------------------------SUBJ:V-N---------------------------------+             
                                         +---------------------------------COMP:N-N(with)---------------------------------+                           |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+                                                    |                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+                   +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+SUBJ:V+            |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |            |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
COMP:N-N(with) (production,Apo)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 269

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                                                                            +---------------------------------SUBJ:V-N---------------------------------+             
                                         +---------------------------------COMP:N-N(with)---------------------------------+                           |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+                                                    |                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+                   +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+SUBJ:V+            |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |            |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
COMP:N-N(with) (production,Apo)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 270

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                                                                            +---------------------------------SUBJ:V-N---------------------------------+             
                                         +---------------------------------COMP:N-N(with)---------------------------------+                           |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+                                                    |                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+                   +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+SUBJ:V+            |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |            |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
COMP:N-N(with) (production,Apo)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 271

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                              +-----------------------------------------------------COMP:V-N(with)-----------------------------------------------------+             
                                         |                                                              |                                             +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                                                              |                                             |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+----SUBJ:V_PASS-N----+      +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+      |      |     +---OBJ:V-N--+    |         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+      |      |     |      +SUBJ:+    |         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,protein)
OBJ:V-N (with,Apo)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(with) (__NODE__,agonist)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 272

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                                                                            +---------------------------------SUBJ:V-N---------------------------------+             
                                         +---------------------OBJ:V-N---------------------+                                                          |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+                           +-------SUBJ:V-N------+--------COMP:V-N(with)--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+                           +-COMP:N-N(in)-+      |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+COMP:N-N(of+       +MOD_ATT+         +MOD_+      |            |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |            |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,production)
SUBJ:V-N (treat,protein)
COMP:V-N(with) (treat,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 273

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                                                +--------------------------------------------COMP:V-N(with)--------------------------------------------+             
                                         |                                                                                |                           +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                                                                                |                           |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+----SUBJ:V_PASS-N----+                              |                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+      |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+      |            |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |            |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,protein)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(with) (__NODE__,Apo)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 274

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                                                +--------------------------------------------COMP:V-N(with)--------------------------------------------+             
                                         |                                                                                |                           +---------------------------------SUBJ:V-N---------------------------------+             
                                         +---------------COMP:N-N(in)---------------+                                     |                           |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+              |                                     |                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+              |                   +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+SUBJ:V+            |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |            |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
COMP:N-N(in) (production,cell)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(with) (__NODE__,Apo)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 275

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                              +-----------------------------------------------------COMP:V-N(with)-----------------------------------------------------+             
                                         |                                                              |                                             +---------------------------------SUBJ:V-N---------------------------------+             
                                         +---------------COMP:N-N(in)---------------+                   |                                             |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+              |             +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+              |             |     +---OBJ:V-N--+    |         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+SUBJ:V+      |     |      +SUBJ:+    |         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
COMP:N-N(in) (production,cell)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,Apo)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(with) (__NODE__,agonist)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 276

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         +------------------SUBJ:V_PASS-N------------------+                                                          +---------------------------------SUBJ:V-N---------------------------------+             
                                         +---------------COMP:N-N(in)---------------+      |                                                          |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+              |      |      +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+              |      +COMP:V_PASS-N(with)+          |         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
COMP:N-N(in) (production,cell)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,production)
COMP:V_PASS-N(with) (treat,anti)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 277

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         +------------------SUBJ:V_PASS-N------------------+                                                          +---------------------------------SUBJ:V-N---------------------------------+             
                                         +---------------COMP:N-N(in)---------------+      |                                                          |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+              |      |      +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+              |      +COMP:V_PASS-N(with)+          |         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
COMP:N-N(in) (production,cell)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,production)
COMP:V_PASS-N(with) (treat,anti)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 278

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                                                                            +---------------------------------SUBJ:V-N---------------------------------+             
                                         +---------------------OBJ:V-N---------------------+                                                          |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+                     +--------COMP:V-N(with)--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+                     |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+COMP:N-N(+    +SUBJ:V+            |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |            |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,Hela)
OBJ:V-N (treat,production)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 279

                     +------------------------------------------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------------------------------------------+             
                     +-------------------------------OBJ:V-N-------------------------------+                                                          +---------------------------------SUBJ:V-N---------------------------------+             
                     |                   +---------------------SUBJ:V-N--------------------+                                                          |                   +--------------------COMP:V-N(with)--------------------+             
                     |                   +--------COMP:N-N(of)-------+                     +--------COMP:V-N(with)--------+                           |                   |                      +---------COMP:V-N(with)--------+             
                     |                   |           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+      |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               +MOD_A+        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+      |            |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |            |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,culture)
SUBJ:V-N (treat,production)
COMP:V-N(with) (treat,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,culture)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 280

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                          +----------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------+             
                                         |                                          |                                                                 +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                                          |                                                                 |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+              +------------COMP:N-N(with)-----------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+              |                   +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+SUBJ:V+            |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |            |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (cell,Hela)
COMP:N-N(with) (cell,Apo)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(in) (__NODE__,cell)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 281

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                          +----------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------+             
                                         |                                          |                                                                 +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                                          |                                                                 |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+              +------------COMP:N-N(with)-----------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+              |                   +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+SUBJ:V+            |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |            |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (cell,Hela)
COMP:N-N(with) (cell,Apo)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(in) (__NODE__,cell)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 282

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                                           +-----------------------------------------------COMP:V-N(with)----------------------------------------------+             
                                         |                                                                           |                                +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                                                                           |                                |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+                            +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+-------OBJ:V-N-------+      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+COMP:N-N(+    +SUBJ:V+      |     |      +MOD_A+    |         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,Hela)
OBJ:V-N (treat,protein)
SUBJ:V-N (treat,cell)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(with) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 283

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                              +-----------------------------------------------------COMP:V-N(with)-----------------------------------------------------+             
                                         |                                                              |                                             +---------------------------------SUBJ:V-N---------------------------------+             
                                         +------------------SUBJ:V_PASS-N------------------+            |                                             |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+                     |      +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+      |      |     +---OBJ:V-N--+    |         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+      |      |     |      +SUBJ:+    |         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,production)
OBJ:V-N (with,Apo)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(with) (__NODE__,agonist)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 284

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                                                +--------------------------------------------COMP:V-N(with)--------------------------------------------+             
                                         |                                                                                |                           +---------------------------------SUBJ:V-N---------------------------------+             
                                         +------------------SUBJ:V_PASS-N------------------+                              |                           |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+                     |                              |                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+      |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+      |            |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |            |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,production)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(with) (__NODE__,Apo)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 285

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                              +-----------------------------------------------------COMP:V-N(with)-----------------------------------------------------+             
                                         |                                                              |                                             +---------------------------------SUBJ:V-N---------------------------------+             
                                         +------------------SUBJ:V_PASS-N------------------+            |                                             |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+                     |      +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+      |      |     +---OBJ:V-N--+    |         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+      |      |     |      +SUBJ:+    |         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,production)
OBJ:V-N (with,Apo)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(with) (__NODE__,agonist)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 286

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                                           +-----------------------------------------------COMP:V-N(with)----------------------------------------------+             
                                         |                                                                           |                                +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                   +-----------OBJ:V-N-----------+                         |                                |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+                   |       +-------SUBJ:V-N------+      +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+----COMP:N-N(of)---+       +-COMP:N-N(in)-+      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           +MOD_ATT+       |         +MOD_+      |      |     |      +MOD_A+    |         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__NODE__)
SUBJ:V-N (treat,protein)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(with) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 287

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                              +-----------------------------------------------------COMP:V-N(with)-----------------------------------------------------+             
                                         |                                                              |                                             +---------------------------------SUBJ:V-N---------------------------------+             
                                         +------------------SUBJ:V_PASS-N------------------+            |                                             |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+                     |      +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+      |      |     +---OBJ:V-N--+    |         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+      |      |     |      +SUBJ:+    |         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,production)
OBJ:V-N (with,Apo)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(with) (__NODE__,agonist)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 288

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                                           +-----------------------------------------------COMP:V-N(with)----------------------------------------------+             
                                         |                                                                           |                                +---------------------------------SUBJ:V-N---------------------------------+             
                                         |           +---------------OBJ:V-N---------------+                         |                                |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+           |               +-------SUBJ:V-N------+      +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           |               +-COMP:N-N(in)-+      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+COMP:N-N(of+       +MOD_ATT+         +MOD_+      |      |     |      +MOD_A+    |         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__SP__)
SUBJ:V-N (treat,protein)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(with) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 289

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                                           +-----------------------------------------------COMP:V-N(with)----------------------------------------------+             
                                         |                                                                           |                                +---------------------------------SUBJ:V-N---------------------------------+             
                                         |           +---------------OBJ:V-N---------------+                         |                                |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+           |               +-------SUBJ:V-N------+      +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           |               +-COMP:N-N(in)-+      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+COMP:N-N(of+       +MOD_ATT+         +MOD_+      |      |     |      +MOD_A+    |         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__SP__)
SUBJ:V-N (treat,protein)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(with) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 290

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         +---------------------OBJ:V-N---------------------+                                                          +---------------------------------SUBJ:V-N---------------------------------+             
                                         +-------------COMP:N-N(in)------------+           |                                                          |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+         |           +--------COMP:V-N(with)--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+         |           |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         |    +SUBJ:V+            |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |            |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
COMP:N-N(in) (production,Hela)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (treat,production)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 291

                     +------------------------------------------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------------------------------------------+             
                     +-------------------------------OBJ:V-N-------------------------------+                                                                                                                                     |             
                     |                   +---------------------SUBJ:V-N--------------------+                                                          +---------------------------------SUBJ:V-N---------------------------------+             
                     |                   +---------------COMP:N-N(in)---------------+      |                                                          |                   +--------------------COMP:V-N(with)--------------------+             
                     |                   +--------COMP:N-N(of)-------+              |      |      +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
                     |                   |           +-MOD_ATT:N-ADJ-+              |      |      |     +---OBJ:V-N--+    |         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               +MOD_A+        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+      +COMP:V-N(wit+      +SUBJ:+    |         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
COMP:N-N(in) (production,cell)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,culture)
SUBJ:V-N (treat,production)
COMP:V-N(with) (treat,agonist)
OBJ:V-N (with,Apo)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,culture)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 292

                     +------------------------------------------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------------------------------------------+             
                     +-------------------------------OBJ:V-N-------------------------------+                                                                                                                                     |             
                     |                   +---------------------SUBJ:V-N--------------------+                                                          +---------------------------------SUBJ:V-N---------------------------------+             
                     |                   +---------------COMP:N-N(in)---------------+      |                                                          |                   +--------------------COMP:V-N(with)--------------------+             
                     |                   +--------COMP:N-N(of)-------+              |      |      +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
                     |                   |           +-MOD_ATT:N-ADJ-+              |      |      |     +---OBJ:V-N--+    |         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               +MOD_A+        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+      +COMP:V-N(wit+      +SUBJ:+    |         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
COMP:N-N(in) (production,cell)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,culture)
SUBJ:V-N (treat,production)
COMP:V-N(with) (treat,agonist)
OBJ:V-N (with,Apo)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,culture)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 293

                     +------------------------------------------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------------------------------------------+             
                     +-------------------------------OBJ:V-N-------------------------------+                                                                                                                                     |             
                     |                   +---------------------SUBJ:V-N--------------------+                                                          +---------------------------------SUBJ:V-N---------------------------------+             
                     |                   +---------------COMP:N-N(in)---------------+      |                                                          |                   +--------------------COMP:V-N(with)--------------------+             
                     |                   +--------COMP:N-N(of)-------+              |      +--------COMP:V-N(with)--------+                           |                   |                      +---------COMP:V-N(with)--------+             
                     |                   |           +-MOD_ATT:N-ADJ-+              |      |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               +MOD_A+        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+      |            |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |            |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
COMP:N-N(in) (production,cell)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,culture)
SUBJ:V-N (treat,production)
COMP:V-N(with) (treat,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,culture)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 294

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                           +------------------------------------------------------------------------COMP:V-N(of)-----------------------------------------------------------------------+             
                                         |                           |                                                                                +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                           |                     +---COMP:V_PASS-N(with)---+                                |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+                           |                     |      +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+SUBJ:V+      |     |      +MOD_A+    |         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,__SP__)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(of) (__NODE__,protein)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 295

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                                                +--------------------------------------------COMP:V-N(with)--------------------------------------------+             
                                         +------------------SUBJ:V_PASS-N------------------+                              |                           +---------------------------------SUBJ:V-N---------------------------------+             
                                         +---------------COMP:N-N(in)---------------+      |                              |                           |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+              |      |                              |                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+              |      |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+      |            |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |            |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
COMP:N-N(in) (production,cell)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,production)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(with) (__NODE__,Apo)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 296

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                                                +--------------------------------------------COMP:V-N(with)--------------------------------------------+             
                                         +------------------SUBJ:V_PASS-N------------------+                              |                           +---------------------------------SUBJ:V-N---------------------------------+             
                                         +---------------COMP:N-N(in)---------------+      |                              |                           |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+              |      |                              |                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+              |      |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+      |            |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |            |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
COMP:N-N(in) (production,cell)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,production)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(with) (__NODE__,Apo)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 297

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                              +-----------------------------------------------------COMP:V-N(with)-----------------------------------------------------+             
                                         +------------------SUBJ:V_PASS-N------------------+            |                                             +---------------------------------SUBJ:V-N---------------------------------+             
                                         +---------------COMP:N-N(in)---------------+      |            |                                             |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+              |      |      +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+              |      |      |     +---OBJ:V-N--+    |         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+      |      |     |      +SUBJ:+    |         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
COMP:N-N(in) (production,cell)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,production)
OBJ:V-N (with,Apo)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(with) (__NODE__,agonist)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 298

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                          +----------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------+             
                                         |                                          |                                     +--------------------------------------------COMP:V-N(with)--------------------------------------------+             
                                         |                                          |                                     |                           +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                                          |                                     |                           |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+              |                                     |                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+              |                   +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+SUBJ:V+            |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |            |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(in) (__NODE__,cell)
COMP:V-N(with) (__NODE__,Apo)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 299

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         +---------------------------------COMP:N-N(with)---------------------------------+                                                                                                      |             
                                         +------------------SUBJ:V_PASS-N------------------+                              |                           +---------------------------------SUBJ:V-N---------------------------------+             
                                         +---------------COMP:N-N(in)---------------+      |                              |                           |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+              |      |                              |                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+              |      |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+      |            |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |            |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
COMP:N-N(in) (production,cell)
COMP:N-N(with) (production,Apo)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,production)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 300

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         +---------------------------------COMP:N-N(with)---------------------------------+                                                                                                      |             
                                         +------------------SUBJ:V_PASS-N------------------+                              |                           +---------------------------------SUBJ:V-N---------------------------------+             
                                         +---------------COMP:N-N(in)---------------+      |                              |                           |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+              |      |                              |                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+              |      |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+      |            |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |            |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
COMP:N-N(in) (production,cell)
COMP:N-N(with) (production,Apo)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,production)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 301

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                           +------------------------------------------------------------------------COMP:V-N(of)-----------------------------------------------------------------------+             
                                         |                           |                                                                                +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                           |                     +---COMP:V_PASS-N(with)---+                                |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+                           +----SUBJ:V_PASS-N----+      +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+      |      |     |      +MOD_A+    |         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,protein)
COMP:V_PASS-N(with) (treat,__SP__)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(of) (__NODE__,protein)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 302

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                                           +-----------------------------------------------COMP:V-N(with)----------------------------------------------+             
                                         |                                                                           |                                +---------------------------------SUBJ:V-N---------------------------------+             
                                         +---------------------OBJ:V-N---------------------+                         |                                |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+                     |      +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+                     |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+COMP:N-N(+    +SUBJ:V+      |     |      +MOD_A+    |         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,Hela)
OBJ:V-N (treat,production)
SUBJ:V-N (treat,cell)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(with) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 303

                     +------------------------------------------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------------------------------------------+             
                     |                                                                                               +-----------------------------------------------COMP:V-N(with)----------------------------------------------+             
                     +-------------------------------OBJ:V-N-------------------------------+                         |                                +---------------------------------SUBJ:V-N---------------------------------+             
                     |                   +---------------------SUBJ:V-N--------------------+                         |                                |                   +--------------------COMP:V-N(with)--------------------+             
                     |                   +--------COMP:N-N(of)-------+                     |      +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
                     |                   |           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               +MOD_A+        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+      |      |     |      +MOD_A+    |         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,culture)
SUBJ:V-N (treat,production)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(with) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 304

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                                           +-----------------------------------------------COMP:V-N(with)----------------------------------------------+             
                                         |                                                                           |                                +---------------------------------SUBJ:V-N---------------------------------+             
                                         +---------------------OBJ:V-N---------------------+                         |                                |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+                     |      +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+                     |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+COMP:N-N(+    +SUBJ:V+      |     |      +MOD_A+    |         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,Hela)
OBJ:V-N (treat,production)
SUBJ:V-N (treat,cell)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(with) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 305

                              +-------------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------------+             
                              +---------------------------OBJ:V-N--------------------------+                   +--------------------------------------------------COMP:V-N(with)-------------------------------------------------+             
                              |          +---------------------SUBJ:V-N--------------------+                   |                                      +---------------------------------SUBJ:V-N---------------------------------+             
                              |          +---------------COMP:N-N(in)---------------+      |                   |                                      |                   +--------------------COMP:V-N(with)--------------------+             
                              |          +--------COMP:N-N(of)-------+              |      |                   |                                      |                   |                      +---------COMP:V-N(with)--------+             
               +--MOD_ATT:N-N-+          |           +-MOD_ATT:N-ADJ-+              |      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     +MOD_ATT:+          |           |       +MOD_ATT+         +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (decrease,cell)
MOD_ATT:N-N (decrease,culture)
COMP:N-N(of) (production,protein)
COMP:N-N(in) (production,cell)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,decrease)
SUBJ:V-N (treat,production)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,decrease)
COMP:V-N(with) (__NODE__,anti)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 306

                     +------------------------------------------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------------------------------------------+             
                     +-------------------------------OBJ:V-N-------------------------------+                         +-----------------------------------------------COMP:V-N(with)----------------------------------------------+             
                     |                   +---------------------SUBJ:V-N--------------------+                         |                                +---------------------------------SUBJ:V-N---------------------------------+             
                     |                   +---------------COMP:N-N(in)---------------+      |                         |                                |                   +--------------------COMP:V-N(with)--------------------+             
                     |                   +--------COMP:N-N(of)-------+              |      |      +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
                     |                   |           +-MOD_ATT:N-ADJ-+              |      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               +MOD_A+        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+      |      |     |      +MOD_A+    |         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
COMP:N-N(in) (production,cell)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,culture)
SUBJ:V-N (treat,production)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(with) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 307

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                                           +-----------------------------------------------COMP:V-N(with)----------------------------------------------+             
                                         +---------------------OBJ:V-N---------------------+                         |                                +---------------------------------SUBJ:V-N---------------------------------+             
                                         +-------------COMP:N-N(in)------------+           |                         |                                |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+         |           |      +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+         |           |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         |    +SUBJ:V+      |     |      +MOD_A+    |         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
COMP:N-N(in) (production,Hela)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (treat,production)
SUBJ:V-N (treat,cell)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(with) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 308

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                                           +-----------------------------------------------COMP:V-N(with)----------------------------------------------+             
                                         +---------------------OBJ:V-N---------------------+                         |                                +---------------------------------SUBJ:V-N---------------------------------+             
                                         +-------------COMP:N-N(in)------------+           |                         |                                |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+         |           |      +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+         |           |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         |    +SUBJ:V+      |     |      +MOD_A+    |         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
COMP:N-N(in) (production,Hela)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (treat,production)
SUBJ:V-N (treat,cell)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(with) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 309

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                           +------------------------------------------------------------------------COMP:V-N(of)-----------------------------------------------------------------------+             
                                         |                           |              +----------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------+             
                                         |                           |              |                                                                 +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                           |              |      +---COMP:V_PASS-N(with)---+                                |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+                           |              |      |      +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+              |      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+SUBJ:V+      |     |      +MOD_A+    |         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,__SP__)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(of) (__NODE__,protein)
COMP:V-N(in) (__NODE__,cell)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 310

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                           +------------------------------------------------------------------------COMP:V-N(of)-----------------------------------------------------------------------+             
                                         |                           |              +----------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------+             
                                         |                           |              |                                                                 +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                           |              |      +---COMP:V_PASS-N(with)---+                                |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+                           |              |      |      +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+              |      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+SUBJ:V+      |     |      +MOD_A+    |         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,__SP__)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(of) (__NODE__,protein)
COMP:V-N(in) (__NODE__,cell)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 311

                                                                                           +--------------------------------------------------COMP:V-N(with)--------------------------------------------------+                                
                              +------------------------COMP:V-N(in)------------------------+--------------------------------------------COMP:V-N(with)-------------------------------------------+            |                                
                              |          +---------------------SUBJ:V-N--------------------+--------------------------------COMP:V-N(with)--------------------------------+                      |            |                                
                              |          +---------------COMP:N-N(in)---------------+      |      +----------------------OBJ:V-N----------------------+          +--------------------------------OBJ:V-N--------------------------------+     
                              |          +--------COMP:N-N(of)-------+              |      +--------COMP:V-N(with)--------+                           |          |        |             +---------------------OBJ:V-N--------------------+     
               +--MOD_ATT:N-N-+          |           +-MOD_ATT:N-ADJ-+              |      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+          |        |             |    +--MOD_ATT:N-ADJ-+          +-MOD_ATT:N-ADJ-+     
               |     +MOD_ATT:+          |           |       +MOD_ATT+         +MOD_+      |      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+          |        |             |    +MOD+            |          |       +MOD_ATT+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |          |        |             |    |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (decrease,cell)
MOD_ATT:N-N (decrease,culture)
COMP:N-N(of) (production,protein)
COMP:N-N(in) (production,cell)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (cell,Hela)
COMP:V-N(in) (treat,decrease)
SUBJ:V-N (treat,production)
COMP:V-N(with) (treat,Apo)
COMP:V-N(with) (treat,cycloheximide)
COMP:V-N(with) (treat,FMK)
COMP:V-N(with) (treat,overproduce)
OBJ:V-N (with,antibody)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (with,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 312

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                     +-------------------------------------------------------------------COMP:V-N(in)------------------------------------------------------------------+             
                                         |                                     |    +------------------------------------------------------------------SUBJ:V-N------------------------------------------------------------------+             
                                         |                                     |    |      +------------------------------------------------COMP:V_PASS-N(with)-----------------------------------------------+                  |             
                                         |                                     |    |      +-----------------------------------------COMP:V_PASS-N(with)-----------------------------------------+            |                  |             
                                         |                                     |    |      +------------------------------COMP:V_PASS-N(with)-----------------------------+                      |            |                  |             
                                         |                                     |    |      |      +----------------------OBJ:V-N----------------------+                   |                      |            |                  |             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+         |    |      +------COMP:V_PASS-N(with)-----+                           |                   |                      |            |                  |             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+         |    |      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |             +-------------OBJ:V-N------------+       |             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         |    +SUBJ:V+      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |             |    +MOD+            |          |       +OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |             |    |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,Apo)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
COMP:V_PASS-N(with) (treat,overproduce)
OBJ:V-N (with,antibody)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (with,__SP__)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(in) (__NODE__,Hela)
SUBJ:V-N (__NODE__,cell)
OBJ:V-N (__NODE__,protein)

Analyse 313

                                                                                           +--------------------------------------------------COMP:V-N(with)--------------------------------------------------+                                
                                                                                           +--------------------------------------------COMP:V-N(with)-------------------------------------------+            |                                
                                                                                           +--------------------------------COMP:V-N(with)--------------------------------+                      |            |                                
                                                     +---------------OBJ:V-N---------------+      +----------------------OBJ:V-N----------------------+          +--------------------------------OBJ:V-N--------------------------------+     
                                                     |               +-------SUBJ:V-N------+--------COMP:V-N(with)--------+                           |          |        |             +---------------------OBJ:V-N--------------------+     
     +--MOD_ATT:N-N--+                               |               +-COMP:N-N(in)-+      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+          |        |             |        |            |          +-MOD_ATT:N-ADJ-+     
     |         +MOD_A+SUBJ:V-N+--OBJ:V-N-+COMP:N-N(of+       +MOD_ATT+         +MOD_+      |      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+          |        |             |    +MOD+            |          |       +MOD_ATT+     
     |         |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |          |        |             |    |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,SB203580)
MOD_ATT:N-N (culture,cell)
SUBJ:V-N (decrease,culture)
OBJ:V-N (decrease,production)
COMP:N-N(of) (production,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__SP__)
SUBJ:V-N (treat,protein)
COMP:V-N(with) (treat,Apo)
COMP:V-N(with) (treat,cycloheximide)
COMP:V-N(with) (treat,FMK)
COMP:V-N(with) (treat,overproduce)
OBJ:V-N (with,antibody)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (with,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 314

                                                                                           +--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+                     
                                                                                           +--------------------------------------------COMP:V-N(with)-------------------------------------------+                       |                     
                                                                                           +--------------------------------COMP:V-N(with)--------------------------------+                      |                       |                     
                                         +-------------------COMP:V-N(in)------------------+      +----------------------OBJ:V-N----------------------+                   |                      |                       |                     
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+                     +--------COMP:V-N(with)--------+                           |          +--------------------------------OBJ:V-N--------------------------------+     
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+                     |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+          |        |             +---------------------OBJ:V-N--------------------+     
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+COMP:N-N(+    +SUBJ:V+      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+          |        |             |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |          |        |             |    |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,Hela)
COMP:V-N(in) (treat,production)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,Apo)
COMP:V-N(with) (treat,cycloheximide)
COMP:V-N(with) (treat,FMK)
COMP:V-N(with) (treat,__SP__)
OBJ:V-N (with,antibody)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (with,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 315

                                                                                           +------------------------------------------------------------COMP:V-N(with)-----------------------------------------------------------+             
                                                                                           +--------------------------------------------COMP:V-N(with)-------------------------------------------+                               |             
                                                                                           +--------------------------------COMP:V-N(with)--------------------------------+                      |                               |             
                                         +---------------------OBJ:V-N---------------------+      +----------------------OBJ:V-N----------------------+          +--------------------------------OBJ:V-N--------------------------------+     
                                         |                           +-------SUBJ:V-N------+--------COMP:V-N(with)--------+                           |          |        |             +---------------------OBJ:V-N--------------------+     
     +--MOD_ATT:N-N--+                   +----COMP:N-N(of)---+       +-COMP:N-N(in)-+      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+          |        |             |        |            +----MOD_ATT:N-N---+       |     
     |         +MOD_A+SUBJ:V-N+--OBJ:V-N-+           +MOD_ATT+       |         +MOD_+      |      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+          |        |             |    +MOD+            |          +MOD_ATT+       |     
     |         |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |          |        |             |    |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,SB203580)
MOD_ATT:N-N (culture,cell)
SUBJ:V-N (decrease,culture)
OBJ:V-N (decrease,production)
COMP:N-N(of) (production,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,production)
SUBJ:V-N (treat,protein)
COMP:V-N(with) (treat,Apo)
COMP:V-N(with) (treat,cycloheximide)
COMP:V-N(with) (treat,FMK)
COMP:V-N(with) (treat,__NODE__)
OBJ:V-N (with,antibody)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (with,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (__NODE__,overproduce)
MOD_ATT:N-ADJ (__NODE__,__SP__)

Analyse 316

                              +------------------------------------------------------------------------------------------COMP:V-N(with)------------------------------------------------------------------------------------------+             
                              +--------------------------------------------------------------------------COMP:V-N(with)--------------------------------------------------------------------------+                               |             
                              +---------------------------------------------------------------COMP:V-N(with)--------------------------------------------------------------+                      |                               |             
                              +---------------------------------------COMP:V-N(with)--------------------------------------+                                               |                      |                               |             
                              |                              +-----------OBJ:V-N-----------+                              |                                      +--------------------------------OBJ:V-N--------------------------------+     
                              |                              |       +-------SUBJ:V-N------+      +----------------------OBJ:V-N----------------------+          |        |             +---------------------OBJ:V-N--------------------+     
     +--MOD_ATT:N-N--+        |          +----COMP:N-N(of)---+       +-COMP:N-N(in)-+      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+          |        |             |        |            +----MOD_ATT:N-N---+       |     
     |         +MOD_A+SUBJ:V-N+--OBJ:V-N-+           +MOD_ATT+       |         +MOD_+      |      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+          |        |             |    +MOD+            |          +MOD_ATT+       |     
     |         |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |          |        |             |    |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,SB203580)
MOD_ATT:N-N (culture,cell)
SUBJ:V-N (decrease,culture)
OBJ:V-N (decrease,production)
COMP:V-N(with) (decrease,Apo)
COMP:V-N(with) (decrease,cycloheximide)
COMP:V-N(with) (decrease,FMK)
COMP:V-N(with) (decrease,__NODE__)
COMP:N-N(of) (production,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__NODE__)
SUBJ:V-N (treat,protein)
OBJ:V-N (with,antibody)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (with,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (__NODE__,overproduce)
MOD_ATT:N-ADJ (__NODE__,__SP__)

Analyse 317

                                                                                           +--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+                     
                                                                                           +--------------------------------------------COMP:V-N(with)-------------------------------------------+                       |                     
                                         +-------------------COMP:V-N(in)------------------+--------------------------------COMP:V-N(with)--------------------------------+                      |                       |                     
                                         |           +-------------COMP:V-N(of)------------+      +----------------------OBJ:V-N----------------------+                   |                      |                       |                     
               +-------MOD_ATT:N-N-------+           |               +-------SUBJ:V-N------+--------COMP:V-N(with)--------+                           |                   |                      |                       |                     
               |     +----MOD_ATT:N-N----+           |               +-COMP:N-N(in)-+      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |             +---------------------OBJ:V-N--------------------+     
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+      |      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |             |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |             |    |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
COMP:V-N(in) (treat,production)
COMP:V-N(of) (treat,__SP__)
SUBJ:V-N (treat,protein)
COMP:V-N(with) (treat,Apo)
COMP:V-N(with) (treat,cycloheximide)
COMP:V-N(with) (treat,FMK)
COMP:V-N(with) (treat,__SP__)
OBJ:V-N (with,antibody)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 318

                                                                                           +--------------------------------------------------COMP:V-N(with)--------------------------------------------------+                                
                                                                                           +--------------------------------------------COMP:V-N(with)-------------------------------------------+            |                                
                                                                                           +--------------------------------COMP:V-N(with)--------------------------------+                      |            |                                
                                         +-------------------COMP:V-N(in)------------------+      +----------------------OBJ:V-N----------------------+                   |                      |            |                                
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+                     +--------COMP:V-N(with)--------+                           |                   |             +---------------------OBJ:V-N--------------------+     
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+         +COMP:V-N(in+      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |             |    +--MOD_ATT:N-ADJ-+          +-MOD_ATT:N-ADJ-+     
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         |    +SUBJ:V+      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |             |    +MOD+            |          |       +MOD_ATT+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |             |    |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:V-N(in) (treat,production)
COMP:V-N(in) (treat,Hela)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,Apo)
COMP:V-N(with) (treat,cycloheximide)
COMP:V-N(with) (treat,FMK)
COMP:V-N(with) (treat,overproduce)
OBJ:V-N (with,antibody)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 319

                              +------------------------------------------------------------------------------------------COMP:V-N(with)------------------------------------------------------------------------------------------+             
                              +--------------------------------------------------------------------------COMP:V-N(with)--------------------------------------------------------------------------+                               |             
                              +---------------------------------------------------------------COMP:V-N(with)--------------------------------------------------------------+                      |                               |             
                              +---------------------------------------COMP:V-N(with)--------------------------------------+                                               |                      |                               |             
                              |          +---------------------OBJ:V-N---------------------+                              |                                               |                      |                               |             
                              |          +-------------COMP:N-N(in)------------+           |                              |                                      +--------------------------------OBJ:V-N--------------------------------+     
                              |          +--------COMP:N-N(of)-------+         |           |      +----------------------OBJ:V-N----------------------+          |        |             +---------------------OBJ:V-N--------------------+     
     +--MOD_ATT:N-N--+        |          |           +-MOD_ATT:N-ADJ-+         |           |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+          |        |             |        |            +----MOD_ATT:N-N---+       |     
     |         +MOD_A+SUBJ:V-N+--OBJ:V-N-+           |       +MOD_ATT+         |    +SUBJ:V+      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+          |        |             |    +MOD+            |          +MOD_ATT+       |     
     |         |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |          |        |             |    |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,SB203580)
MOD_ATT:N-N (culture,cell)
SUBJ:V-N (decrease,culture)
OBJ:V-N (decrease,production)
COMP:V-N(with) (decrease,Apo)
COMP:V-N(with) (decrease,cycloheximide)
COMP:V-N(with) (decrease,FMK)
COMP:V-N(with) (decrease,__NODE__)
COMP:N-N(of) (production,protein)
COMP:N-N(in) (production,Hela)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (treat,production)
SUBJ:V-N (treat,cell)
OBJ:V-N (with,antibody)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (with,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (__NODE__,overproduce)
MOD_ATT:N-ADJ (__NODE__,__SP__)

Analyse 320

                                                                                           +--------------------------------------------------COMP:V-N(with)--------------------------------------------------+                                
                                                                                           +--------------------------------------------COMP:V-N(with)-------------------------------------------+            |                                
                                         +-------------------COMP:V-N(in)------------------+--------------------------------COMP:V-N(with)--------------------------------+                      |            |                                
                                         +-------------COMP:N-N(in)------------+           |      +----------------------OBJ:V-N----------------------+                   |                      |            |                                
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+         |           +--------COMP:V-N(with)--------+                           |                   |             +---------------------OBJ:V-N--------------------+     
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+         |           |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |             |        |            |          +-MOD_ATT:N-ADJ-+     
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         |    +SUBJ:V+      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |             |    +MOD+            |          |       +MOD_ATT+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |             |    |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
COMP:N-N(in) (production,Hela)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:V-N(in) (treat,production)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,Apo)
COMP:V-N(with) (treat,cycloheximide)
COMP:V-N(with) (treat,FMK)
COMP:V-N(with) (treat,overproduce)
OBJ:V-N (with,antibody)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 321

                                                                                           +--------------------------------------------------COMP:V-N(with)--------------------------------------------------+                                
                     +-----------------------------COMP:V-N(in)----------------------------+--------------------------------------------COMP:V-N(with)-------------------------------------------+            |                                
                     |                   +---------------------SUBJ:V-N--------------------+--------------------------------COMP:V-N(with)--------------------------------+                      |            |                                
                     |                   +---------------COMP:N-N(in)---------------+      |      +----------------------OBJ:V-N----------------------+                   |                      |            |                                
                     |                   +--------COMP:N-N(of)-------+              |      +--------COMP:V-N(with)--------+                           |                   |             +---------------------OBJ:V-N--------------------+     
                     |                   |           +-MOD_ATT:N-ADJ-+              |      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |             |    +--MOD_ATT:N-ADJ-+          +-MOD_ATT:N-ADJ-+     
               +MOD_A+        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+      |      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |             |    +MOD+            |          |       +MOD_ATT+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |             |    |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
COMP:N-N(in) (production,cell)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (cell,Hela)
COMP:V-N(in) (treat,culture)
SUBJ:V-N (treat,production)
COMP:V-N(with) (treat,Apo)
COMP:V-N(with) (treat,cycloheximide)
COMP:V-N(with) (treat,FMK)
COMP:V-N(with) (treat,overproduce)
OBJ:V-N (with,antibody)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 322

                                                                                           +--------------------------------------------------COMP:V-N(with)--------------------------------------------------+                                
                                                                                           +--------------------------------------------COMP:V-N(with)-------------------------------------------+            |                                
                                                                                           +--------------------------------COMP:V-N(with)--------------------------------+                      |            |                                
                                         +-------------------COMP:V-N(in)------------------+      +----------------------OBJ:V-N----------------------+                   |                      |            |                                
               +-------MOD_ATT:N-N-------+                           +-------SUBJ:V-N------+--------COMP:V-N(with)--------+                           |                   |             +---------------------OBJ:V-N--------------------+     
               |     +----MOD_ATT:N-N----+----COMP:N-N(of)---+       +-COMP:N-N(in)-+      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |             |    +--MOD_ATT:N-ADJ-+          +-MOD_ATT:N-ADJ-+     
               |     |        +MOD_ATT:N-+           +MOD_ATT+       |         +MOD_+      |      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |             |    +MOD+            |          |       +MOD_ATT+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |             |    |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
COMP:V-N(in) (treat,production)
SUBJ:V-N (treat,protein)
COMP:V-N(with) (treat,Apo)
COMP:V-N(with) (treat,cycloheximide)
COMP:V-N(with) (treat,FMK)
COMP:V-N(with) (treat,overproduce)
OBJ:V-N (with,antibody)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 323

                                                                                           +--------------------------------------------------COMP:V-N(with)--------------------------------------------------+                                
                                                                                           +--------------------------------------------COMP:V-N(with)-------------------------------------------+            |                                
                                                                                           +--------------------------------COMP:V-N(with)--------------------------------+                      |            |                                
                                         +-------------------COMP:V-N(in)------------------+      +----------------------OBJ:V-N----------------------+                   |                      |            |                                
               +-------MOD_ATT:N-N-------+                           +-------SUBJ:V-N------+--------COMP:V-N(with)--------+                           |                   |             +---------------------OBJ:V-N--------------------+     
               |     +----MOD_ATT:N-N----+                           +-COMP:N-N(in)-+      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |             |        |            |          +-MOD_ATT:N-ADJ-+     
               |     |        +MOD_ATT:N-+COMP:N-N(of+       +MOD_ATT+         +MOD_+      |      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |             |    +MOD+            |          |       +MOD_ATT+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |             |    |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
COMP:V-N(in) (treat,production)
SUBJ:V-N (treat,protein)
COMP:V-N(with) (treat,Apo)
COMP:V-N(with) (treat,cycloheximide)
COMP:V-N(with) (treat,FMK)
COMP:V-N(with) (treat,overproduce)
OBJ:V-N (with,antibody)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 324

                                                                                           +------------------------------------------------------------COMP:V-N(with)-----------------------------------------------------------+             
                                                                                           +--------------------------------------------COMP:V-N(with)-------------------------------------------+                               |             
                                                                                           +--------------------------------COMP:V-N(with)--------------------------------+                      |                               |             
                                         +-------------------COMP:V-N(in)------------------+      +----------------------OBJ:V-N----------------------+                   |                      |                               |             
               +-------MOD_ATT:N-N-------+                           +-------SUBJ:V-N------+--------COMP:V-N(with)--------+                           |                   |             +---------------------OBJ:V-N--------------------+     
               |     +----MOD_ATT:N-N----+----COMP:N-N(of)---+       +-COMP:N-N(in)-+      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |             |        |            +----MOD_ATT:N-N---+       |     
               |     |        +MOD_ATT:N-+           +MOD_ATT+       |         +MOD_+      |      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |             |    +MOD+            |          +MOD_ATT+       |     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |             |    |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
COMP:V-N(in) (treat,production)
SUBJ:V-N (treat,protein)
COMP:V-N(with) (treat,Apo)
COMP:V-N(with) (treat,cycloheximide)
COMP:V-N(with) (treat,FMK)
COMP:V-N(with) (treat,__NODE__)
OBJ:V-N (with,antibody)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (__NODE__,overproduce)
MOD_ATT:N-ADJ (__NODE__,__SP__)

Analyse 325

                                                                                           +------------------------------------------------------------COMP:V-N(with)-----------------------------------------------------------+             
                                                                                           +--------------------------------------------COMP:V-N(with)-------------------------------------------+                               |             
                                                                                           +--------------------------------COMP:V-N(with)--------------------------------+                      |                               |             
                                         +-------------------COMP:V-N(in)------------------+      +----------------------OBJ:V-N----------------------+                   |                      |                               |             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+                     +--------COMP:V-N(with)--------+                           |                   |             +---------------------OBJ:V-N--------------------+     
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+                     |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |             |        |            +----MOD_ATT:N-N---+       |     
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+COMP:N-N(+    +SUBJ:V+      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |             |    +MOD+            |          +MOD_ATT+       |     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |             |    |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,Hela)
COMP:V-N(in) (treat,production)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,Apo)
COMP:V-N(with) (treat,cycloheximide)
COMP:V-N(with) (treat,FMK)
COMP:V-N(with) (treat,__NODE__)
OBJ:V-N (with,antibody)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (__NODE__,overproduce)
MOD_ATT:N-ADJ (__NODE__,__SP__)

Analyse 326

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                          +------------------------------------------------------------------SUBJ:V-N------------------------------------------------------------------+             
                                         |                                          |      +------------------------------------------------COMP:V_PASS-N(with)-----------------------------------------------+                  |             
                                         |                                          |      +-----------------------------------------COMP:V_PASS-N(with)-----------------------------------------+            |                  |             
                                         |                                          |      +------------------------------COMP:V_PASS-N(with)-----------------------------+                      |            |                  |             
                                         +-------------COMP:N-N(in)------------+    |      |      +----------------------OBJ:V-N----------------------+                   |                      |            |                  |             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+         |    |      +------COMP:V_PASS-N(with)-----+                           |                   |             +-------------OBJ:V-N------------+       |             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+         |    |      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |             |    +--MOD_ATT:N-ADJ-+          |       |             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         |    +SUBJ:V+      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |             |    +MOD+            |          |       +OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |             |    |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
COMP:N-N(in) (production,Hela)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,Apo)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
COMP:V_PASS-N(with) (treat,overproduce)
OBJ:V-N (with,antibody)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (with,__SP__)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
SUBJ:V-N (__NODE__,cell)
OBJ:V-N (__NODE__,protein)

Analyse 327

                                         +----------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------+                     
                                         |                           +--------------------------------------------------------------------COMP:V-N(of)-------------------------------------------------------------------+                     
                                         |                           |         +---------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------+                     
                                         |                           |         |    +--------------------------------------------------------------SUBJ:V-N--------------------------------------------------------------+                     
                                         |                           |         |    |      +------------------------------------------------COMP:V_PASS-N(with)-----------------------------------------------+          |                     
                                         |                           |         |    |      +-----------------------------------------COMP:V_PASS-N(with)-----------------------------------------+            |          |                     
                                         |                           |         |    |      +------------------------------COMP:V_PASS-N(with)-----------------------------+                      |            |          |                     
                                         |                           |         |    |      |      +----------------------OBJ:V-N----------------------+                   |                      |            |          |                     
               +-------MOD_ATT:N-N-------+                           |         |    |      +------COMP:V_PASS-N(with)-----+                           |                   |                      |            |          |                     
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+         |    |      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                      |            |          +----OBJ:V-N----+     
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         |    +SUBJ:V+      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          |       +MOD_ATT+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,Apo)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
COMP:V_PASS-N(with) (treat,overproduce)
OBJ:V-N (with,antibody)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__SP__,production)
COMP:V-N(of) (__SP__,protein)
COMP:V-N(in) (__SP__,Hela)
SUBJ:V-N (__SP__,cell)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 328

                                         +----------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------+                     
                                         |                           +--------------------------------------------------------------------COMP:V-N(of)-------------------------------------------------------------------+                     
                                         |                           |         +---------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------+                     
                                         |                           |         |    +--------------------------------------------------------------SUBJ:V-N--------------------------------------------------------------+                     
                                         |                           |         |    |      +------------------------------------------------COMP:V_PASS-N(with)-----------------------------------------------+          |                     
                                         |                           |         |    |      +-----------------------------------------COMP:V_PASS-N(with)-----------------------------------------+            |          |                     
                                         |                           |         |    |      +------------------------------COMP:V_PASS-N(with)-----------------------------+                      |            |          |                     
                                         |                           |         |    |      |      +----------------------OBJ:V-N----------------------+                   |                      |            |          |                     
               +-------MOD_ATT:N-N-------+                           |         |    |      +------COMP:V_PASS-N(with)-----+                           |                   |                      |            |          |                     
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+         |    |      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                      |            |          +----OBJ:V-N----+     
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         |    +SUBJ:V+      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          |       +MOD_ATT+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,Apo)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
COMP:V_PASS-N(with) (treat,overproduce)
OBJ:V-N (with,antibody)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__SP__,production)
COMP:V-N(of) (__SP__,protein)
COMP:V-N(in) (__SP__,Hela)
SUBJ:V-N (__SP__,cell)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 329

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                                                                            +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                                                                                                            |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+                            +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+      +COMP:V_PASS-N(with)+          |         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+SUBJ:V+      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,anti)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 330

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                                                                            +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                                                                                                            |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+----SUBJ:V_PASS-N----+      +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+      +COMP:V_PASS-N(with)+          |         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,protein)
COMP:V_PASS-N(with) (treat,anti)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 331

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                                                                            +---------------------------------SUBJ:V-N---------------------------------+             
                                         +---------------COMP:N-N(in)---------------+                                                                 |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+              |                                                                 |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+              |             +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+SUBJ:V+COMP:V_PASS-+      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
COMP:N-N(in) (production,cell)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,agonist)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 332

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                                                                            +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                                                                                                            |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+                            +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+-------OBJ:V-N-------+---COMP:V-N(with)--+          |         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+COMP:N-N(+    +SUBJ:V+      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,Hela)
OBJ:V-N (treat,protein)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,anti)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 333

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                                                                            +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                   +-----------OBJ:V-N-----------+                                                          |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+                   |       +-------SUBJ:V-N------+      +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+----COMP:N-N(of)---+       +-COMP:N-N(in)-+      +---COMP:V-N(with)--+          |         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           +MOD_ATT+       |         +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__NODE__)
SUBJ:V-N (treat,protein)
COMP:V-N(with) (treat,anti)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 334

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                                                                            +---------------------------------SUBJ:V-N---------------------------------+             
                                         |           +---------------OBJ:V-N---------------+                                                          |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+           |               +-------SUBJ:V-N------+      +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           |               +-COMP:N-N(in)-+      +---COMP:V-N(with)--+          |         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+COMP:N-N(of+       +MOD_ATT+         +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__SP__)
SUBJ:V-N (treat,protein)
COMP:V-N(with) (treat,anti)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 335

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                                                                            +---------------------------------SUBJ:V-N---------------------------------+             
                                         +------------------SUBJ:V_PASS-N------------------+                                                          |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+                     |      +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+      +COMP:V_PASS-N(with)+          |         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,production)
COMP:V_PASS-N(with) (treat,anti)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 336

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         +------------------SUBJ:V_PASS-N------------------+                                                          +---------------------------------SUBJ:V-N---------------------------------+             
                                         +---------------COMP:N-N(in)---------------+      |                                                          |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+              |      |                                                          |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+              |      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+      +COMP:V_PASS-+      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
COMP:N-N(in) (production,cell)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,production)
COMP:V_PASS-N(with) (treat,agonist)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 337

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                                     +--------------------------------------------------COMP:V-N(with)-------------------------------------------------+             
                                         |                                                                     |                                      +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                                                                     |                                      |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+----SUBJ:V_PASS-N----+                   |                                      |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,protein)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(with) (__NODE__,anti)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 338

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         +------------------SUBJ:V_PASS-N------------------+                                                          +---------------------------------SUBJ:V-N---------------------------------+             
                                         +---------------COMP:N-N(in)---------------+      |                                                          |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+              |      |                                                          |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+              |      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+      +COMP:V_PASS-+      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
COMP:N-N(in) (production,cell)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,production)
COMP:V_PASS-N(with) (treat,agonist)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 339

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                                                                            +---------------------------------SUBJ:V-N---------------------------------+             
                                         +---------------------OBJ:V-N---------------------+                                                          |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+                           +-------SUBJ:V-N------+      +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+                           +-COMP:N-N(in)-+      +---COMP:V-N(with)--+          |         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+COMP:N-N(of+       +MOD_ATT+         +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,production)
SUBJ:V-N (treat,protein)
COMP:V-N(with) (treat,anti)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 340

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                          +----------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------+             
                                         |                                          |                                                                 +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                                          |                                                                 |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+              |                                                                 |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+              |             +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+SUBJ:V+COMP:V_PASS-+      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,agonist)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(in) (__NODE__,cell)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 341

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         +------------------SUBJ:V_PASS-N------------------+                                                          +---------------------------------SUBJ:V-N---------------------------------+             
                                         +---------------COMP:N-N(in)---------------+      |                                                          |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+              |      |      +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+              |      +COMP:V_PASS-N(with)+          |         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
COMP:N-N(in) (production,cell)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,production)
COMP:V_PASS-N(with) (treat,anti)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 342

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                                                                            +---------------------------------SUBJ:V-N---------------------------------+             
                                         +---------------------OBJ:V-N---------------------+                                                          |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+                           +-------SUBJ:V-N------+      +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+----COMP:N-N(of)---+       +-COMP:N-N(in)-+      +---COMP:V-N(with)--+          |         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           +MOD_ATT+       |         +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,production)
SUBJ:V-N (treat,protein)
COMP:V-N(with) (treat,anti)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 343

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         +------------------SUBJ:V_PASS-N------------------+                                                          +---------------------------------SUBJ:V-N---------------------------------+             
                                         +---------------COMP:N-N(in)---------------+      |                                                          |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+              |      |      +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+              |      +COMP:V_PASS-N(with)+          |         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
COMP:N-N(in) (production,cell)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,production)
COMP:V_PASS-N(with) (treat,anti)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 344

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                          +----------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------+             
                                         |                                          |                                                                 +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                                          |                                                                 |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+              |             +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+              |      +COMP:V_PASS-N(with)+          |         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+SUBJ:V+      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,anti)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(in) (__NODE__,cell)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 345

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                              +-----------------------------------------------------COMP:V-N(with)-----------------------------------------------------+             
                                         |                                                              |                                             +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                   +-----------OBJ:V-N-----------+            |                                             |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+                   |       +-------SUBJ:V-N------+      +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+----COMP:N-N(of)---+       +-COMP:N-N(in)-+      |      |     +---OBJ:V-N--+    |         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           +MOD_ATT+       |         +MOD_+      |      |     |      +SUBJ:+    |         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__NODE__)
SUBJ:V-N (treat,protein)
OBJ:V-N (with,Apo)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(with) (__NODE__,agonist)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 346

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                                                                            +---------------------------------SUBJ:V-N---------------------------------+             
                                         +---------------------OBJ:V-N---------------------+                                                          |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+                     |      +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+                     +---COMP:V-N(with)--+          |         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+COMP:N-N(+    +SUBJ:V+      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,Hela)
OBJ:V-N (treat,production)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,anti)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 347

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                                                                            +---------------------------------SUBJ:V-N---------------------------------+             
                                         +---------------------------------COMP:N-N(with)---------------------------------+                           |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+                                                    |                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+-------OBJ:V-N-------+            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+COMP:N-N(+    +SUBJ:V+            |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |            |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
COMP:N-N(with) (production,Apo)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,Hela)
OBJ:V-N (treat,protein)
SUBJ:V-N (treat,cell)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 348

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                                                                            +---------------------------------SUBJ:V-N---------------------------------+             
                                         +---------------------OBJ:V-N---------------------+                                                          |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+                     |      +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+                     +---COMP:V-N(with)--+          |         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+COMP:N-N(+    +SUBJ:V+      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,Hela)
OBJ:V-N (treat,production)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,anti)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 349

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                                                                            +---------------------------------SUBJ:V-N---------------------------------+             
                                         +---------------------------------COMP:N-N(with)---------------------------------+                           |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+                                                    |                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+-------OBJ:V-N-------+            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+COMP:N-N(+    +SUBJ:V+            |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |            |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
COMP:N-N(with) (production,Apo)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,Hela)
OBJ:V-N (treat,protein)
SUBJ:V-N (treat,cell)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 350

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                              +-----------------------------------------------------COMP:V-N(with)-----------------------------------------------------+             
                                         |                                                              |                                             +---------------------------------SUBJ:V-N---------------------------------+             
                                         |           +---------------OBJ:V-N---------------+            |                                             |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+           |               +-------SUBJ:V-N------+      +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           |               +-COMP:N-N(in)-+      |      |     +---OBJ:V-N--+    |         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+COMP:N-N(of+       +MOD_ATT+         +MOD_+      |      |     |      +SUBJ:+    |         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__SP__)
SUBJ:V-N (treat,protein)
OBJ:V-N (with,Apo)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(with) (__NODE__,agonist)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 351

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                              +-----------------------------------------------------COMP:V-N(with)-----------------------------------------------------+             
                                         |                                                              |                                             +---------------------------------SUBJ:V-N---------------------------------+             
                                         |           +---------------OBJ:V-N---------------+            |                                             |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+           |               +-------SUBJ:V-N------+      +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           |               +-COMP:N-N(in)-+      |      |     +---OBJ:V-N--+    |         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+COMP:N-N(of+       +MOD_ATT+         +MOD_+      |      |     |      +SUBJ:+    |         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__SP__)
SUBJ:V-N (treat,protein)
OBJ:V-N (with,Apo)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(with) (__NODE__,agonist)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 352

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                              +-----------------------------------------------------COMP:V-N(with)-----------------------------------------------------+             
                                         |                                                              |                                             +---------------------------------SUBJ:V-N---------------------------------+             
                                         |           +---------------OBJ:V-N---------------+            |                                             |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+           |               +-------SUBJ:V-N------+      +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           |               +-COMP:N-N(in)-+      |      |     +---OBJ:V-N--+    |         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+COMP:N-N(of+       +MOD_ATT+         +MOD_+      |      |     |      +SUBJ:+    |         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__SP__)
SUBJ:V-N (treat,protein)
OBJ:V-N (with,Apo)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(with) (__NODE__,agonist)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 353

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         +---------------------------------COMP:N-N(with)---------------------------------+                           +---------------------------------SUBJ:V-N---------------------------------+             
                                         |           +---------------OBJ:V-N---------------+                              |                           |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+           |               +-------SUBJ:V-N------+                              |                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           |               +-COMP:N-N(in)-+      |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+COMP:N-N(of+       +MOD_ATT+         +MOD_+      |            |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |            |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,__SP__)
COMP:N-N(with) (production,Apo)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__SP__)
SUBJ:V-N (treat,protein)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 354

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                           +------------------------------------------------------------------------COMP:V-N(of)-----------------------------------------------------------------------+             
                                         |                           |                                                                                +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                           |                                                                                |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+                           |                            +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+             |     +---OBJ:V-N--+    |         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+SUBJ:V+COMP:V_PASS-+      +SUBJ:+    |         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,agonist)
OBJ:V-N (with,Apo)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(of) (__NODE__,protein)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 355

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         +---------------------OBJ:V-N---------------------+                                                          +---------------------------------SUBJ:V-N---------------------------------+             
                                         +-------------COMP:N-N(in)------------+           |                                                          |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+         |           |      +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+         |           +---COMP:V-N(with)--+          |         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         |    +SUBJ:V+      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
COMP:N-N(in) (production,Hela)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (treat,production)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,anti)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 356

                     +------------------------------------------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------------------------------------------+             
                     +-------------------------------OBJ:V-N-------------------------------+                                                                                                                                     |             
                     |                   +---------------------SUBJ:V-N--------------------+                                                          +---------------------------------SUBJ:V-N---------------------------------+             
                     |                   +---------------COMP:N-N(in)---------------+      |                                                          |                   +--------------------COMP:V-N(with)--------------------+             
                     |                   +--------COMP:N-N(of)-------+              |      |      +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
                     |                   |           +-MOD_ATT:N-ADJ-+              |      +---COMP:V-N(with)--+          |         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               +MOD_A+        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
COMP:N-N(in) (production,cell)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,culture)
SUBJ:V-N (treat,production)
COMP:V-N(with) (treat,anti)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,culture)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 357

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         +---------------------OBJ:V-N---------------------+                                                          +---------------------------------SUBJ:V-N---------------------------------+             
                                         +-------------COMP:N-N(in)------------+           |                                                          |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+         |           |      +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+         |           +---COMP:V-N(with)--+          |         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         |    +SUBJ:V+      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
COMP:N-N(in) (production,Hela)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (treat,production)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,anti)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 358

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                                                +--------------------------------------------COMP:V-N(with)--------------------------------------------+             
                                         |                                                                                |                           +---------------------------------SUBJ:V-N---------------------------------+             
                                         +---------------------OBJ:V-N---------------------+                              |                           |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+                           +-------SUBJ:V-N------+                              |                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+                           +-COMP:N-N(in)-+      |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+COMP:N-N(of+       +MOD_ATT+         +MOD_+      |            |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |            |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,production)
SUBJ:V-N (treat,protein)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(with) (__NODE__,Apo)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 359

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                              +-----------------------------------------------------COMP:V-N(with)-----------------------------------------------------+             
                                         |                                                              |                                             +---------------------------------SUBJ:V-N---------------------------------+             
                                         +---------------------OBJ:V-N---------------------+            |                                             |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+                           +-------SUBJ:V-N------+      +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+                           +-COMP:N-N(in)-+      |      |     +---OBJ:V-N--+    |         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+COMP:N-N(of+       +MOD_ATT+         +MOD_+      |      |     |      +SUBJ:+    |         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,production)
SUBJ:V-N (treat,protein)
OBJ:V-N (with,Apo)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(with) (__NODE__,agonist)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 360

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                           +------------------------------------------------------------------------COMP:V-N(of)-----------------------------------------------------------------------+             
                                         |                           |                                                                                +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                           |                                                                                |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+                           +----SUBJ:V_PASS-N----+------COMP:V_PASS-N(with)-----+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+      |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+      |            |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |            |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,protein)
COMP:V_PASS-N(with) (treat,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(of) (__NODE__,protein)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 361

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                           +------------------------------------------------------------------------COMP:V-N(of)-----------------------------------------------------------------------+             
                                         |                           |                                                                                +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                           |                                                                                |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+                           +----SUBJ:V_PASS-N----+      +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+      |      |     +---OBJ:V-N--+    |         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+      +COMP:V_PASS-+      +SUBJ:+    |         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,protein)
COMP:V_PASS-N(with) (treat,agonist)
OBJ:V-N (with,Apo)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(of) (__NODE__,protein)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 362

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                           +------------------------------------------------------------------------COMP:V-N(of)-----------------------------------------------------------------------+             
                                         |                           |                                                                                +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                           |                                                                                |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+                           +----SUBJ:V_PASS-N----+      +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+      |      |     +---OBJ:V-N--+    |         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+      +COMP:V_PASS-+      +SUBJ:+    |         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,protein)
COMP:V_PASS-N(with) (treat,agonist)
OBJ:V-N (with,Apo)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(of) (__NODE__,protein)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 363

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                          +----------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------+             
                                         |                                          |                          +--------------------------------------------------COMP:V-N(with)-------------------------------------------------+             
                                         |                                          |                          |                                      +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                                          |                          |                                      |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+              |                          |                                      |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+              |             +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+SUBJ:V+      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(in) (__NODE__,cell)
COMP:V-N(with) (__NODE__,anti)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 364

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                           +------------------------------------------------------------------------COMP:V-N(of)-----------------------------------------------------------------------+             
                                         |                           |                                                                                +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                           |                                                                                |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+                           +----SUBJ:V_PASS-N----+      +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+      |      |     +---OBJ:V-N--+    |         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+      +COMP:V_PASS-+      +SUBJ:+    |         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,protein)
COMP:V_PASS-N(with) (treat,agonist)
OBJ:V-N (with,Apo)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(of) (__NODE__,protein)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 365

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                                                +--------------------------------------------COMP:V-N(with)--------------------------------------------+             
                                         |                                                                                |                           +---------------------------------SUBJ:V-N---------------------------------+             
                                         +---------------------OBJ:V-N---------------------+                              |                           |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+                           +-------SUBJ:V-N------+                              |                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+----COMP:N-N(of)---+       +-COMP:N-N(in)-+      |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           +MOD_ATT+       |         +MOD_+      |            |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |            |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,production)
SUBJ:V-N (treat,protein)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(with) (__NODE__,Apo)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 366

                              +-------------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------------+             
                              |                                                                                +--------------------------------------------------COMP:V-N(with)-------------------------------------------------+             
                              +---------------------------OBJ:V-N--------------------------+                   |                                      +---------------------------------SUBJ:V-N---------------------------------+             
                              |          +---------------------SUBJ:V-N--------------------+                   |                                      |                   +--------------------COMP:V-N(with)--------------------+             
                              |          +--------COMP:N-N(of)-------+                     |                   |                                      |                   |                      +---------COMP:V-N(with)--------+             
               +--MOD_ATT:N-N-+          |           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     +MOD_ATT:+          |           |       +MOD_ATT+         +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (decrease,cell)
MOD_ATT:N-N (decrease,culture)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,decrease)
SUBJ:V-N (treat,production)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,decrease)
COMP:V-N(with) (__NODE__,anti)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 367

                     +------------------------------------------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------------------------------------------+             
                     |                                                                                                    +--------------------------------------------COMP:V-N(with)--------------------------------------------+             
                     +-------------------------------OBJ:V-N-------------------------------+                              |                           +---------------------------------SUBJ:V-N---------------------------------+             
                     |                   +---------------------SUBJ:V-N--------------------+                              |                           |                   +--------------------COMP:V-N(with)--------------------+             
                     |                   +--------COMP:N-N(of)-------+                     |                              |                           |                   |                      +---------COMP:V-N(with)--------+             
                     |                   |           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+      |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               +MOD_A+        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+      |            |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |            |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,culture)
SUBJ:V-N (treat,production)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(with) (__NODE__,Apo)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 368

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                                                +--------------------------------------------COMP:V-N(with)--------------------------------------------+             
                                         |                                                                                |                           +---------------------------------SUBJ:V-N---------------------------------+             
                                         +---------------------OBJ:V-N---------------------+                              |                           |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+                     |                              |                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+                     |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+COMP:N-N(+    +SUBJ:V+            |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |            |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,Hela)
OBJ:V-N (treat,production)
SUBJ:V-N (treat,cell)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(with) (__NODE__,Apo)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 369

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                              +-----------------------------------------------------COMP:V-N(with)-----------------------------------------------------+             
                                         |                                                              |                                             +---------------------------------SUBJ:V-N---------------------------------+             
                                         +---------------------OBJ:V-N---------------------+            |                                             |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+                     |      +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+                     |      |     +---OBJ:V-N--+    |         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+COMP:N-N(+    +SUBJ:V+      |     |      +SUBJ:+    |         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,Hela)
OBJ:V-N (treat,production)
SUBJ:V-N (treat,cell)
OBJ:V-N (with,Apo)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(with) (__NODE__,agonist)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 370

                     +------------------------------------------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------------------------------------------+             
                     |                                                                                  +-----------------------------------------------------COMP:V-N(with)-----------------------------------------------------+             
                     +-------------------------------OBJ:V-N-------------------------------+            |                                             +---------------------------------SUBJ:V-N---------------------------------+             
                     |                   +---------------------SUBJ:V-N--------------------+            |                                             |                   +--------------------COMP:V-N(with)--------------------+             
                     |                   +--------COMP:N-N(of)-------+                     |      +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
                     |                   |           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+      |      |     +---OBJ:V-N--+    |         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               +MOD_A+        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+      |      |     |      +SUBJ:+    |         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,culture)
SUBJ:V-N (treat,production)
OBJ:V-N (with,Apo)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(with) (__NODE__,agonist)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 371

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                              +-----------------------------------------------------COMP:V-N(with)-----------------------------------------------------+             
                                         |                                                              |                                             +---------------------------------SUBJ:V-N---------------------------------+             
                                         +---------------------OBJ:V-N---------------------+            |                                             |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+                     |      +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+                     |      |     +---OBJ:V-N--+    |         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+COMP:N-N(+    +SUBJ:V+      |     |      +SUBJ:+    |         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,Hela)
OBJ:V-N (treat,production)
SUBJ:V-N (treat,cell)
OBJ:V-N (with,Apo)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(with) (__NODE__,agonist)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 372

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                           +------------------------------------------------------------------------COMP:V-N(of)-----------------------------------------------------------------------+             
                                         |                           |                                                                                +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                           |                     +------COMP:V-N(with)-----+                                |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+                           |                     |      +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+-------OBJ:V-N-------+      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+COMP:N-N(+    +SUBJ:V+      |     |      +MOD_A+    |         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,Hela)
OBJ:V-N (treat,protein)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,__SP__)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(of) (__NODE__,protein)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 373

                              +-------------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------------+             
                              +---------------------------------------COMP:N-N(with)--------------------------------------+                                                                                                      |             
                              +---------------------------OBJ:V-N--------------------------+                              |                           +---------------------------------SUBJ:V-N---------------------------------+             
                              |          +---------------------SUBJ:V-N--------------------+                              |                           |                   +--------------------COMP:V-N(with)--------------------+             
                              |          +--------COMP:N-N(of)-------+                     |                              |                           |                   |                      +---------COMP:V-N(with)--------+             
               +--MOD_ATT:N-N-+          |           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+      |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     +MOD_ATT:+          |           |       +MOD_ATT+         +MOD_+      |            |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |            |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (decrease,cell)
MOD_ATT:N-N (decrease,culture)
COMP:N-N(with) (decrease,Apo)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,decrease)
SUBJ:V-N (treat,production)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,decrease)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 374

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                           +------------------------------------------------------------------------COMP:V-N(of)-----------------------------------------------------------------------+             
                                         |                           |                                                                                +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                           |                     +------COMP:V-N(with)-----+                                |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+                           |                     |      +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+-------OBJ:V-N-------+      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+COMP:N-N(+    +SUBJ:V+      |     |      +MOD_A+    |         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,Hela)
OBJ:V-N (treat,protein)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,__SP__)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(of) (__NODE__,protein)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 375

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                   +----------------------------------------------------------------------------COMP:V-N(of)---------------------------------------------------------------------------+             
                                         |                   |                                                                                        +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                   +-----------OBJ:V-N-----------+------COMP:V-N(with)-----+                                |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+                   |       +-------SUBJ:V-N------+      +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+                   |       +-COMP:N-N(in)-+      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           +MOD_ATT+       |         +MOD_+      |      |     |      +MOD_A+    |         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__NODE__)
SUBJ:V-N (treat,protein)
COMP:V-N(with) (treat,__SP__)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(of) (__NODE__,__NODE__)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 376

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |           +--------------------------------------------------------------------------------COMP:V-N(of)-------------------------------------------------------------------------------+             
                                         |           |                                                                                                +---------------------------------SUBJ:V-N---------------------------------+             
                                         |           +---------------OBJ:V-N---------------+------COMP:V-N(with)-----+                                |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+           |               +-------SUBJ:V-N------+      +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           |               +-COMP:N-N(in)-+      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+      |      |     |      +MOD_A+    |         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__SP__)
SUBJ:V-N (treat,protein)
COMP:V-N(with) (treat,__SP__)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(of) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 377

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                                                +--------------------------------------------COMP:V-N(with)--------------------------------------------+             
                                         +---------------------OBJ:V-N---------------------+                              |                           +---------------------------------SUBJ:V-N---------------------------------+             
                                         +-------------COMP:N-N(in)------------+           |                              |                           |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+         |           |                              |                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+         |           |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         |    +SUBJ:V+            |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |            |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
COMP:N-N(in) (production,Hela)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (treat,production)
SUBJ:V-N (treat,cell)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(with) (__NODE__,Apo)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 378

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                              +-----------------------------------------------------COMP:V-N(with)-----------------------------------------------------+             
                                         +---------------------OBJ:V-N---------------------+            |                                             +---------------------------------SUBJ:V-N---------------------------------+             
                                         +-------------COMP:N-N(in)------------+           |            |                                             |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+         |           |      +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+         |           |      |     +---OBJ:V-N--+    |         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         |    +SUBJ:V+      |     |      +SUBJ:+    |         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
COMP:N-N(in) (production,Hela)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (treat,production)
SUBJ:V-N (treat,cell)
OBJ:V-N (with,Apo)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(with) (__NODE__,agonist)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 379

                              +-------------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------------+             
                              +---------------------------OBJ:V-N--------------------------+                   +--------------------------------------------------COMP:V-N(with)-------------------------------------------------+             
                              |          +---------------------SUBJ:V-N--------------------+                   |                                      +---------------------------------SUBJ:V-N---------------------------------+             
                              |          +---------------COMP:N-N(in)---------------+      |                   |                                      |                   +--------------------COMP:V-N(with)--------------------+             
                              |          +--------COMP:N-N(of)-------+              |      |                   |                                      |                   |                      +---------COMP:V-N(with)--------+             
               +--MOD_ATT:N-N-+          |           +-MOD_ATT:N-ADJ-+              |      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     +MOD_ATT:+          |           |       +MOD_ATT+         +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (decrease,cell)
MOD_ATT:N-N (decrease,culture)
COMP:N-N(of) (production,protein)
COMP:N-N(in) (production,cell)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,decrease)
SUBJ:V-N (treat,production)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,decrease)
COMP:V-N(with) (__NODE__,anti)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 380

                     +------------------------------------------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------------------------------------------+             
                     +-------------------------------OBJ:V-N-------------------------------+                              +--------------------------------------------COMP:V-N(with)--------------------------------------------+             
                     |                   +---------------------SUBJ:V-N--------------------+                              |                           +---------------------------------SUBJ:V-N---------------------------------+             
                     |                   +---------------COMP:N-N(in)---------------+      |                              |                           |                   +--------------------COMP:V-N(with)--------------------+             
                     |                   +--------COMP:N-N(of)-------+              |      |                              |                           |                   |                      +---------COMP:V-N(with)--------+             
                     |                   |           +-MOD_ATT:N-ADJ-+              |      |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               +MOD_A+        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+      |            |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |            |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
COMP:N-N(in) (production,cell)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,culture)
SUBJ:V-N (treat,production)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(with) (__NODE__,Apo)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 381

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                           +------------------------------------------------------------------------COMP:V-N(of)-----------------------------------------------------------------------+             
                                         |                           |              +----------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------+             
                                         |                           |              |                                                                 +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                           |              |                                                                 |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+                           |              |      +------COMP:V_PASS-N(with)-----+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+              |      |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+SUBJ:V+            |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |            |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(of) (__NODE__,protein)
COMP:V-N(in) (__NODE__,cell)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 382

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                           +------------------------------------------------------------------------COMP:V-N(of)-----------------------------------------------------------------------+             
                                         |                           |              +----------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------+             
                                         |                           |              |                                +-----------------------------------------------COMP:V-N(with)----------------------------------------------+             
                                         |                           |              |                                |                                +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                           |              |                                |                                |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+                           |              |             +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+              |             |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+SUBJ:V+      |     |      +MOD_A+    |         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(of) (__NODE__,protein)
COMP:V-N(in) (__NODE__,cell)
COMP:V-N(with) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 383

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                           +------------------------------------------------------------------------COMP:V-N(of)-----------------------------------------------------------------------+             
                                         |                           |              +----------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------+             
                                         |                           |              |                                +-----------------------------------------------COMP:V-N(with)----------------------------------------------+             
                                         |                           |              |                                |                                +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                           |              |                                |                                |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+                           |              |             +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+              |             |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+SUBJ:V+      |     |      +MOD_A+    |         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(of) (__NODE__,protein)
COMP:V-N(in) (__NODE__,cell)
COMP:V-N(with) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 384

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                           +------------------------------------------------------------------------COMP:V-N(of)-----------------------------------------------------------------------+             
                                         |                           |              +----------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------+             
                                         |                           |              |                                +-----------------------------------------------COMP:V-N(with)----------------------------------------------+             
                                         |                           |              |                                |                                +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                           |              |                                |                                |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+                           |              |             +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+              |             |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+SUBJ:V+      |     |      +MOD_A+    |         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(of) (__NODE__,protein)
COMP:V-N(in) (__NODE__,cell)
COMP:V-N(with) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 385

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                                                                            +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                                                                                                            |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+                                                                                |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+             +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+SUBJ:V+COMP:V_PASS-+      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,agonist)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 386

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                                                                            +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                                                                                                            |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+                                                                                |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+             +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+SUBJ:V+COMP:V_PASS-+      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,agonist)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 387

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                                                                            +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                                                                                                            |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+                            +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+      +COMP:V_PASS-N(with)+          |         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+SUBJ:V+      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,anti)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 388

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                                                                            +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                                                                                                            |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+                            +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+-------OBJ:V-N-------+---COMP:V-N(with)--+          |         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+COMP:N-N(+    +SUBJ:V+      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,Hela)
OBJ:V-N (treat,protein)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,anti)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 389

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                                                                            +---------------------------------SUBJ:V-N---------------------------------+             
                                         +---------------COMP:N-N(in)---------------+                                                                 |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+              |             +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+              |      +COMP:V_PASS-N(with)+          |         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+SUBJ:V+      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
COMP:N-N(in) (production,cell)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,anti)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 390

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                                                                            +---------------------------------SUBJ:V-N---------------------------------+             
                                         +---------------COMP:N-N(in)---------------+                                                                 |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+              |             +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+              |      +COMP:V_PASS-N(with)+          |         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+SUBJ:V+      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
COMP:N-N(in) (production,cell)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,anti)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 391

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                                                                            +---------------------------------SUBJ:V-N---------------------------------+             
                                         |           +---------------OBJ:V-N---------------+                                                          |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+           |               +-------SUBJ:V-N------+      +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           |               +-COMP:N-N(in)-+      +---COMP:V-N(with)--+          |         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+COMP:N-N(of+       +MOD_ATT+         +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__SP__)
SUBJ:V-N (treat,protein)
COMP:V-N(with) (treat,anti)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 392

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                                                                            +---------------------------------SUBJ:V-N---------------------------------+             
                                         +------------------SUBJ:V_PASS-N------------------+                                                          |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+                     |                                                          |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+      +COMP:V_PASS-+      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,production)
COMP:V_PASS-N(with) (treat,agonist)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 393

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                                                                            +---------------------------------SUBJ:V-N---------------------------------+             
                                         +------------------SUBJ:V_PASS-N------------------+                                                          |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+                     |      +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+      +COMP:V_PASS-N(with)+          |         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,production)
COMP:V_PASS-N(with) (treat,anti)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 394

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                                     +--------------------------------------------------COMP:V-N(with)-------------------------------------------------+             
                                         |                                                                     |                                      +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                                                                     |                                      |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+                                         |                                      |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+             +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+SUBJ:V+      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(with) (__NODE__,anti)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 395

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                                                                            +---------------------------------SUBJ:V-N---------------------------------+             
                                         +---------------------OBJ:V-N---------------------+                                                          |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+                           +-------SUBJ:V-N------+      +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+                           +-COMP:N-N(in)-+      +---COMP:V-N(with)--+          |         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+COMP:N-N(of+       +MOD_ATT+         +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,production)
SUBJ:V-N (treat,protein)
COMP:V-N(with) (treat,anti)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 396

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                                     +--------------------------------------------------COMP:V-N(with)-------------------------------------------------+             
                                         |                                                                     |                                      +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                                                                     |                                      |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+----SUBJ:V_PASS-N----+                   |                                      |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,protein)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(with) (__NODE__,anti)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 397

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         +------------------SUBJ:V_PASS-N------------------+                                                          +---------------------------------SUBJ:V-N---------------------------------+             
                                         +---------------COMP:N-N(in)---------------+      |                                                          |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+              |      |                                                          |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+              |      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+      +COMP:V_PASS-+      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
COMP:N-N(in) (production,cell)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,production)
COMP:V_PASS-N(with) (treat,agonist)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 398

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                                                                            +---------------------------------SUBJ:V-N---------------------------------+             
                                         +---------------------OBJ:V-N---------------------+                                                          |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+                           +-------SUBJ:V-N------+      +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+                           +-COMP:N-N(in)-+      +---COMP:V-N(with)--+          |         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+COMP:N-N(of+       +MOD_ATT+         +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,production)
SUBJ:V-N (treat,protein)
COMP:V-N(with) (treat,anti)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 399

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                                                +--------------------------------------------COMP:V-N(with)--------------------------------------------+             
                                         |                                                                                |                           +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                                                                                |                           |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+                                                    |                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+-------OBJ:V-N-------+            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+COMP:N-N(+    +SUBJ:V+            |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |            |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,Hela)
OBJ:V-N (treat,protein)
SUBJ:V-N (treat,cell)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(with) (__NODE__,Apo)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 400

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                              +-----------------------------------------------------COMP:V-N(with)-----------------------------------------------------+             
                                         |                                                              |                                             +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                                                              |                                             |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+                            +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+-------OBJ:V-N-------+      |     +---OBJ:V-N--+    |         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+COMP:N-N(+    +SUBJ:V+      |     |      +SUBJ:+    |         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,Hela)
OBJ:V-N (treat,protein)
SUBJ:V-N (treat,cell)
OBJ:V-N (with,Apo)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(with) (__NODE__,agonist)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 401

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                                     +--------------------------------------------------COMP:V-N(with)-------------------------------------------------+             
                                         |                                                                     |                                      +---------------------------------SUBJ:V-N---------------------------------+             
                                         +---------------COMP:N-N(in)---------------+                          |                                      |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+              |                          |                                      |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+              |             +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+SUBJ:V+      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
COMP:N-N(in) (production,cell)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(with) (__NODE__,anti)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 402

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                                                +--------------------------------------------COMP:V-N(with)--------------------------------------------+             
                                         |                                                                                |                           +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                                                                                |                           |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+                                                    |                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+-------OBJ:V-N-------+            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+COMP:N-N(+    +SUBJ:V+            |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |            |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,Hela)
OBJ:V-N (treat,protein)
SUBJ:V-N (treat,cell)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(with) (__NODE__,Apo)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 403

                     +------------------------------------------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------------------------------------------+             
                     +-------------------------------OBJ:V-N-------------------------------+                                                          +---------------------------------SUBJ:V-N---------------------------------+             
                     |                   +---------------------SUBJ:V-N--------------------+                                                          |                   +--------------------COMP:V-N(with)--------------------+             
                     |                   +--------COMP:N-N(of)-------+                     |      +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
                     |                   |           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+      +---COMP:V-N(with)--+          |         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               +MOD_A+        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,culture)
SUBJ:V-N (treat,production)
COMP:V-N(with) (treat,anti)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,culture)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 404

                     +------------------------------------------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------------------------------------------+             
                     +-------------------------------OBJ:V-N-------------------------------+                                                          +---------------------------------SUBJ:V-N---------------------------------+             
                     |                   +---------------------SUBJ:V-N--------------------+                                                          |                   +--------------------COMP:V-N(with)--------------------+             
                     |                   +--------COMP:N-N(of)-------+                     |      +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
                     |                   |           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+      +---COMP:V-N(with)--+          |         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               +MOD_A+        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,culture)
SUBJ:V-N (treat,production)
COMP:V-N(with) (treat,anti)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,culture)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 405

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                              +-----------------------------------------------------COMP:V-N(with)-----------------------------------------------------+             
                                         |                                                              |                                             +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                   +-----------OBJ:V-N-----------+            |                                             |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+                   |       +-------SUBJ:V-N------+      +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+----COMP:N-N(of)---+       +-COMP:N-N(in)-+      |      |     +---OBJ:V-N--+    |         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           +MOD_ATT+       |         +MOD_+      |      |     |      +SUBJ:+    |         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__NODE__)
SUBJ:V-N (treat,protein)
OBJ:V-N (with,Apo)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(with) (__NODE__,agonist)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 406

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                                                                            +---------------------------------SUBJ:V-N---------------------------------+             
                                         +---------------------OBJ:V-N---------------------+                                                          |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+                     |      +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+                     +---COMP:V-N(with)--+          |         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+COMP:N-N(+    +SUBJ:V+      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,Hela)
OBJ:V-N (treat,production)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,anti)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 407

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                                                +--------------------------------------------COMP:V-N(with)--------------------------------------------+             
                                         |                                                                                |                           +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                   +-----------OBJ:V-N-----------+                              |                           |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+                   |       +-------SUBJ:V-N------+                              |                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+----COMP:N-N(of)---+       +-COMP:N-N(in)-+      |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           +MOD_ATT+       |         +MOD_+      |            |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |            |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__NODE__)
SUBJ:V-N (treat,protein)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(with) (__NODE__,Apo)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 408

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                              +-----------------------------------------------------COMP:V-N(with)-----------------------------------------------------+             
                                         |                                                              |                                             +---------------------------------SUBJ:V-N---------------------------------+             
                                         |           +---------------OBJ:V-N---------------+            |                                             |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+           |               +-------SUBJ:V-N------+      +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           |               +-COMP:N-N(in)-+      |      |     +---OBJ:V-N--+    |         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+COMP:N-N(of+       +MOD_ATT+         +MOD_+      |      |     |      +SUBJ:+    |         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__SP__)
SUBJ:V-N (treat,protein)
OBJ:V-N (with,Apo)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(with) (__NODE__,agonist)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 409

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         +---------------------------------COMP:N-N(with)---------------------------------+                           +---------------------------------SUBJ:V-N---------------------------------+             
                                         |           +---------------OBJ:V-N---------------+                              |                           |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+           |               +-------SUBJ:V-N------+                              |                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           |               +-COMP:N-N(in)-+      |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+COMP:N-N(of+       +MOD_ATT+         +MOD_+      |            |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |            |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,__SP__)
COMP:N-N(with) (production,Apo)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__SP__)
SUBJ:V-N (treat,protein)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 410

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         +---------------------------------COMP:N-N(with)---------------------------------+                           +---------------------------------SUBJ:V-N---------------------------------+             
                                         |           +---------------OBJ:V-N---------------+                              |                           |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+           |               +-------SUBJ:V-N------+                              |                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           |               +-COMP:N-N(in)-+      |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+COMP:N-N(of+       +MOD_ATT+         +MOD_+      |            |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |            |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,__SP__)
COMP:N-N(with) (production,Apo)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__SP__)
SUBJ:V-N (treat,protein)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 411

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                           +------------------------------------------------------------------------COMP:V-N(of)-----------------------------------------------------------------------+             
                                         |                           |                                                                                +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                           |                                                                                |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+                           |                            +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+             |     +---OBJ:V-N--+    |         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+SUBJ:V+COMP:V_PASS-+      +SUBJ:+    |         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,agonist)
OBJ:V-N (with,Apo)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(of) (__NODE__,protein)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 412

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                           +------------------------------------------------------------------------COMP:V-N(of)-----------------------------------------------------------------------+             
                                         |                           |                                                                                +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                           |                                                                                |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+                           |                            +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+             |     +---OBJ:V-N--+    |         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+SUBJ:V+COMP:V_PASS-+      +SUBJ:+    |         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,agonist)
OBJ:V-N (with,Apo)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(of) (__NODE__,protein)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 413

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                           +------------------------------------------------------------------------COMP:V-N(of)-----------------------------------------------------------------------+             
                                         |                           |                                                                                +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                           |                                                                                |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+                           |                     +------COMP:V_PASS-N(with)-----+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+      |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+SUBJ:V+            |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |            |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(of) (__NODE__,protein)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 414

                     +------------------------------------------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------------------------------------------+             
                     +-------------------------------OBJ:V-N-------------------------------+                                                                                                                                     |             
                     |                   +---------------------SUBJ:V-N--------------------+                                                          +---------------------------------SUBJ:V-N---------------------------------+             
                     |                   +---------------COMP:N-N(in)---------------+      |                                                          |                   +--------------------COMP:V-N(with)--------------------+             
                     |                   +--------COMP:N-N(of)-------+              |      |      +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
                     |                   |           +-MOD_ATT:N-ADJ-+              |      +---COMP:V-N(with)--+          |         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               +MOD_A+        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
COMP:N-N(in) (production,cell)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,culture)
SUBJ:V-N (treat,production)
COMP:V-N(with) (treat,anti)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,culture)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 415

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                                                +--------------------------------------------COMP:V-N(with)--------------------------------------------+             
                                         |                                                                                |                           +---------------------------------SUBJ:V-N---------------------------------+             
                                         +---------------------OBJ:V-N---------------------+                              |                           |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+                           +-------SUBJ:V-N------+                              |                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+                           +-COMP:N-N(in)-+      |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+COMP:N-N(of+       +MOD_ATT+         +MOD_+      |            |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |            |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,production)
SUBJ:V-N (treat,protein)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(with) (__NODE__,Apo)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 416

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                              +-----------------------------------------------------COMP:V-N(with)-----------------------------------------------------+             
                                         |                                                              |                                             +---------------------------------SUBJ:V-N---------------------------------+             
                                         +---------------------OBJ:V-N---------------------+            |                                             |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+                           +-------SUBJ:V-N------+      +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+----COMP:N-N(of)---+       +-COMP:N-N(in)-+      |      |     +---OBJ:V-N--+    |         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           +MOD_ATT+       |         +MOD_+      |      |     |      +SUBJ:+    |         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,production)
SUBJ:V-N (treat,protein)
OBJ:V-N (with,Apo)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(with) (__NODE__,agonist)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 417

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                          +----------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------+             
                                         |                                          |                          +--------------------------------------------------COMP:V-N(with)-------------------------------------------------+             
                                         |                                          |                          |                                      +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                                          |                          |                                      |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+              |                          |                                      |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+              |             +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+SUBJ:V+      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(in) (__NODE__,cell)
COMP:V-N(with) (__NODE__,anti)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 418

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                           +------------------------------------------------------------------------COMP:V-N(of)-----------------------------------------------------------------------+             
                                         |                           |                                                                                +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                           |                                                                                |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+                           +----SUBJ:V_PASS-N----+      +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+      |      |     +---OBJ:V-N--+    |         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+      +COMP:V_PASS-+      +SUBJ:+    |         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,protein)
COMP:V_PASS-N(with) (treat,agonist)
OBJ:V-N (with,Apo)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(of) (__NODE__,protein)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 419

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                                                +--------------------------------------------COMP:V-N(with)--------------------------------------------+             
                                         |                                                                                |                           +---------------------------------SUBJ:V-N---------------------------------+             
                                         +---------------------OBJ:V-N---------------------+                              |                           |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+                           +-------SUBJ:V-N------+                              |                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+----COMP:N-N(of)---+       +-COMP:N-N(in)-+      |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           +MOD_ATT+       |         +MOD_+      |            |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |            |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,production)
SUBJ:V-N (treat,protein)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(with) (__NODE__,Apo)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 420

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                                     +--------------------------------------------------COMP:V-N(with)-------------------------------------------------+             
                                         +------------------SUBJ:V_PASS-N------------------+                   |                                      +---------------------------------SUBJ:V-N---------------------------------+             
                                         +---------------COMP:N-N(in)---------------+      |                   |                                      |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+              |      |                   |                                      |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+              |      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
COMP:N-N(in) (production,cell)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,production)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(with) (__NODE__,anti)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 421

                     +------------------------------------------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------------------------------------------+             
                     |                                                                                  +-----------------------------------------------------COMP:V-N(with)-----------------------------------------------------+             
                     +-------------------------------OBJ:V-N-------------------------------+            |                                             +---------------------------------SUBJ:V-N---------------------------------+             
                     |                   +---------------------SUBJ:V-N--------------------+            |                                             |                   +--------------------COMP:V-N(with)--------------------+             
                     |                   +--------COMP:N-N(of)-------+                     |      +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
                     |                   |           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+      |      |     +---OBJ:V-N--+    |         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               +MOD_A+        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+      |      |     |      +SUBJ:+    |         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,culture)
SUBJ:V-N (treat,production)
OBJ:V-N (with,Apo)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(with) (__NODE__,agonist)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 422

                              +-------------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------------+             
                              +---------------------------------------COMP:N-N(with)--------------------------------------+                                                                                                      |             
                              +---------------------------OBJ:V-N--------------------------+                              |                           +---------------------------------SUBJ:V-N---------------------------------+             
                              |          +---------------------SUBJ:V-N--------------------+                              |                           |                   +--------------------COMP:V-N(with)--------------------+             
                              |          +--------COMP:N-N(of)-------+                     |                              |                           |                   |                      +---------COMP:V-N(with)--------+             
               +--MOD_ATT:N-N-+          |           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+      |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     +MOD_ATT:+          |           |       +MOD_ATT+         +MOD_+      |            |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |            |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (decrease,cell)
MOD_ATT:N-N (decrease,culture)
COMP:N-N(with) (decrease,Apo)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,decrease)
SUBJ:V-N (treat,production)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,decrease)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 423

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                           +------------------------------------------------------------------------COMP:V-N(of)-----------------------------------------------------------------------+             
                                         |                           |                                                                                +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                           |                     +------COMP:V-N(with)-----+                                |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+                           |                     |      +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+-------OBJ:V-N-------+      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+COMP:N-N(+    +SUBJ:V+      |     |      +MOD_A+    |         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,Hela)
OBJ:V-N (treat,protein)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,__SP__)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(of) (__NODE__,protein)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 424

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                   +----------------------------------------------------------------------------COMP:V-N(of)---------------------------------------------------------------------------+             
                                         |                   |                                                                                        +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                   +-----------OBJ:V-N-----------+------COMP:V-N(with)-----+                                |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+                   |       +-------SUBJ:V-N------+      +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+                   |       +-COMP:N-N(in)-+      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           +MOD_ATT+       |         +MOD_+      |      |     |      +MOD_A+    |         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__NODE__)
SUBJ:V-N (treat,protein)
COMP:V-N(with) (treat,__SP__)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(of) (__NODE__,__NODE__)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 425

                              +-------------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------------+             
                              +---------------------------OBJ:V-N--------------------------+                   +--------------------------------------------------COMP:V-N(with)-------------------------------------------------+             
                              |          +---------------------SUBJ:V-N--------------------+                   |                                      +---------------------------------SUBJ:V-N---------------------------------+             
                              |          +---------------COMP:N-N(in)---------------+      |                   |                                      |                   +--------------------COMP:V-N(with)--------------------+             
                              |          +--------COMP:N-N(of)-------+              |      |                   |                                      |                   |                      +---------COMP:V-N(with)--------+             
               +--MOD_ATT:N-N-+          |           +-MOD_ATT:N-ADJ-+              |      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     +MOD_ATT:+          |           |       +MOD_ATT+         +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (decrease,cell)
MOD_ATT:N-N (decrease,culture)
COMP:N-N(of) (production,protein)
COMP:N-N(in) (production,cell)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,decrease)
SUBJ:V-N (treat,production)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,decrease)
COMP:V-N(with) (__NODE__,anti)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 426

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |           +--------------------------------------------------------------------------------COMP:V-N(of)-------------------------------------------------------------------------------+             
                                         |           |                                                                                                +---------------------------------SUBJ:V-N---------------------------------+             
                                         |           +---------------OBJ:V-N---------------+------COMP:V-N(with)-----+                                |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+           |               +-------SUBJ:V-N------+      +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           |               +-COMP:N-N(in)-+      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+      |      |     |      +MOD_A+    |         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__SP__)
SUBJ:V-N (treat,protein)
COMP:V-N(with) (treat,__SP__)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(of) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 427

                              +-------------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------------+             
                              +---------------------------OBJ:V-N--------------------------+                   +--------------------------------------------------COMP:V-N(with)-------------------------------------------------+             
                              |          +---------------------SUBJ:V-N--------------------+                   |                                      +---------------------------------SUBJ:V-N---------------------------------+             
                              |          +---------------COMP:N-N(in)---------------+      |                   |                                      |                   +--------------------COMP:V-N(with)--------------------+             
                              |          +--------COMP:N-N(of)-------+              |      |                   |                                      |                   |                      +---------COMP:V-N(with)--------+             
               +--MOD_ATT:N-N-+          |           +-MOD_ATT:N-ADJ-+              |      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     +MOD_ATT:+          |           |       +MOD_ATT+         +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (decrease,cell)
MOD_ATT:N-N (decrease,culture)
COMP:N-N(of) (production,protein)
COMP:N-N(in) (production,cell)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,decrease)
SUBJ:V-N (treat,production)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,decrease)
COMP:V-N(with) (__NODE__,anti)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 428

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                              +-----------------------------------------------------COMP:V-N(with)-----------------------------------------------------+             
                                         +---------------------OBJ:V-N---------------------+            |                                             +---------------------------------SUBJ:V-N---------------------------------+             
                                         +-------------COMP:N-N(in)------------+           |            |                                             |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+         |           |      +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+         |           |      |     +---OBJ:V-N--+    |         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         |    +SUBJ:V+      |     |      +SUBJ:+    |         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
COMP:N-N(in) (production,Hela)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (treat,production)
SUBJ:V-N (treat,cell)
OBJ:V-N (with,Apo)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(with) (__NODE__,agonist)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 429

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                              +-----------------------------------------------------COMP:V-N(with)-----------------------------------------------------+             
                                         +---------------------OBJ:V-N---------------------+            |                                             +---------------------------------SUBJ:V-N---------------------------------+             
                                         +-------------COMP:N-N(in)------------+           |            |                                             |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+         |           |      +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+         |           |      |     +---OBJ:V-N--+    |         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         |    +SUBJ:V+      |     |      +SUBJ:+    |         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
COMP:N-N(in) (production,Hela)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (treat,production)
SUBJ:V-N (treat,cell)
OBJ:V-N (with,Apo)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(with) (__NODE__,agonist)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 430

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                           +------------------------------------------------------------------------COMP:V-N(of)-----------------------------------------------------------------------+             
                                         |                           |                                               +-----------------------------------------------COMP:V-N(with)----------------------------------------------+             
                                         |                           |                                               |                                +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                           |                                               |                                |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+                           |                            +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+             |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+SUBJ:V+      |     |      +MOD_A+    |         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(of) (__NODE__,protein)
COMP:V-N(with) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 431

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                           +------------------------------------------------------------------------COMP:V-N(of)-----------------------------------------------------------------------+             
                                         |                           |                                               +-----------------------------------------------COMP:V-N(with)----------------------------------------------+             
                                         |                           |                                               |                                +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                           |                                               |                                |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+                           |                            +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+             |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+SUBJ:V+      |     |      +MOD_A+    |         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(of) (__NODE__,protein)
COMP:V-N(with) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 432

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                           +------------------------------------------------------------------------COMP:V-N(of)-----------------------------------------------------------------------+             
                                         |                           |              +----------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------+             
                                         |                           |              |                                                                 +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                           |              |                                                                 |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+                           |              |             +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+              |             |     +---OBJ:V-N--+    |         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+SUBJ:V+COMP:V_PASS-+      +SUBJ:+    |         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,agonist)
OBJ:V-N (with,Apo)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(of) (__NODE__,protein)
COMP:V-N(in) (__NODE__,cell)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 433

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                           +------------------------------------------------------------------------COMP:V-N(of)-----------------------------------------------------------------------+             
                                         |                           |                                               +-----------------------------------------------COMP:V-N(with)----------------------------------------------+             
                                         |                           |                                               |                                +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                           |                                               |                                |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+                           +----SUBJ:V_PASS-N----+      +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+      |      |     |      +MOD_A+    |         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,protein)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(of) (__NODE__,protein)
COMP:V-N(with) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 434

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                           +------------------------------------------------------------------------COMP:V-N(of)-----------------------------------------------------------------------+             
                                         |                           |                                               +-----------------------------------------------COMP:V-N(with)----------------------------------------------+             
                                         |                           |                                               |                                +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                           |                                               |                                |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+                           +----SUBJ:V_PASS-N----+      +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+      |      |     |      +MOD_A+    |         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,protein)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(of) (__NODE__,protein)
COMP:V-N(with) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 435

                     +------------------------------------------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------------------------------------------+             
                     |        +---------------------------------------------------------------------------------------------SUBJ:V-N---------------------------------------------------------------------------------------------+             
                     |        |                                                            +--------------------------------------------------COMP:V-N(with)--------------------------------------------------+                  |             
                     |        |                                                            +--------------------------------------------COMP:V-N(with)-------------------------------------------+            |                  |             
                     |        +---------------------------OBJ:V-N--------------------------+--------------------------------COMP:V-N(with)--------------------------------+                      |            |                  |             
                     |        |          +---------------------SUBJ:V-N--------------------+      +----------------------OBJ:V-N----------------------+                   |                      |            |                  |             
                     |        |          +--------COMP:N-N(of)-------+                     +--------COMP:V-N(with)--------+                           |          +------------------------OBJ:V-N------------------------+       |             
                     |        |          |           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+          |        |             +-------------OBJ:V-N------------+       |             
               +MOD_A+        |          |           |       +MOD_ATT+         +MOD_+      |      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+          |        |             |    +MOD+            |          |       +OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |          |        |             |    |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,decrease)
SUBJ:V-N (treat,production)
COMP:V-N(with) (treat,Apo)
COMP:V-N(with) (treat,cycloheximide)
COMP:V-N(with) (treat,FMK)
COMP:V-N(with) (treat,overproduce)
OBJ:V-N (with,antibody)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (with,__SP__)
OBJ:V-N (with,__SP__)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,culture)
SUBJ:V-N (__NODE__,decrease)
OBJ:V-N (__NODE__,protein)

Analyse 436

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                           +------------------------------------------------------------------------COMP:V-N(of)-----------------------------------------------------------------------+             
                                         |                           |         +-------------------------------------------------------------------COMP:V-N(in)------------------------------------------------------------------+             
                                         |                           |         |    +------------------------------------------------------------------SUBJ:V-N------------------------------------------------------------------+             
                                         |                           |         |    |      +------------------------------------------------COMP:V_PASS-N(with)-----------------------------------------------+                  |             
                                         |                           |         |    |      +-----------------------------------------COMP:V_PASS-N(with)-----------------------------------------+            |                  |             
                                         |                           |         |    |      +------------------------------COMP:V_PASS-N(with)-----------------------------+                      |            |                  |             
                                         |                           |         |    |      |      +----------------------OBJ:V-N----------------------+                   |                      |            |                  |             
               +-------MOD_ATT:N-N-------+                           |         |    |      +------COMP:V_PASS-N(with)-----+                           |                   |                      |            |                  |             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+         |    |      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                      |            |                  |             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         |    +SUBJ:V+      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |                  +OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |                  |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,Apo)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
COMP:V_PASS-N(with) (treat,overproduce)
OBJ:V-N (with,antibody)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(of) (__NODE__,protein)
COMP:V-N(in) (__NODE__,Hela)
SUBJ:V-N (__NODE__,cell)
OBJ:V-N (__NODE__,protein)

Analyse 437

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                                                                            +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                   +-----------OBJ:V-N-----------+                                                          |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+                   |       +-------SUBJ:V-N------+                                                          |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+----COMP:N-N(of)---+       +-COMP:N-N(in)-+      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           +MOD_ATT+       |         +MOD_+      +COMP:V-N(wit+      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__NODE__)
SUBJ:V-N (treat,protein)
COMP:V-N(with) (treat,agonist)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 438

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                                                                            +---------------------------------SUBJ:V-N---------------------------------+             
                                         |           +---------------OBJ:V-N---------------+                                                          |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+           |               +-------SUBJ:V-N------+                                                          |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           |               +-COMP:N-N(in)-+      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+COMP:N-N(of+       +MOD_ATT+         +MOD_+      +COMP:V-N(wit+      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__SP__)
SUBJ:V-N (treat,protein)
COMP:V-N(with) (treat,agonist)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 439

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                                                                            +---------------------------------SUBJ:V-N---------------------------------+             
                                         |           +---------------OBJ:V-N---------------+                                                          |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+           |               +-------SUBJ:V-N------+                                                          |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           |               +-COMP:N-N(in)-+      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+COMP:N-N(of+       +MOD_ATT+         +MOD_+      +COMP:V-N(wit+      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__SP__)
SUBJ:V-N (treat,protein)
COMP:V-N(with) (treat,agonist)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 440

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                                                                            +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                   +-----------OBJ:V-N-----------+                                                          |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+                   |       +-------SUBJ:V-N------+      +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+----COMP:N-N(of)---+       +-COMP:N-N(in)-+      +---COMP:V-N(with)--+          |         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           +MOD_ATT+       |         +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__NODE__)
SUBJ:V-N (treat,protein)
COMP:V-N(with) (treat,anti)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 441

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                              +-----------------------------------------------------COMP:V-N(with)-----------------------------------------------------+             
                                         |                                                              |                                             +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                                                              |                                             |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+                                  |                                             |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+             +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+SUBJ:V+      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(with) (__NODE__,agonist)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 442

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                              +-----------------------------------------------------COMP:V-N(with)-----------------------------------------------------+             
                                         |                                                              |                                             +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                                                              |                                             |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+----SUBJ:V_PASS-N----+            |                                             |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+      |      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,protein)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(with) (__NODE__,agonist)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 443

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                              +-----------------------------------------------------COMP:V-N(with)-----------------------------------------------------+             
                                         |                                                              |                                             +---------------------------------SUBJ:V-N---------------------------------+             
                                         +---------------COMP:N-N(in)---------------+                   |                                             |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+              |                   |                                             |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+              |             +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+SUBJ:V+      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
COMP:N-N(in) (production,cell)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(with) (__NODE__,agonist)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 444

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                                                                            +---------------------------------SUBJ:V-N---------------------------------+             
                                         +---------------------OBJ:V-N---------------------+                                                          |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+                           +-------SUBJ:V-N------+      +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+----COMP:N-N(of)---+       +-COMP:N-N(in)-+      +---COMP:V-N(with)--+          |         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           +MOD_ATT+       |         +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,production)
SUBJ:V-N (treat,protein)
COMP:V-N(with) (treat,anti)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 445

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                                     +--------------------------------------------------COMP:V-N(with)-------------------------------------------------+             
                                         |                                                                     |                                      +---------------------------------SUBJ:V-N---------------------------------+             
                                         +---------------COMP:N-N(in)---------------+                          |                                      |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+              |                          |                                      |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+              |             +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+SUBJ:V+      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
COMP:N-N(in) (production,cell)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(with) (__NODE__,anti)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 446

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                                                                            +---------------------------------SUBJ:V-N---------------------------------+             
                                         +---------------------OBJ:V-N---------------------+                                                          |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+                           +-------SUBJ:V-N------+      +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+----COMP:N-N(of)---+       +-COMP:N-N(in)-+      +---COMP:V-N(with)--+          |         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           +MOD_ATT+       |         +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,production)
SUBJ:V-N (treat,protein)
COMP:V-N(with) (treat,anti)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 447

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                                     +--------------------------------------------------COMP:V-N(with)-------------------------------------------------+             
                                         |                                                                     |                                      +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                   +-----------OBJ:V-N-----------+                   |                                      |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+                   |       +-------SUBJ:V-N------+                   |                                      |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+----COMP:N-N(of)---+       +-COMP:N-N(in)-+      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           +MOD_ATT+       |         +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__NODE__)
SUBJ:V-N (treat,protein)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(with) (__NODE__,anti)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 448

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                              +-----------------------------------------------------COMP:V-N(with)-----------------------------------------------------+             
                                         |                                                              |                                             +---------------------------------SUBJ:V-N---------------------------------+             
                                         +------------------SUBJ:V_PASS-N------------------+            |                                             |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+                     |            |                                             |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+      |      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,production)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(with) (__NODE__,agonist)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 449

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                              +-----------------------------------------------------COMP:V-N(with)-----------------------------------------------------+             
                                         |                                                              |                                             +---------------------------------SUBJ:V-N---------------------------------+             
                                         +------------------SUBJ:V_PASS-N------------------+            |                                             |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+                     |            |                                             |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+      |      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,production)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(with) (__NODE__,agonist)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 450

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                              +-----------------------------------------------------COMP:V-N(with)-----------------------------------------------------+             
                                         |                                                              |                                             +---------------------------------SUBJ:V-N---------------------------------+             
                                         +------------------SUBJ:V_PASS-N------------------+            |                                             |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+                     |            |                                             |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+      |      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,production)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(with) (__NODE__,agonist)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 451

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                                     +--------------------------------------------------COMP:V-N(with)-------------------------------------------------+             
                                         |                                                                     |                                      +---------------------------------SUBJ:V-N---------------------------------+             
                                         |           +---------------OBJ:V-N---------------+                   |                                      |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+           |               +-------SUBJ:V-N------+                   |                                      |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           |               +-COMP:N-N(in)-+      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+COMP:N-N(of+       +MOD_ATT+         +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__SP__)
SUBJ:V-N (treat,protein)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(with) (__NODE__,anti)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 452

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                           +------------------------------------------------------------------------COMP:V-N(of)-----------------------------------------------------------------------+             
                                         |                           |                                                                                +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                           |                                                                                |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+                           |                            +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+      +COMP:V_PASS-N(with)+          |         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+SUBJ:V+      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,anti)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(of) (__NODE__,protein)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 453

                     +------------------------------------------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------------------------------------------+             
                     +-------------------------------OBJ:V-N-------------------------------+                                                                                                                                     |             
                     |                   +---------------------SUBJ:V-N--------------------+                                                          +---------------------------------SUBJ:V-N---------------------------------+             
                     |                   +---------------COMP:N-N(in)---------------+      |                                                          |                   +--------------------COMP:V-N(with)--------------------+             
                     |                   +--------COMP:N-N(of)-------+              |      |                                                          |                   |                      +---------COMP:V-N(with)--------+             
                     |                   |           +-MOD_ATT:N-ADJ-+              |      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               +MOD_A+        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+      +COMP:V-N(wit+      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
COMP:N-N(in) (production,cell)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,culture)
SUBJ:V-N (treat,production)
COMP:V-N(with) (treat,agonist)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,culture)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 454

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         +---------------------OBJ:V-N---------------------+                                                          +---------------------------------SUBJ:V-N---------------------------------+             
                                         +-------------COMP:N-N(in)------------+           |                                                          |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+         |           |                                                          |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+         |           |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         |    +SUBJ:V+COMP:V-N(wit+      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
COMP:N-N(in) (production,Hela)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (treat,production)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,agonist)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 455

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         +---------------------OBJ:V-N---------------------+                                                          +---------------------------------SUBJ:V-N---------------------------------+             
                                         +-------------COMP:N-N(in)------------+           |                                                          |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+         |           |                                                          |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+         |           |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         |    +SUBJ:V+COMP:V-N(wit+      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
COMP:N-N(in) (production,Hela)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (treat,production)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,agonist)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 456

                     +------------------------------------------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------------------------------------------+             
                     +-------------------------------OBJ:V-N-------------------------------+                                                                                                                                     |             
                     |                   +---------------------SUBJ:V-N--------------------+                                                          +---------------------------------SUBJ:V-N---------------------------------+             
                     |                   +---------------COMP:N-N(in)---------------+      |                                                          |                   +--------------------COMP:V-N(with)--------------------+             
                     |                   +--------COMP:N-N(of)-------+              |      |      +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
                     |                   |           +-MOD_ATT:N-ADJ-+              |      +---COMP:V-N(with)--+          |         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               +MOD_A+        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
COMP:N-N(in) (production,cell)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,culture)
SUBJ:V-N (treat,production)
COMP:V-N(with) (treat,anti)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,culture)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 457

                     +------------------------------------------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------------------------------------------+             
                     +-------------------------------OBJ:V-N-------------------------------+                                                                                                                                     |             
                     |                   +---------------------SUBJ:V-N--------------------+                                                          +---------------------------------SUBJ:V-N---------------------------------+             
                     |                   +---------------COMP:N-N(in)---------------+      |                                                          |                   +--------------------COMP:V-N(with)--------------------+             
                     |                   +--------COMP:N-N(of)-------+              |      |      +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
                     |                   |           +-MOD_ATT:N-ADJ-+              |      +---COMP:V-N(with)--+          |         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               +MOD_A+        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
COMP:N-N(in) (production,cell)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,culture)
SUBJ:V-N (treat,production)
COMP:V-N(with) (treat,anti)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,culture)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 458

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                              +-----------------------------------------------------COMP:V-N(with)-----------------------------------------------------+             
                                         +------------------SUBJ:V_PASS-N------------------+            |                                             +---------------------------------SUBJ:V-N---------------------------------+             
                                         +---------------COMP:N-N(in)---------------+      |            |                                             |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+              |      |            |                                             |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+              |      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+      |      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
COMP:N-N(in) (production,cell)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,production)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(with) (__NODE__,agonist)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 459

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                          +----------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------+             
                                         |                                          |                   +-----------------------------------------------------COMP:V-N(with)-----------------------------------------------------+             
                                         |                                          |                   |                                             +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                                          |                   |                                             |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+              |                   |                                             |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+              |             +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+SUBJ:V+      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(in) (__NODE__,cell)
COMP:V-N(with) (__NODE__,agonist)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 460

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                                     +--------------------------------------------------COMP:V-N(with)-------------------------------------------------+             
                                         |                                                                     |                                      +---------------------------------SUBJ:V-N---------------------------------+             
                                         +---------------------OBJ:V-N---------------------+                   |                                      |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+                           +-------SUBJ:V-N------+                   |                                      |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+                           +-COMP:N-N(in)-+      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+COMP:N-N(of+       +MOD_ATT+         +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,production)
SUBJ:V-N (treat,protein)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(with) (__NODE__,anti)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 461

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                           +------------------------------------------------------------------------COMP:V-N(of)-----------------------------------------------------------------------+             
                                         |                           |                                                                                +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                           |                                                                                |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+                           +----SUBJ:V_PASS-N----+      +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+      +COMP:V_PASS-N(with)+          |         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,protein)
COMP:V_PASS-N(with) (treat,anti)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(of) (__NODE__,protein)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 462

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                                     +--------------------------------------------------COMP:V-N(with)-------------------------------------------------+             
                                         |                                                                     |                                      +---------------------------------SUBJ:V-N---------------------------------+             
                                         +---------------------OBJ:V-N---------------------+                   |                                      |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+                           +-------SUBJ:V-N------+                   |                                      |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+----COMP:N-N(of)---+       +-COMP:N-N(in)-+      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           +MOD_ATT+       |         +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,production)
SUBJ:V-N (treat,protein)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(with) (__NODE__,anti)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 463

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                           +------------------------------------------------------------------------COMP:V-N(of)-----------------------------------------------------------------------+             
                                         |                           |                                                                                +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                           |                                                                                |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+                           |                     +--------COMP:V-N(with)--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+-------OBJ:V-N-------+            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+COMP:N-N(+    +SUBJ:V+            |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |            |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,Hela)
OBJ:V-N (treat,protein)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(of) (__NODE__,protein)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 464

                     +------------------------------------------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------------------------------------------+             
                     |                                                                                         +--------------------------------------------------COMP:V-N(with)-------------------------------------------------+             
                     +-------------------------------OBJ:V-N-------------------------------+                   |                                      +---------------------------------SUBJ:V-N---------------------------------+             
                     |                   +---------------------SUBJ:V-N--------------------+                   |                                      |                   +--------------------COMP:V-N(with)--------------------+             
                     |                   +--------COMP:N-N(of)-------+                     |                   |                                      |                   |                      +---------COMP:V-N(with)--------+             
                     |                   |           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               +MOD_A+        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,culture)
SUBJ:V-N (treat,production)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(with) (__NODE__,anti)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 465

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                                     +--------------------------------------------------COMP:V-N(with)-------------------------------------------------+             
                                         |                                                                     |                                      +---------------------------------SUBJ:V-N---------------------------------+             
                                         +---------------------OBJ:V-N---------------------+                   |                                      |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+                     |                   |                                      |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+                     |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+COMP:N-N(+    +SUBJ:V+      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,Hela)
OBJ:V-N (treat,production)
SUBJ:V-N (treat,cell)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(with) (__NODE__,anti)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 466

                     +------------------------------------------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------------------------------------------+             
                     |                                                                                         +--------------------------------------------------COMP:V-N(with)-------------------------------------------------+             
                     +-------------------------------OBJ:V-N-------------------------------+                   |                                      +---------------------------------SUBJ:V-N---------------------------------+             
                     |                   +---------------------SUBJ:V-N--------------------+                   |                                      |                   +--------------------COMP:V-N(with)--------------------+             
                     |                   +--------COMP:N-N(of)-------+                     |                   |                                      |                   |                      +---------COMP:V-N(with)--------+             
                     |                   |           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               +MOD_A+        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,culture)
SUBJ:V-N (treat,production)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(with) (__NODE__,anti)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 467

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                           +------------------------------------------------------------------------COMP:V-N(of)-----------------------------------------------------------------------+             
                                         |                           |                                                                                +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                           |                                                                                |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+                           |                     +--------COMP:V-N(with)--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+-------OBJ:V-N-------+            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+COMP:N-N(+    +SUBJ:V+            |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |            |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,Hela)
OBJ:V-N (treat,protein)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(of) (__NODE__,protein)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 468

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                           +------------------------------------------------------------------------COMP:V-N(of)-----------------------------------------------------------------------+             
                                         |                           |                                                                                +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                           |                                                                                |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+                           |                     +--------COMP:V-N(with)--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+-------OBJ:V-N-------+            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+COMP:N-N(+    +SUBJ:V+            |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |            |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,Hela)
OBJ:V-N (treat,protein)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(of) (__NODE__,protein)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 469

                     +------------------------------------------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------------------------------------------+             
                     |                                                                                         +--------------------------------------------------COMP:V-N(with)-------------------------------------------------+             
                     +-------------------------------OBJ:V-N-------------------------------+                   |                                      +---------------------------------SUBJ:V-N---------------------------------+             
                     |                   +---------------------SUBJ:V-N--------------------+                   |                                      |                   +--------------------COMP:V-N(with)--------------------+             
                     |                   +--------COMP:N-N(of)-------+                     |                   |                                      |                   |                      +---------COMP:V-N(with)--------+             
                     |                   |           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               +MOD_A+        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,culture)
SUBJ:V-N (treat,production)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(with) (__NODE__,anti)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 470

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |           +--------------------------------------------------------------------------------COMP:V-N(of)-------------------------------------------------------------------------------+             
                                         |           |                                                                                                +---------------------------------SUBJ:V-N---------------------------------+             
                                         |           +---------------OBJ:V-N---------------+                                                          |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+           |               +-------SUBJ:V-N------+--------COMP:V-N(with)--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           |               +-COMP:N-N(in)-+      |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+      |            |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |            |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__SP__)
SUBJ:V-N (treat,protein)
COMP:V-N(with) (treat,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(of) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 471

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                           +------------------------------------------------------------------------COMP:V-N(of)-----------------------------------------------------------------------+             
                                         |                           |                                                    +--------------------------------------------COMP:V-N(with)--------------------------------------------+             
                                         |                           |                                                    |                           +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                           |                                                    |                           |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+                           |                                                    |                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+                   +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+SUBJ:V+            |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |            |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(of) (__NODE__,protein)
COMP:V-N(with) (__NODE__,Apo)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 472

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                           +------------------------------------------------------------------------COMP:V-N(of)-----------------------------------------------------------------------+             
                                         |                           |                                                                                +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                           +-------------------COMP:N-N(with)-------------------+                           |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+                           +----SUBJ:V_PASS-N----+                              |                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+      |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+      |            |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |            |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
COMP:N-N(with) (protein,Apo)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,protein)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(of) (__NODE__,protein)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 473

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                           +------------------------------------------------------------------------COMP:V-N(of)-----------------------------------------------------------------------+             
                                         |                           |                                                    +--------------------------------------------COMP:V-N(with)--------------------------------------------+             
                                         |                           |                                                    |                           +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                           |                                                    |                           |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+                           |                                                    |                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+                   +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+SUBJ:V+            |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |            |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(of) (__NODE__,protein)
COMP:V-N(with) (__NODE__,Apo)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 474

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                           +------------------------------------------------------------------------COMP:V-N(of)-----------------------------------------------------------------------+             
                                         |                           |                                  +-----------------------------------------------------COMP:V-N(with)-----------------------------------------------------+             
                                         |                           |                                  |                                             +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                           |                                  |                                             |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+                           +----SUBJ:V_PASS-N----+      +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+      |      |     +---OBJ:V-N--+    |         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+      |      |     |      +SUBJ:+    |         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,protein)
OBJ:V-N (with,Apo)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(of) (__NODE__,protein)
COMP:V-N(with) (__NODE__,agonist)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 475

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                           +------------------------------------------------------------------------COMP:V-N(of)-----------------------------------------------------------------------+             
                                         |                           |                                                    +--------------------------------------------COMP:V-N(with)--------------------------------------------+             
                                         |                           |                                                    |                           +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                           |                                                    |                           |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+                           +----SUBJ:V_PASS-N----+                              |                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+      |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+      |            |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |            |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,protein)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(of) (__NODE__,protein)
COMP:V-N(with) (__NODE__,Apo)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 476

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                           +------------------------------------------------------------------------COMP:V-N(of)-----------------------------------------------------------------------+             
                                         |                           |              +----------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------+             
                                         |                           |              |                                                                 +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                           |              |                                                                 |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+                           |              +------------COMP:N-N(with)-----------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+              |                   +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+SUBJ:V+            |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |            |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (cell,Hela)
COMP:N-N(with) (cell,Apo)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(of) (__NODE__,protein)
COMP:V-N(in) (__NODE__,cell)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 477

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                           +------------------------------------------------------------------------COMP:V-N(of)-----------------------------------------------------------------------+             
                                         |                           |              +----------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------+             
                                         |                           |              |                                                                 +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                           |              |                                                                 |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+                           |              +------------COMP:N-N(with)-----------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+              |                   +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+SUBJ:V+            |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |            |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (cell,Hela)
COMP:N-N(with) (cell,Apo)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(of) (__NODE__,protein)
COMP:V-N(in) (__NODE__,cell)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 478

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                           +------------------------------------------------------------------------COMP:V-N(of)-----------------------------------------------------------------------+             
                                         |                           |              +----------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------+             
                                         |                           |              |                   +-----------------------------------------------------COMP:V-N(with)-----------------------------------------------------+             
                                         |                           |              |                   |                                             +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                           |              |                   |                                             |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+                           |              |             +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+              |             |     +---OBJ:V-N--+    |         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+SUBJ:V+      |     |      +SUBJ:+    |         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,Apo)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(of) (__NODE__,protein)
COMP:V-N(in) (__NODE__,cell)
COMP:V-N(with) (__NODE__,agonist)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 479

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                                                                            +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                                                                                                            |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+                                                                                |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+-------OBJ:V-N-------+      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+COMP:N-N(+    +SUBJ:V+COMP:V-N(wit+      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,Hela)
OBJ:V-N (treat,protein)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,agonist)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 480

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                                                                            +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                                                                                                            |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+                                                                                |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+-------OBJ:V-N-------+      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+COMP:N-N(+    +SUBJ:V+COMP:V-N(wit+      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,Hela)
OBJ:V-N (treat,protein)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,agonist)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 481

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                                                                            +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                                                                                                            |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+                            +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+-------OBJ:V-N-------+---COMP:V-N(with)--+          |         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+COMP:N-N(+    +SUBJ:V+      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,Hela)
OBJ:V-N (treat,protein)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,anti)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 482

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                                                                            +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                                                                                                            |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+                            +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+-------OBJ:V-N-------+---COMP:V-N(with)--+          |         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+COMP:N-N(+    +SUBJ:V+      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,Hela)
OBJ:V-N (treat,protein)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,anti)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 483

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                                                                            +---------------------------------SUBJ:V-N---------------------------------+             
                                         |           +---------------OBJ:V-N---------------+                                                          |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+           |               +-------SUBJ:V-N------+                                                          |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           |               +-COMP:N-N(in)-+      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+COMP:N-N(of+       +MOD_ATT+         +MOD_+      +COMP:V-N(wit+      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__SP__)
SUBJ:V-N (treat,protein)
COMP:V-N(with) (treat,agonist)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 484

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                                                                            +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                   +-----------OBJ:V-N-----------+                                                          |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+                   |       +-------SUBJ:V-N------+      +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+----COMP:N-N(of)---+       +-COMP:N-N(in)-+      +---COMP:V-N(with)--+          |         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           +MOD_ATT+       |         +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__NODE__)
SUBJ:V-N (treat,protein)
COMP:V-N(with) (treat,anti)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 485

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                                                                            +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                   +-----------OBJ:V-N-----------+                                                          |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+                   |       +-------SUBJ:V-N------+      +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+----COMP:N-N(of)---+       +-COMP:N-N(in)-+      +---COMP:V-N(with)--+          |         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           +MOD_ATT+       |         +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__NODE__)
SUBJ:V-N (treat,protein)
COMP:V-N(with) (treat,anti)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 486

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                              +-----------------------------------------------------COMP:V-N(with)-----------------------------------------------------+             
                                         |                                                              |                                             +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                                                              |                                             |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+                                  |                                             |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+             +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+SUBJ:V+      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(with) (__NODE__,agonist)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 487

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                              +-----------------------------------------------------COMP:V-N(with)-----------------------------------------------------+             
                                         |                                                              |                                             +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                                                              |                                             |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+                                  |                                             |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+             +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+SUBJ:V+      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(with) (__NODE__,agonist)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 488

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                                     +--------------------------------------------------COMP:V-N(with)-------------------------------------------------+             
                                         |                                                                     |                                      +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                                                                     |                                      |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+                                         |                                      |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+             +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+SUBJ:V+      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(with) (__NODE__,anti)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 489

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                                     +--------------------------------------------------COMP:V-N(with)-------------------------------------------------+             
                                         |                                                                     |                                      +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                                                                     |                                      |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+                                         |                                      |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+             +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+SUBJ:V+      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(with) (__NODE__,anti)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 490

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                              +-----------------------------------------------------COMP:V-N(with)-----------------------------------------------------+             
                                         |                                                              |                                             +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                                                              |                                             |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+----SUBJ:V_PASS-N----+            |                                             |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+      |      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,protein)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(with) (__NODE__,agonist)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 491

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                                                                            +---------------------------------SUBJ:V-N---------------------------------+             
                                         +---------------------OBJ:V-N---------------------+                                                          |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+                           +-------SUBJ:V-N------+                                                          |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+----COMP:N-N(of)---+       +-COMP:N-N(in)-+      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           +MOD_ATT+       |         +MOD_+      +COMP:V-N(wit+      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,production)
SUBJ:V-N (treat,protein)
COMP:V-N(with) (treat,agonist)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 492

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                                                                            +---------------------------------SUBJ:V-N---------------------------------+             
                                         +---------------------OBJ:V-N---------------------+                                                          |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+                     |                                                          |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+                     |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+COMP:N-N(+    +SUBJ:V+COMP:V-N(wit+      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,Hela)
OBJ:V-N (treat,production)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,agonist)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 493

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                                                                            +---------------------------------SUBJ:V-N---------------------------------+             
                                         +---------------------OBJ:V-N---------------------+                                                          |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+                     |      +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+                     +---COMP:V-N(with)--+          |         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+COMP:N-N(+    +SUBJ:V+      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,Hela)
OBJ:V-N (treat,production)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,anti)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 494

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                              +-----------------------------------------------------COMP:V-N(with)-----------------------------------------------------+             
                                         |                                                              |                                             +---------------------------------SUBJ:V-N---------------------------------+             
                                         +------------------SUBJ:V_PASS-N------------------+            |                                             |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+                     |            |                                             |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+      |      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,production)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(with) (__NODE__,agonist)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 495

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                                     +--------------------------------------------------COMP:V-N(with)-------------------------------------------------+             
                                         |                                                                     |                                      +---------------------------------SUBJ:V-N---------------------------------+             
                                         +------------------SUBJ:V_PASS-N------------------+                   |                                      |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+                     |                   |                                      |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,production)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(with) (__NODE__,anti)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 496

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         +---------------------OBJ:V-N---------------------+                                                          +---------------------------------SUBJ:V-N---------------------------------+             
                                         +-------------COMP:N-N(in)------------+           |                                                          |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+         |           |                                                          |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+         |           |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         |    +SUBJ:V+COMP:V-N(wit+      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
COMP:N-N(in) (production,Hela)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (treat,production)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,agonist)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 497

                     +------------------------------------------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------------------------------------------+             
                     +-------------------------------OBJ:V-N-------------------------------+                                                                                                                                     |             
                     |                   +---------------------SUBJ:V-N--------------------+                                                          +---------------------------------SUBJ:V-N---------------------------------+             
                     |                   +---------------COMP:N-N(in)---------------+      |                                                          |                   +--------------------COMP:V-N(with)--------------------+             
                     |                   +--------COMP:N-N(of)-------+              |      |                                                          |                   |                      +---------COMP:V-N(with)--------+             
                     |                   |           +-MOD_ATT:N-ADJ-+              |      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               +MOD_A+        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+      +COMP:V-N(wit+      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
COMP:N-N(in) (production,cell)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,culture)
SUBJ:V-N (treat,production)
COMP:V-N(with) (treat,agonist)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,culture)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 498

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         +---------------------OBJ:V-N---------------------+                                                          +---------------------------------SUBJ:V-N---------------------------------+             
                                         +-------------COMP:N-N(in)------------+           |                                                          |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+         |           |      +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+         |           +---COMP:V-N(with)--+          |         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         |    +SUBJ:V+      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
COMP:N-N(in) (production,Hela)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (treat,production)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,anti)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 499

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         +---------------------OBJ:V-N---------------------+                                                          +---------------------------------SUBJ:V-N---------------------------------+             
                                         +-------------COMP:N-N(in)------------+           |                                                          |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+         |           |      +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+         |           +---COMP:V-N(with)--+          |         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         |    +SUBJ:V+      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
COMP:N-N(in) (production,Hela)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (treat,production)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,anti)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 500

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                          +----------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------+             
                                         |                                          |                   +-----------------------------------------------------COMP:V-N(with)-----------------------------------------------------+             
                                         |                                          |                   |                                             +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                                          |                   |                                             |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+              |                   |                                             |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+              |             +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+SUBJ:V+      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(in) (__NODE__,cell)
COMP:V-N(with) (__NODE__,agonist)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 501

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                          +----------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------+             
                                         |                                          |                          +--------------------------------------------------COMP:V-N(with)-------------------------------------------------+             
                                         |                                          |                          |                                      +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                                          |                          |                                      |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+              |                          |                                      |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+              |             +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+SUBJ:V+      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(in) (__NODE__,cell)
COMP:V-N(with) (__NODE__,anti)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 502

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                                     +--------------------------------------------------COMP:V-N(with)-------------------------------------------------+             
                                         |                                                                     |                                      +---------------------------------SUBJ:V-N---------------------------------+             
                                         +---------------------OBJ:V-N---------------------+                   |                                      |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+                           +-------SUBJ:V-N------+                   |                                      |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+----COMP:N-N(of)---+       +-COMP:N-N(in)-+      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           +MOD_ATT+       |         +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,production)
SUBJ:V-N (treat,protein)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(with) (__NODE__,anti)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 503

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                                     +--------------------------------------------------COMP:V-N(with)-------------------------------------------------+             
                                         |                                                                     |                                      +---------------------------------SUBJ:V-N---------------------------------+             
                                         +---------------------OBJ:V-N---------------------+                   |                                      |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+                     |                   |                                      |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+                     |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+COMP:N-N(+    +SUBJ:V+      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,Hela)
OBJ:V-N (treat,production)
SUBJ:V-N (treat,cell)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(with) (__NODE__,anti)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 504

                     +------------------------------------------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------------------------------------------+             
                     |                                                                                         +--------------------------------------------------COMP:V-N(with)-------------------------------------------------+             
                     +-------------------------------OBJ:V-N-------------------------------+                   |                                      +---------------------------------SUBJ:V-N---------------------------------+             
                     |                   +---------------------SUBJ:V-N--------------------+                   |                                      |                   +--------------------COMP:V-N(with)--------------------+             
                     |                   +--------COMP:N-N(of)-------+                     |                   |                                      |                   |                      +---------COMP:V-N(with)--------+             
                     |                   |           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               +MOD_A+        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,culture)
SUBJ:V-N (treat,production)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(with) (__NODE__,anti)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 505

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                           +------------------------------------------------------------------------COMP:V-N(of)-----------------------------------------------------------------------+             
                                         |                           |                                                                                +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                           |                                                                                |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+                           |                     +--------COMP:V-N(with)--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+-------OBJ:V-N-------+            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+COMP:N-N(+    +SUBJ:V+            |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |            |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,Hela)
OBJ:V-N (treat,protein)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(of) (__NODE__,protein)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 506

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                                     +--------------------------------------------------COMP:V-N(with)-------------------------------------------------+             
                                         |                                                                     |                                      +---------------------------------SUBJ:V-N---------------------------------+             
                                         +---------------------OBJ:V-N---------------------+                   |                                      |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+                     |                   |                                      |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+                     |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+COMP:N-N(+    +SUBJ:V+      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,Hela)
OBJ:V-N (treat,production)
SUBJ:V-N (treat,cell)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(with) (__NODE__,anti)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 507

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |           +--------------------------------------------------------------------------------COMP:V-N(of)-------------------------------------------------------------------------------+             
                                         |           |                                                                                                +---------------------------------SUBJ:V-N---------------------------------+             
                                         |           +---------------OBJ:V-N---------------+                                                          |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+           |               +-------SUBJ:V-N------+      +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           |               +-COMP:N-N(in)-+      |      |     +---OBJ:V-N--+    |         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+      +COMP:V-N(wit+      +SUBJ:+    |         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__SP__)
SUBJ:V-N (treat,protein)
COMP:V-N(with) (treat,agonist)
OBJ:V-N (with,Apo)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(of) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 508

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |           +--------------------------------------------------------------------------------COMP:V-N(of)-------------------------------------------------------------------------------+             
                                         |           |                                                                                                +---------------------------------SUBJ:V-N---------------------------------+             
                                         |           +---------------OBJ:V-N---------------+                                                          |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+           |               +-------SUBJ:V-N------+      +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           |               +-COMP:N-N(in)-+      |      |     +---OBJ:V-N--+    |         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+      +COMP:V-N(wit+      +SUBJ:+    |         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__SP__)
SUBJ:V-N (treat,protein)
COMP:V-N(with) (treat,agonist)
OBJ:V-N (with,Apo)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(of) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 509

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                           +------------------------------------------------------------------------COMP:V-N(of)-----------------------------------------------------------------------+             
                                         |                           |                                                                                +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                           +-------------------COMP:N-N(with)-------------------+                           |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+                           +----SUBJ:V_PASS-N----+                              |                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+      |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+      |            |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |            |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
COMP:N-N(with) (protein,Apo)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,protein)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(of) (__NODE__,protein)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 510

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                           +------------------------------------------------------------------------COMP:V-N(of)-----------------------------------------------------------------------+             
                                         |                           |                                                    +--------------------------------------------COMP:V-N(with)--------------------------------------------+             
                                         |                           |                                                    |                           +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                           |                                                    |                           |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+                           |                                                    |                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+                   +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+SUBJ:V+            |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |            |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(of) (__NODE__,protein)
COMP:V-N(with) (__NODE__,Apo)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 511

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                           +------------------------------------------------------------------------COMP:V-N(of)-----------------------------------------------------------------------+             
                                         |                           |                                  +-----------------------------------------------------COMP:V-N(with)-----------------------------------------------------+             
                                         |                           |                                  |                                             +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                           |                                  |                                             |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+                           |                            +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+             |     +---OBJ:V-N--+    |         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+SUBJ:V+      |     |      +SUBJ:+    |         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,Apo)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(of) (__NODE__,protein)
COMP:V-N(with) (__NODE__,agonist)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 512

                     +------------------------------------------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------------------------------------------+             
                     +-------------------------------OBJ:V-N-------------------------------+                   +--------------------------------------------------COMP:V-N(with)-------------------------------------------------+             
                     |                   +---------------------SUBJ:V-N--------------------+                   |                                      +---------------------------------SUBJ:V-N---------------------------------+             
                     |                   +---------------COMP:N-N(in)---------------+      |                   |                                      |                   +--------------------COMP:V-N(with)--------------------+             
                     |                   +--------COMP:N-N(of)-------+              |      |                   |                                      |                   |                      +---------COMP:V-N(with)--------+             
                     |                   |           +-MOD_ATT:N-ADJ-+              |      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               +MOD_A+        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
COMP:N-N(in) (production,cell)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,culture)
SUBJ:V-N (treat,production)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(with) (__NODE__,anti)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 513

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                                     +--------------------------------------------------COMP:V-N(with)-------------------------------------------------+             
                                         +---------------------OBJ:V-N---------------------+                   |                                      +---------------------------------SUBJ:V-N---------------------------------+             
                                         +-------------COMP:N-N(in)------------+           |                   |                                      |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+         |           |                   |                                      |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+         |           |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         |    +SUBJ:V+      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
COMP:N-N(in) (production,Hela)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (treat,production)
SUBJ:V-N (treat,cell)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(with) (__NODE__,anti)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 514

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                           +------------------------------------------------------------------------COMP:V-N(of)-----------------------------------------------------------------------+             
                                         |                           |                                                    +--------------------------------------------COMP:V-N(with)--------------------------------------------+             
                                         |                           |                                                    |                           +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                           |                                                    |                           |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+                           +----SUBJ:V_PASS-N----+                              |                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+      |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+      |            |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |            |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,protein)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(of) (__NODE__,protein)
COMP:V-N(with) (__NODE__,Apo)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 515

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                           +------------------------------------------------------------------------COMP:V-N(of)-----------------------------------------------------------------------+             
                                         |                           |              +----------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------+             
                                         |                           |              |                                                                 +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                           |              |                                                                 |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+                           |              |             +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+              |      +COMP:V_PASS-N(with)+          |         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+SUBJ:V+      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,anti)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(of) (__NODE__,protein)
COMP:V-N(in) (__NODE__,cell)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 516

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                           +------------------------------------------------------------------------COMP:V-N(of)-----------------------------------------------------------------------+             
                                         |                           |              +----------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------+             
                                         |                           |              |                                                                 +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                           |              |                                                                 |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+                           |              |             +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+              |      +COMP:V_PASS-N(with)+          |         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+SUBJ:V+      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,anti)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(of) (__NODE__,protein)
COMP:V-N(in) (__NODE__,cell)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 517

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                           +------------------------------------------------------------------------COMP:V-N(of)-----------------------------------------------------------------------+             
                                         |                           |              +----------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------+             
                                         |                           |              |                                                                 +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                           |              |                                                                 |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+                           |              |             +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+              |      +COMP:V_PASS-N(with)+          |         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+SUBJ:V+      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,anti)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(of) (__NODE__,protein)
COMP:V-N(in) (__NODE__,cell)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 518

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                           +------------------------------------------------------------------------COMP:V-N(of)-----------------------------------------------------------------------+             
                                         |                           |              +----------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------+             
                                         |                           |              |                                                                 +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                           |              |                                                                 |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+                           |              +------------COMP:N-N(with)-----------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+              |                   +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+SUBJ:V+            |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |            |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (cell,Hela)
COMP:N-N(with) (cell,Apo)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(of) (__NODE__,protein)
COMP:V-N(in) (__NODE__,cell)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 519

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                   +----------------------------------------------------------------------------COMP:V-N(of)---------------------------------------------------------------------------+             
                                         |                   |                                                       +-----------------------------------------------COMP:V-N(with)----------------------------------------------+             
                                         |                   |                                                       |                                +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                   +-----------OBJ:V-N-----------+                         |                                |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+                   |       +-------SUBJ:V-N------+      +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+                   |       +-COMP:N-N(in)-+      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           +MOD_ATT+       |         +MOD_+      |      |     |      +MOD_A+    |         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__NODE__)
SUBJ:V-N (treat,protein)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(of) (__NODE__,__NODE__)
COMP:V-N(with) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 520

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                           +------------------------------------------------------------------------COMP:V-N(of)-----------------------------------------------------------------------+             
                                         |                           |              +----------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------+             
                                         |                           |              |                                     +--------------------------------------------COMP:V-N(with)--------------------------------------------+             
                                         |                           |              |                                     |                           +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                           |              |                                     |                           |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+                           |              |                                     |                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+              |                   +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+SUBJ:V+            |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |            |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(of) (__NODE__,protein)
COMP:V-N(in) (__NODE__,cell)
COMP:V-N(with) (__NODE__,Apo)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 521

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                           +------------------------------------------------------------------------COMP:V-N(of)-----------------------------------------------------------------------+             
                                         |                           |              +------------------------------------------------------------------SUBJ:V-N------------------------------------------------------------------+             
                                         |                           |              |      +------------------------------------------------COMP:V_PASS-N(with)-----------------------------------------------+                  |             
                                         |                           |              |      +-----------------------------------------COMP:V_PASS-N(with)-----------------------------------------+            |                  |             
                                         |                           |              |      +------------------------------COMP:V_PASS-N(with)-----------------------------+                      |            |                  |             
                                         |                           |              |      |      +----------------------OBJ:V-N----------------------+                   |                      |            |                  |             
               +-------MOD_ATT:N-N-------+                           |              |      +------COMP:V_PASS-N(with)-----+                           |                   |             +-------------OBJ:V-N------------+       |             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+              |      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |             |    +--MOD_ATT:N-ADJ-+          |       |             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+COMP:N-N(+    +SUBJ:V+      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |             |    +MOD+            |          |       +OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |             |    |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,Apo)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
COMP:V_PASS-N(with) (treat,overproduce)
OBJ:V-N (with,antibody)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (with,__SP__)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(of) (__NODE__,protein)
SUBJ:V-N (__NODE__,cell)
OBJ:V-N (__NODE__,protein)

Analyse 522

                                                                                           +--------------------------------------------------COMP:V-N(with)--------------------------------------------------+                                
                     +-----------------------------COMP:V-N(in)----------------------------+--------------------------------------------COMP:V-N(with)-------------------------------------------+            |                                
                     |                   +---------------------SUBJ:V-N--------------------+--------------------------------COMP:V-N(with)--------------------------------+                      |            |                                
                     |                   +---------------COMP:N-N(in)---------------+      |      +----------------------OBJ:V-N----------------------+          +--------------------------------OBJ:V-N--------------------------------+     
                     |                   +--------COMP:N-N(of)-------+              |      +--------COMP:V-N(with)--------+                           |          |        |             +---------------------OBJ:V-N--------------------+     
                     |                   |           +-MOD_ATT:N-ADJ-+              |      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+          |        |             |    +--MOD_ATT:N-ADJ-+          +-MOD_ATT:N-ADJ-+     
               +MOD_A+        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+      |      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+          |        |             |    +MOD+            |          |       +MOD_ATT+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |          |        |             |    |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
COMP:N-N(in) (production,cell)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (cell,Hela)
COMP:V-N(in) (treat,culture)
SUBJ:V-N (treat,production)
COMP:V-N(with) (treat,Apo)
COMP:V-N(with) (treat,cycloheximide)
COMP:V-N(with) (treat,FMK)
COMP:V-N(with) (treat,overproduce)
OBJ:V-N (with,antibody)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (with,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 523

                                                                                           +--------------------------------------------------COMP:V-N(with)--------------------------------------------------+                                
                                                                                           +--------------------------------------------COMP:V-N(with)-------------------------------------------+            |                                
                                                                                           +--------------------------------COMP:V-N(with)--------------------------------+                      |            |                                
                                         +-------------------COMP:V-N(in)------------------+      +----------------------OBJ:V-N----------------------+          +--------------------------------OBJ:V-N--------------------------------+     
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+                     +--------COMP:V-N(with)--------+                           |          |        |             +---------------------OBJ:V-N--------------------+     
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+                     |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+          |        |             |    +--MOD_ATT:N-ADJ-+          +-MOD_ATT:N-ADJ-+     
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+COMP:N-N(+    +SUBJ:V+      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+          |        |             |    +MOD+            |          |       +MOD_ATT+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |          |        |             |    |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,Hela)
COMP:V-N(in) (treat,production)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,Apo)
COMP:V-N(with) (treat,cycloheximide)
COMP:V-N(with) (treat,FMK)
COMP:V-N(with) (treat,overproduce)
OBJ:V-N (with,antibody)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (with,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 524

                                                                                           +--------------------------------------------------COMP:V-N(with)--------------------------------------------------+                                
                                                                                           +--------------------------------------------COMP:V-N(with)-------------------------------------------+            |                                
                     +-----------------------------COMP:V-N(in)----------------------------+--------------------------------COMP:V-N(with)--------------------------------+                      |            |                                
                     |                   +---------------------SUBJ:V-N--------------------+      +----------------------OBJ:V-N----------------------+          +--------------------------------OBJ:V-N--------------------------------+     
                     |                   +--------COMP:N-N(of)-------+                     +--------COMP:V-N(with)--------+                           |          |        |             +---------------------OBJ:V-N--------------------+     
                     |                   |           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+          |        |             |        |            |          +-MOD_ATT:N-ADJ-+     
               +MOD_A+        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+      |      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+          |        |             |    +MOD+            |          |       +MOD_ATT+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |          |        |             |    |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
COMP:V-N(in) (treat,culture)
SUBJ:V-N (treat,production)
COMP:V-N(with) (treat,Apo)
COMP:V-N(with) (treat,cycloheximide)
COMP:V-N(with) (treat,FMK)
COMP:V-N(with) (treat,overproduce)
OBJ:V-N (with,antibody)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (with,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 525

                                                                                           +--------------------------------------------------COMP:V-N(with)--------------------------------------------------+                                
                                                                                           +--------------------------------------------COMP:V-N(with)-------------------------------------------+            |                                
                                                                                           +--------------------------------COMP:V-N(with)--------------------------------+                      |            |                                
                                         +-------------------COMP:V-N(in)------------------+      +----------------------OBJ:V-N----------------------+          +--------------------------------OBJ:V-N--------------------------------+     
               +-------MOD_ATT:N-N-------+                           +-------SUBJ:V-N------+--------COMP:V-N(with)--------+                           |          |        |             +---------------------OBJ:V-N--------------------+     
               |     +----MOD_ATT:N-N----+----COMP:N-N(of)---+       +-COMP:N-N(in)-+      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+          |        |             |        |            |          +-MOD_ATT:N-ADJ-+     
               |     |        +MOD_ATT:N-+           +MOD_ATT+       |         +MOD_+      |      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+          |        |             |    +MOD+            |          |       +MOD_ATT+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |          |        |             |    |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
COMP:V-N(in) (treat,production)
SUBJ:V-N (treat,protein)
COMP:V-N(with) (treat,Apo)
COMP:V-N(with) (treat,cycloheximide)
COMP:V-N(with) (treat,FMK)
COMP:V-N(with) (treat,overproduce)
OBJ:V-N (with,antibody)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (with,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 526

                                                                                           +--------------------------------------------------COMP:V-N(with)--------------------------------------------------+                                
                                                                                           +--------------------------------------------COMP:V-N(with)-------------------------------------------+            |                                
                                         +-------------------COMP:V-N(in)------------------+--------------------------------COMP:V-N(with)--------------------------------+                      |            |                                
                                         +-------------COMP:N-N(in)------------+           |      +----------------------OBJ:V-N----------------------+          +--------------------------------OBJ:V-N--------------------------------+     
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+         |           +--------COMP:V-N(with)--------+                           |          |        |             +---------------------OBJ:V-N--------------------+     
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+         |           |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+          |        |             |        |            |          +-MOD_ATT:N-ADJ-+     
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         |    +SUBJ:V+      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+          |        |             |    +MOD+            |          |       +MOD_ATT+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |          |        |             |    |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
COMP:N-N(in) (production,Hela)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:V-N(in) (treat,production)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,Apo)
COMP:V-N(with) (treat,cycloheximide)
COMP:V-N(with) (treat,FMK)
COMP:V-N(with) (treat,overproduce)
OBJ:V-N (with,antibody)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (with,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 527

                                                                                           +--------------------------------------------------COMP:V-N(with)--------------------------------------------------+                                
                                                                                           +--------------------------------------------COMP:V-N(with)-------------------------------------------+            |                                
                                         +-------------------COMP:V-N(in)------------------+--------------------------------COMP:V-N(with)--------------------------------+                      |            |                                
                                         |                   +---------COMP:V-N(of)--------+      +----------------------OBJ:V-N----------------------+                   |                      |            |                                
               +-------MOD_ATT:N-N-------+                   |       +-------SUBJ:V-N------+--------COMP:V-N(with)--------+                           |                   |             +---------------------OBJ:V-N--------------------+     
               |     +----MOD_ATT:N-N----+                   |       +-COMP:N-N(in)-+      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |             |    +--MOD_ATT:N-ADJ-+          +-MOD_ATT:N-ADJ-+     
               |     |        +MOD_ATT:N-+           +MOD_ATT+       |         +MOD_+      |      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |             |    +MOD+            |          |       +MOD_ATT+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |             |    |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
COMP:V-N(in) (treat,production)
COMP:V-N(of) (treat,__NODE__)
SUBJ:V-N (treat,protein)
COMP:V-N(with) (treat,Apo)
COMP:V-N(with) (treat,cycloheximide)
COMP:V-N(with) (treat,FMK)
COMP:V-N(with) (treat,overproduce)
OBJ:V-N (with,antibody)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 528

                                                                                           +------------------------------------------------------------COMP:V-N(with)-----------------------------------------------------------+             
                                                                                           +--------------------------------------------COMP:V-N(with)-------------------------------------------+                               |             
                                                                                           +--------------------------------COMP:V-N(with)--------------------------------+                      |                               |             
                                         +-------------------COMP:V-N(in)------------------+      +----------------------OBJ:V-N----------------------+                   |                      |                               |             
               +-------MOD_ATT:N-N-------+                           +-----COMP:V-N(of)----+--------COMP:V-N(with)--------+                           |                   |             +---------------------OBJ:V-N--------------------+     
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+         +COMP:V-N(in+      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |             |        |            +----MOD_ATT:N-N---+       |     
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         |    +SUBJ:V+      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |             |    +MOD+            |          +MOD_ATT+       |     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |             |    |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:V-N(in) (treat,production)
COMP:V-N(of) (treat,protein)
COMP:V-N(in) (treat,Hela)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,Apo)
COMP:V-N(with) (treat,cycloheximide)
COMP:V-N(with) (treat,FMK)
COMP:V-N(with) (treat,__NODE__)
OBJ:V-N (with,antibody)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (__NODE__,overproduce)
MOD_ATT:N-ADJ (__NODE__,__SP__)

Analyse 529

                                                                                           +--------------------------------------------------COMP:V-N(with)--------------------------------------------------+                                
                                                                                           +--------------------------------------------COMP:V-N(with)-------------------------------------------+            |                                
                                                                                           +--------------------------------COMP:V-N(with)--------------------------------+                      |            |                                
                                         +-------------------COMP:V-N(in)------------------+      +----------------------OBJ:V-N----------------------+                   |                      |            |                                
               +-------MOD_ATT:N-N-------+                           +-----COMP:V-N(of)----+--------COMP:V-N(with)--------+                           |                   |             +---------------------OBJ:V-N--------------------+     
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+         +COMP:V-N(in+      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |             |    +--MOD_ATT:N-ADJ-+          +-MOD_ATT:N-ADJ-+     
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         |    +SUBJ:V+      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |             |    +MOD+            |          |       +MOD_ATT+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |             |    |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:V-N(in) (treat,production)
COMP:V-N(of) (treat,protein)
COMP:V-N(in) (treat,Hela)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,Apo)
COMP:V-N(with) (treat,cycloheximide)
COMP:V-N(with) (treat,FMK)
COMP:V-N(with) (treat,overproduce)
OBJ:V-N (with,antibody)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 530

                                                                                           +--------------------------------------------------COMP:V-N(with)--------------------------------------------------+                                
                                                                                           +--------------------------------------------COMP:V-N(with)-------------------------------------------+            |                                
                                         +-------------------COMP:V-N(in)------------------+--------------------------------COMP:V-N(with)--------------------------------+                      |            |                                
                                         |                   +---------COMP:V-N(of)--------+      +----------------------OBJ:V-N----------------------+                   |                      |            |                                
               +-------MOD_ATT:N-N-------+                   |       +-------SUBJ:V-N------+--------COMP:V-N(with)--------+                           |                   |             +---------------------OBJ:V-N--------------------+     
               |     +----MOD_ATT:N-N----+                   |       +-COMP:N-N(in)-+      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |             |        |            |          +-MOD_ATT:N-ADJ-+     
               |     |        +MOD_ATT:N-+           +MOD_ATT+       |         +MOD_+      |      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |             |    +MOD+            |          |       +MOD_ATT+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |             |    |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
COMP:V-N(in) (treat,production)
COMP:V-N(of) (treat,__NODE__)
SUBJ:V-N (treat,protein)
COMP:V-N(with) (treat,Apo)
COMP:V-N(with) (treat,cycloheximide)
COMP:V-N(with) (treat,FMK)
COMP:V-N(with) (treat,overproduce)
OBJ:V-N (with,antibody)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 531

                                                                                           +--------------------------------------------------COMP:V-N(with)--------------------------------------------------+                                
                                                                                           +--------------------------------------------COMP:V-N(with)-------------------------------------------+            |                                
                                                                                           +--------------------------------COMP:V-N(with)--------------------------------+                      |            |                                
                                         +-------------------COMP:V-N(in)------------------+      +----------------------OBJ:V-N----------------------+                   |                      |            |                                
               +-------MOD_ATT:N-N-------+                           +-----COMP:V-N(of)----+--------COMP:V-N(with)--------+                           |                   |             +---------------------OBJ:V-N--------------------+     
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+         +COMP:V-N(in+      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |             |        |            |          +-MOD_ATT:N-ADJ-+     
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         |    +SUBJ:V+      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |             |    +MOD+            |          |       +MOD_ATT+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |             |    |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:V-N(in) (treat,production)
COMP:V-N(of) (treat,protein)
COMP:V-N(in) (treat,Hela)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,Apo)
COMP:V-N(with) (treat,cycloheximide)
COMP:V-N(with) (treat,FMK)
COMP:V-N(with) (treat,overproduce)
OBJ:V-N (with,antibody)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 532

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                              +-----------------------------------------------------COMP:V-N(with)-----------------------------------------------------+             
                                         |                                                              |                                             +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                                                              |                                             |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+                                  |                                             |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+-------OBJ:V-N-------+      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+COMP:N-N(+    +SUBJ:V+      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,Hela)
OBJ:V-N (treat,protein)
SUBJ:V-N (treat,cell)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(with) (__NODE__,agonist)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 533

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                   +-----------------------COMP:N-N(with)-----------------------+                           +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                   +-----------OBJ:V-N-----------+                              |                           |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+                   |       +-------SUBJ:V-N------+                              |                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+----COMP:N-N(of)---+       +-COMP:N-N(in)-+      |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           +MOD_ATT+       |         +MOD_+      |            |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |            |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(with) (__NODE__,Apo)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__NODE__)
SUBJ:V-N (treat,protein)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 534

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                              +-----------------------------------------------------COMP:V-N(with)-----------------------------------------------------+             
                                         |                                                              |                                             +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                                                              |                                             |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+                                  |                                             |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+-------OBJ:V-N-------+      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+COMP:N-N(+    +SUBJ:V+      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,Hela)
OBJ:V-N (treat,protein)
SUBJ:V-N (treat,cell)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(with) (__NODE__,agonist)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 535

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                              +-----------------------------------------------------COMP:V-N(with)-----------------------------------------------------+             
                                         |                                                              |                                             +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                                                              |                                             |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+                                  |                                             |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+-------OBJ:V-N-------+      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+COMP:N-N(+    +SUBJ:V+      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,Hela)
OBJ:V-N (treat,protein)
SUBJ:V-N (treat,cell)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(with) (__NODE__,agonist)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 536

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                                     +--------------------------------------------------COMP:V-N(with)-------------------------------------------------+             
                                         |                                                                     |                                      +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                                                                     |                                      |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+                                         |                                      |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+-------OBJ:V-N-------+      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+COMP:N-N(+    +SUBJ:V+      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,Hela)
OBJ:V-N (treat,protein)
SUBJ:V-N (treat,cell)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(with) (__NODE__,anti)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 537

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                                     +--------------------------------------------------COMP:V-N(with)-------------------------------------------------+             
                                         |                                                                     |                                      +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                                                                     |                                      |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+                                         |                                      |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+-------OBJ:V-N-------+      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+COMP:N-N(+    +SUBJ:V+      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,Hela)
OBJ:V-N (treat,protein)
SUBJ:V-N (treat,cell)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(with) (__NODE__,anti)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 538

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |           +---------------------------COMP:N-N(with)---------------------------+                           +---------------------------------SUBJ:V-N---------------------------------+             
                                         |           +---------------OBJ:V-N---------------+                              |                           |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+           |               +-------SUBJ:V-N------+                              |                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           |               +-COMP:N-N(in)-+      |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+COMP:N-N(of+       +MOD_ATT+         +MOD_+      |            |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |            |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,__SP__)
COMP:N-N(with) (__SP__,Apo)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__SP__)
SUBJ:V-N (treat,protein)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 539

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                              +-----------------------------------------------------COMP:V-N(with)-----------------------------------------------------+             
                                         |                                                              |                                             +---------------------------------SUBJ:V-N---------------------------------+             
                                         |           +---------------OBJ:V-N---------------+            |                                             |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+           |               +-------SUBJ:V-N------+            |                                             |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           |               +-COMP:N-N(in)-+      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+COMP:N-N(of+       +MOD_ATT+         +MOD_+      |      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__SP__)
SUBJ:V-N (treat,protein)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(with) (__NODE__,agonist)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 540

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                                     +--------------------------------------------------COMP:V-N(with)-------------------------------------------------+             
                                         |                                                                     |                                      +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                   +-----------OBJ:V-N-----------+                   |                                      |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+                   |       +-------SUBJ:V-N------+                   |                                      |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+----COMP:N-N(of)---+       +-COMP:N-N(in)-+      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           +MOD_ATT+       |         +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__NODE__)
SUBJ:V-N (treat,protein)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(with) (__NODE__,anti)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 541

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                                     +--------------------------------------------------COMP:V-N(with)-------------------------------------------------+             
                                         |                                                                     |                                      +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                   +-----------OBJ:V-N-----------+                   |                                      |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+                   |       +-------SUBJ:V-N------+                   |                                      |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+----COMP:N-N(of)---+       +-COMP:N-N(in)-+      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           +MOD_ATT+       |         +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__NODE__)
SUBJ:V-N (treat,protein)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(with) (__NODE__,anti)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 542

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                           +------------------------------------------------------------------------COMP:V-N(of)-----------------------------------------------------------------------+             
                                         |                           |                                                                                +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                           |                                                                                |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+                           |                                                                                |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+             +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+SUBJ:V+COMP:V_PASS-+      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,agonist)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(of) (__NODE__,protein)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 543

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                           +------------------------------------------------------------------------COMP:V-N(of)-----------------------------------------------------------------------+             
                                         |                           |                                                                                +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                           |                                                                                |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+                           |                                                                                |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+             +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+SUBJ:V+COMP:V_PASS-+      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,agonist)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(of) (__NODE__,protein)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 544

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                              +-----------------------------------------------------COMP:V-N(with)-----------------------------------------------------+             
                                         |                                                              |                                             +---------------------------------SUBJ:V-N---------------------------------+             
                                         +---------------------OBJ:V-N---------------------+            |                                             |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+                           +-------SUBJ:V-N------+            |                                             |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+                           +-COMP:N-N(in)-+      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+COMP:N-N(of+       +MOD_ATT+         +MOD_+      |      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,production)
SUBJ:V-N (treat,protein)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(with) (__NODE__,agonist)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 545

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                              +-----------------------------------------------------COMP:V-N(with)-----------------------------------------------------+             
                                         |                                                              |                                             +---------------------------------SUBJ:V-N---------------------------------+             
                                         +---------------------OBJ:V-N---------------------+            |                                             |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+                           +-------SUBJ:V-N------+            |                                             |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+----COMP:N-N(of)---+       +-COMP:N-N(in)-+      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           +MOD_ATT+       |         +MOD_+      |      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,production)
SUBJ:V-N (treat,protein)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(with) (__NODE__,agonist)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 546

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                              +-----------------------------------------------------COMP:V-N(with)-----------------------------------------------------+             
                                         |                                                              |                                             +---------------------------------SUBJ:V-N---------------------------------+             
                                         +---------------------OBJ:V-N---------------------+            |                                             |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+                           +-------SUBJ:V-N------+            |                                             |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+----COMP:N-N(of)---+       +-COMP:N-N(in)-+      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           +MOD_ATT+       |         +MOD_+      |      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,production)
SUBJ:V-N (treat,protein)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(with) (__NODE__,agonist)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 547

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                                     +--------------------------------------------------COMP:V-N(with)-------------------------------------------------+             
                                         |                                                                     |                                      +---------------------------------SUBJ:V-N---------------------------------+             
                                         +---------------------OBJ:V-N---------------------+                   |                                      |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+                           +-------SUBJ:V-N------+                   |                                      |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+----COMP:N-N(of)---+       +-COMP:N-N(in)-+      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           +MOD_ATT+       |         +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,production)
SUBJ:V-N (treat,protein)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(with) (__NODE__,anti)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 548

                     +------------------------------------------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------------------------------------------+             
                     |                                                                                  +-----------------------------------------------------COMP:V-N(with)-----------------------------------------------------+             
                     +-------------------------------OBJ:V-N-------------------------------+            |                                             +---------------------------------SUBJ:V-N---------------------------------+             
                     |                   +---------------------SUBJ:V-N--------------------+            |                                             |                   +--------------------COMP:V-N(with)--------------------+             
                     |                   +--------COMP:N-N(of)-------+                     |            |                                             |                   |                      +---------COMP:V-N(with)--------+             
                     |                   |           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               +MOD_A+        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+      |      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,culture)
SUBJ:V-N (treat,production)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(with) (__NODE__,agonist)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 549

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                           +------------------------------------------------------------------------COMP:V-N(of)-----------------------------------------------------------------------+             
                                         |                           |                                                                                +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                           |                                                                                |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+                           +----SUBJ:V_PASS-N----+      +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+      +COMP:V_PASS-N(with)+          |         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,protein)
COMP:V_PASS-N(with) (treat,anti)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(of) (__NODE__,protein)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 550

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         +---------------------------------COMP:N-N(with)---------------------------------+                           +---------------------------------SUBJ:V-N---------------------------------+             
                                         +---------------------OBJ:V-N---------------------+                              |                           |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+                           +-------SUBJ:V-N------+                              |                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+----COMP:N-N(of)---+       +-COMP:N-N(in)-+      |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           +MOD_ATT+       |         +MOD_+      |            |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |            |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,__NODE__)
COMP:N-N(with) (production,Apo)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,production)
SUBJ:V-N (treat,protein)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 551

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                   +----------------------------------------------------------------------------COMP:V-N(of)---------------------------------------------------------------------------+             
                                         |                   |                                                                                        +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                   +-----------OBJ:V-N-----------+                                                          |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+                   |       +-------SUBJ:V-N------+      +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+                   |       +-COMP:N-N(in)-+      +---COMP:V-N(with)--+          |         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           +MOD_ATT+       |         +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__NODE__)
SUBJ:V-N (treat,protein)
COMP:V-N(with) (treat,anti)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(of) (__NODE__,__NODE__)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 552

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |           +--------------------------------------------------------------------------------COMP:V-N(of)-------------------------------------------------------------------------------+             
                                         |           |                                                                                                +---------------------------------SUBJ:V-N---------------------------------+             
                                         |           +---------------OBJ:V-N---------------+                                                          |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+           |               +-------SUBJ:V-N------+      +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           |               +-COMP:N-N(in)-+      +---COMP:V-N(with)--+          |         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__SP__)
SUBJ:V-N (treat,protein)
COMP:V-N(with) (treat,anti)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(of) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 553

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |           +--------------------------------------------------------------------------------COMP:V-N(of)-------------------------------------------------------------------------------+             
                                         |           |                                                                                                +---------------------------------SUBJ:V-N---------------------------------+             
                                         |           +---------------OBJ:V-N---------------+                                                          |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+           |               +-------SUBJ:V-N------+      +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           |               +-COMP:N-N(in)-+      +---COMP:V-N(with)--+          |         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__SP__)
SUBJ:V-N (treat,protein)
COMP:V-N(with) (treat,anti)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(of) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 554

                     +------------------------------------------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------------------------------------------+             
                     +-------------------------------OBJ:V-N-------------------------------+            +-----------------------------------------------------COMP:V-N(with)-----------------------------------------------------+             
                     |                   +---------------------SUBJ:V-N--------------------+            |                                             +---------------------------------SUBJ:V-N---------------------------------+             
                     |                   +---------------COMP:N-N(in)---------------+      |            |                                             |                   +--------------------COMP:V-N(with)--------------------+             
                     |                   +--------COMP:N-N(of)-------+              |      |            |                                             |                   |                      +---------COMP:V-N(with)--------+             
                     |                   |           +-MOD_ATT:N-ADJ-+              |      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               +MOD_A+        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+      |      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
COMP:N-N(in) (production,cell)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,culture)
SUBJ:V-N (treat,production)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(with) (__NODE__,agonist)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 555

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                              +-----------------------------------------------------COMP:V-N(with)-----------------------------------------------------+             
                                         +---------------------OBJ:V-N---------------------+            |                                             +---------------------------------SUBJ:V-N---------------------------------+             
                                         +-------------COMP:N-N(in)------------+           |            |                                             |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+         |           |            |                                             |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+         |           |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         |    +SUBJ:V+      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
COMP:N-N(in) (production,Hela)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (treat,production)
SUBJ:V-N (treat,cell)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(with) (__NODE__,agonist)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 556

                     +------------------------------------------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------------------------------------------+             
                     +-------------------------------OBJ:V-N-------------------------------+                   +--------------------------------------------------COMP:V-N(with)-------------------------------------------------+             
                     |                   +---------------------SUBJ:V-N--------------------+                   |                                      +---------------------------------SUBJ:V-N---------------------------------+             
                     |                   +---------------COMP:N-N(in)---------------+      |                   |                                      |                   +--------------------COMP:V-N(with)--------------------+             
                     |                   +--------COMP:N-N(of)-------+              |      |                   |                                      |                   |                      +---------COMP:V-N(with)--------+             
                     |                   |           +-MOD_ATT:N-ADJ-+              |      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               +MOD_A+        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
COMP:N-N(in) (production,cell)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,culture)
SUBJ:V-N (treat,production)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(with) (__NODE__,anti)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 557

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                                     +--------------------------------------------------COMP:V-N(with)-------------------------------------------------+             
                                         +---------------------OBJ:V-N---------------------+                   |                                      +---------------------------------SUBJ:V-N---------------------------------+             
                                         +-------------COMP:N-N(in)------------+           |                   |                                      |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+         |           |                   |                                      |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+         |           |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         |    +SUBJ:V+      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
COMP:N-N(in) (production,Hela)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (treat,production)
SUBJ:V-N (treat,cell)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(with) (__NODE__,anti)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 558

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                                     +--------------------------------------------------COMP:V-N(with)-------------------------------------------------+             
                                         +---------------------OBJ:V-N---------------------+                   |                                      +---------------------------------SUBJ:V-N---------------------------------+             
                                         +-------------COMP:N-N(in)------------+           |                   |                                      |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+         |           |                   |                                      |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+         |           |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         |    +SUBJ:V+      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
COMP:N-N(in) (production,Hela)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (treat,production)
SUBJ:V-N (treat,cell)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(with) (__NODE__,anti)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 559

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         +---------------------------------COMP:N-N(with)---------------------------------+                                                                                                      |             
                                         +---------------------OBJ:V-N---------------------+                              |                           +---------------------------------SUBJ:V-N---------------------------------+             
                                         +-------------COMP:N-N(in)------------+           |                              |                           |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+         |           |                              |                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+         |           |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         |    +SUBJ:V+            |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |            |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
COMP:N-N(in) (production,Hela)
COMP:N-N(with) (production,Apo)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (treat,production)
SUBJ:V-N (treat,cell)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 560

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                           +------------------------------------------------------------------------COMP:V-N(of)-----------------------------------------------------------------------+             
                                         |                           |              +----------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------+             
                                         |                           |              |                                                                 +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                           |              |                                                                 |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+                           |              |                                                                 |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+              |             +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+SUBJ:V+COMP:V_PASS-+      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,agonist)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(of) (__NODE__,protein)
COMP:V-N(in) (__NODE__,cell)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 561

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                           +------------------------------------------------------------------------COMP:V-N(of)-----------------------------------------------------------------------+             
                                         |                           |              +----------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------+             
                                         |                           |              |                                                                 +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                           |              |                                                                 |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+                           |              |             +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+              |      +COMP:V_PASS-N(with)+          |         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+SUBJ:V+      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,anti)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(of) (__NODE__,protein)
COMP:V-N(in) (__NODE__,cell)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 562

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                           +------------------------------------------------------------------------COMP:V-N(of)-----------------------------------------------------------------------+             
                                         |                           |                                                    +--------------------------------------------COMP:V-N(with)--------------------------------------------+             
                                         |                           |                                                    |                           +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                           |                                                    |                           |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+                           |                                                    |                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+-------OBJ:V-N-------+            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+COMP:N-N(+    +SUBJ:V+            |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |            |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,Hela)
OBJ:V-N (treat,protein)
SUBJ:V-N (treat,cell)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(of) (__NODE__,protein)
COMP:V-N(with) (__NODE__,Apo)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 563

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                   +----------------------------------------------------------------------------COMP:V-N(of)---------------------------------------------------------------------------+             
                                         |                   |                                          +-----------------------------------------------------COMP:V-N(with)-----------------------------------------------------+             
                                         |                   |                                          |                                             +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                   +-----------OBJ:V-N-----------+            |                                             |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+                   |       +-------SUBJ:V-N------+      +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+                   |       +-COMP:N-N(in)-+      |      |     +---OBJ:V-N--+    |         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           +MOD_ATT+       |         +MOD_+      |      |     |      +SUBJ:+    |         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__NODE__)
SUBJ:V-N (treat,protein)
OBJ:V-N (with,Apo)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(of) (__NODE__,__NODE__)
COMP:V-N(with) (__NODE__,agonist)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 564

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                   +----------------------------------------------------------------------------COMP:V-N(of)---------------------------------------------------------------------------+             
                                         |                   |                                                            +--------------------------------------------COMP:V-N(with)--------------------------------------------+             
                                         |                   |                                                            |                           +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                   +-----------OBJ:V-N-----------+                              |                           |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+                   |       +-------SUBJ:V-N------+                              |                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+                   |       +-COMP:N-N(in)-+      |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           +MOD_ATT+       |         +MOD_+      |            |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |            |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__NODE__)
SUBJ:V-N (treat,protein)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(of) (__NODE__,__NODE__)
COMP:V-N(with) (__NODE__,Apo)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 565

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |           +--------------------------------------------------------------------------------COMP:V-N(of)-------------------------------------------------------------------------------+             
                                         |           |                                                  +-----------------------------------------------------COMP:V-N(with)-----------------------------------------------------+             
                                         |           |                                                  |                                             +---------------------------------SUBJ:V-N---------------------------------+             
                                         |           +---------------OBJ:V-N---------------+            |                                             |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+           |               +-------SUBJ:V-N------+      +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           |               +-COMP:N-N(in)-+      |      |     +---OBJ:V-N--+    |         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+      |      |     |      +SUBJ:+    |         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__SP__)
SUBJ:V-N (treat,protein)
OBJ:V-N (with,Apo)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(of) (__NODE__,__SP__)
COMP:V-N(with) (__NODE__,agonist)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 566

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |           +--------------------------------------------------------------------------------COMP:V-N(of)-------------------------------------------------------------------------------+             
                                         |           |                                                  +-----------------------------------------------------COMP:V-N(with)-----------------------------------------------------+             
                                         |           |                                                  |                                             +---------------------------------SUBJ:V-N---------------------------------+             
                                         |           +---------------OBJ:V-N---------------+            |                                             |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+           |               +-------SUBJ:V-N------+      +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           |               +-COMP:N-N(in)-+      |      |     +---OBJ:V-N--+    |         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+      |      |     |      +SUBJ:+    |         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__SP__)
SUBJ:V-N (treat,protein)
OBJ:V-N (with,Apo)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(of) (__NODE__,__SP__)
COMP:V-N(with) (__NODE__,agonist)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 567

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |           +--------------------------------------------------------------------------------COMP:V-N(of)-------------------------------------------------------------------------------+             
                                         |           |                                                  +-----------------------------------------------------COMP:V-N(with)-----------------------------------------------------+             
                                         |           |                                                  |                                             +---------------------------------SUBJ:V-N---------------------------------+             
                                         |           +---------------OBJ:V-N---------------+            |                                             |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+           |               +-------SUBJ:V-N------+      +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           |               +-COMP:N-N(in)-+      |      |     +---OBJ:V-N--+    |         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+      |      |     |      +SUBJ:+    |         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__SP__)
SUBJ:V-N (treat,protein)
OBJ:V-N (with,Apo)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(of) (__NODE__,__SP__)
COMP:V-N(with) (__NODE__,agonist)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 568

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                           +------------------------------------------------------------------------COMP:V-N(of)-----------------------------------------------------------------------+             
                                         |                           |              +----------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------+             
                                         |                           |              |                          +--------------------------------------------------COMP:V-N(with)-------------------------------------------------+             
                                         |                           |              |                          |                                      +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                           |              |                          |                                      |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+                           |              |                          |                                      |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+              |             +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+SUBJ:V+      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(of) (__NODE__,protein)
COMP:V-N(in) (__NODE__,cell)
COMP:V-N(with) (__NODE__,anti)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 569

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                                                                            +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                                                                                                            |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+-------------------COMP:N-N(with)-------------------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+-------OBJ:V-N-------+            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+COMP:N-N(+    +SUBJ:V+            |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |            |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,Hela)
COMP:N-N(with) (protein,Apo)
OBJ:V-N (treat,protein)
SUBJ:V-N (treat,cell)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 570

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                              +-----------------------------------------------------COMP:V-N(with)-----------------------------------------------------+             
                                         |                                                              |                                             +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                                                              |                                             |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+                                  |                                             |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+-------OBJ:V-N-------+      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+COMP:N-N(+    +SUBJ:V+      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,Hela)
OBJ:V-N (treat,protein)
SUBJ:V-N (treat,cell)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(with) (__NODE__,agonist)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 571

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                              +-----------------------------------------------------COMP:V-N(with)-----------------------------------------------------+             
                                         |                                                              |                                             +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                                                              |                                             |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+                                  |                                             |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+-------OBJ:V-N-------+      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+COMP:N-N(+    +SUBJ:V+      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,Hela)
OBJ:V-N (treat,protein)
SUBJ:V-N (treat,cell)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(with) (__NODE__,agonist)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 572

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                                     +--------------------------------------------------COMP:V-N(with)-------------------------------------------------+             
                                         |                                                                     |                                      +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                   +-----------OBJ:V-N-----------+                   |                                      |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+                   |       +-------SUBJ:V-N------+                   |                                      |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+----COMP:N-N(of)---+       +-COMP:N-N(in)-+      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           +MOD_ATT+       |         +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__NODE__)
SUBJ:V-N (treat,protein)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(with) (__NODE__,anti)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 573

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                                     +--------------------------------------------------COMP:V-N(with)-------------------------------------------------+             
                                         |                                                                     |                                      +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                   +-----------OBJ:V-N-----------+                   |                                      |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+                   |       +-------SUBJ:V-N------+                   |                                      |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+----COMP:N-N(of)---+       +-COMP:N-N(in)-+      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           +MOD_ATT+       |         +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__NODE__)
SUBJ:V-N (treat,protein)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(with) (__NODE__,anti)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 574

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                              +-----------------------------------------------------COMP:V-N(with)-----------------------------------------------------+             
                                         |                                                              |                                             +---------------------------------SUBJ:V-N---------------------------------+             
                                         |           +---------------OBJ:V-N---------------+            |                                             |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+           |               +-------SUBJ:V-N------+            |                                             |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           |               +-COMP:N-N(in)-+      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+COMP:N-N(of+       +MOD_ATT+         +MOD_+      |      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__SP__)
SUBJ:V-N (treat,protein)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(with) (__NODE__,agonist)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 575

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |           +---------------------------COMP:N-N(with)---------------------------+                           +---------------------------------SUBJ:V-N---------------------------------+             
                                         |           +---------------OBJ:V-N---------------+                              |                           |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+           |               +-------SUBJ:V-N------+                              |                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           |               +-COMP:N-N(in)-+      |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+COMP:N-N(of+       +MOD_ATT+         +MOD_+      |            |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |            |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,__SP__)
COMP:N-N(with) (__SP__,Apo)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__SP__)
SUBJ:V-N (treat,protein)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 576

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                           +------------------------------------------------------------------------COMP:V-N(of)-----------------------------------------------------------------------+             
                                         |                           |                                                                                +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                           |                                                                                |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+                           |                            +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+      +COMP:V_PASS-N(with)+          |         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+SUBJ:V+      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,anti)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(of) (__NODE__,protein)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 577

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                           +------------------------------------------------------------------------COMP:V-N(of)-----------------------------------------------------------------------+             
                                         |                           |                                                                                +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                           |                                                                                |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+                           |                            +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+      +COMP:V_PASS-N(with)+          |         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+SUBJ:V+      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,anti)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(of) (__NODE__,protein)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 578

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                              +-----------------------------------------------------COMP:V-N(with)-----------------------------------------------------+             
                                         |                                                              |                                             +---------------------------------SUBJ:V-N---------------------------------+             
                                         +---------------------OBJ:V-N---------------------+            |                                             |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+                           +-------SUBJ:V-N------+            |                                             |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+                           +-COMP:N-N(in)-+      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+COMP:N-N(of+       +MOD_ATT+         +MOD_+      |      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,production)
SUBJ:V-N (treat,protein)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(with) (__NODE__,agonist)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 579

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                              +-----------------------------------------------------COMP:V-N(with)-----------------------------------------------------+             
                                         |                                                              |                                             +---------------------------------SUBJ:V-N---------------------------------+             
                                         +---------------------OBJ:V-N---------------------+            |                                             |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+                           +-------SUBJ:V-N------+            |                                             |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+                           +-COMP:N-N(in)-+      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+COMP:N-N(of+       +MOD_ATT+         +MOD_+      |      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,production)
SUBJ:V-N (treat,protein)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(with) (__NODE__,agonist)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 580

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                              +-----------------------------------------------------COMP:V-N(with)-----------------------------------------------------+             
                                         |                                                              |                                             +---------------------------------SUBJ:V-N---------------------------------+             
                                         +---------------------OBJ:V-N---------------------+            |                                             |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+                           +-------SUBJ:V-N------+            |                                             |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+                           +-COMP:N-N(in)-+      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+COMP:N-N(of+       +MOD_ATT+         +MOD_+      |      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,production)
SUBJ:V-N (treat,protein)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(with) (__NODE__,agonist)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 581

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                                     +--------------------------------------------------COMP:V-N(with)-------------------------------------------------+             
                                         |                                                                     |                                      +---------------------------------SUBJ:V-N---------------------------------+             
                                         +---------------------OBJ:V-N---------------------+                   |                                      |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+                           +-------SUBJ:V-N------+                   |                                      |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+                           +-COMP:N-N(in)-+      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+COMP:N-N(of+       +MOD_ATT+         +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,production)
SUBJ:V-N (treat,protein)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(with) (__NODE__,anti)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 582

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                                     +--------------------------------------------------COMP:V-N(with)-------------------------------------------------+             
                                         |                                                                     |                                      +---------------------------------SUBJ:V-N---------------------------------+             
                                         +---------------------OBJ:V-N---------------------+                   |                                      |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+                           +-------SUBJ:V-N------+                   |                                      |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+                           +-COMP:N-N(in)-+      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+COMP:N-N(of+       +MOD_ATT+         +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,production)
SUBJ:V-N (treat,protein)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(with) (__NODE__,anti)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 583

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                                     +--------------------------------------------------COMP:V-N(with)-------------------------------------------------+             
                                         |                                                                     |                                      +---------------------------------SUBJ:V-N---------------------------------+             
                                         +---------------------OBJ:V-N---------------------+                   |                                      |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+                           +-------SUBJ:V-N------+                   |                                      |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+----COMP:N-N(of)---+       +-COMP:N-N(in)-+      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           +MOD_ATT+       |         +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,production)
SUBJ:V-N (treat,protein)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(with) (__NODE__,anti)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 584

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                              +-----------------------------------------------------COMP:V-N(with)-----------------------------------------------------+             
                                         |                                                              |                                             +---------------------------------SUBJ:V-N---------------------------------+             
                                         +---------------------OBJ:V-N---------------------+            |                                             |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+                     |            |                                             |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+                     |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+COMP:N-N(+    +SUBJ:V+      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,Hela)
OBJ:V-N (treat,production)
SUBJ:V-N (treat,cell)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(with) (__NODE__,agonist)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 585

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                           +------------------------------------------------------------------------COMP:V-N(of)-----------------------------------------------------------------------+             
                                         |                           |                                                                                +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                           |                                                                                |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+                           +----SUBJ:V_PASS-N----+      +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+      +COMP:V_PASS-N(with)+          |         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,protein)
COMP:V_PASS-N(with) (treat,anti)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(of) (__NODE__,protein)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 586

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                           +------------------------------------------------------------------------COMP:V-N(of)-----------------------------------------------------------------------+             
                                         |                           |                                                                                +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                           |                                                                                |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+                           +----SUBJ:V_PASS-N----+      +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+      +COMP:V_PASS-N(with)+          |         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,protein)
COMP:V_PASS-N(with) (treat,anti)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(of) (__NODE__,protein)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 587

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                           +------------------------------------------------------------------------COMP:V-N(of)-----------------------------------------------------------------------+             
                                         |                           |                                                                                +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                           |                                                                                |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+                           +----SUBJ:V_PASS-N----+      +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+      +COMP:V_PASS-N(with)+          |         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,protein)
COMP:V_PASS-N(with) (treat,anti)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(of) (__NODE__,protein)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 588

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                           +------------------------------------------------------------------------COMP:V-N(of)-----------------------------------------------------------------------+             
                                         |                           |                                                                                +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                           |                                                                                |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+                           |                            +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+-------OBJ:V-N-------+---COMP:V-N(with)--+          |         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+COMP:N-N(+    +SUBJ:V+      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,Hela)
OBJ:V-N (treat,protein)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,anti)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(of) (__NODE__,protein)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 589

                     +------------------------------------------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------------------------------------------+             
                     |                                                                                         +--------------------------------------------------COMP:V-N(with)-------------------------------------------------+             
                     +-------------------------------OBJ:V-N-------------------------------+                   |                                      +---------------------------------SUBJ:V-N---------------------------------+             
                     |                   +---------------------SUBJ:V-N--------------------+                   |                                      |                   +--------------------COMP:V-N(with)--------------------+             
                     |                   +--------COMP:N-N(of)-------+                     |                   |                                      |                   |                      +---------COMP:V-N(with)--------+             
                     |                   |           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               +MOD_A+        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,culture)
SUBJ:V-N (treat,production)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(with) (__NODE__,anti)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 590

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                                     +--------------------------------------------------COMP:V-N(with)-------------------------------------------------+             
                                         |                                                                     |                                      +---------------------------------SUBJ:V-N---------------------------------+             
                                         +---------------------OBJ:V-N---------------------+                   |                                      |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+                     |                   |                                      |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+                     |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+COMP:N-N(+    +SUBJ:V+      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,Hela)
OBJ:V-N (treat,production)
SUBJ:V-N (treat,cell)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(with) (__NODE__,anti)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 591

                     +------------------------------------------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------------------------------------------+             
                     |                                                                                         +--------------------------------------------------COMP:V-N(with)-------------------------------------------------+             
                     +-------------------------------OBJ:V-N-------------------------------+                   |                                      +---------------------------------SUBJ:V-N---------------------------------+             
                     |                   +---------------------SUBJ:V-N--------------------+                   |                                      |                   +--------------------COMP:V-N(with)--------------------+             
                     |                   +--------COMP:N-N(of)-------+                     |                   |                                      |                   |                      +---------COMP:V-N(with)--------+             
                     |                   |           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               +MOD_A+        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,culture)
SUBJ:V-N (treat,production)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(with) (__NODE__,anti)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 592

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                                     +--------------------------------------------------COMP:V-N(with)-------------------------------------------------+             
                                         |                                                                     |                                      +---------------------------------SUBJ:V-N---------------------------------+             
                                         +---------------------OBJ:V-N---------------------+                   |                                      |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+                     |                   |                                      |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+                     |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+COMP:N-N(+    +SUBJ:V+      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,Hela)
OBJ:V-N (treat,production)
SUBJ:V-N (treat,cell)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(with) (__NODE__,anti)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 593

                     +------------------------------------------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------------------------------------------+             
                     |                                                                                         +--------------------------------------------------COMP:V-N(with)-------------------------------------------------+             
                     +-------------------------------OBJ:V-N-------------------------------+                   |                                      +---------------------------------SUBJ:V-N---------------------------------+             
                     |                   +---------------------SUBJ:V-N--------------------+                   |                                      |                   +--------------------COMP:V-N(with)--------------------+             
                     |                   +--------COMP:N-N(of)-------+                     |                   |                                      |                   |                      +---------COMP:V-N(with)--------+             
                     |                   |           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               +MOD_A+        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,culture)
SUBJ:V-N (treat,production)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(with) (__NODE__,anti)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 594

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                                     +--------------------------------------------------COMP:V-N(with)-------------------------------------------------+             
                                         |                                                                     |                                      +---------------------------------SUBJ:V-N---------------------------------+             
                                         +---------------------OBJ:V-N---------------------+                   |                                      |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+                     |                   |                                      |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+                     |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+COMP:N-N(+    +SUBJ:V+      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,Hela)
OBJ:V-N (treat,production)
SUBJ:V-N (treat,cell)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(with) (__NODE__,anti)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 595

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         +---------------------------------COMP:N-N(with)---------------------------------+                           +---------------------------------SUBJ:V-N---------------------------------+             
                                         +---------------------OBJ:V-N---------------------+                              |                           |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+                     |                              |                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+                     |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+COMP:N-N(+    +SUBJ:V+            |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |            |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
COMP:N-N(with) (production,Apo)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,Hela)
OBJ:V-N (treat,production)
SUBJ:V-N (treat,cell)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 596

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         +---------------------------------COMP:N-N(with)---------------------------------+                           +---------------------------------SUBJ:V-N---------------------------------+             
                                         +---------------------OBJ:V-N---------------------+                              |                           |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+                     |                              |                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+                     |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+COMP:N-N(+    +SUBJ:V+            |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |            |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
COMP:N-N(with) (production,Apo)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,Hela)
OBJ:V-N (treat,production)
SUBJ:V-N (treat,cell)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 597

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |           +--------------------------------------------------------------------------------COMP:V-N(of)-------------------------------------------------------------------------------+             
                                         |           |                                                                                                +---------------------------------SUBJ:V-N---------------------------------+             
                                         |           +---------------OBJ:V-N---------------+                                                          |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+           |               +-------SUBJ:V-N------+      +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           |               +-COMP:N-N(in)-+      +---COMP:V-N(with)--+          |         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__SP__)
SUBJ:V-N (treat,protein)
COMP:V-N(with) (treat,anti)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(of) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 598

                     +------------------------------------------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------------------------------------------+             
                     +-------------------------------OBJ:V-N-------------------------------+            +-----------------------------------------------------COMP:V-N(with)-----------------------------------------------------+             
                     |                   +---------------------SUBJ:V-N--------------------+            |                                             +---------------------------------SUBJ:V-N---------------------------------+             
                     |                   +---------------COMP:N-N(in)---------------+      |            |                                             |                   +--------------------COMP:V-N(with)--------------------+             
                     |                   +--------COMP:N-N(of)-------+              |      |            |                                             |                   |                      +---------COMP:V-N(with)--------+             
                     |                   |           +-MOD_ATT:N-ADJ-+              |      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               +MOD_A+        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+      |      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
COMP:N-N(in) (production,cell)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,culture)
SUBJ:V-N (treat,production)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(with) (__NODE__,agonist)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 599

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                           +------------------------------------------------------------------------COMP:V-N(of)-----------------------------------------------------------------------+             
                                         |                           |                                         +--------------------------------------------------COMP:V-N(with)-------------------------------------------------+             
                                         |                           |                                         |                                      +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                           |                                         |                                      |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+                           |                                         |                                      |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+             +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+SUBJ:V+      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(of) (__NODE__,protein)
COMP:V-N(with) (__NODE__,anti)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 600

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                           +------------------------------------------------------------------------COMP:V-N(of)-----------------------------------------------------------------------+             
                                         |                           |                                         +--------------------------------------------------COMP:V-N(with)-------------------------------------------------+             
                                         |                           |                                         |                                      +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                           |                                         |                                      |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+                           |                                         |                                      |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+             +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+SUBJ:V+      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(of) (__NODE__,protein)
COMP:V-N(with) (__NODE__,anti)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 601

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                                                                     +--------------------------------------------------COMP:V-N(with)-------------------------------------------------+             
                                         +---------------------OBJ:V-N---------------------+                   |                                      +---------------------------------SUBJ:V-N---------------------------------+             
                                         +-------------COMP:N-N(in)------------+           |                   |                                      |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+         |           |                   |                                      |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+         |           |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         |    +SUBJ:V+      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
COMP:N-N(in) (production,Hela)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (treat,production)
SUBJ:V-N (treat,cell)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(with) (__NODE__,anti)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 602

                     +------------------------------------------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------------------------------------------+             
                     +-------------------------------OBJ:V-N-------------------------------+                   +--------------------------------------------------COMP:V-N(with)-------------------------------------------------+             
                     |                   +---------------------SUBJ:V-N--------------------+                   |                                      +---------------------------------SUBJ:V-N---------------------------------+             
                     |                   +---------------COMP:N-N(in)---------------+      |                   |                                      |                   +--------------------COMP:V-N(with)--------------------+             
                     |                   +--------COMP:N-N(of)-------+              |      |                   |                                      |                   |                      +---------COMP:V-N(with)--------+             
                     |                   |           +-MOD_ATT:N-ADJ-+              |      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               +MOD_A+        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (production,decrease)
COMP:N-N(of) (production,protein)
COMP:N-N(in) (production,cell)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,culture)
SUBJ:V-N (treat,production)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(with) (__NODE__,anti)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 603

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                           +------------------------------------------------------------------------COMP:V-N(of)-----------------------------------------------------------------------+             
                                         |                           |              +----------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------+             
                                         |                           |              |                                                                 +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                           |              |                                                                 |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+                           |              |                                                                 |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+              |             +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+SUBJ:V+COMP:V_PASS-+      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,agonist)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(of) (__NODE__,protein)
COMP:V-N(in) (__NODE__,cell)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 604

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                           +------------------------------------------------------------------------COMP:V-N(of)-----------------------------------------------------------------------+             
                                         |                           |                                         +--------------------------------------------------COMP:V-N(with)-------------------------------------------------+             
                                         |                           |                                         |                                      +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                           |                                         |                                      |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+                           +----SUBJ:V_PASS-N----+                   |                                      |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,protein)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(of) (__NODE__,protein)
COMP:V-N(with) (__NODE__,anti)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 605

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                           +------------------------------------------------------------------------COMP:V-N(of)-----------------------------------------------------------------------+             
                                         |                           |                                                    +--------------------------------------------COMP:V-N(with)--------------------------------------------+             
                                         |                           |                                                    |                           +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                           |                                                    |                           |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+                           |                                                    |                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+-------OBJ:V-N-------+            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+COMP:N-N(+    +SUBJ:V+            |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |            |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,Hela)
OBJ:V-N (treat,protein)
SUBJ:V-N (treat,cell)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(of) (__NODE__,protein)
COMP:V-N(with) (__NODE__,Apo)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 606

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                           +------------------------------------------------------------------------COMP:V-N(of)-----------------------------------------------------------------------+             
                                         |                           |                                                    +--------------------------------------------COMP:V-N(with)--------------------------------------------+             
                                         |                           |                                                    |                           +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                           |                                                    |                           |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+                           |                                                    |                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+-------OBJ:V-N-------+            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+COMP:N-N(+    +SUBJ:V+            |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |            |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,Hela)
OBJ:V-N (treat,protein)
SUBJ:V-N (treat,cell)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(of) (__NODE__,protein)
COMP:V-N(with) (__NODE__,Apo)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 607

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                           +------------------------------------------------------------------------COMP:V-N(of)-----------------------------------------------------------------------+             
                                         |                           |                                                    +--------------------------------------------COMP:V-N(with)--------------------------------------------+             
                                         |                           |                                                    |                           +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                           |                                                    |                           |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+                           |                                                    |                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+-------OBJ:V-N-------+            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+COMP:N-N(+    +SUBJ:V+            |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |            |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,Hela)
OBJ:V-N (treat,protein)
SUBJ:V-N (treat,cell)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(of) (__NODE__,protein)
COMP:V-N(with) (__NODE__,Apo)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 608

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                   +----------------------------------------------------------------------------COMP:V-N(of)---------------------------------------------------------------------------+             
                                         |                   |                                                            +--------------------------------------------COMP:V-N(with)--------------------------------------------+             
                                         |                   |                                                            |                           +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                   +-----------OBJ:V-N-----------+                              |                           |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+                   |       +-------SUBJ:V-N------+                              |                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+                   |       +-COMP:N-N(in)-+      |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           +MOD_ATT+       |         +MOD_+      |            |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |            |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__NODE__)
SUBJ:V-N (treat,protein)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(of) (__NODE__,__NODE__)
COMP:V-N(with) (__NODE__,Apo)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 609

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                   +----------------------------------------------------------------------------COMP:V-N(of)---------------------------------------------------------------------------+             
                                         |                   |                                                            +--------------------------------------------COMP:V-N(with)--------------------------------------------+             
                                         |                   |                                                            |                           +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                   +-----------OBJ:V-N-----------+                              |                           |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+                   |       +-------SUBJ:V-N------+                              |                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+                   |       +-COMP:N-N(in)-+      |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           +MOD_ATT+       |         +MOD_+      |            |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |            |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__NODE__)
SUBJ:V-N (treat,protein)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(of) (__NODE__,__NODE__)
COMP:V-N(with) (__NODE__,Apo)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 610

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                   +----------------------------------------------------------------------------COMP:V-N(of)---------------------------------------------------------------------------+             
                                         |                   |                                          +-----------------------------------------------------COMP:V-N(with)-----------------------------------------------------+             
                                         |                   |                                          |                                             +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                   +-----------OBJ:V-N-----------+            |                                             |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+                   |       +-------SUBJ:V-N------+      +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+                   |       +-COMP:N-N(in)-+      |      |     +---OBJ:V-N--+    |         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           +MOD_ATT+       |         +MOD_+      |      |     |      +SUBJ:+    |         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__NODE__)
SUBJ:V-N (treat,protein)
OBJ:V-N (with,Apo)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(of) (__NODE__,__NODE__)
COMP:V-N(with) (__NODE__,agonist)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 611

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |           +--------------------------------------------------------------------------------COMP:V-N(of)-------------------------------------------------------------------------------+             
                                         |           |                                                                    +--------------------------------------------COMP:V-N(with)--------------------------------------------+             
                                         |           |                                                                    |                           +---------------------------------SUBJ:V-N---------------------------------+             
                                         |           +---------------OBJ:V-N---------------+                              |                           |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+           |               +-------SUBJ:V-N------+                              |                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           |               +-COMP:N-N(in)-+      |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+      |            |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |            |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__SP__)
SUBJ:V-N (treat,protein)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(of) (__NODE__,__SP__)
COMP:V-N(with) (__NODE__,Apo)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 612

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |           +--------------------------------------------------------------------------------COMP:V-N(of)-------------------------------------------------------------------------------+             
                                         |           |                                                  +-----------------------------------------------------COMP:V-N(with)-----------------------------------------------------+             
                                         |           |                                                  |                                             +---------------------------------SUBJ:V-N---------------------------------+             
                                         |           +---------------OBJ:V-N---------------+            |                                             |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+           |               +-------SUBJ:V-N------+      +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           |               +-COMP:N-N(in)-+      |      |     +---OBJ:V-N--+    |         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+      |      |     |      +SUBJ:+    |         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__SP__)
SUBJ:V-N (treat,protein)
OBJ:V-N (with,Apo)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(of) (__NODE__,__SP__)
COMP:V-N(with) (__NODE__,agonist)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 613

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |           +--------------------------------------------------------------------------------COMP:V-N(of)-------------------------------------------------------------------------------+             
                                         |           |                                                  +-----------------------------------------------------COMP:V-N(with)-----------------------------------------------------+             
                                         |           |                                                  |                                             +---------------------------------SUBJ:V-N---------------------------------+             
                                         |           +---------------OBJ:V-N---------------+            |                                             |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+           |               +-------SUBJ:V-N------+      +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           |               +-COMP:N-N(in)-+      |      |     +---OBJ:V-N--+    |         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+      |      |     |      +SUBJ:+    |         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__SP__)
SUBJ:V-N (treat,protein)
OBJ:V-N (with,Apo)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(of) (__NODE__,__SP__)
COMP:V-N(with) (__NODE__,agonist)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 614

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |           +--------------------------------------------------------------------------------COMP:V-N(of)-------------------------------------------------------------------------------+             
                                         |           |                                                                    +--------------------------------------------COMP:V-N(with)--------------------------------------------+             
                                         |           |                                                                    |                           +---------------------------------SUBJ:V-N---------------------------------+             
                                         |           +---------------OBJ:V-N---------------+                              |                           |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+           |               +-------SUBJ:V-N------+                              |                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           |               +-COMP:N-N(in)-+      |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+      |            |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |            |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__SP__)
SUBJ:V-N (treat,protein)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(of) (__NODE__,__SP__)
COMP:V-N(with) (__NODE__,Apo)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 615

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |           +--------------------------------------------------------------------------------COMP:V-N(of)-------------------------------------------------------------------------------+             
                                         |           |                                                  +-----------------------------------------------------COMP:V-N(with)-----------------------------------------------------+             
                                         |           |                                                  |                                             +---------------------------------SUBJ:V-N---------------------------------+             
                                         |           +---------------OBJ:V-N---------------+            |                                             |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+           |               +-------SUBJ:V-N------+      +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           |               +-COMP:N-N(in)-+      |      |     +---OBJ:V-N--+    |         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+      |      |     |      +SUBJ:+    |         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__SP__)
SUBJ:V-N (treat,protein)
OBJ:V-N (with,Apo)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(of) (__NODE__,__SP__)
COMP:V-N(with) (__NODE__,agonist)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 616

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                           +------------------------------------------------------------------------COMP:V-N(of)-----------------------------------------------------------------------+             
                                         |                           |                                                                                +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                           |                                                                                |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+                           |                                                                                |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+-------OBJ:V-N-------+      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+COMP:N-N(+    +SUBJ:V+COMP:V-N(wit+      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,Hela)
OBJ:V-N (treat,protein)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,agonist)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(of) (__NODE__,protein)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 617

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |           +--------------------------------------------------------------------------------COMP:V-N(of)-------------------------------------------------------------------------------+             
                                         |           |                                                                                                +---------------------------------SUBJ:V-N---------------------------------+             
                                         |           +---------------OBJ:V-N---------------+                                                          |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+           |               +-------SUBJ:V-N------+                                                          |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           |               +-COMP:N-N(in)-+      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+      +COMP:V-N(wit+      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__SP__)
SUBJ:V-N (treat,protein)
COMP:V-N(with) (treat,agonist)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(of) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 618

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                           +------------------------------------------------------------------------COMP:V-N(of)-----------------------------------------------------------------------+             
                                         |                           |                                         +--------------------------------------------------COMP:V-N(with)-------------------------------------------------+             
                                         |                           |                                         |                                      +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                           |                                         |                                      |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+                           |                                         |                                      |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+             +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+SUBJ:V+      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(of) (__NODE__,protein)
COMP:V-N(with) (__NODE__,anti)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 619

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                           +------------------------------------------------------------------------COMP:V-N(of)-----------------------------------------------------------------------+             
                                         |                           |                                         +--------------------------------------------------COMP:V-N(with)-------------------------------------------------+             
                                         |                           |                                         |                                      +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                           |                                         |                                      |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+                           |                                         |                                      |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+             +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+SUBJ:V+      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(of) (__NODE__,protein)
COMP:V-N(with) (__NODE__,anti)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 620

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                           +------------------------------------------------------------------------COMP:V-N(of)-----------------------------------------------------------------------+             
                                         |                           |                                         +--------------------------------------------------COMP:V-N(with)-------------------------------------------------+             
                                         |                           |                                         |                                      +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                           |                                         |                                      |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+                           |                                         |                                      |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+             +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+SUBJ:V+      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(of) (__NODE__,protein)
COMP:V-N(with) (__NODE__,anti)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 621

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                           +------------------------------------------------------------------------COMP:V-N(of)-----------------------------------------------------------------------+             
                                         |                           |                                         +--------------------------------------------------COMP:V-N(with)-------------------------------------------------+             
                                         |                           |                                         |                                      +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                           |                                         |                                      |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+                           +----SUBJ:V_PASS-N----+                   |                                      |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,protein)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(of) (__NODE__,protein)
COMP:V-N(with) (__NODE__,anti)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 622

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                           +------------------------------------------------------------------------COMP:V-N(of)-----------------------------------------------------------------------+             
                                         |                           |                                         +--------------------------------------------------COMP:V-N(with)-------------------------------------------------+             
                                         |                           |                                         |                                      +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                           |                                         |                                      |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+                           +----SUBJ:V_PASS-N----+                   |                                      |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,protein)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(of) (__NODE__,protein)
COMP:V-N(with) (__NODE__,anti)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 623

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                   +----------------------------------------------------------------------------COMP:V-N(of)---------------------------------------------------------------------------+             
                                         |                   |                                                 +--------------------------------------------------COMP:V-N(with)-------------------------------------------------+             
                                         |                   |                                                 |                                      +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                   +-----------OBJ:V-N-----------+                   |                                      |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+                   |       +-------SUBJ:V-N------+                   |                                      |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+                   |       +-COMP:N-N(in)-+      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           +MOD_ATT+       |         +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__NODE__)
SUBJ:V-N (treat,protein)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(of) (__NODE__,__NODE__)
COMP:V-N(with) (__NODE__,anti)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 624

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                           +------------------------------------------------------------------------COMP:V-N(of)-----------------------------------------------------------------------+             
                                         |                           |                                                                                +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                           |                                                                                |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+                           |                            +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+-------OBJ:V-N-------+---COMP:V-N(with)--+          |         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+COMP:N-N(+    +SUBJ:V+      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,Hela)
OBJ:V-N (treat,protein)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,anti)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(of) (__NODE__,protein)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 625

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                           +------------------------------------------------------------------------COMP:V-N(of)-----------------------------------------------------------------------+             
                                         |                           |                                                                                +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                           |                                                                                |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+                           |                            +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+-------OBJ:V-N-------+---COMP:V-N(with)--+          |         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+COMP:N-N(+    +SUBJ:V+      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,Hela)
OBJ:V-N (treat,protein)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,anti)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(of) (__NODE__,protein)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 626

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                   +----------------------------------------------------------------------------COMP:V-N(of)---------------------------------------------------------------------------+             
                                         |                   |                                                                                        +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                   +-----------OBJ:V-N-----------+                                                          |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+                   |       +-------SUBJ:V-N------+                                                          |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+                   |       +-COMP:N-N(in)-+      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           +MOD_ATT+       |         +MOD_+      +COMP:V-N(wit+      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__NODE__)
SUBJ:V-N (treat,protein)
COMP:V-N(with) (treat,agonist)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(of) (__NODE__,__NODE__)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 627

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                   +----------------------------------------------------------------------------COMP:V-N(of)---------------------------------------------------------------------------+             
                                         |                   |                                                                                        +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                   +-----------OBJ:V-N-----------+                                                          |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+                   |       +-------SUBJ:V-N------+      +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+                   |       +-COMP:N-N(in)-+      +---COMP:V-N(with)--+          |         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           +MOD_ATT+       |         +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__NODE__)
SUBJ:V-N (treat,protein)
COMP:V-N(with) (treat,anti)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(of) (__NODE__,__NODE__)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 628

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                   +----------------------------------------------------------------------------COMP:V-N(of)---------------------------------------------------------------------------+             
                                         |                   |                                                                                        +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                   +-----------OBJ:V-N-----------+                                                          |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+                   |       +-------SUBJ:V-N------+      +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+                   |       +-COMP:N-N(in)-+      +---COMP:V-N(with)--+          |         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           +MOD_ATT+       |         +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__NODE__)
SUBJ:V-N (treat,protein)
COMP:V-N(with) (treat,anti)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(of) (__NODE__,__NODE__)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 629

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                   +----------------------------------------------------------------------------COMP:V-N(of)---------------------------------------------------------------------------+             
                                         |                   |                                                                                        +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                   +-----------OBJ:V-N-----------+                                                          |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+                   |       +-------SUBJ:V-N------+      +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+                   |       +-COMP:N-N(in)-+      +---COMP:V-N(with)--+          |         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           +MOD_ATT+       |         +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__NODE__)
SUBJ:V-N (treat,protein)
COMP:V-N(with) (treat,anti)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(of) (__NODE__,__NODE__)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 630

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |           +--------------------------------------------------------------------------------COMP:V-N(of)-------------------------------------------------------------------------------+             
                                         |           |                                                                                                +---------------------------------SUBJ:V-N---------------------------------+             
                                         |           +---------------OBJ:V-N---------------+                                                          |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+           |               +-------SUBJ:V-N------+      +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           |               +-COMP:N-N(in)-+      +---COMP:V-N(with)--+          |         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__SP__)
SUBJ:V-N (treat,protein)
COMP:V-N(with) (treat,anti)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(of) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 631

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |           +--------------------------------------------------------------------------------COMP:V-N(of)-------------------------------------------------------------------------------+             
                                         |           |                                                                                                +---------------------------------SUBJ:V-N---------------------------------+             
                                         |           +---------------OBJ:V-N---------------+                                                          |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+           |               +-------SUBJ:V-N------+      +--------OBJ:V-N--------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           |               +-COMP:N-N(in)-+      +---COMP:V-N(with)--+          |         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__SP__)
SUBJ:V-N (treat,protein)
COMP:V-N(with) (treat,anti)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(of) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 632

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                           +------------------------------------------------------------------------COMP:V-N(of)-----------------------------------------------------------------------+             
                                         |                           |                                         +--------------------------------------------------COMP:V-N(with)-------------------------------------------------+             
                                         |                           |                                         |                                      +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                           |                                         |                                      |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+                           +----SUBJ:V_PASS-N----+                   |                                      |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+-COMP:N-N(in)-+      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,protein)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(of) (__NODE__,protein)
COMP:V-N(with) (__NODE__,anti)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 633

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                   +----------------------------------------------------------------------------COMP:V-N(of)---------------------------------------------------------------------------+             
                                         |                   |                                                 +--------------------------------------------------COMP:V-N(with)-------------------------------------------------+             
                                         |                   |                                                 |                                      +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                   +-----------OBJ:V-N-----------+                   |                                      |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+                   |       +-------SUBJ:V-N------+                   |                                      |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+                   |       +-COMP:N-N(in)-+      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           +MOD_ATT+       |         +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__NODE__)
SUBJ:V-N (treat,protein)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(of) (__NODE__,__NODE__)
COMP:V-N(with) (__NODE__,anti)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 634

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                           +------------------------------------------------------------------------COMP:V-N(of)-----------------------------------------------------------------------+             
                                         |                           |              +----------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------+             
                                         |                           |              |                          +--------------------------------------------------COMP:V-N(with)-------------------------------------------------+             
                                         |                           |              |                          |                                      +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                           |              |                          |                                      |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+                           |              |                          |                                      |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+              |             +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+SUBJ:V+      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(of) (__NODE__,protein)
COMP:V-N(in) (__NODE__,cell)
COMP:V-N(with) (__NODE__,anti)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 635

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                           +------------------------------------------------------------------------COMP:V-N(of)-----------------------------------------------------------------------+             
                                         |                           |              +----------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------+             
                                         |                           |              |                          +--------------------------------------------------COMP:V-N(with)-------------------------------------------------+             
                                         |                           |              |                          |                                      +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                           |              |                          |                                      |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+                           |              |                          |                                      |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+              |             +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+SUBJ:V+      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(of) (__NODE__,protein)
COMP:V-N(in) (__NODE__,cell)
COMP:V-N(with) (__NODE__,anti)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 636

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                           +------------------------------------------------------------------------COMP:V-N(of)-----------------------------------------------------------------------+             
                                         |                           |              +------------------------------------------------------------------SUBJ:V-N------------------------------------------------------------------+             
                                         |                           |              |      +------------------------------------------------COMP:V_PASS-N(with)-----------------------------------------------+                  |             
                                         |                           |              |      +-----------------------------------------COMP:V_PASS-N(with)-----------------------------------------+            |                  |             
                                         |                           |              |      +------------------------------COMP:V_PASS-N(with)-----------------------------+                      |            |                  |             
                                         |                           |              |      |      +----------------------OBJ:V-N----------------------+          +------------------------OBJ:V-N------------------------+       |             
               +-------MOD_ATT:N-N-------+                           |              |      +------COMP:V_PASS-N(with)-----+                           |          |        |             +-------------OBJ:V-N------------+       |             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+              |      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+          |        |             |    +--MOD_ATT:N-ADJ-+          |       |             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+COMP:N-N(+    +SUBJ:V+      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+          |        |             |    +MOD+            |          |       +OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |          |        |             |    |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,Apo)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
COMP:V_PASS-N(with) (treat,overproduce)
OBJ:V-N (with,antibody)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (with,__SP__)
OBJ:V-N (with,__SP__)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(of) (__NODE__,protein)
SUBJ:V-N (__NODE__,cell)
OBJ:V-N (__NODE__,protein)

Analyse 637

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                           +------------------------------------------------------------------------COMP:V-N(of)-----------------------------------------------------------------------+             
                                         |                           |         +-------------------------------------------------------------------COMP:V-N(in)------------------------------------------------------------------+             
                                         |                           |         |    +------------------------------------------------------------------SUBJ:V-N------------------------------------------------------------------+             
                                         |                           |         |    |      +------------------------------------------------COMP:V_PASS-N(with)-----------------------------------------------+                  |             
                                         |                           |         |    |      +-----------------------------------------COMP:V_PASS-N(with)-----------------------------------------+            |                  |             
                                         |                           |         |    |      +------------------------------COMP:V_PASS-N(with)-----------------------------+                      |            |                  |             
                                         |                           |         |    |      |      +----------------------OBJ:V-N----------------------+                   |                      |            |                  |             
               +-------MOD_ATT:N-N-------+                           |         |    |      +------COMP:V_PASS-N(with)-----+                           |          +------------------------OBJ:V-N------------------------+       |             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+         |    |      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+          |        |             +-------------OBJ:V-N------------+       |             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         |    +SUBJ:V+      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+          |        |             |    +MOD+            |          |       +OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |          |        |             |    |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,Apo)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
COMP:V_PASS-N(with) (treat,overproduce)
OBJ:V-N (with,antibody)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (with,__SP__)
OBJ:V-N (with,__SP__)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(of) (__NODE__,protein)
COMP:V-N(in) (__NODE__,Hela)
SUBJ:V-N (__NODE__,cell)
OBJ:V-N (__NODE__,protein)

Analyse 638

                                                                                           +------------------------------------------------------------COMP:V-N(with)-----------------------------------------------------------+             
                                                                                           +--------------------------------------------COMP:V-N(with)-------------------------------------------+                               |             
                                                                                           +--------------------------------COMP:V-N(with)--------------------------------+                      |                               |             
                                                                                           |      +----------------------OBJ:V-N----------------------+          +--------------------------------OBJ:V-N--------------------------------+     
               +-------MOD_ATT:N-N-------+-------------------COMP:V-N(in)------------------+--------COMP:V-N(with)--------+                           |          |        |             +---------------------OBJ:V-N--------------------+     
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+-----COMP:V-N(of)----+      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+          |        |             |        |            +----MOD_ATT:N-N---+       |     
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+COMP:N-N(+    +SUBJ:V+      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+          |        |             |    +MOD+            |          +MOD_ATT+       |     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |          |        |             |    |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,Hela)
COMP:V-N(in) (treat,production)
COMP:V-N(of) (treat,protein)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,Apo)
COMP:V-N(with) (treat,cycloheximide)
COMP:V-N(with) (treat,FMK)
COMP:V-N(with) (treat,__NODE__)
OBJ:V-N (with,antibody)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (with,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (__NODE__,overproduce)
MOD_ATT:N-ADJ (__NODE__,__SP__)

Analyse 639

                                                                                           +------------------------------------------------------------COMP:V-N(with)-----------------------------------------------------------+             
                                                                                           +--------------------------------------------COMP:V-N(with)-------------------------------------------+                               |             
                                                                                           +--------------------------------COMP:V-N(with)--------------------------------+                      |                               |             
                                         +-------------------COMP:V-N(in)------------------+      +----------------------OBJ:V-N----------------------+          +--------------------------------OBJ:V-N--------------------------------+     
               +-------MOD_ATT:N-N-------+                           +-----COMP:V-N(of)----+--------COMP:V-N(with)--------+                           |          |        |             +---------------------OBJ:V-N--------------------+     
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+         +COMP:V-N(in+      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+          |        |             |        |            +----MOD_ATT:N-N---+       |     
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         |    +SUBJ:V+      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+          |        |             |    +MOD+            |          +MOD_ATT+       |     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |          |        |             |    |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:V-N(in) (treat,production)
COMP:V-N(of) (treat,protein)
COMP:V-N(in) (treat,Hela)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,Apo)
COMP:V-N(with) (treat,cycloheximide)
COMP:V-N(with) (treat,FMK)
COMP:V-N(with) (treat,__NODE__)
OBJ:V-N (with,antibody)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (with,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (__NODE__,overproduce)
MOD_ATT:N-ADJ (__NODE__,__SP__)

Analyse 640

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                   +----------------------------------------------------------------------------COMP:V-N(of)---------------------------------------------------------------------------+             
                                         |                   +-----------------------COMP:N-N(with)-----------------------+                           +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                   +-----------OBJ:V-N-----------+                              |                           |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+                   |       +-------SUBJ:V-N------+                              |                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+                   |       +-COMP:N-N(in)-+      |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           +MOD_ATT+       |         +MOD_+      |            |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |            |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(with) (__NODE__,Apo)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__NODE__)
SUBJ:V-N (treat,protein)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(of) (__NODE__,__NODE__)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 641

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                           +------------------------------------------------------------------------COMP:V-N(of)-----------------------------------------------------------------------+             
                                         |                           |                                  +-----------------------------------------------------COMP:V-N(with)-----------------------------------------------------+             
                                         |                           |                                  |                                             +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                           |                                  |                                             |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+                           |                                  |                                             |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+-------OBJ:V-N-------+      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+COMP:N-N(+    +SUBJ:V+      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,Hela)
OBJ:V-N (treat,protein)
SUBJ:V-N (treat,cell)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(of) (__NODE__,protein)
COMP:V-N(with) (__NODE__,agonist)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 642

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                   +----------------------------------------------------------------------------COMP:V-N(of)---------------------------------------------------------------------------+             
                                         |                   |                                                 +--------------------------------------------------COMP:V-N(with)-------------------------------------------------+             
                                         |                   |                                                 |                                      +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                   +-----------OBJ:V-N-----------+                   |                                      |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+                   |       +-------SUBJ:V-N------+                   |                                      |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+                   |       +-COMP:N-N(in)-+      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           +MOD_ATT+       |         +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__NODE__)
SUBJ:V-N (treat,protein)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(of) (__NODE__,__NODE__)
COMP:V-N(with) (__NODE__,anti)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 643

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |           +--------------------------------------------------------------------------------COMP:V-N(of)-------------------------------------------------------------------------------+             
                                         |           |                                                         +--------------------------------------------------COMP:V-N(with)-------------------------------------------------+             
                                         |           |                                                         |                                      +---------------------------------SUBJ:V-N---------------------------------+             
                                         |           +---------------OBJ:V-N---------------+                   |                                      |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+           |               +-------SUBJ:V-N------+                   |                                      |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           |               +-COMP:N-N(in)-+      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__SP__)
SUBJ:V-N (treat,protein)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(of) (__NODE__,__SP__)
COMP:V-N(with) (__NODE__,anti)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 644

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |           +--------------------------------------------------------------------------------COMP:V-N(of)-------------------------------------------------------------------------------+             
                                         |           |                                                         +--------------------------------------------------COMP:V-N(with)-------------------------------------------------+             
                                         |           |                                                         |                                      +---------------------------------SUBJ:V-N---------------------------------+             
                                         |           +---------------OBJ:V-N---------------+                   |                                      |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+           |               +-------SUBJ:V-N------+                   |                                      |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           |               +-COMP:N-N(in)-+      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+                   |                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__SP__)
SUBJ:V-N (treat,protein)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(of) (__NODE__,__SP__)
COMP:V-N(with) (__NODE__,anti)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 645

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                           +------------------------------------------------------------------------COMP:V-N(of)-----------------------------------------------------------------------+             
                                         |                           |                                                                                +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                           |                                                                                |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+                           +-------------------COMP:N-N(with)-------------------+                           |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+-------OBJ:V-N-------+            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+COMP:N-N(+    +SUBJ:V+            |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |            |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,Hela)
COMP:N-N(with) (protein,Apo)
OBJ:V-N (treat,protein)
SUBJ:V-N (treat,cell)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(of) (__NODE__,protein)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 646

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                           +------------------------------------------------------------------------COMP:V-N(of)-----------------------------------------------------------------------+             
                                         |                           |                                  +-----------------------------------------------------COMP:V-N(with)-----------------------------------------------------+             
                                         |                           |                                  |                                             +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                           |                                  |                                             |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+                           |                                  |                                             |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+-------OBJ:V-N-------+      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+COMP:N-N(+    +SUBJ:V+      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,Hela)
OBJ:V-N (treat,protein)
SUBJ:V-N (treat,cell)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(of) (__NODE__,protein)
COMP:V-N(with) (__NODE__,agonist)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 647

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                           +------------------------------------------------------------------------COMP:V-N(of)-----------------------------------------------------------------------+             
                                         |                           |                                         +--------------------------------------------------COMP:V-N(with)-------------------------------------------------+             
                                         |                           |                                         |                                      +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                           |                                         |                                      |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+                           |                                         |                                      |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+-------OBJ:V-N-------+      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+COMP:N-N(+    +SUBJ:V+      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,Hela)
OBJ:V-N (treat,protein)
SUBJ:V-N (treat,cell)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(of) (__NODE__,protein)
COMP:V-N(with) (__NODE__,anti)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 648

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |                           +------------------------------------------------------------------------COMP:V-N(of)-----------------------------------------------------------------------+             
                                         |                           |                                         +--------------------------------------------------COMP:V-N(with)-------------------------------------------------+             
                                         |                           |                                         |                                      +---------------------------------SUBJ:V-N---------------------------------+             
                                         |                           |                                         |                                      |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+                           |                                         |                                      |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+-------OBJ:V-N-------+      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+COMP:N-N(+    +SUBJ:V+      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,Hela)
OBJ:V-N (treat,protein)
SUBJ:V-N (treat,cell)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(of) (__NODE__,protein)
COMP:V-N(with) (__NODE__,anti)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 649

                                         +--------------------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------------------+             
                                         |           +--------------------------------------------------------------------------------COMP:V-N(of)-------------------------------------------------------------------------------+             
                                         |           |                                                  +-----------------------------------------------------COMP:V-N(with)-----------------------------------------------------+             
                                         |           |                                                  |                                             +---------------------------------SUBJ:V-N---------------------------------+             
                                         |           +---------------OBJ:V-N---------------+            |                                             |                   +--------------------COMP:V-N(with)--------------------+             
               +-------MOD_ATT:N-N-------+           |               +-------SUBJ:V-N------+            |                                             |                   |                      +---------COMP:V-N(with)--------+             
               |     +----MOD_ATT:N-N----+           |               +-COMP:N-N(in)-+      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+                   |                      |            +--COMP:V-N(with)--+             
               |     |        +MOD_ATT:N-+           |       +MOD_ATT+         +MOD_+      |      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+                   |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+     
               |     |        |          |           |       |       |         |    |      |      |     |      |     |    |         |        |        |                   |                  |   |            |          |       |       |     
 SB203580 in cell culture decreases production of __SP__ __NODE__ protein in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (production,cell)
MOD_ATT:N-N (production,culture)
MOD_ATT:N-N (production,decrease)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(in) (protein,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__SP__)
SUBJ:V-N (treat,protein)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(in) (__NODE__,production)
COMP:V-N(of) (__NODE__,__SP__)
COMP:V-N(with) (__NODE__,agonist)
SUBJ:V-N (__NODE__,antibody)
COMP:V-N(with) (__NODE__,cycloheximide)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)